|
Name |
Accession |
Description |
Interval |
E-value |
| LCL_NRPS-like |
cd19531 |
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar ... |
951-1363 |
1.00e-131 |
|
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar domains including the C-domain of SgcC5, a free-standing NRPS with both ester- and amide- bond forming activity; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. Streptomyces globisporus SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380454 [Multi-domain] Cd Length: 427 Bit Score: 412.90 E-value: 1.00e-131
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 951 YYPLTAAQMRV-FMDeQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDGDPVQRIHEHCDFHLE 1029
Cdd:cd19531 1 PLPLSFAQQRLwFLD-QLEPGSAAYNIPGALRLRGPLDVAALERALNELVARHEALRTTFVEVDGEPVQVILPPLPLPLP 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1030 IVHLQG-------QQLHTAVNG-CIRPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYEGR-- 1099
Cdd:cd19531 80 VVDLSGlpeaereAEAQRLAREeARRPFDLARGPLLRATLLRLGEDEHVLLLTMHHIVSDGWSMGVLLRELAALYAAFla 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1100 ----ELHDLPVQYVDFAQWQTSAPVVEDLRRQEQFWQSMFADYRPLPGIPTDHTPEAnERSFAGGHITWEPDPVLSRRLY 1175
Cdd:cd19531 160 grpsPLPPLPIQYADYAVWQREWLQGEVLERQLAYWREQLAGAPPVLELPTDRPRPA-VQSFRGARVRFTLPAELTAALR 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1176 AVAAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGRRRAEVRQVVGMFVNALAIRSYPEGDKPFSSFLQEIRGTML 1255
Cdd:cd19531 239 ALARREGATLFMTLLAAFQVLLHRYSGQDDIVVGTPVAGRNRAELEGLIGFFVNTLVLRTDLSGDPTFRELLARVRETAL 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1256 QAYEHQDYPLERLAKQLDLHHSRDH--LmFDTVFSMLNYEDFAVRSDDLQFEYAELPTLSEIYNLRVEIVESPERLRGTF 1333
Cdd:cd19531 319 EAYAHQDLPFEKLVEALQPERDLSRspL-FQVMFVLQNAPAAALELPGLTVEPLEVDSGTAKFDLTLSLTETDGGLRGSL 397
|
410 420 430
....*....|....*....|....*....|
gi 517718121 1334 KYGQELYEARTVSQLAQDYERILAAVAESP 1363
Cdd:cd19531 398 EYNTDLFDAATIERMAGHFQTLLEAIVADP 427
|
|
| A_NRPS |
cd05930 |
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain ... |
17-449 |
1.17e-129 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341253 [Multi-domain] Cd Length: 444 Bit Score: 408.07 E-value: 1.17e-129
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 17 PERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTML 96
Cdd:cd05930 1 PDAVAVVDGDQSLTYAELDARANRLARYLRERGVGPGDLVAVLLERSLEMVVAILAVLKAGAAYVPLDPSYPAERLAYIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 97 DTAEVSCLLCDdaqferaetlqghegkyfvlrarqamsvqagskeayshsanATDPIYIYFTSGSTGKPKAVVGKNESLL 176
Cdd:cd05930 81 EDSGAKLVLTD-----------------------------------------PDDLAYVIYTSGSTGKPKGVMVEHRGLV 119
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 177 HFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPEsREIILDPLRLVHWLEHSRVHVVHCTPSLFR-F 255
Cdd:cd05930 120 NLLLWMQEAYPLTPGDRVLQFTSFSFDVSVWEIFGALLAGATLVVLP-EEVRKDPEALADLLAEEGITVLHLTPSLLRlL 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 256 INHLSLTAdsYPDLRYVLLAGETIRPESLKNWYDnLGNRVRLVNLYGPTETTMIKLFYPIKPEDVHRESIPIGRPLPDTS 335
Cdd:cd05930 199 LQELELAA--LPSLRLVLVGGEALPPDLVRRWRE-LLPGARLVNLYGPTEATVDATYYRVPPDDEEDGRVPIGRPIPNTR 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 336 VYLLDEQQQPVSGSEAGEICIATRYMTHGYFPSshPDQTA--FIPDPCRdqsGEIMMYRTGDMGRWLPEGELALLGRKDN 413
Cdd:cd05930 276 VYVLDENLRPVPPGVPGELYIGGAGLARGYLNR--PELTAerFVPNPFG---PGERMYRTGDLVRWLPDGNLEFLGRIDD 350
|
410 420 430
....*....|....*....|....*....|....*.
gi 517718121 414 QVKIRGNRVELGDIEHRLTNMAGIREAVVRMRAKAD 449
Cdd:cd05930 351 QVKIRGYRIELGEIEAALLAHPGVREAAVVAREDGD 386
|
|
| EntF |
COG1020 |
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ... |
14-442 |
3.39e-120 |
|
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440643 [Multi-domain] Cd Length: 1329 Bit Score: 407.71 E-value: 3.39e-120
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 14 AAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMqDRCA-SIAAVIGILKLGGVFVPLDPLHPDERL 92
Cdd:COG1020 487 ARTPDAVAVVFGDQSLTYAELNARANRLAHHLRALGVGPGDLVGVCL-ERSLeMVVALLAVLKAGAAYVPLDPAYPAERL 565
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 93 VTMLDTAEVSCLLCDDAQferAETLQGHEGKYFVLrarQAMSVQAGSKEAYSHSANATDPIYIYFTSGSTGKPKAVVGKN 172
Cdd:COG1020 566 AYMLEDAGARLVLTQSAL---AARLPELGVPVLAL---DALALAAEPATNPPVPVTPDDLAYVIYTSGSTGRPKGVMVEH 639
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 173 ESLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPeSREIILDPLRLVHWLEHSRVHVVHCTPSL 252
Cdd:COG1020 640 RALVNLLAWMQRRYGLGPGDRVLQFASLSFDASVWEIFGALLSGATLVLA-PPEARRDPAALAELLARHRVTVLNLTPSL 718
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 253 FR-FINHLsltADSYPDLRYVLLAGETIRPESLKNWYDNLGnRVRLVNLYGPTETTMIKLFYPIKPEDVHRESIPIGRPL 331
Cdd:COG1020 719 LRaLLDAA---PEALPSLRLVLVGGEALPPELVRRWRARLP-GARLVNLYGPTETTVDSTYYEVTPPDADGGSVPIGRPI 794
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 332 PDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPCrDQSGEIMmYRTGDMGRWLPEGELALLG 409
Cdd:COG1020 795 ANTRVYVLDAHLQPVPVGVPGELYIGGAGLARGYL--NRPELTAerFVADPF-GFPGARL-YRTGDLARWLPDGNLEFLG 870
|
410 420 430
....*....|....*....|....*....|...
gi 517718121 410 RKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:COG1020 871 RADDQVKIRGFRIELGEIEAALLQHPGVREAVV 903
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
783-1375 |
3.45e-115 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 401.46 E-value: 3.45e-115
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 783 VQLQVEEAQEPLLIAYYLADKMIDD-------EQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALPSPfEQDTT 855
Cdd:PRK12467 942 VVLAQPGDAGLQLVAYLVPAAVADGaehqatrDELKAQLRQVLPDYMVPAHLLLLDSLPLTPNGKLDRKALPKP-DASAV 1020
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 856 ARIYKAPNSSTELKLLDIWTHILGIKRISADDHFLQIGVHSLNIMTLIAQVYENFQVELPLEQVFEHDTLEEIAAYIDEQ 935
Cdd:PRK12467 1021 QATFVAPQTELEKRLAAIWADVLKVERVGLTDNFFELGGHSLLATQVISRVRQRLGIQVPLRTLFEHQTLAGFAQAVAAQ 1100
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 936 DSQYGVRIEPAAKQAYYPLTAAQMRVFMDEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDGD 1015
Cdd:PRK12467 1101 QQGAQPALPDVDRDQPLPLSYAQERQWFLWQLEPGSAAYHIPQALRLKGPLDIEALERSFDALVARHESLRTTFVQEDGR 1180
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1016 PVQRIHEHCDFHLEIVHLQG-----QQLHTAVNGCIR-PFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQ 1089
Cdd:PRK12467 1181 TRQVIHPVGSLTLEEPLLLAadkdeAQLKVYVEAEARqPFDLEQGPLLRVGLLRLAADEHVLVLTLHHIVSDGWSMQVLV 1260
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1090 RDLAALYEGR------ELHDLPVQYVDFAQWQTSAPVVEDLRRQEQFWQSMFADYRPLPGIPTDHtPEANERSFAGGHIT 1163
Cdd:PRK12467 1261 DELVALYAAYsqgqslQLPALPIQYADYAVWQRQWMDAGERARQLAYWKAQLGGEQPVLELPTDR-PRPAVQSHRGARLA 1339
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1164 WEPDPVLSRRLYAVAAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGRRRAEVRQVVGMFVNALAIRSYPEGDKPF 1243
Cdd:PRK12467 1340 FELPPALAEGLRALARREGVTLFMLLLASFQTLLHRYSGQDDIRVGVPIANRNRAETEGLIGFFVNTQVLRAEVDGQASF 1419
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1244 SSFLQEIRGTMLQAYEHQDYPLERLAKQLDLHHSRDH-----LMFD---TVFSM------LNYEDFAVRSDDLQFEyael 1309
Cdd:PRK12467 1420 QQLLQQVKQAALEAQAHQDLPFEQLVEALQPERSLSHsplfqVMFNhqrDDHQAqaqlpgLSVESLSWESQTAQFD---- 1495
|
570 580 590 600 610 620
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 517718121 1310 ptlseiynLRVEIVESPERLRGTFKYGQELYEARTVSQLAQDYERILAAVAESPNIKLKDIEIRTP 1375
Cdd:PRK12467 1496 --------LTLDTYESSEGLQASLTYATDLFEASTIERLAGHWLNLLQGLVADPERRLGELDLLDE 1553
|
|
| AA-adenyl-dom |
TIGR01733 |
amino acid adenylation domain; This model represents a domain responsible for the specific ... |
30-442 |
5.46e-111 |
|
amino acid adenylation domain; This model represents a domain responsible for the specific recognition of amino acids and activation as adenylyl amino acids. The reaction catalyzed is aa + ATP -> aa-AMP + PPi. These domains are usually found as components of multi-domain non-ribosomal peptide synthetases and are usually called "A-domains" in that context. A-domains are almost invariably followed by "T-domains" (thiolation domains, pfam00550) to which the amino acid adenylate is transferred as a thiol-ester to a bound pantetheine cofactor with the release of AMP (these are also called peptide carrier proteins, or PCPs. When the A-domain does not represent the first module (corresponding to the first amino acid in the product molecule) it is usually preceded by a "C-domain" (condensation domain, pfam00668) which catalyzes the ligation of two amino acid thiol-esters from neighboring modules. This domain is a subset of the AMP-binding domain found in Pfam (pfam00501) which also hits substrate--CoA ligases and luciferases. Sequences scoring in between trusted and noise for this model may be ambiguous as to whether they activate amino acids or other molecules lacking an alpha amino group.
Pssm-ID: 273779 [Multi-domain] Cd Length: 409 Bit Score: 356.19 E-value: 5.46e-111
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 30 SYKELDAESDRICELLHAHGAAQY-DHIGILMqDRCAS-IAAVIGILKLGGVFVPLDPLHPDERLVTMLDTAEVSCLLCD 107
Cdd:TIGR01733 1 TYRELDERANRLARHLRAAGGVGPgDRVAVLL-ERSAElVVAILAVLKAGAAYVPLDPAYPAERLAFILEDAGARLLLTD 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 108 DAQFERAETLQGHEGkyfVLRARQAMSVQAGSKEAYSHS-ANATDPIYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWL 186
Cdd:TIGR01733 80 SALASRLAGLVLPVI---LLDPLELAALDDAPAPPPPDApSGPDDLAYVIYTSGSTGRPKGVVVTHRSLVNLLAWLARRY 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 187 DLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPESREIILDPLRLVHWLEHSRVHVVHCTPSLFRfinHLSLTADSY 266
Cdd:TIGR01733 157 GLDPDDRVLQFASLSFDASVEEIFGALLAGATLVVPPEDEERDDAALLAALIAEHPVTVLNLTPSLLA---LLAAALPPA 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 267 PD-LRYVLLAGETIRPESLKNWYDNLGNrVRLVNLYGPTETTMIKLFYPIKPEDVHRES-IPIGRPLPDTSVYLLDEQQQ 344
Cdd:TIGR01733 234 LAsLRLVILGGEALTPALVDRWRARGPG-ARLINLYGPTETTVWSTATLVDPDDAPRESpVPIGRPLANTRLYVLDDDLR 312
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 345 PVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPCRDQSGEiMMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRV 422
Cdd:TIGR01733 313 PVPVGVVGELYIGGPGVARGYL--NRPELTAerFVPDPFAGGDGA-RLYRTGDLVRYLPDGNLEFLGRIDDQVKIRGYRI 389
|
410 420
....*....|....*....|
gi 517718121 423 ELGDIEHRLTNMAGIREAVV 442
Cdd:TIGR01733 390 ELGEIEAALLRHPGVREAVV 409
|
|
| A_NRPS_Srf_like |
cd12117 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis ... |
10-452 |
2.02e-101 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis termination module Surfactin (SrfA-C); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the adenylation domain of the Bacillus subtilis termination module (Surfactin domain, SrfA-C) which recognizes a specific amino acid building block, which is then activated and transferred to the terminal thiol of the 4'-phosphopantetheine (Ppan) arm of the downstream peptidyl carrier protein (PCP) domain.
Pssm-ID: 341282 [Multi-domain] Cd Length: 483 Bit Score: 332.63 E-value: 2.02e-101
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 10 ARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPD 89
Cdd:cd12117 4 EEQAARTPDAVAVVYGDRSLTYAELNERANRLARRLRAAGVGPGDVVGVLAERSPELVVALLAVLKAGAAYVPLDPELPA 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 90 ERLVTMLDTAEVSCLLCDdaqfeRAETLQGHEGKYFVLRARQAMsvqAGSKEAYSHSANATDPIYIYFTSGSTGKPKAVV 169
Cdd:cd12117 84 ERLAFMLADAGAKVLLTD-----RSLAGRAGGLEVAVVIDEALD---AGPAGNPAVPVSPDDLAYVMYTSGSTGRPKGVA 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 170 GKNESLLHFMNwEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTiCIPESREIILDPLRLVHWLEHSRVHVVHCT 249
Cdd:cd12117 156 VTHRGVVRLVK-NTNYVTLGPDDRVLQTSPLAFDASTFEIWGALLNGAR-LVLAPKGTLLDPDALGALIAEEGVTVLWLT 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 250 PSLFRFInhlsltADSYPD----LRYVLLAGETIRPESLKNWYDNLGnRVRLVNLYGPTETTMIKLFYPIKPEDVHRESI 325
Cdd:cd12117 234 AALFNQL------ADEDPEcfagLRELLTGGEVVSPPHVRRVLAACP-GLRLVNGYGPTENTTFTTSHVVTELDEVAGSI 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 326 PIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPcrDQSGEiMMYRTGDMGRWLPEG 403
Cdd:cd12117 307 PIGRPIANTRVYVLDEDGRPVPPGVPGELYVGGDGLALGYL--NRPALTAerFVADP--FGPGE-RLYRTGDLARWLPDG 381
|
410 420 430 440
....*....|....*....|....*....|....*....|....*....
gi 517718121 404 ELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVVRMRAKADTPK 452
Cdd:cd12117 382 RLEFLGRIDDQVKIRGFRIELGEIEAALRAHPGVREAVVVVREDAGGDK 430
|
|
| A_NRPS_VisG_like |
cd17651 |
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) ... |
9-445 |
1.41e-100 |
|
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes virginiamycin S synthetase (VisG) in Streptomyces virginiae; VisG is involved in virginiamycin S (VS) biosynthesis as the provider of an L-pheGly molecule, a highly specific substrate for the last condensation step by VisF. This family also includes linear gramicidin synthetase B (LgrB) in Brevibacillus brevis. Substrate specificity analysis using residues of the substrate-binding pockets of all 16 adenylation domains has shown good agreement of the substrate amino acids predicted with the sequence of linear gramicidin. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341306 [Multi-domain] Cd Length: 491 Bit Score: 330.46 E-value: 1.41e-100
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMqDRCAS-IAAVIGILKLGGVFVPLDPLH 87
Cdd:cd17651 1 FERQAARTPDAPALVAEGRRLTYAELDRRANRLAHRLRARGVGPGDLVALCA-RRSAElVVALLAILKAGAAYVPLDPAY 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 88 PDERLVTMLDTAEVSCLLCDDAQFERAETLQGhegkyFVLRARQAMSVQAGSKEaysHSA--NATDPIYIYFTSGSTGKP 165
Cdd:cd17651 80 PAERLAFMLADAGPVLVLTHPALAGELAVELV-----AVTLLDQPGAAAGADAE---PDPalDADDLAYVIYTSGSTGRP 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 166 KAVVGKNESLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPeSREIILDPLRLVHWLEHSRVHV 245
Cdd:cd17651 152 KGVVMPHRSLANLVAWQARASSLGPGARTLQFAGLGFDVSVQEIFSTLCAGATLVLP-PEEVRTDPPALAAWLDEQRISR 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 246 VHC-TPSLFRFINHLSLTADSYPDLRYVLLAGETIRP-ESLKNWYDNLGNRvRLVNLYGPTETTMIKLFYPIKPEDVHRE 323
Cdd:cd17651 231 VFLpTVALRALAEHGRPLGVRLAALRYLLTGGEQLVLtEDLREFCAGLPGL-RLHNHYGPTETHVVTALSLPGDPAAWPA 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 324 SIPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPcrdQSGEIMMYRTGDMGRWLP 401
Cdd:cd17651 310 PPPIGRPIDNTRVYVLDAALRPVPPGVPGELYIGGAGLARGYL--NRPELTAerFVPDP---FVPGARMYRTGDLARWLP 384
|
410 420 430 440
....*....|....*....|....*....|....*....|....
gi 517718121 402 EGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVVRMR 445
Cdd:cd17651 385 DGELEFLGRADDQVKIRGFRIELGEIEAALARHPGVREAVVLAR 428
|
|
| Condensation |
pfam00668 |
Condensation domain; This domain is found in many multi-domain enzymes which synthesize ... |
948-1372 |
1.54e-95 |
|
Condensation domain; This domain is found in many multi-domain enzymes which synthesize peptide antibiotics. This domain catalyzes a condensation reaction to form peptide bonds in non- ribosomal peptide biosynthesis. It is usually found to the carboxy side of a phosphopantetheine binding domain (pfam00550). It has been shown that mutations in the HHXXXDG motif abolish activity suggesting this is part of the active site.
Pssm-ID: 395541 [Multi-domain] Cd Length: 454 Bit Score: 315.43 E-value: 1.54e-95
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 948 KQAYYPLTAAQMRVFMDEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDI-VDGDPVQRIHEHCDF 1026
Cdd:pfam00668 1 VQDEYPLSPAQKRMWFLEKLEPHSSAYNMPAVLKLTGELDPERLEKALQELINRHDALRTVFIRqENGEPVQVILEERPF 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1027 HL---EIVHLQGQQLHTAVNGCIR-----PFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYE- 1097
Cdd:pfam00668 81 ELeiiDISDLSESEEEEAIEAFIQrdlqsPFDLEKGPLFRAGLFRIAENRHHLLLSMHHIIVDGVSLGILLRDLADLYQq 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1098 ---GRELHDLPVQ-YVDFAQWQTSAPVVEDLRRQEQFWQSMFADYRPLPGIPTDHTPEANeRSFAGGHITWEPDPVLSRR 1173
Cdd:pfam00668 161 llkGEPLPLPPKTpYKDYAEWLQQYLQSEDYQKDAAYWLEQLEGELPVLQLPKDYARPAD-RSFKGDRLSFTLDEDTEEL 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1174 LYAVAAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGRRRAEVRQVVGMFVNALAIRSYPEGDKPFSSFLQEIRGT 1253
Cdd:pfam00668 240 LRKLAKAHGTTLNDVLLAAYGLLLSRYTGQDDIVVGTPGSGRPSPDIERMVGMFVNTLPLRIDPKGGKTFSELIKRVQED 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1254 MLQAYEHQDYPLERLAKQLDLHHS-RDHLMFDTVFSMLNYedfavrsdDLQFEYAELPTLSEI-------------YNLR 1319
Cdd:pfam00668 320 LLSAEPHQGYPFGDLVNDLRLPRDlSRHPLFDPMFSFQNY--------LGQDSQEEEFQLSELdlsvssvieeeakYDLS 391
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|...
gi 517718121 1320 VEIVESPERLRGTFKYGQELYEARTVSQLAQDYERILAAVAESPNIKLKDIEI 1372
Cdd:pfam00668 392 LTASERGGGLTIKIDYNTSLFDEETIERFAEHFKELLEQAIAHPSQPLSELDL 444
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
783-1376 |
9.68e-95 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 338.86 E-value: 9.68e-95
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 783 VQLQVEEAQEPLLIAYYLADKMIDD--EQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALPSPfEQDTTARIYK 860
Cdd:PRK12316 2433 VVVAQDGASGKQLVAYVVPDDAAEDllAELRAWLAARLPAYMVPAHWVVLERLPLNPNGKLDRKALPKP-DVSQLRQAYV 2511
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 861 APNSSTELKLLDIWTHILGIKRISADDHFLQIGVHSLNIMTLIAQVYENFQVELPLEQVFEHDTLEEIAAYIDEQDSQYG 940
Cdd:PRK12316 2512 APQEGLEQRLAAIWQAVLKVEQVGLDDHFFELGGHSLLATQVVSRVRQDLGLEVPLRILFERPTLAAFAASLESGQTSRA 2591
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 941 VRIEPAAKQAYYPLTAAQMRVFMDEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDGDPVQRI 1020
Cdd:PRK12316 2592 PVLQKVTRVQPLPLSHAQQRQWFLWQLEPESAAYHLPSALHLRGVLDQAALEQAFDALVLRHETLRTRFVEVGEQTRQVI 2671
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1021 HEHCDFHLEIVHLQ----GQQLHTAVNGCIRPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALY 1096
Cdd:PRK12316 2672 LPNMSLRIVLEDCAgvadAAIRQRVAEEIQRPFDLARGPLLRVRLLALDGQEHVLVITQHHIVSDGWSMQVMVDELVQAY 2751
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1097 EGR------ELHDLPVQYVDFAQWQTSAPVVEDLRRQEQFWQSMFADYRPLPGIPTDHtPEANERSFAGGHITWEPDPVL 1170
Cdd:PRK12316 2752 AGArrgeqpTLPPLPLQYADYAAWQRAWMDSGEGARQLDYWRERLGGEQPVLELPLDR-PRPALQSHRGARLDVALDVAL 2830
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1171 SRRLYAVAAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGRRRAEVRQVVGMFVNALAIRSYPEGDKPFSSFLQEI 1250
Cdd:PRK12316 2831 SRELLALARREGVTLFMLLLASFQVLLHRYSGQSDIRVGVPIANRNRAETERLIGFFVNTQVLRAQVDAQLAFRDLLGQV 2910
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1251 RGTMLQAYEHQDYPLERLAKQLDLHHSRDH-LMFDTVFSMLNYEDFAVRSDDLQFEYAELPTLSEIYNLRVEIVESPERL 1329
Cdd:PRK12316 2911 KEQALGAQAHQDLPFEQLVEALQPERSLSHsPLFQVMYNHQSGERAAAQLPGLHIESFAWDGAATQFDLALDTWESAEGL 2990
|
570 580 590 600
....*....|....*....|....*....|....*....|....*..
gi 517718121 1330 RGTFKYGQELYEARTVSQLAQDYERILAAVAESPNIKLKDIEIRTPQ 1376
Cdd:PRK12316 2991 GASLTYATDLFDARTVERLARHWQNLLRGMVENPQRSVDELAMLDAE 3037
|
|
| A_NRPS_Ta1_like |
cd12116 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A ... |
17-445 |
2.60e-94 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A polyketide synthase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the myxovirescin (TA) antibiotic biosynthetic gene in Myxococcus xanthus; TA production plays a role in predation. It also includes the salinosporamide A polyketide synthase which is involved in the biosynthesis of salinosporamide A, a marine microbial metabolite whose chlorine atom is crucial for potent proteasome inhibition and anticancer activity.
Pssm-ID: 341281 [Multi-domain] Cd Length: 470 Bit Score: 312.30 E-value: 2.60e-94
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 17 PERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTML 96
Cdd:cd12116 1 PDATAVRDDDRSLSYAELDERANRLAARLRARGVGPGDRVAVYLPRSARLVAAMLAVLKAGAAYVPLDPDYPADRLRYIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 97 DTAEVSCLLCDDAQFERaetlqghegkyFVLRARQAMSVQAGSKEAYSHSANATDP---IYIYFTSGSTGKPKAVVGKNE 173
Cdd:cd12116 81 EDAEPALVLTDDALPDR-----------LPAGLPVLLLALAAAAAAPAAPRTPVSPddlAYVIYTSGSTGRPKGVVVSHR 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 174 SLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIpESREIILDPLRLVHWLEHSRVHVVHCTPSLF 253
Cdd:cd12116 150 NLVNFLHSMRERLGLGPGDRLLAVTTYAFDISLLELLLPLLAGARVVI-APRETQRDPEALARLIEAHSITVMQATPATW 228
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 254 RfinhLSLTADSYPDLRYVLLAGETIRPESLKnwyDNLGNRVR-LVNLYGPTETTMIKLFYPIKPEDVHresIPIGRPLP 332
Cdd:cd12116 229 R----MLLDAGWQGRAGLTALCGGEALPPDLA---ARLLSRVGsLWNLYGPTETTIWSTAARVTAAAGP---IPIGRPLA 298
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 333 DTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPCRDQSGEimMYRTGDMGRWLPEGELALLGR 410
Cdd:cd12116 299 NTQVYVLDAALRPVPPGVPGELYIGGDGVAQGYL--GRPALTAerFVPDPFAGPGSR--LYRTGDLVRRRADGRLEYLGR 374
|
410 420 430
....*....|....*....|....*....|....*
gi 517718121 411 KDNQVKIRGNRVELGDIEHRLTNMAGIREAVVRMR 445
Cdd:cd12116 375 ADGQVKIRGHRIELGEIEAALAAHPGVAQAAVVVR 409
|
|
| A_NRPS_Bac |
cd17655 |
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of ... |
17-442 |
9.43e-94 |
|
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetases 1, 2, and 3 (BA1, also known as ATP-dependent cysteine adenylase or cysteine activase, BA2, also known as ATP-dependent lysine adenylase or lysine activase, and BA3, also known as ATP-dependent isoleucine adenylase or isoleucine activase) in Bacilli. Bacitracin is a mixture of related cyclic peptides used as a polypeptide antibiotic. This family also includes gramicidin synthetase 1 involved in synthesis of the cyclic peptide antibiotic gramicidin S via activation of phenylalanine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341310 [Multi-domain] Cd Length: 490 Bit Score: 311.57 E-value: 9.43e-94
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 17 PERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTML 96
Cdd:cd17655 11 PDHTAVVFEDQTLTYRELNERANQLARTLREKGVGPDTIVGIMAERSLEMIVGILGILKAGGAYLPIDPDYPEERIQYIL 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 97 DTAEVSCLLCDDAQferaETLQGHEGKYFVLRARQamsVQAGSKEAYSHSANATDPIYIYFTSGSTGKPKAVVGKNESLL 176
Cdd:cd17655 91 EDSGADILLTQSHL----QPPIAFIGLIDLLDEDT---IYHEESENLEPVSKSDDLAYVIYTSGSTGKPKGVMIEHRGVV 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 177 HFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIpESREIILDPLRLVHWLEHSRVHVVHCTPSLFRFI 256
Cdd:cd17655 164 NLVEWANKVIYQGEHLRVALFASISFDASVTEIFASLLSGNTLYI-VRKETVLDGQALTQYIRQNRITIIDLTPAHLKLL 242
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 257 NHLSLTadSYPDLRYVLLAGETIRPESLKNWYDNLGNRVRLVNLYGPTETTMIKLFYPIKPEDVHRESIPIGRPLPDTSV 336
Cdd:cd17655 243 DAADDS--EGLSLKHLIVGGEALSTELAKKIIELFGTNPTITNAYGPTETTVDASIYQYEPETDQQVSVPIGKPLGNTRI 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 337 YLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPCRdqSGEiMMYRTGDMGRWLPEGELALLGRKDNQ 414
Cdd:cd17655 321 YILDQYGRPQPVGVAGELYIGGEGVARGYL--NRPELTAekFVDDPFV--PGE-RMYRTGDLARWLPDGNIEFLGRIDHQ 395
|
410 420
....*....|....*....|....*...
gi 517718121 415 VKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd17655 396 VKIRGYRIELGEIEARLLQHPDIKEAVV 423
|
|
| A_NRPS_AB3403-like |
cd17646 |
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or ... |
9-449 |
1.85e-93 |
|
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341301 [Multi-domain] Cd Length: 488 Bit Score: 310.75 E-value: 1.85e-93
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHP 88
Cdd:cd17646 4 VAEQAARTPDAPAVVDEGRTLTYRELDERANRLAHLLRARGVGPEDRVAVLLPRSADLVVALLAVLKAGAAYLPLDPGYP 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 89 DERLVTMLDTAEVSCLLCDDAQFERAETLQGHEgkyfVLRARQAMSVQAGSKEAYSHSANatdPIYIYFTSGSTGKPKAV 168
Cdd:cd17646 84 ADRLAYMLADAGPAVVLTTADLAARLPAGGDVA----LLGDEALAAPPATPPLVPPRPDN---LAYVIYTSGSTGRPKGV 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 169 VGKNESLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPES---ReiilDPLRLVHWLEHSRVHV 245
Cdd:cd17646 157 MVTHAGIVNRLLWMQDEYPLGPGDRVLQKTPLSFDVSVWELFWPLVAGARLVVARPgghR----DPAYLAALIREHGVTT 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 246 VHCTPSLFR-FINhlSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGnrVRLVNLYGPTETTMIKLFYPIKPEDVhRES 324
Cdd:cd17646 233 CHFVPSMLRvFLA--EPAAGSCASLRRVFCSGEALPPELAARFLALPG--AELHNLYGPTEAAIDVTHWPVRGPAE-TPS 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 325 IPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPCRDQSgeiMMYRTGDMGRWLPE 402
Cdd:cd17646 308 VPIGRPVPNTRLYVLDDALRPVPVGVPGELYLGGVQLARGYL--GRPALTAerFVPDPFGPGS---RMYRTGDLARWRPD 382
|
410 420 430 440
....*....|....*....|....*....|....*....|....*..
gi 517718121 403 GELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVVRMRAKAD 449
Cdd:cd17646 383 GALEFLGRSDDQVKIRGFRVEPGEIEAALAAHPAVTHAVVVARAAPA 429
|
|
| DltA |
cd05945 |
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes ... |
14-450 |
1.04e-89 |
|
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes D-alanyl carrier protein ligase DltA and aliphatic beta-amino acid adenylation enzymes IdnL1 and CmiS6. DltA incorporates D-ala in techoic acids in gram-positive bacteria via a two-step process, starting with adenylation of D-alanine that transfers D-alanine to the D-alanyl carrier protein. IdnL1, a short-chain aliphatic beta-amino acid adenylation enzyme, recognizes 3-aminobutanoic acid, and is involved in the synthesis of the macrolactam antibiotic incednine. CmiS6 is a medium-chain beta-amino acid adenylation enzyme that recognizes 3-aminononanoic acid, and is involved in the synthesis of cremimycin, also a macrolactam antibiotic. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341267 [Multi-domain] Cd Length: 449 Bit Score: 298.78 E-value: 1.04e-89
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 14 AAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLV 93
Cdd:cd05945 2 AANPDRPAVVEGGRTLTYRELKERADALAAALASLGLDAGDPVVVYGHKSPDAIAAFLAALKAGHAYVPLDASSPAERIR 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 94 TMLDTAEVSCLLCDDaqferaetlqghegkyfvlrarqamsvqagskeayshsanaTDPIYIYFTSGSTGKPKAVVGKNE 173
Cdd:cd05945 82 EILDAAKPALLIADG-----------------------------------------DDNAYIIFTSGSTGRPKGVQISHD 120
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 174 SLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTiCIPESREIILDPLRLVHWLEHSRVHVVHCTPSLF 253
Cdd:cd05945 121 NLVSFTNWMLSDFPLGPGDVFLNQAPFSFDLSVMDLYPALASGAT-LVPVPRDATADPKQLFRFLAEHGITVWVSTPSFA 199
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 254 RF-INHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGNRvRLVNLYGPTETTMIKLFYPIKPEDVHR-ESIPIGRPL 331
Cdd:cd05945 200 AMcLLSPTFTPESLPSLRHFLFCGEVLPHKTARALQQRFPDA-RIYNTYGPTEATVAVTYIEVTPEVLDGyDRLPIGYAK 278
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 332 PDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFPSSHPDQTAFIPDPCRdqsgeiMMYRTGDMGRWLPEGELALLGRK 411
Cdd:cd05945 279 PGAKLVILDEDGRPVPPGEKGELVISGPSVSKGYLNNPEKTAAAFFPDEGQ------RAYRTGDLVRLEADGLLFYRGRL 352
|
410 420 430
....*....|....*....|....*....|....*....
gi 517718121 412 DNQVKIRGNRVELGDIEHRLTNMAGIREAVVRMRAKADT 450
Cdd:cd05945 353 DFQVKLNGYRIELEEIEAALRQVPGVKEAVVVPKYKGEK 391
|
|
| A_NRPS_Cytc1-like |
cd17643 |
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation ... |
17-445 |
2.43e-89 |
|
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Streptomyces sp. cytotrienin synthetase (CytC1), a relatively promiscuous adenylation enzyme that installs the aminoacyl moieties on the phosphopantetheinyl arm of the holo carrier protein CytC2. Also included are Streptomyces sp Thr1, involved in the biosynthesis of 4-chlorothreonine, Pseudomonas aeruginosa pyoverdine synthetase D (PvdD), involved in the biosynthesis of the siderophore pyoverdine and Pseudomonas syringae syringopeptin synthetase, where syringpeptin is a necrosis-inducing phytotoxin that functions as a virulence determinant in the plant-pathogen interaction. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341298 [Multi-domain] Cd Length: 450 Bit Score: 297.68 E-value: 2.43e-89
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 17 PERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTML 96
Cdd:cd17643 1 PEAVAVVDEDRRLTYGELDARANRLARTLRAEGVGPGDRVALALPRSAELIVALLAILKAGGAYVPIDPAYPVERIAFIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 97 DTAEVSCLLCDdaqferaetlqghegkyfvlrarqamsvqagskeayshsanATDPIYIYFTSGSTGKPKAVVGKNESLL 176
Cdd:cd17643 81 ADSGPSLLLTD-----------------------------------------PDDLAYVIYTSGSTGRPKGVVVSHANVL 119
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 177 HFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPEsREIILDPLRLVHWLEHSRVHVVHCTPSLFR-F 255
Cdd:cd17643 120 ALFAATQRWFGFNEDDVWTLFHSYAFDFSVWEIWGALLHGGRLVVVP-YEVARSPEDFARLLRDEGVTVLNQTPSAFYqL 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 256 INHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGN-RVRLVNLYGPTETTMIKLFYPIKPEDVH-RESIPIGRPLPD 333
Cdd:cd17643 199 VEAADRDGRDPLALRYVIFGGEALEAAMLRPWAGRFGLdRPQLVNMYGITETTVHVTFRPLDAADLPaAAASPIGRPLPG 278
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 334 TSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPcrDQSGEIMMYRTGDMGRWLPEGELALLGRK 411
Cdd:cd17643 279 LRVYVLDADGRPVPPGVVGELYVSGAGVARGYL--GRPELTAerFVANP--FGGPGSRMYRTGDLARRLPDGELEYLGRA 354
|
410 420 430
....*....|....*....|....*....|....
gi 517718121 412 DNQVKIRGNRVELGDIEHRLTNMAGIREAVVRMR 445
Cdd:cd17643 355 DEQVKIRGFRIELGEIEAALATHPSVRDAAVIVR 388
|
|
| A_NRPS_GliP_like |
cd17653 |
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of ... |
14-444 |
1.35e-87 |
|
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of nonribosomal peptide synthases (NRPS) gliotoxin biosynthesis protein P (GliP), thioclapurine biosynthesis protein P (tcpP) and Sirodesmin biosynthesis protein P (SirP). In the filamentous fungus Aspergillus fumigatus, NRPS GliP is involved in the biosynthesis of gliotoxin, which is initiated by the condensation of serine and phenylalanine. Studies show that GliP is not required for invasive aspergillosis, suggesting that the principal targets of gliotoxin are neutrophils or other phagocytes. SirP is a phytotoxin produced by the fungus Leptosphaeria maculans, which causes blackleg disease of canola (Brassica napus). In the fungus Claviceps purpurea, NRPS tcpP catalyzes condensation of tyrosine and glycine, part of biosynthesis of an unusual class of epipolythiodioxopiperazines (ETPs) that lacks the reactive thiol group for toxicity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341308 [Multi-domain] Cd Length: 433 Bit Score: 292.29 E-value: 1.35e-87
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 14 AAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLV 93
Cdd:cd17653 8 AAHPDAVAVESLGGSLTYGELDAASNALANRLLQLGVVPGDVVPLLSDRSLEMLVAILAILKAGAAYVPLDAKLPSARIQ 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 94 TMLDTAEVSCLLCDDAQferaetlqghegkyfvlrarqamsvqagskeayshsanaTDPIYIYFTSGSTGKPKAVVGKNE 173
Cdd:cd17653 88 AILRTSGATLLLTTDSP---------------------------------------DDLAYIIFTSGSTGIPKGVMVPHR 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 174 SLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPESREIILDPLRlvhwlehsRVHVVHCTPSLf 253
Cdd:cd17653 129 GVLNYVSQPPARLDVGPGSRVAQVLSIAFDACIGEIFSTLCNGGTLVLADPSDPFAHVAR--------TVDALMSTPSI- 199
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 254 rfinhLS-LTADSYPDLRYVLLAGETIRPESLKNWydnlGNRVRLVNLYGPTETTMIKLFYPIKPEDvhreSIPIGRPLP 332
Cdd:cd17653 200 -----LStLSPQDFPNLKTIFLGGEAVPPSLLDRW----SPGRRLYNAYGPTECTISSTMTELLPGQ----PVTIGKPIP 266
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 333 DTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFPSshPDQTA--FIPDPcrDQSGEiMMYRTGDMGRWLPEGELALLGR 410
Cdd:cd17653 267 NSTCYILDADLQPVPEGVVGEICISGVQVARGYLGN--PALTAskFVPDP--FWPGS-RMYRTGDYGRWTEDGGLEFLGR 341
|
410 420 430
....*....|....*....|....*....|....*
gi 517718121 411 KDNQVKIRGNRVELGDIEHR-LTNMAGIREAVVRM 444
Cdd:cd17653 342 EDNQVKVRGFRINLEEIEEVvLQSQPEVTQAAAIV 376
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
838-1372 |
5.10e-87 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 314.80 E-value: 5.10e-87
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 838 NGKLDYNALpSPFEQDTTARIYKAPNSSTELKLLDIWTHILGIKRISADDHFLQIGVHSLNIMTLIAQVYENFQVELPLE 917
Cdd:PRK05691 560 DGSLDSYAL-FPALQAVEAAQTAASGDELQARIAAIWCEQLKVEQVAADDHFFLLGGNSIAATQVVARLRDELGIDLNLR 638
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 918 QVFEHDTLEEIAAYIDEQDSQYGV---RIEPAAKQAYYPLTAAQMRVFMDEQLVNTGSGYHITTAFMIYGPIDVTRLERA 994
Cdd:PRK05691 639 QLFEAPTLAAFSAAVARQLAGGGAaqaAIARLPRGQALPQSLAQNRLWLLWQLDPQSAAYNIPGGLHLRGELDEAALRAS 718
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 995 CGQLIERHEALRTSFDIVDGDPVQRIHEHCDFHLEIVHLQGQQLH--TAVNGCIR------PFQLERAPLIRSILIPLAE 1066
Cdd:PRK05691 719 FQRLVERHESLRTRFYERDGVALQRIDAQGEFALQRIDLSDLPEAerEARAAQIReeearqPFDLEKGPLLRVTLVRLDD 798
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1067 EQHLLVLDMHHIVADGKSVFLLQRDLAALYEGR------ELHDLPVQYVDFAQWQTSAPVVEDLRRQEQFWQSMFADYRP 1140
Cdd:PRK05691 799 EEHQLLVTLHHIVADGWSLNILLDEFSRLYAAAcqgqtaELAPLPLGYADYGAWQRQWLAQGEAARQLAYWKAQLGDEQP 878
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1141 LPGIPTDHTPEANERSFAGGHiTWEPDPVLSRRLYAVAAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGRRRAEV 1220
Cdd:PRK05691 879 VLELATDHPRSARQAHSAARY-SLRVDASLSEALRGLAQAHQATLFMVLLAAFQALLHRYSGQGDIRIGVPNANRPRLET 957
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1221 RQVVGMFVNALAIRSYPEGDKPFSSFLQEIRGTMLQAYEHQDYPLERLAKQLDlhHSRDHLMFDTVFSMLNYEDFAVRS- 1299
Cdd:PRK05691 958 QGLVGFFINTQVLRAQLDGRLPFTALLAQVRQATLGAQAHQDLPFEQLVEALP--QAREQGLFQVMFNHQQRDLSALRRl 1035
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 517718121 1300 DDLQFEyaELPTLSE--IYNLRVEIVESPE-RLRGTFKYGQELYEARTVSQLAQDYERILAAVAESPNIKLKDIEI 1372
Cdd:PRK05691 1036 PGLLAE--ELPWHSReaKFDLQLHSEEDRNgRLTLSFDYAAELFDAATIERLAEHFLALLEQVCEDPQRALGDVQL 1109
|
|
| A_NRPS_Sfm_like |
cd12115 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene ... |
9-442 |
2.10e-86 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene cluster from Streptomyces lavendulae; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the saframycin A gene cluster from Streptomyces lavendulae which implicates the NRPS system for assembling the unusual tetrapeptidyl skeleton in an iterative manner. It also includes saframycin Mx1 produced by Myxococcus xanthus NRPS.
Pssm-ID: 341280 [Multi-domain] Cd Length: 447 Bit Score: 289.22 E-value: 2.10e-86
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHP 88
Cdd:cd12115 5 VEAQAARTPDAIALVCGDESLTYAELNRRANRLAARLRAAGVGPESRVGVCLERTPDLVVALLAVLKAGAAYVPLDPAYP 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 89 DERLVTMLDTAEVSCLLCDdaqferaetlqghegkyfvlrarqamsvqagskeayshsanATDPIYIYFTSGSTGKPKAV 168
Cdd:cd12115 85 PERLRFILEDAQARLVLTD-----------------------------------------PDDLAYVIYTSGSTGRPKGV 123
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 169 VGKNESLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPESreiildPLRLVHWLEHSRVHVVHC 248
Cdd:cd12115 124 AIEHRNAAAFLQWAAAAFSAEELAGVLASTSICFDLSVFELFGPLATGGKVVLADN------VLALPDLPAAAEVTLINT 197
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 249 TPSLFRFInhlsLTADSYP-DLRYVLLAGETIRPESLKNWYDNLgNRVRLVNLYGPTETTMIKLFYPIKPEDVhrESIPI 327
Cdd:cd12115 198 VPSAAAEL----LRHDALPaSVRVVNLAGEPLPRDLVQRLYARL-QVERVVNLYGPSEDTTYSTVAPVPPGAS--GEVSI 270
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 328 GRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPCRDQSgeiMMYRTGDMGRWLPEGEL 405
Cdd:cd12115 271 GRPLANTQAYVLDRALQPVPLGVPGELYIGGAGVARGYL--GRPGLTAerFLPDPFGPGA---RLYRTGDLVRWRPDGLL 345
|
410 420 430
....*....|....*....|....*....|....*..
gi 517718121 406 ALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd12115 346 EFLGRADNQVKVRGFRIELGEIEAALRSIPGVREAVV 382
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
788-1367 |
2.21e-86 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 312.87 E-value: 2.21e-86
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 788 EEAQEPLLIAYYLADKMIDDEQLSVY--LRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALPSPFEQdttARIYKAPNSS 865
Cdd:PRK05691 1562 EGAAGAQLVGYYTGEAGQEAEAERLKaaLAAELPEYMVPAQLIRLDQMPLGPSGKLDRRALPEPVWQ---QREHVEPRTE 1638
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 866 TELKLLDIWTHILGIKRISADDHFLQIGVHSLNIMTLIAQVYENFQVELPLEQVFEHDTLEEIAAYIdEQDSQYGVR--- 942
Cdd:PRK05691 1639 LQQQIAAIWREVLGLPRVGLRDDFFALGGHSLLATQIVSRTRQACDVELPLRALFEASELGAFAEQV-ARIQAAGERnsq 1717
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 943 --IEPAAKQAYYPLTAAQMRVFMDEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDGDPVQRI 1020
Cdd:PRK05691 1718 gaIARVDRSQPVPLSYSQQRMWFLWQMEPDSPAYNVGGMARLSGVLDVDRFEAALQALILRHETLRTTFPSVDGVPVQQV 1797
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1021 HEHCDFHL---EIVHLQG-------QQLhtAVNGCIRPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQR 1090
Cdd:PRK05691 1798 AEDSGLRMdwqDFSALPAdarqqrlQQL--ADSEAHQPFDLERGPLLRACLVKAAEREHYFVLTLHHIVTEGWAMDIFAR 1875
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1091 DLAALYE----GRE--LHDLPVQYVDFAQWQTSAPVVEDLRRQEQFWQSMFADYRPLPGIPTDHtPEANERSFAGGHITW 1164
Cdd:PRK05691 1876 ELGALYEafldDREspLEPLPVQYLDYSVWQRQWLESGERQRQLDYWKAQLGNEHPLLELPADR-PRPPVQSHRGELYRF 1954
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1165 EPDPVLSRRLYAVAAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGRRRAEVRQVVGMFVNALAIRSYPEGDKPFS 1244
Cdd:PRK05691 1955 DLSPELAARVRAFNAQRGLTLFMTMTATLAALLYRYSGQRDLRIGAPVANRIRPESEGLIGAFLNTQVLRCQLDGQMSVS 2034
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1245 SFLQEIRGTMLQAYEHQDYPLERLAKQLDLHHSRDHlmfDTVFS-MLNYEDFAVRSD----DLQFEYAELPTLSEIYNLR 1319
Cdd:PRK05691 2035 ELLEQVRQTVIEGQSHQDLPFDHLVEALQPPRSAAY---NPLFQvMCNVQRWEFQQSrqlaGMTVEYLVNDARATKFDLN 2111
|
570 580 590 600
....*....|....*....|....*....|....*....|....*...
gi 517718121 1320 VEIVESPERLRGTFKYGQELYEARTVSQLAQDYERILAAVAESPNIKL 1367
Cdd:PRK05691 2112 LEVTDLDGRLGCCLTYSRDLFDEPRIARMAEHWQNLLEALLGDPQQRL 2159
|
|
| A_NRPS_PvdJ-like |
cd17649 |
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal ... |
17-442 |
5.10e-86 |
|
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes pyoverdine biosynthesis protein PvdJ involved in the synthesis of pyoverdine, which consists of a chromophore group attached to a variable peptide chain and comprises around 6-12 amino acids that are specific for each Pseudomonas species, and for which the peptide might be first synthesized before the chromophore assembly. Also included is ornibactin biosynthesis protein OrbI; ornibactin is a tetrapeptide siderophore with an l-ornithine-d-hydroxyaspartate-l-serine-l-ornithine backbone. The adenylation domain at the N-terminal of OrbI possibly initiates the ornibactin with the binding of N5-hydroxyornithine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341304 [Multi-domain] Cd Length: 450 Bit Score: 288.50 E-value: 5.10e-86
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 17 PERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTML 96
Cdd:cd17649 1 PDAVALVFGDQSLSYAELDARANRLAHRLRALGVGPEVRVGIALERSLEMVVALLAILKAGGAYVPLDPEYPAERLRYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 97 DTAEVSCLLCddaqferaetlqgHEGKyfvlrarqamsvqagskeayshsanatDPIYIYFTSGSTGKPKAVVGKNESLL 176
Cdd:cd17649 81 EDSGAGLLLT-------------HHPR---------------------------QLAYVIYTSGSTGTPKGVAVSHGPLA 120
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 177 HFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPeSREIILDPLRLVHWLEHSRVHVVHCTPS-LFRF 255
Cdd:cd17649 121 AHCQATAERYGLTPGDRELQFASFNFDGAHEQLLPPLICGACVVLR-PDELWASADELAEMVRELGVTVLDLPPAyLQQL 199
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 256 INHL-SLTADSYPDLRYVLLAGETIRPESLKNWydnLGNRVRLVNLYGPTETTMIKLFYPIKPEDVHR-ESIPIGRPLPD 333
Cdd:cd17649 200 AEEAdRTGDGRPPSLRLYIFGGEALSPELLRRW---LKAPVRLFNAYGPTEATVTPLVWKCEAGAARAgASMPIGRPLGG 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 334 TSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPcrdQSGEIM-MYRTGDMGRWLPEGELALLGR 410
Cdd:cd17649 277 RSAYILDADLNPVPVGVTGELYIGGEGLARGYL--GRPELTAerFVPDP---FGAPGSrLYRTGDLARWRDDGVIEYLGR 351
|
410 420 430
....*....|....*....|....*....|..
gi 517718121 411 KDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd17649 352 VDHQVKIRGFRIELGEIEAALLEHPGVREAAV 383
|
|
| A_NRPS_CmdD_like |
cd17652 |
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) ... |
17-445 |
2.05e-84 |
|
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes phosphinothricin tripeptide (PTT, phosphinothricylalanylalanine) synthetase, where PTT is a natural-product antibiotic and potent herbicide that is produced by Streptomyces hygroscopicus. This adenylation domain has been confirmed to directly activate beta-tyrosine, and fluorinated chondramides are produced through precursor-directed biosynthesis. Also included in this family is chondramide synthase D (also known as ATP-dependent phenylalanine adenylase or phenylalanine activase or tyrosine activase). Chondramides A-D are depsipeptide antitumor and antifungal antibiotics produced by C. crocatus, are a class of mixed peptide/polyketide depsipeptides comprised of three amino acids (alanine, N-methyltryptophan, plus the unusual amino acid beta-tyrosine or alpha-methoxy-beta-tyrosine) and a polyketide chain ([E]-7-hydroxy-2,4,6-trimethyloct-4-enoic acid).
Pssm-ID: 341307 [Multi-domain] Cd Length: 436 Bit Score: 283.37 E-value: 2.05e-84
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 17 PERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMqDRCAS-IAAVIGILKLGGVFVPLDPLHPDERLVTM 95
Cdd:cd17652 1 PDAPAVVFGDETLTYAELNARANRLARLLAARGVGPERLVALAL-PRSAElVVAILAVLKAGAAYLPLDPAYPAERIAYM 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 96 LDTAEVSCLLcddaqferaetlqghegkyfvlrarqamsvqagskeayshsANATDPIYIYFTSGSTGKPKAVVGKNESL 175
Cdd:cd17652 80 LADARPALLL-----------------------------------------TTPDNLAYVIYTSGSTGRPKGVVVTHRGL 118
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 176 LHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPESREIIL-DPLRLVhwLEHSRVHVVHCTPSLFR 254
Cdd:cd17652 119 ANLAAAQIAAFDVGPGSRVLQFASPSFDASVWELLMALLAGATLVLAPAEELLPgEPLADL--LREHRITHVTLPPAALA 196
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 255 finhlSLTADSYPDLRYVLLAGETIRPESLKNWydnlGNRVRLVNLYGPTETTMIKLFY-PIKPEDVhresIPIGRPLPD 333
Cdd:cd17652 197 -----ALPPDDLPDLRTLVVAGEACPAELVDRW----APGRRMINAYGPTETTVCATMAgPLPGGGV----PPIGRPVPG 263
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 334 TSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPCRDQSGEimMYRTGDMGRWLPEGELALLGRK 411
Cdd:cd17652 264 TRVYVLDARLRPVPPGVPGELYIAGAGLARGYL--NRPGLTAerFVADPFGAPGSR--MYRTGDLARWRADGQLEFLGRA 339
|
410 420 430
....*....|....*....|....*....|....
gi 517718121 412 DNQVKIRGNRVELGDIEHRLTNMAGIREAVVRMR 445
Cdd:cd17652 340 DDQVKIRGFRIELGEVEAALTEHPGVAEAVVVVR 373
|
|
| LCL_NRPS-like |
cd19540 |
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; ... |
953-1363 |
9.02e-84 |
|
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380463 [Multi-domain] Cd Length: 433 Bit Score: 281.23 E-value: 9.02e-84
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 953 PLTAAQMRV-FMDeQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDGDPVQRIH--EHCDFHLE 1029
Cdd:cd19540 3 PLSFAQQRLwFLN-RLDGPSAAYNIPLALRLTGALDVDALRAALADVVARHESLRTVFPEDDGGPYQVVLpaAEARPDLT 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1030 IVHLQGQQLHTAVNGCI-RPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYEGR------ELH 1102
Cdd:cd19540 82 VVDVTEDELAARLAEAArRGFDLTAELPLRARLFRLGPDEHVLVLVVHHIAADGWSMAPLARDLATAYAARragrapDWA 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1103 DLPVQYVDFAQWQTSAPVVED-----LRRQEQFWQSMFADyrpLPG---IPTDHtPEANERSFAGGHITWEPDPVLSRRL 1174
Cdd:cd19540 162 PLPVQYADYALWQRELLGDEDdpdslAARQLAYWRETLAG---LPEeleLPTDR-PRPAVASYRGGTVEFTIDAELHARL 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1175 YAVAAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGRRRAEVRQVVGMFVNALAIRSYPEGDKPFSSFLQEIRGTM 1254
Cdd:cd19540 238 AALAREHGATLFMVLHAALAVLLSRLGAGDDIPIGTPVAGRGDEALDDLVGMFVNTLVLRTDVSGDPTFAELLARVRETD 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1255 LQAYEHQDYPLERLAKQLDLHHSRDH--LmFDTVFSMLNYEDFAVRSDDLQFEYAELPTLSEIYNLRVEIVES------P 1326
Cdd:cd19540 318 LAAFAHQDVPFERLVEALNPPRSTARhpL-FQVMLAFQNTAAATLELPGLTVEPVPVDTGVAKFDLSFTLTERrdadgaP 396
|
410 420 430
....*....|....*....|....*....|....*..
gi 517718121 1327 ERLRGTFKYGQELYEARTVSQLAQDYERILAAVAESP 1363
Cdd:cd19540 397 AGLTGELEYATDLFDRSTAERLADRFVRVLEAVVADP 433
|
|
| AMP-binding |
pfam00501 |
AMP-binding enzyme; |
9-418 |
1.03e-83 |
|
AMP-binding enzyme;
Pssm-ID: 459834 [Multi-domain] Cd Length: 417 Bit Score: 280.74 E-value: 1.03e-83
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIECG-QQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLH 87
Cdd:pfam00501 1 LERQAARTPDKTALEVGeGRRLTYRELDERANRLAAGLRALGVGKGDRVAILLPNSPEWVVAFLACLKAGAVYVPLNPRL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 88 PDERLVTMLDTAEVSCLLCDDAQ------------FERAETLQGHEGKYFVLRARQAMSVQAGSKEAYSHSANATDPIYI 155
Cdd:pfam00501 81 PAEELAYILEDSGAKVLITDDALkleellealgklEVVKLVLVLDRDPVLKEEPLPEEAKPADVPPPPPPPPDPDDLAYI 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 156 YFTSGSTGKPKAVVGKNESLLHFM----NWEASWLDLTDPMRVSQLTSIGFDA-VLRDIFVPICAGGTICIPEsREIILD 230
Cdd:pfam00501 161 IYTSGTTGKPKGVMLTHRNLVANVlsikRVRPRGFGLGPDDRVLSTLPLFHDFgLSLGLLGPLLAGATVVLPP-GFPALD 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 231 PLRLVHWLEHSRVHVVHCTPSLFRFI-NHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGNRVrlVNLYGPTETTMI 309
Cdd:pfam00501 240 PAALLELIERYKVTVLYGVPTLLNMLlEAGAPKRALLSSLRLVLSGGAPLPPELARRFRELFGGAL--VNGYGLTETTGV 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 310 KLFYPikPEDVHRESIP-IGRPLPDTSVYLLDEQ-QQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPcrdqs 385
Cdd:pfam00501 318 VTTPL--PLDEDLRSLGsVGRPLPGTEVKIVDDEtGEPVPPGEPGELCVRGPGVMKGYL--NDPELTAeaFDEDG----- 388
|
410 420 430
....*....|....*....|....*....|...
gi 517718121 386 geimMYRTGDMGRWLPEGELALLGRKDNQVKIR 418
Cdd:pfam00501 389 ----WYRTGDLGRRDEDGYLEIVGRKKDQIKLG 417
|
|
| LCL_NRPS |
cd19538 |
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; ... |
953-1363 |
8.71e-82 |
|
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380461 [Multi-domain] Cd Length: 432 Bit Score: 275.68 E-value: 8.71e-82
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 953 PLTAAQMRVFMDEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDGDPVQRIHEHCDFHLEIVH 1032
Cdd:cd19538 3 PLSFAQRRLWFLHQLEGPSATYNIPLVIKLKGKLDVQALQQALYDVVERHESLRTVFPEEDGVPYQLILEEDEATPKLEI 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1033 LQ--GQQLHTAVNGCIR-PFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYEGR------ELHD 1103
Cdd:cd19538 83 KEvdEEELESEINEAVRyPFDLSEEPPFRATLFELGENEHVLLLLLHHIAADGWSLAPLTRDLSKAYRARckgeapELAP 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1104 LPVQYVDFAQWQ-----TSAPVVEDLRRQEQFWQSMFADYRPLPGIPTDHtPEANERSFAGGHITWEPDPVLSRRLYAVA 1178
Cdd:cd19538 163 LPVQYADYALWQqellgDESDPDSLIARQLAYWKKQLAGLPDEIELPTDY-PRPAESSYEGGTLTFEIDSELHQQLLQLA 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1179 AEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGRRRAEVRQVVGMFVNALAIRSYPEGDKPFSSFLQEIRGTMLQAY 1258
Cdd:cd19538 242 KDNNVTLFMVLQAGFAALLTRLGAGTDIPIGSPVAGRNDDSLEDLVGFFVNTLVLRTDTSGNPSFRELLERVKETNLEAY 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1259 EHQDYPLERLAKQLDLHHSRD-HLMFDTVFSMLNyedfavrSDDLQFEYAELPTLSEIYN-------LRVEIVE-----S 1325
Cdd:cd19538 322 EHQDIPFERLVEALNPTRSRSrHPLFQIMLALQN-------TPQPSLDLPGLEAKLELRTvgsakfdLTFELREqyndgT 394
|
410 420 430
....*....|....*....|....*....|....*...
gi 517718121 1326 PERLRGTFKYGQELYEARTVSQLAQDYERILAAVAESP 1363
Cdd:cd19538 395 PNGIEGFIEYRTDLFDHETIEALAQRYLLLLESAVENP 432
|
|
| A_NRPS_SidN3_like |
cd05918 |
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); ... |
17-442 |
6.97e-80 |
|
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family of siderophore-synthesizing NRPS includes the third adenylation domain of SidN from the endophytic fungus Neotyphodium lolii, ferrichrome siderophore synthetase, HC-toxin synthetase, and enniatin synthase. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341242 [Multi-domain] Cd Length: 481 Bit Score: 272.11 E-value: 6.97e-80
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 17 PERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMqDRCA-SIAAVIGILKLGGVFVPLDPLHPDERLVTM 95
Cdd:cd05918 13 PDAPAVCAWDGSLTYAELDRLSSRLAHHLRSLGVGPGVFVPLCF-EKSKwAVVAMLAVLKAGGAFVPLDPSHPLQRLQEI 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 96 LDTAEVSCLLCDDAQferaetlqghegkyfvlrarqamsvqagskeayshsanatDPIYIYFTSGSTGKPKAVVGKNESL 175
Cdd:cd05918 92 LQDTGAKVVLTSSPS----------------------------------------DAAYVIFTSGSTGKPKGVVIEHRAL 131
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 176 LHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPeSREIILDplRLVHWLEHSRVHVVHCTPSLFRF 255
Cdd:cd05918 132 STSALAHGRALGLTSESRVLQFASYTFDVSILEIFTTLAAGGCLCIP-SEEDRLN--DLAGFINRLRVTWAFLTPSVARL 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 256 INHLSLtadsyPDLRYVLLAGETIRPESLKNWydnlGNRVRLVNLYGPTETTMIKLFYPIKPEDvhrESIPIGRPLPdTS 335
Cdd:cd05918 209 LDPEDV-----PSLRTLVLGGEALTQSDVDTW----ADRVRLINAYGPAECTIAATVSPVVPST---DPRNIGRPLG-AT 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 336 VYLLDEQ--QQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDP-----CRDQSGEiMMYRTGDMGRWLPEGELA 406
Cdd:cd05918 276 CWVVDPDnhDRLVPIGAVGELLIEGPILARGYL--NDPEKTAaaFIEDPawlkqEGSGRGR-RLYRTGDLVRYNPDGSLE 352
|
410 420 430
....*....|....*....|....*....|....*..
gi 517718121 407 LLGRKDNQVKIRGNRVELGDIEHRLTN-MAGIREAVV 442
Cdd:cd05918 353 YVGRKDTQVKIRGQRVELGEIEHHLRQsLPGAKEVVV 389
|
|
| A_NRPS_TlmIV_like |
cd12114 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including ... |
17-442 |
2.86e-79 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Streptoalloteichus tallysomycin biosynthesis genes; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the TLM biosynthetic gene cluster from Streptoalloteichus that consists of nine NRPS genes; the N-terminal module of TlmVI (NRPS-5) and the starter module of BlmVI (NRPS-5) are comprised of the acyl CoA ligase (AL) and acyl carrier protein (ACP)-like domains, which are thought to be involved in the biosynthesis of the beta-aminoalaninamide moiety.
Pssm-ID: 341279 [Multi-domain] Cd Length: 477 Bit Score: 270.30 E-value: 2.86e-79
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 17 PERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTML 96
Cdd:cd12114 1 PDATAVICGDGTLTYGELAERARRVAGALKAAGVRPGDLVAVTLPKGPEQVVAVLGILAAGAAYVPVDIDQPAARREAIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 97 DTAEVSCLLCDDAQferaetLQGHEGKYFVLRARQamSVQAGSKEAYSHSANATDPIYIYFTSGSTGKPKAVVGKNESLL 176
Cdd:cd12114 81 ADAGARLVLTDGPD------AQLDVAVFDVLILDL--DALAAPAPPPPVDVAPDDLAYVIFTSGSTGTPKGVMISHRAAL 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 177 HFMnweaswLDLTDPMRVSQ------LTSIGFDAVLRDIFVPICAGGTICIP-ESREiiLDPLRLVHWLEHSRVHVVHCT 249
Cdd:cd12114 153 NTI------LDINRRFAVGPddrvlaLSSLSFDLSVYDIFGALSAGATLVLPdEARR--RDPAHWAELIERHGVTLWNSV 224
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 250 PSLFRFI-NHLSLTADSYPDLRYVLLAGETIrPESLKNWYDNLGNRVRLVNLYGPTETTMIKLFYPIKPEDVHRESIPIG 328
Cdd:cd12114 225 PALLEMLlDVLEAAQALLPSLRLVLLSGDWI-PLDLPARLRALAPDARLISLGGATEASIWSIYHPIDEVPPDWRSIPYG 303
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 329 RPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFPSSHPDQTAFIPDPcrdqSGEiMMYRTGDMGRWLPEGELALL 408
Cdd:cd12114 304 RPLANQRYRVLDPRGRDCPDWVPGELWIGGRGVALGYLGDPELTAARFVTHP----DGE-RLYRTGDLGRYRPDGTLEFL 378
|
410 420 430
....*....|....*....|....*....|....
gi 517718121 409 GRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd12114 379 GRRDGQVKVRGYRIELGEIEAALQAHPGVARAVV 412
|
|
| EntF |
COG1020 |
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ... |
942-1376 |
1.02e-78 |
|
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440643 [Multi-domain] Cd Length: 1329 Bit Score: 285.98 E-value: 1.02e-78
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 942 RIEPAAKQAYYPLTAAQMRVFMDEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDGDPVQRIH 1021
Cdd:COG1020 8 ALPPAAAAAPLPLSAAQQRLWLLLLLLLGSAAYNLALALLLLGLLLVAALLLLAALLARRRRALRTRLRTRAGRPVQVIQ 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1022 EHCDFHLEIVHLQ--------GQQLHTAVNGCIRPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLA 1093
Cdd:COG1020 88 PVVAAPLPVVVLLvdlealaeAAAEAAAAAEALAPFDLLRGPLLRLLLLLLLLLLLLLLLALHHIISDGLSDGLLLAELL 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1094 ALY------EGRELHDLPVQYVDFAQWQTSAPVVEDLRRQEQFWQSMFADYRPLPGIPTDHTPEAnERSFAGGHITWEPD 1167
Cdd:COG1020 168 RLYlaayagAPLPLPPLPIQYADYALWQREWLQGEELARQLAYWRQQLAGLPPLLELPTDRPRPA-VQSYRGARVSFRLP 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1168 PVLSRRLYAVAAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGRRRAEVRQVVGMFVNALAIRSYPEGDKPFSSFL 1247
Cdd:COG1020 247 AELTAALRALARRHGVTLFMVLLAAFALLLARYSGQDDVVVGTPVAGRPRPELEGLVGFFVNTLPLRVDLSGDPSFAELL 326
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1248 QEIRGTMLQAYEHQDYPLERLAKQLDLHHSRDHL-MFDTVFSMLNYEDFAVRSDDLQFEYAELPTLSEIYNLRVEIVESP 1326
Cdd:COG1020 327 ARVRETLLAAYAHQDLPFERLVEELQPERDLSRNpLFQVMFVLQNAPADELELPGLTLEPLELDSGTAKFDLTLTVVETG 406
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|
gi 517718121 1327 ERLRGTFKYGQELYEARTVSQLAQDYERILAAVAESPNIKLKDIEIRTPQ 1376
Cdd:COG1020 407 DGLRLTLEYNTDLFDAATIERMAGHLVTLLEALAADPDQPLGDLPLLTAA 456
|
|
| A_NRPS_ApnA-like |
cd17644 |
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the ... |
17-445 |
6.93e-78 |
|
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Planktothrix agardhii anabaenopeptin synthetase (ApnA A1), which is capable of activating two chemically distinct amino acids (Arg and Tyr). Structural studies show that the architecture of the active site forces Arg to adopt a Tyr-like conformation, thus explaining the bispecificity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341299 [Multi-domain] Cd Length: 465 Bit Score: 265.84 E-value: 6.93e-78
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 17 PERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTML 96
Cdd:cd17644 14 PDAVAVVFEDQQLTYEELNTKANQLAHYLQSLGVKSESLVGICVERSLEMIIGLLAILKAGGAYVPLDPNYPQERLTYIL 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 97 DTAEVSCLLCddaqferaetlQGHegkyfvlrarqamsvqagskeayshsanatDPIYIYFTSGSTGKPKAVVGKNESLL 176
Cdd:cd17644 94 EDAQISVLLT-----------QPE------------------------------NLAYVIYTSGSTGKPKGVMIEHQSLV 132
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 177 HFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICI-PEsrEIILDPLRLVHWLEHSRVHVVHCTPSLFR- 254
Cdd:cd17644 133 NLSHGLIKEYGITSSDRVLQFASIAFDVAAEEIYVTLLSGATLVLrPE--EMRSSLEDFVQYIQQWQLTVLSLPPAYWHl 210
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 255 FINHLSLTADSYPD-LRYVLLAGETIRPESLKNWYDNLGNRVRLVNLYGPTETTMIKLFY-PIKPEDVHRESIPIGRPLP 332
Cdd:cd17644 211 LVLELLLSTIDLPSsLRLVIVGGEAVQPELVRQWQKNVGNFIQLINVYGPTEATIAATVCrLTQLTERNITSVPIGRPIA 290
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 333 DTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPCRDQSGEiMMYRTGDMGRWLPEGELALLGR 410
Cdd:cd17644 291 NTQVYILDENLQPVPVGVPGELHIGGVGLARGYL--NRPELTAekFISHPFNSSESE-RLYKTGDLARYLPDGNIEYLGR 367
|
410 420 430
....*....|....*....|....*....|....*
gi 517718121 411 KDNQVKIRGNRVELGDIEHRLTNMAGIREAVVRMR 445
Cdd:cd17644 368 IDNQVKIRGFRIELGEIEAVLSQHNDVKTAVVIVR 402
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
14-442 |
6.21e-74 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 273.37 E-value: 6.21e-74
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 14 AAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLV 93
Cdd:PRK12316 4562 RMTPDAVAVVFDEEKLTYAELNRRANRLAHALIARGVGPEVLVGIAMERSAEMMVGLLAVLKAGGAYVPLDPEYPRERLA 4641
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 94 TMLDTAEVSCLLCDDAQFERAETLQGhegkyfvlraRQAMSV-QAGSKEAYSHS--ANATDP---IYIYFTSGSTGKPKA 167
Cdd:PRK12316 4642 YMMEDSGAALLLTQSHLLQRLPIPDG----------LASLALdRDEDWEGFPAHdpAVRLHPdnlAYVIYTSGSTGRPKG 4711
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 168 VVGKNESLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPESReiILDPLRLVHWLEHSRVHVVH 247
Cdd:PRK12316 4712 VAVSHGSLVNHLHATGERYELTPDDRVLQFMSFSFDGSHEGLYHPLINGASVVIRDDS--LWDPERLYAEIHEHRVTVLV 4789
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 248 CTPSLFR-FINHLSLTADsYPDLRYVLLAGETIRPESLKNWYDNLGNrVRLVNLYGPTETTMIKLFYPIKPEDVH-RESI 325
Cdd:PRK12316 4790 FPPVYLQqLAEHAERDGE-PPSLRVYCFGGEAVAQASYDLAWRALKP-VYLFNGYGPTETTVTVLLWKARDGDACgAAYM 4867
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 326 PIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPCRDQSGEimMYRTGDMGRWLPEG 403
Cdd:PRK12316 4868 PIGTPLGNRSGYVLDGQLNPLPVGVAGELYLGGEGVARGYL--ERPALTAerFVPDPFGAPGGR--LYRTGDLARYRADG 4943
|
410 420 430
....*....|....*....|....*....|....*....
gi 517718121 404 ELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK12316 4944 VIDYLGRVDHQVKIRGFRIELGEIEARLREHPAVREAVV 4982
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
11-443 |
6.78e-74 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 273.19 E-value: 6.78e-74
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 11 RAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDE 90
Cdd:PRK12467 520 AQARQHPERPALVFGEQVLSYAELNRQANRLAHVLIAAGVGPDVLVGIAVERSIEMVVGLLAVLKAGGAYVPLDPEYPQD 599
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 91 RLVTMLDTAEVSCLLCDDAQFERAETLQGHEgkyfVLRARQAMSVQAGSKEAYSHSANATDPI-YIYFTSGSTGKPKAVV 169
Cdd:PRK12467 600 RLAYMLDDSGVRLLLTQSHLLAQLPVPAGLR----SLCLDEPADLLCGYSGHNPEVALDPDNLaYVIYTSGSTGQPKGVA 675
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 170 GKNESLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIpESREIILDPLRLVHWLEHSRVHVVHCT 249
Cdd:PRK12467 676 ISHGALANYVCVIAERLQLAADDSMLMVSTFAFDLGVTELFGALASGATLHL-LPPDCARDAEAFAALMADQGVTVLKIV 754
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 250 PSLFRFINHLSLTADSYPdLRYVLLAGETIRPESLKNWYDnLGNRVRLVNLYGPTETTMIKLFYPIKPEDVHRESIPIGR 329
Cdd:PRK12467 755 PSHLQALLQASRVALPRP-QRALVCGGEALQVDLLARVRA-LGPGARLINHYGPTETTVGVSTYELSDEERDFGNVPIGQ 832
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 330 PLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPCRDQSGEimMYRTGDMGRWLPEGELAL 407
Cdd:PRK12467 833 PLANLGLYILDHYLNPVPVGVVGELYIGGAGLARGYH--RRPALTAerFVPDPFGADGGR--LYRTGDLARYRADGVIEY 908
|
410 420 430
....*....|....*....|....*....|....*.
gi 517718121 408 LGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVVR 443
Cdd:PRK12467 909 LGRMDHQVKIRGFRIELGEIEARLLAQPGVREAVVL 944
|
|
| MenE/FadK |
COG0318 |
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid ... |
9-442 |
8.23e-74 |
|
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) is part of the Pathway/BioSystem: Menaquinone biosynthesis
Pssm-ID: 440087 [Multi-domain] Cd Length: 452 Bit Score: 253.58 E-value: 8.23e-74
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHP 88
Cdd:COG0318 5 LRRAAARHPDRPALVFGGRRLTYAELDARARRLAAALRALGVGPGDRVALLLPNSPEFVVAFLAALRAGAVVVPLNPRLT 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 89 DERLVTMLDTAEVSCLLCddaqferaetlqghegkyfvlrarqamsvqagskeayshsanatdpIYIYFTSGSTGKPKAV 168
Cdd:COG0318 85 AEELAYILEDSGARALVT----------------------------------------------ALILYTSGTTGRPKGV 118
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 169 VGKNESLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLR-DIFVPICAGGTICIPESReiilDPLRLVHWLEHSRVHVVH 247
Cdd:COG0318 119 MLTHRNLLANAAAIAAALGLTPGDVVLVALPLFHVFGLTvGLLAPLLAGATLVLLPRF----DPERVLELIERERVTVLF 194
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 248 CTPSLF-RFINHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGnrVRLVNLYGPTETTMIKLFYPIKPEDVHRESIp 326
Cdd:COG0318 195 GVPTMLaRLLRHPEFARYDLSSLRLVVSGGAPLPPELLERFEERFG--VRIVEGYGLTETSPVVTVNPEDPGERRPGSV- 271
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 327 iGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTAfipDPCRDqsGeimMYRTGDMGRWLPEGELA 406
Cdd:COG0318 272 -GRPLPGVEVRIVDEDGRELPPGEVGEIVVRGPNVMKGYW--NDPEATA---EAFRD--G---WLRTGDLGRLDEDGYLY 340
|
410 420 430
....*....|....*....|....*....|....*.
gi 517718121 407 LLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:COG0318 341 IVGRKKDMIISGGENVYPAEVEEVLAAHPGVAEAAV 376
|
|
| A_NRPS_PpsD_like |
cd17650 |
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation ... |
17-455 |
2.21e-73 |
|
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetase 1 (BacA) in Bacillus licheniformis, tyrocidine synthetase in Brevibacillus brevis, plipastatin synthase (PpsD, an important antifungal protein) in Bacillus subtilis and mannopeptimycin peptide synthetase (MppB) in Streptomyces hygroscopicus. Plipastatin has strong fungitoxic activity and is involved in inhibition of phospholipase A2 and biofilm formation. Bacitracin, a mixture of related cyclic peptides, is used as a polypeptide antibiotic while function of tyrocidine is thought to be regulation of sporulation. MppB is involved in biosynthetic pathway of mannopeptimycin, a novel class of mannosylated lipoglycopeptides. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341305 [Multi-domain] Cd Length: 447 Bit Score: 252.39 E-value: 2.21e-73
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 17 PERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTML 96
Cdd:cd17650 1 PDAIAVSDATRQLTYRELNERANQLARTLRGLGVAPGSVVGVCADRSLDAIVGLLAVLKAGGAYVPIDPDYPAERLQYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 97 DTAEVSCLLCDdaqferaetlqghegkyfvlrarqamsvqagskeayshsanATDPIYIYFTSGSTGKPKAVVGKNESLL 176
Cdd:cd17650 81 EDSGAKLLLTQ-----------------------------------------PEDLAYVIYTSGTTGKPKGVMVEHRNVA 119
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 177 H-FMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTIcIPESREIILDPLRLVHWLEHSRVHVVHCTPSLFR- 254
Cdd:cd17650 120 HaAHAWRREYELDSFPVRLLQMASFSFDVFAGDFARSLLNGGTL-VICPDEVKLDPAALYDLILKSRITLMESTPALIRp 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 255 FINHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGNRVRLVNLYGPTETTMIKLFYPIKPEDVHR-ESIPIGRPLPD 333
Cdd:cd17650 199 VMAYVYRNGLDLSAMRLLIVGSDGCKAQDFKTLAARFGQGMRIINSYGVTEATIDSTYYEEGRDPLGDsANVPIGRPLPN 278
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 334 TSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPCrdQSGEiMMYRTGDMGRWLPEGELALLGRK 411
Cdd:cd17650 279 TAMYVLDERLQPQPVGVAGELYIGGAGVARGYL--NRPELTAerFVENPF--APGE-RMYRTGDLARWRADGNVELLGRV 353
|
410 420 430 440
....*....|....*....|....*....|....*....|....
gi 517718121 412 DNQVKIRGNRVELGDIEHRLTNMAGIREAVVRMRAKADTPKGMA 455
Cdd:cd17650 354 DHQVKIRGFRIELGEIESQLARHPAIDEAVVAVREDKGGEARLC 397
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
14-442 |
1.51e-70 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 262.40 E-value: 1.51e-70
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 14 AAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLV 93
Cdd:PRK12467 1585 AATPEAVALVFGEQELTYGELNRRANRLAHRLIALGVGPEVLVGIAVERSLEMVVGLLAILKAGGAYVPLDPEYPRERLA 1664
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 94 TMLDTAEVSCLLCDDAQFERAETLQGHEGkyFVLRARQAMSvqagskEAYSHS--ANATDP---IYIYFTSGSTGKPKAV 168
Cdd:PRK12467 1665 YMIEDSGIELLLTQSHLQARLPLPDGLRS--LVLDQEDDWL------EGYSDSnpAVNLAPqnlAYVIYTSGSTGRPKGA 1736
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 169 VGKNESLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPESrEIILDPLRLVHWLEHSRVHVVHC 248
Cdd:PRK12467 1737 GNRHGALVNRLCATQEAYQLSAADVVLQFTSFAFDVSVWELFWPLINGARLVIAPP-GAHRDPEQLIQLIERQQVTTLHF 1815
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 249 TPSLFR-FINHLSLTADSyPDLRYVLLAGETIRPESLKNWYDNLGNRvRLVNLYGPTETTMIKLFYPIKPEDVH-RESIP 326
Cdd:PRK12467 1816 VPSMLQqLLQMDEQVEHP-LSLRRVVCGGEALEVEALRPWLERLPDT-GLFNLYGPTETAVDVTHWTCRRKDLEgRDSVP 1893
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 327 IGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPCRDQSGEimMYRTGDMGRWLPEGE 404
Cdd:PRK12467 1894 IGQPIANLSTYILDASLNPVPIGVAGELYLGGVGLARGYL--NRPALTAerFVADPFGTVGSR--LYRTGDLARYRADGV 1969
|
410 420 430
....*....|....*....|....*....|....*...
gi 517718121 405 LALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK12467 1970 IEYLGRIDHQVKIRGFRIELGEIEARLREQGGVREAVV 2007
|
|
| SgcC5_NRPS-like |
cd19539 |
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- ... |
953-1363 |
2.32e-69 |
|
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- bond forming activity and similar C-domains of modular NRPSs; SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. This subfamily also includes similar C-domains of modular NRPSs such as Penicillium chrysogenum N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase PCBAB. Condensation (C) domains of NRPSs normally catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380462 [Multi-domain] Cd Length: 427 Bit Score: 239.97 E-value: 2.32e-69
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 953 PLTAAQMRVFMDEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDGD-PVQRIHEHCDFHLEIV 1031
Cdd:cd19539 3 PLSFAQERLWFIDQGEDGGPAYNIPGAWRLTGPLDVEALREALRDVVARHEALRTLLVRDDGGvPRQEILPPGPAPLEVR 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1032 HL---------QGQQLHTAVNGciRPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYEGRE-- 1100
Cdd:cd19539 83 DLsdpdsdrerRLEELLRERES--RGFDLDEEPPIRAVLGRFDPDDHVLVLVAHHTAFDAWSLDVFARDLAALYAARRkg 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1101 ----LHDLPVQYVDFAQWQ---TSAPVVEDLRRqeqFWQSMFADYRPLPgIPTDHtPEANERSFAGGHITWEPDPVLSRR 1173
Cdd:cd19539 161 paapLPELRQQYKEYAAWQreaLAAPRAAELLD---FWRRRLRGAEPTA-LPTDR-PRPAGFPYPGADLRFELDAELVAA 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1174 LYAVAAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGRRRAEVRQVVGMFVNALAIRSYPEGDKPFSSFLQEIRGT 1253
Cdd:cd19539 236 LRELAKRARSSLFMVLLAAYCVLLRRYTGQTDIVVGTPVAGRNHPRFESTVGFFVNLLPLRVDVSDCATFRDLIARVRKA 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1254 MLQAYEHQDYPLERLAKQL-DLHHSRDHLMFDTVFSMLN--YEDFAVRSDDLQFEYAELPTLSEiYNLRVEIVESPERLR 1330
Cdd:cd19539 316 LVDAQRHQELPFQQLVAELpVDRDAGRHPLVQIVFQVTNapAGELELAGGLSYTEGSDIPDGAK-FDLNLTVTEEGTGLR 394
|
410 420 430
....*....|....*....|....*....|...
gi 517718121 1331 GTFKYGQELYEARTVSQLAQDYERILAAVAESP 1363
Cdd:cd19539 395 GSLGYATSLFDEETIQGFLADYLQVLRQLLANP 427
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
912-1370 |
7.08e-69 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 257.19 E-value: 7.08e-69
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 912 VELPLE--QVFehdtleeIAAYIDEQDSQYGVRIePAAKQA--YYPLTAAQMRVFMDEQLVNTGSGYHITTAFMIYGPID 987
Cdd:PRK12316 14 IELPLEkrRVF-------LATLRGEGVDFSLFPI-PAGVSSaeRDRLSYAQQRMWFLWQLEPQSGAYNLPSAVRLNGPLD 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 988 VTRLERACGQLIERHEALRTSFDIVDGDPVQRIHEHCDFHLEIVHLQGQ---QLHTAVN-----GCIRPFQLERAPLIRS 1059
Cdd:PRK12316 86 RQALERAFASLVQRHETLRTVFPRGADDSLAQVPLDRPLEVEFEDCSGLpeaEQEARLRdeaqrESLQPFDLCEGPLLRV 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1060 ILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYEGR------ELHDLPVQYVDFAQWQTSAPVVEDLRRQEQFWQS 1133
Cdd:PRK12316 166 RLLRLGEEEHVLLLTLHHIVSDGWSMNVLIEEFSRFYSAYatgaepGLPALPIQYADYALWQRSWLEAGEQERQLEYWRA 245
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1134 MFADYRPLPGIPTDHtPEANERSFAGGHITWEPDPVLSRRLYAVAAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVE 1213
Cdd:PRK12316 246 QLGEEHPVLELPTDH-PRPAVPSYRGSRYEFSIDPALAEALRGTARRQGLTLFMLLLGAFNVLLHRYSGQTDIRVGVPIA 324
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1214 GRRRAEVRQVVGMFVNALAIRSYPEGDKPFSSFLQEIRGTMLQAYEHQDYPLERLAKQLDLHHSRDHLMFDTVfsMLNYE 1293
Cdd:PRK12316 325 NRNRAEVEGLIGFFVNTQVLRSVFDGRTRVATLLAGVKDTVLGAQAHQDLPFERLVEALKVERSLSHSPLFQV--MYNHQ 402
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1294 ----DFAVRSD--DLQFEYAELPTLSEIYNLRVEIVESPERLRGTFKYGQELYEARTVSQLAQDYERILAAVAESPNIKL 1367
Cdd:PRK12316 403 plvaDIEALDTvaGLEFGQLEWKSRTTQFDLTLDTYEKGGRLHAALTYATDLFEARTVERMARHWQNLLRGMVENPQARV 482
|
...
gi 517718121 1368 KDI 1370
Cdd:PRK12316 483 DEL 485
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
912-1370 |
9.72e-69 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 256.63 E-value: 9.72e-69
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 912 VELPLEQvfehdtleeiAAYIDEQDSQYGVRIE----PAAKQAY--YPLTAAQMRVFMDEQLVNTGSGYHITTAFMIYGP 985
Cdd:PRK12467 14 ITLPLEK----------RRLYLEKMQEEGVSFAnlpiPQVRSAFerIPLSYAQERQWFLWQLDPDSAAYNIPTALRLRGE 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 986 IDVTRLERACGQLIERHEALRTSFDIVDGDPVQRIHEHCDFHLEIVHL-------QGQQLHTAVNGCI-RPFQLERAPLI 1057
Cdd:PRK12467 84 LDVSALRRAFDALVARHESLRTRFVQDEEGFRQVIDASLSLTIPLDDLaneqgraRESQIEAYINEEVaRPFDLANGPLL 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1058 RSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYEGR------ELHDLPVQYVDFAQWQTSAPVVEDLRRQEQFW 1131
Cdd:PRK12467 164 RVRLLRLADDEHVLVVTLHHIISDGWSMRVLVEELVQLYSAYsqgrepSLPALPIQYADYAIWQRSWLEAGERERQLAYW 243
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1132 QSMFADYRPLPGIPTDHtPEANERSFAGGHITWEPDPVLSRRLYAVAAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTP 1211
Cdd:PRK12467 244 QEQLGGEHTVLELPTDR-PRPAVPSYRGARLRVDLPQALSAGLKALAQREGVTLFMVLLASFQTLLHRYSGQSDIRIGVP 322
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1212 VEGRRRAEVRQVVGMFVNALAIRSYPEGDKPFSSFLQEIRGTMLQAYEHQDYPLERLAKQLDLHHSRDHL-MFDTVFSML 1290
Cdd:PRK12467 323 NANRNRVETERLIGFFVNTQVLKAEVDPQASFLELLQQVKRTALGAQAHQDLPFEQLVEALQPERSLSHSpLFQVMFNHQ 402
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1291 NyedfaVRSDDLQFEYAELP--TLSEI--------YNLRVEIVESPERLRGTFKYGQELYEARTVSQLAQDYERILAAVA 1360
Cdd:PRK12467 403 N-----TATGGRDREGAQLPglTVEELswarhtaqFDLALDTYESAQGLWAAFTYATDLFEATTIERLATHWRNLLEAIV 477
|
490
....*....|
gi 517718121 1361 ESPNIKLKDI 1370
Cdd:PRK12467 478 AEPRRRLGEL 487
|
|
| A_NRPS_ProA |
cd17656 |
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the ... |
17-446 |
8.36e-68 |
|
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains gramicidin S synthase 2 (also known as ATP-dependent proline adenylase or proline activase or ProA). ProA is a multifunctional enzyme involved in synthesis of the cyclic peptide antibiotic gramicidin S and able to activate and polymerize the amino acids proline, valine, ornithine and leucine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341311 [Multi-domain] Cd Length: 479 Bit Score: 237.37 E-value: 8.36e-68
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 17 PERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTML 96
Cdd:cd17656 2 PDAVAVVFENQKLTYRELNERSNQLARFLREKGVKKDSIVAIMMERSAEMIVGILGILKAGGAFVPIDPEYPEERRIYIM 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 97 DTAEVSCLLcddAQFERAETLQgHEGKYFVLrarQAMSVQAGSKEAYSHSANATDPIYIYFTSGSTGKPKAVVGKNESLL 176
Cdd:cd17656 82 LDSGVRVVL---TQRHLKSKLS-FNKSTILL---EDPSISQEDTSNIDYINNSDDLLYIIYTSGTTGKPKGVQLEHKNMV 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 177 HFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPeSREIILDPLRLVHWLEHSRVHVVHCTPSLFRFI 256
Cdd:cd17656 155 NLLHFEREKTNINFSDKVLQFATCSFDVCYQEIFSTLLSGGTLYII-REETKRDVEQLFDLVKRHNIEVVFLPVAFLKFI 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 257 NHLSLTADSYPD-LRYVLLAGETIRPESLKNWYDNLGNrVRLVNLYGPTETTMIKLfYPIKPEDVHRESIPIGRPLPDTS 335
Cdd:cd17656 234 FSEREFINRFPTcVKHIITAGEQLVITNEFKEMLHEHN-VHLHNHYGPSETHVVTT-YTINPEAEIPELPPIGKPISNTW 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 336 VYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPCRDQSgeiMMYRTGDMGRWLPEGELALLGRKDN 413
Cdd:cd17656 312 IYILDQEQQLQPQGIVGELYISGASVARGYL--NRQELTAekFFPDPFDPNE---RMYRTGDLARYLPDGNIEFLGRADH 386
|
410 420 430
....*....|....*....|....*....|...
gi 517718121 414 QVKIRGNRVELGDIEHRLTNMAGIREAVVRMRA 446
Cdd:cd17656 387 QVKIRGYRIELGEIEAQLLNHPGVSEAVVLDKA 419
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
14-442 |
3.63e-67 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 251.80 E-value: 3.63e-67
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 14 AAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLV 93
Cdd:PRK12316 522 ERTPEAPALAFGEETLDYAELNRRANRLAHALIERGVGPDVLVGVAMERSIEMVVALLAILKAGGAYVPLDPEYPAERLA 601
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 94 TMLDTAEVSCLLcddAQFERAETLQGHEGKYFVLRARQAMSVQAGSKEAYSHSANATDPIYIYFTSGSTGKPKAVVGKNE 173
Cdd:PRK12316 602 YMLEDSGVQLLL---SQSHLGRKLPLAAGVQVLDLDRPAAWLEGYSEENPGTELNPENLAYVIYTSGSTGKPKGAGNRHR 678
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 174 SLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPeSREIILDPLRLVHWLEHSRVHVVHCTPSLF 253
Cdd:PRK12316 679 ALSNRLCWMQQAYGLGVGDTVLQKTPFSFDVSVWEFFWPLMSGARLVVA-APGDHRDPAKLVELINREGVDTLHFVPSML 757
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 254 RFINHLSLTADSYPdLRYVLLAGETIRPESLKNWYDNLGNrVRLVNLYGPTETTmIKLFYPIKPEDVHReSIPIGRPLPD 333
Cdd:PRK12316 758 QAFLQDEDVASCTS-LRRIVCSGEALPADAQEQVFAKLPQ-AGLYNLYGPTEAA-IDVTHWTCVEEGGD-SVPIGRPIAN 833
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 334 TSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPCRDqsGEiMMYRTGDMGRWLPEGELALLGRK 411
Cdd:PRK12316 834 LACYILDANLEPVPVGVLGELYLAGRGLARGYH--GRPGLTAerFVPSPFVA--GE-RMYRTGDLARYRADGVIEYAGRI 908
|
410 420 430
....*....|....*....|....*....|.
gi 517718121 412 DNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK12316 909 DHQVKLRGLRIELGEIEARLLEHPWVREAAV 939
|
|
| A_NRPS_LgrA-like |
cd17645 |
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This ... |
17-455 |
9.45e-67 |
|
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes linear gramicidin synthetase (LgrA) in Brevibacillus brevis. LgrA has a formylation domain fused to the N-terminal end that formylates its substrate for linear gramicidin synthesis to proceed. This formyl group is essential for the clinically important antibacterial activity of gramicidin by enabling head-to-head gramicidin dimers to make a beta-helical pore in gram-positive bacterial membranes, allowing free passage of monovalent cations, destroying the ion gradient and killing bacteria. This family also includes bacitracin synthetase 1 (known as ATP-dependent cysteine adenylase or BA1); it activates cysteine, incorporates two D-amino acids, releases and cyclizes the mature bacitracin, an antibiotic that is a mixture of related cyclic peptides that disrupt gram positive bacteria by interfering with cell wall and peptidoglycan synthesis. Also included is surfactin synthetase which activates and polymerizes the amino acids Leu, Glu, Asp, and Val to form the antibiotic surfactin.
Pssm-ID: 341300 [Multi-domain] Cd Length: 440 Bit Score: 232.83 E-value: 9.45e-67
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 17 PERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTML 96
Cdd:cd17645 12 PDHVAVVDRGQSLTYKQLNEKANQLARHLRGKGVKPDDQVGIMLDKSLDMIAAILGVLKAGGAYVPIDPDYPGERIAYML 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 97 DTAEVSCLLcddaqferaetlqghegkyfvlrarqamsvqagskeayshsANATDPIYIYFTSGSTGKPKAVVGKNESLL 176
Cdd:cd17645 92 ADSSAKILL-----------------------------------------TNPDDLAYVIYTSGSTGLPKGVMIEHHNLV 130
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 177 HFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPESrEIILDPLRLVHWLEHSRVHVVHC-TPSLFRF 255
Cdd:cd17645 131 NLCEWHRPYFGVTPADKSLVYASFSFDASAWEIFPHLTAGAALHVVPS-ERRLDLDALNDYFNQEGITISFLpTGAAEQF 209
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 256 I---NHlsltadsypDLRYVLLAGETIRpESLKNWYdnlgnrvRLVNLYGPTETTMIKLFYPIKPEDvhrESIPIGRPLP 332
Cdd:cd17645 210 MqldNQ---------SLRVLLTGGDKLK-KIERKGY-------KLVNNYGPTENTVVATSFEIDKPY---ANIPIGKPID 269
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 333 DTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPcrDQSGEiMMYRTGDMGRWLPEGELALLGR 410
Cdd:cd17645 270 NTRVYILDEALQLQPIGVAGELCIAGEGLARGYL--NRPELTAekFIVHP--FVPGE-RMYRTGDLAKFLPDGNIEFLGR 344
|
410 420 430 440
....*....|....*....|....*....|....*....|....*
gi 517718121 411 KDNQVKIRGNRVELGDIEHRLTNMAGIREAVVRMRAKADTPKGMA 455
Cdd:cd17645 345 LDQQVKIRGYRIEPGEIEPFLMNHPLIELAAVLAKEDADGRKYLV 389
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
9-452 |
2.92e-65 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 243.41 E-value: 2.92e-65
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHP 88
Cdd:PRK10252 464 VAQQAAKTPDAPALADARYQFSYREMREQVVALANLLRERGVKPGDSVAVALPRSVFLTLALHAIVEAGAAWLPLDTGYP 543
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 89 DERLVTMLDTAEVSCLLCDDAQFERAETLQGHEgkyfVLRARQAMSVQAGSKEAYSHSAnatDPIYIYFTSGSTGKPKAV 168
Cdd:PRK10252 544 DDRLKMMLEDARPSLLITTADQLPRFADVPDLT----SLCYNAPLAPQGAAPLQLSQPH---HTAYIIFTSGSTGRPKGV 616
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 169 VGKNESLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICI--PESREiilDPLRLVHWLEHSRVHVV 246
Cdd:PRK10252 617 MVGQTAIVNRLLWMQNHYPLTADDVVLQKTPCSFDVSVWEFFWPFIAGAKLVMaePEAHR---DPLAMQQFFAEYGVTTT 693
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 247 HCTPS-LFRFINhlSLTADSYPD----LRYVLLAGETIrPESLKNWYDNLGNrVRLVNLYGPTETTMIKLFYPIKPED-- 319
Cdd:PRK10252 694 HFVPSmLAAFVA--SLTPEGARQscasLRQVFCSGEAL-PADLCREWQQLTG-APLHNLYGPTEAAVDVSWYPAFGEEla 769
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 320 -VHRESIPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPCRdqSGEiMMYRTGDM 396
Cdd:PRK10252 770 aVRGSSVPIGYPVWNTGLRILDARMRPVPPGVAGDLYLTGIQLAQGYL--GRPDLTAsrFIADPFA--PGE-RMYRTGDV 844
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*.
gi 517718121 397 GRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVVRMRAKADTPK 452
Cdd:PRK10252 845 ARWLDDGAVEYLGRSDDQLKIRGQRIELGEIDRAMQALPDVEQAVTHACVINQAAA 900
|
|
| C_NRPS-like |
cd19066 |
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of ... |
952-1363 |
7.66e-65 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long, with various activities such as antibiotic, antifungal, antitumor and immunosuppression. There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380453 [Multi-domain] Cd Length: 427 Bit Score: 226.91 E-value: 7.66e-65
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 952 YPLTAAQMRVFMDEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDGDPVQRIHEH-CDFHLEI 1030
Cdd:cd19066 2 IPLSPMQRGMWFLKKLATDPSAFNVAIEMFLTGSLDLARLKQALDAVMERHDVLRTRFCEEAGRYEQVVLDKtVRFRIEI 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1031 VHLQGQQLHTAV------NGCIRPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYEG-----R 1099
Cdd:cd19066 82 IDLRNLADPEARllelidQIQQTIYDLERGPLVRVALFRLADERDVLVVAIHHIIVDGGSFQILFEDISSVYDAaerqkP 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1100 ELHDLPVQYVDFAQWQTSAPVVEDLRRQEQFWQSMFADYRPLPGIPTDHTPEANeRSFAGGHITWEPDPVLSRRLYAVAA 1179
Cdd:cd19066 162 TLPPPVGSYADYAAWLEKQLESEAAQADLAYWTSYLHGLPPPLPLPKAKRPSQV-ASYEVLTLEFFLRSEETKRLREVAR 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1180 EQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGRRRAEVRQVVGMFVNALAIRSYPEGDKPFSSFLQEIRGTMLQAYE 1259
Cdd:cd19066 241 ESGTTPTQLLLAAFALALKRLTASIDVVIGLTFLNRPDEAVEDTIGLFLNLLPLRIDTSPDATFPELLKRTKEQSREAIE 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1260 HQDYPLERLAKQLDLHHSR-DHLMFDTVFSMLNYeDFAVRSDDLQFEYAELPTLSE--IYNLRVEIVESPER-LRGTFKY 1335
Cdd:cd19066 321 HQRVPFIELVRHLGVVPEApKHPLFEPVFTFKNN-QQQLGKTGGFIFTTPVYTSSEgtVFDLDLEASEDPDGdLLLRLEY 399
|
410 420
....*....|....*....|....*...
gi 517718121 1336 GQELYEARTVSQLAQDYERILAAVAESP 1363
Cdd:cd19066 400 SRGVYDERTIDRFAERYMTALRQLIENP 427
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
17-442 |
6.73e-64 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 241.22 E-value: 6.73e-64
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 17 PERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTML 96
Cdd:PRK12467 3109 PEAPALVFGDQQLSYAELNRRANRLAHRLIAIGVGPDVLVGVAVERSVEMIVALLAVLKAGGAYVPLDPEYPRERLAYMI 3188
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 97 DTAEVSCLLCDDAQFERAEtlqghegkyfVLRARQAMSVQAGSKEAYSHS--ANATDP---IYIYFTSGSTGKPKAVVGK 171
Cdd:PRK12467 3189 EDSGVKLLLTQAHLLEQLP----------APAGDTALTLDRLDLNGYSENnpSTRVMGenlAYVIYTSGSTGKPKGVGVR 3258
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 172 NESLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPESReiILDPLRLVHWLEHSRVHVVHCTPS 251
Cdd:PRK12467 3259 HGALANHLCWIAEAYELDANDRVLLFMSFSFDGAQERFLWTLICGGCLVVRDND--LWDPEELWQAIHAHRISIACFPPA 3336
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 252 LFRFINHLSLTADsYPDLRYVLLAGETIRPESLKNWYDNLGNRvRLVNLYGPTETTMIKLFYPIKPEDVHRES-IPIGRP 330
Cdd:PRK12467 3337 YLQQFAEDAGGAD-CASLDIYVFGGEAVPPAAFEQVKRKLKPR-GLTNGYGPTEAVVTVTLWKCGGDAVCEAPyAPIGRP 3414
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 331 LPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPCRDQSGEimMYRTGDMGRWLPEGELALL 408
Cdd:PRK12467 3415 VAGRSIYVLDGQLNPVPVGVAGELYIGGVGLARGYH--QRPSLTAerFVADPFSGSGGR--LYRTGDLARYRADGVIEYL 3490
|
410 420 430
....*....|....*....|....*....|....
gi 517718121 409 GRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK12467 3491 GRIDHQVKIRGFRIELGEIEARLLQHPSVREAVV 3524
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
14-442 |
1.91e-63 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 239.86 E-value: 1.91e-63
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 14 AAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLV 93
Cdd:PRK12316 2014 ARAPEAIAVVFGDQHLSYAELDSRANRLAHRLRARGVGPEVRVAIAAERSFELVVALLAVLKAGGAYVPLDPNYPAERLA 2093
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 94 TMLDTAEVSCLLCDDAQFERAETLQGHEgkyfVLRARQAMSVQAGSKEAYSHSANATDPIYIYFTSGSTGKPKAVVGKNE 173
Cdd:PRK12316 2094 YMLEDSGAALLLTQRHLLERLPLPAGVA----RLPLDRDAEWADYPDTAPAVQLAGENLAYVIYTSGSTGLPKGVAVSHG 2169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 174 SLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPESReiILDPLRLVHWLEHSRVHVVHCTPS-L 252
Cdd:PRK12316 2170 ALVAHCQAAGERYELSPADCELQFMSFSFDGAHEQWFHPLLNGARVLIRDDE--LWDPEQLYDEMERHGVTILDFPPVyL 2247
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 253 FRFINHLSLTADSyPDLRYVLLAGETIRPESLKNWYDNLGNrVRLVNLYGPTETTMIKLFYPIKPEDVH-RESIPIGRPL 331
Cdd:PRK12316 2248 QQLAEHAERDGRP-PAVRVYCFGGEAVPAASLRLAWEALRP-VYLFNGYGPTEAVVTPLLWKCRPQDPCgAAYVPIGRAL 2325
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 332 PDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPCrDQSGEiMMYRTGDMGRWLPEGELALLG 409
Cdd:PRK12316 2326 GNRRAYILDADLNLLAPGMAGELYLGGEGLARGYL--NRPGLTAerFVPDPF-SASGE-RLYRTGDLARYRADGVVEYLG 2401
|
410 420 430
....*....|....*....|....*....|...
gi 517718121 410 RKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK12316 2402 RIDHQVKIRGFRIELGEIEARLQAHPAVREAVV 2434
|
|
| A_NRPS_ACVS-like |
cd17648 |
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV ... |
17-458 |
4.63e-63 |
|
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV synthetase (ACVS, EC 6.3.2.26; also known as N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase or delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase) is involved in medically important antibiotic biosynthesis. ACV synthetase is active in an early step in the penicillin G biosynthesis pathway which involves the formation of the tripeptide 6-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine (ACV); each of the constituent amino acids of the tripeptide ACV are activated as aminoacyl-adenylates with peptide bonds formed through the participation of amino acid thioester intermediates. ACV is then cyclized by the action of isopenicillin N synthase.
Pssm-ID: 341303 [Multi-domain] Cd Length: 453 Bit Score: 222.66 E-value: 4.63e-63
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 17 PERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDH-IGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLvtm 95
Cdd:cd17648 1 PDRVAVVYGDKRLTYRELNERANRLAHYLLSVAEIRPDDlVGLVLDKSELMIIAILAVWKAGAAYVPIDPSYPDERI--- 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 96 ldtaevscllcddaqferaetlqghegkYFVLRARQAMSVQAGSkeayshsanaTDPIYIYFTSGSTGKPKAVVGKNESL 175
Cdd:cd17648 78 ----------------------------QFILEDTGARVVITNS----------TDLAYAIYTSGTTGKPKGVLVEHGSV 119
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 176 LHFMNWEASWLDLTDP--MRVSQLTSIGFDAVLRDIFVPICAGGTICIPESrEIILDPLRLVHWLEHSRVHVVHCTPSLF 253
Cdd:cd17648 120 VNLRTSLSERYFGRDNgdEAVLFFSNYVFDFFVEQMTLALLNGQKLVVPPD-EMRFDPDRFYAYINREKVTYLSGTPSVL 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 254 RFINHLSLtadsyPDLRYVLLAGETIRPESlknwYDNLGNRV--RLVNLYGPTETTM--IKLFYPikpeDVHRESIPIGR 329
Cdd:cd17648 199 QQYDLARL-----PHLKRVDAAGEEFTAPV----FEKLRSRFagLIINAYGPTETTVtnHKRFFP----GDQRFDKSLGR 265
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 330 PLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPC-----RDQSGEIMMYRTGDMGRWLPE 402
Cdd:cd17648 266 PVRNTKCYVLNDAMKRVPVGAVGELYLGGDGVARGYL--NRPELTAerFLPNPFqteqeRARGRNARLYKTGDLVRWLPS 343
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*.
gi 517718121 403 GELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVVRMRAKADTPKGMAQQH 458
Cdd:cd17648 344 GELEYLGRNDFQVKIRGQRIEPGEVEAALASYPGVRECAVVAKEDASQAQSRIQKY 399
|
|
| COG4908 |
COG4908 |
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General ... |
954-1186 |
2.15e-61 |
|
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General function prediction only];
Pssm-ID: 443936 [Multi-domain] Cd Length: 243 Bit Score: 210.28 E-value: 2.15e-61
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 954 LTAAQMRVFMDEQlvnTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDGDPVQRIHEHCDFHLEIVHL 1033
Cdd:COG4908 1 LSPAQKRFLFLEP---GSNAYNIPAVLRLEGPLDVEALERALRELVRRHPALRTRFVEEDGEPVQRIDPDADLPLEVVDL 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1034 QG-------QQLHTAVNGCI-RPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYEGRE----- 1100
Cdd:COG4908 78 SAlpepereAELEELVAEEAsRPFDLARGPLLRAALIRLGEDEHVLLLTIHHIISDGWSLGILLRELAALYAALLegepp 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1101 -LHDLPVQYVDFAQWQTSAPVVEDLRRQEQFWQSMFADYRPLPGIPTDHtPEANERSFAGGHITWEPDPVLSRRLYAVAA 1179
Cdd:COG4908 158 pLPELPIQYADYAAWQRAWLQSEALEKQLEYWRQQLAGAPPVLELPTDR-PRPAVQTFRGATLSFTLPAELTEALKALAK 236
|
....*..
gi 517718121 1180 EQQTTLF 1186
Cdd:COG4908 237 AHGATVN 243
|
|
| DCL_NRPS |
cd19543 |
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the ... |
952-1363 |
5.33e-57 |
|
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor; The DCL-type Condensation (C) domain catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. This domain is D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains in addition to the LCL- and DCL-types such as starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380465 [Multi-domain] Cd Length: 423 Bit Score: 203.97 E-value: 5.33e-57
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 952 YPLTAAQ--MrVFmdEQLVNTGSG-YHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIV-DGDPVQRIHEHCDFH 1027
Cdd:cd19543 2 YPLSPMQegM-LF--HSLLDPGSGaYVEQMVITLEGPLDPDRFRAAWQAVVDRHPILRTSFVWEgLGEPLQVVLKDRKLP 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1028 LEIVHLQG----------QQLHTAVNgcIRPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALY- 1096
Cdd:cd19543 79 WRELDLSHlseaeqeaelEALAEEDR--ERGFDLARAPLMRLTLIRLGDDRYRLVWSFHHILLDGWSLPILLKELFAIYa 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1097 ---EGRELHDLPVQ-YVDFAQWqtsapvvedLRRQ-----EQFWQSMFADYRPLPGIPTDhTPEANERSFAGGHITWEPD 1167
Cdd:cd19543 157 algEGQPPSLPPVRpYRDYIAW---------LQRQdkeaaEAYWREYLAGFEEPTPLPKE-LPADADGSYEPGEVSFELS 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1168 PVLSRRLYAVAAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGrRRAE---VRQVVGMFVNALAIRSYPEGDKPFS 1244
Cdd:cd19543 227 AELTARLQELARQHGVTLNTVVQGAWALLLSRYSGRDDVVFGTTVSG-RPAElpgIETMVGLFINTLPVRVRLDPDQTVL 305
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1245 SFLQEIRGTMLQAYEHQDYPLERLAKQLDLHHSrdhlMFDTVFSMLNY-EDFAVR----SDDLQFEYAELPTLSEiYNLR 1319
Cdd:cd19543 306 ELLKDLQAQQLELREHEYVPLYEIQAWSEGKQA----LFDHLLVFENYpVDESLEeeqdEDGLRITDVSAEEQTN-YPLT 380
|
410 420 430 440
....*....|....*....|....*....|....*....|....
gi 517718121 1320 VEIVESpERLRGTFKYGQELYEARTVSQLAQDYERILAAVAESP 1363
Cdd:cd19543 381 VVAIPG-EELTIKLSYDAEVFDEATIERLLGHLRRVLEQVAANP 423
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
14-442 |
1.16e-56 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 217.90 E-value: 1.16e-56
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 14 AAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLV 93
Cdd:PRK12316 3068 ERTPDAVALAFGEQRLSYAELNRRANRLAHRLIERGVGPDVLVGVAVERSLEMVVGLLAILKAGGAYVPLDPEYPEERLA 3147
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 94 TMLDTAEVSCLLCddaqferaetlQGHEgKYFVLRARQAMSVQAGSKEAYSHS-ANATDP---IYIYFTSGSTGKPKAVV 169
Cdd:PRK12316 3148 YMLEDSGAQLLLS-----------QSHL-RLPLAQGVQVLDLDRGDENYAEANpAIRTMPenlAYVIYTSGSTGKPKGVG 3215
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 170 GKNESLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIpESREIILDPLRLVHWLEHSRVHVVHCT 249
Cdd:PRK12316 3216 IRHSALSNHLCWMQQAYGLGVGDRVLQFTTFSFDVFVEELFWPLMSGARVVL-AGPEDWRDPALLVELINSEGVDVLHAY 3294
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 250 PSLFRFINHlSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGnrvrLVNLYGPTETTMIKLFYPIKPEdvHRESIPIGR 329
Cdd:PRK12316 3295 PSMLQAFLE-EEDAHRCTSLKRIVCGGEALPADLQQQVFAGLP----LYNLYGPTEATITVTHWQCVEE--GKDAVPIGR 3367
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 330 PLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPCrdQSGEiMMYRTGDMGRWLPEGELAL 407
Cdd:PRK12316 3368 PIANRACYILDGSLEPVPVGALGELYLGGEGLARGYH--NRPGLTAerFVPDPF--VPGE-RLYRTGDLARYRADGVIEY 3442
|
410 420 430
....*....|....*....|....*....|....*
gi 517718121 408 LGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK12316 3443 IGRVDHQVKIRGFRIELGEIEARLLEHPWVREAVV 3477
|
|
| C_PKS-NRPS |
cd19532 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
953-1363 |
2.78e-55 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHxxxD motif, a few such as Monascus pilosus lovastatin nonaketide synthase MokA have a non-canonical HRxxxD motif in the C-domain and are unable to catalyze amide-bond formation. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380455 [Multi-domain] Cd Length: 421 Bit Score: 198.83 E-value: 2.78e-55
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 953 PLTAAQMRV-FMDeQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSF--DIVDGDPVQRIHEHCDFHLE 1029
Cdd:cd19532 3 PMSFGQSRFwFLQ-QYLEDPTTFNVTFSYRLTGPLDVARLERAVRAVGQRHEALRTCFftDPEDGEPMQGVLASSPLRLE 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1030 IVHLQG--------QQLHTAVngcirpFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYEGREL 1101
Cdd:cd19532 82 HVQISDeaeveeefERLKNHV------YDLESGETMRIVLLSLSPTEHYLIFGYHHIAMDGVSFQIFLRDLERAYNGQPL 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1102 HDLPVQYVDFAQWQTSAPVVEDLRRQEQFWQSMFAD-YRPLPGIPTDHTPE-------ANERSFAggHItwepDPVLSRR 1173
Cdd:cd19532 156 LPPPLQYLDFAARQRQDYESGALDEDLAYWKSEFSTlPEPLPLLPFAKVKSrppltryDTHTAER--RL----DAALAAR 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1174 LYAVAAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGRRRAEVRQVVGMFVNALAIRSYPEGDKPFSSFLQEIRGT 1253
Cdd:cd19532 230 IKEASRKLRVTPFHFYLAALQVLLARLLDVDDICIGIADANRTDEDFMETIGFFLNLLPLRFRRDPSQTFADVLKETRDK 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1254 MLQAYEHQDYPLERLAKQLDLHHSRDHL-MFDTVFsmlNY-----EDFAVRSDDLQFEYAELPTLSeiYNLRVEIVESPE 1327
Cdd:cd19532 310 AYAALAHSRVPFDVLLDELGVPRSATHSpLFQVFI---NYrqgvaESRPFGDCELEGEEFEDARTP--YDLSLDIIDNPD 384
|
410 420 430
....*....|....*....|....*....|....*....
gi 517718121 1328 ---RLrgTFKYGQELYEARTVSQLAQDYERILAAVAESP 1363
Cdd:cd19532 385 gdcLL--TLKVQSSLYSEEDAELLLDSYVNLLEAFARDP 421
|
|
| C_PKS-NRPS_PksJ-like |
cd20484 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
952-1363 |
1.89e-54 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs), similar to Bacillus subtilis PksJ; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily have the typical C-domain HHxxxD motif. PksJ is involved in some intermediate steps for the synthesis of the antibiotic polyketide bacillaene which is important in secondary metabolism. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380472 [Multi-domain] Cd Length: 430 Bit Score: 196.77 E-value: 1.89e-54
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 952 YPLTAAQMRVFMDEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDGDPVQRIHEHCDFHLE-- 1029
Cdd:cd20484 2 SPLSEGQKGLWMLQKMSPEMSAYNVPLCFRFSSKLDVEKFKQACQFVLEQHPILKSVIEEEDGVPFQKIEPSKPLSFQee 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1030 -IVHLQGQQ----LHTAVNgciRPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDL----AALYEGRE 1100
Cdd:cd20484 82 dISSLKESEiiayLREKAK---EPFVLENGPLMRVHLFSRSEQEHFVLITIHHIIFDGSSSLTLIHSLldayQALLQGKQ 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1101 LHDLPV--QYVDFAQWQTSAPVVEDLRRQEQFWQSMFADYRPLPGIPTDHtPEANERSFAGGHITWEPDPVLSRRLYAVA 1178
Cdd:cd20484 159 PTLASSpaSYYDFVAWEQDMLAGAEGEEHRAYWKQQLSGTLPILELPADR-PRSSAPSFEGQTYTRRLPSELSNQIKSFA 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1179 AEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGRRRAEVRQVVGMFVNALAIRSYPEGDKPFSSFLQEIRGTMLQAY 1258
Cdd:cd20484 238 RSQSINLSTVFLGIFKLLLHRYTGQEDIIVGMPTMGRPEERFDSLIGYFINMLPIRSRILGEETFSDFIRKLQLTVLDGL 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1259 EHQDYPLERLAKQLDLHHSRDHL-MFDTVFSmlnYEDFaVRSDDLQFEYAELPTLSEI-----------YNLRVEIVESP 1326
Cdd:cd20484 318 DHAAYPFPAMVRDLNIPRSQANSpVFQVAFF---YQNF-LQSTSLQQFLAEYQDVLSIefvegihqegeYELVLEVYEQE 393
|
410 420 430
....*....|....*....|....*....|....*..
gi 517718121 1327 ERLRGTFKYGQELYEARTVSQLAQDYERILAAVAESP 1363
Cdd:cd20484 394 DRFTLNIKYNPDLFDASTIERMMEHYVKLAEELIANP 430
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
9-452 |
1.64e-52 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 204.25 E-value: 1.64e-52
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHP 88
Cdd:PRK05691 1137 LNEQARQTPERIALVWDGGSLDYAELHAQANRLAHYLRDKGVGPDVCVAIAAERSPQLLVGLLAILKAGGAYVPLDPDYP 1216
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 89 DERLVTMLDTAEVSCLLCDDAQFERAETLQGhegkyFVLRARQAMSVQAGSKEAYSHSANATDPIYIYFTSGSTGKPKAV 168
Cdd:PRK05691 1217 AERLAYMLADSGVELLLTQSHLLERLPQAEG-----VSAIALDSLHLDSWPSQAPGLHLHGDNLAYVIYTSGSTGQPKGV 1291
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 169 VGKNESLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIP---ESReiilDPLRLVHWLEHSRVHV 245
Cdd:PRK05691 1292 GNTHAALAERLQWMQATYALDDSDVLMQKAPISFDVSVWECFWPLITGCRLVLAgpgEHR----DPQRIAELVQQYGVTT 1367
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 246 VHCTPSLFRFINHLSLTADSYpDLRYVLLAGETIRPEsLKNWYDNLGNRVRLVNLYGPTETTMIKLFYPIKPEDVHREsi 325
Cdd:PRK05691 1368 LHFVPPLLQLFIDEPLAAACT-SLRRLFSGGEALPAE-LRNRVLQRLPQVQLHNRYGPTETAINVTHWQCQAEDGERS-- 1443
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 326 PIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFPSshPDQTA--FIPDPCRDQSGEimMYRTGDMGRWLPEG 403
Cdd:PRK05691 1444 PIGRPLGNVLCRVLDAELNLLPPGVAGELCIGGAGLARGYLGR--PALTAerFVPDPLGEDGAR--LYRTGDRARWNADG 1519
|
410 420 430 440
....*....|....*....|....*....|....*....|....*....
gi 517718121 404 ELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVVRMRAKADTPK 452
Cdd:PRK05691 1520 ALEYLGRLDQQVKLRGFRVEPEEIQARLLAQPGVAQAAVLVREGAAGAQ 1568
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
14-442 |
1.64e-51 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 200.78 E-value: 1.64e-51
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 14 AAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLV 93
Cdd:PRK05691 3731 AAHPQRIAASCLDQQWSYAELNRAANRLGHALRAAGVGVDQPVALLAERGLDLLGMIVGSFKAGAGYLPLDPGLPAQRLQ 3810
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 94 TMLDTAEVSCLLCDDAQFERAETLQGHEG-----KYFVLRARQAMSVQAGSKEAYSHSANATdpiYIYFTSGSTGKPKAV 168
Cdd:PRK05691 3811 RIIELSRTPVLVCSAACREQARALLDELGcanrpRLLVWEEVQAGEVASHNPGIYSGPDNLA---YVIYTSGSTGLPKGV 3887
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 169 VGKNESLLHFMNWEASWLDLTDPMRVSQLTSIGFD-AVLRDIFVPICAGGTICIPESreIILDPLRLVHWLEHSRVHVVH 247
Cdd:PRK05691 3888 MVEQRGMLNNQLSKVPYLALSEADVIAQTASQSFDiSVWQFLAAPLFGARVEIVPNA--IAHDPQGLLAHVQAQGITVLE 3965
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 248 CTPSLFRFInhLSLTADSYPDLRYVLLAGETIRPESLKNW---YDNLGnrvrLVNLYGPTETTMIKLFYPIKPEDVHRES 324
Cdd:PRK05691 3966 SVPSLIQGM--LAEDRQALDGLRWMLPTGEAMPPELARQWlqrYPQIG----LVNAYGPAECSDDVAFFRVDLASTRGSY 4039
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 325 IPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDPcRDQSGEiMMYRTGDMGRWLPE 402
Cdd:PRK05691 4040 LPIGSPTDNNRLYLLDEALELVPLGAVGELCVAGTGVGRGYV--GDPLRTAlaFVPHP-FGAPGE-RLYRTGDLARRRSD 4115
|
410 420 430 440
....*....|....*....|....*....|....*....|
gi 517718121 403 GELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK05691 4116 GVLEYVGRIDHQVKIRGYRIELGEIEARLHEQAEVREAAV 4155
|
|
| starter-C_NRPS |
cd19533 |
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases ... |
952-1363 |
1.32e-48 |
|
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. While standard C-domains catalyze peptide bond formation between two amino acids, an initial, ('starter') C-domain may instead acylate an amino acid with a fatty acid. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380456 [Multi-domain] Cd Length: 419 Bit Score: 179.49 E-value: 1.32e-48
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 952 YPLTAAQMRVFMDEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDGDPVQRIHEHCDFHLEIV 1031
Cdd:cd19533 2 LPLTSAQRGVWFAEQLDPEGSIYNLAEYLEITGPVDLAVLERALRQVIAEAETLRLRFTEEEGEPYQWIDPYTPVPIRHI 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1032 HLQGQQL-HTAVNGCIR-----PFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALY----EGREL 1101
Cdd:cd19533 82 DLSGDPDpEGAAQQWMQedlrkPLPLDNDPLFRHALFTLGDNRHFWYQRVHHIVMDGFSFALFGQRVAEIYtallKGRPA 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1102 HDLPV-----------QYVDFAQWQtsapvvedlrRQEQFWQSMFADYRPlpgiPTDHTPEANERSFAGGHITWEPDPVL 1170
Cdd:cd19533 162 PPAPFgsfldlveeeqAYRQSERFE----------RDRAFWTEQFEDLPE----PVSLARRAPGRSLAFLRRTAELPPEL 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1171 SRRLYAVAAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGRRRAEVRQVVGMFVNALAIRSYPEGDKPFSSFLQEI 1250
Cdd:cd19533 228 TRTLLEAAEAHGASWPSFFIALVAAYLHRLTGANDVVLGVPVMGRLGAAARQTPGMVANTLPLRLTVDPQQTFAELVAQV 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1251 RGTMLQAYEHQDYPLERLAKQLDLHHSRDHLmFDTVfsmLNYE--DFAVRSDDLQFEYAelpTLSEIYNLRVEIVESPER 1328
Cdd:cd19533 308 SRELRSLLRHQRYRYEDLRRDLGLTGELHPL-FGPT---VNYMpfDYGLDFGGVVGLTH---NLSSGPTNDLSIFVYDRD 380
|
410 420 430
....*....|....*....|....*....|....*....
gi 517718121 1329 ----LRGTFKYGQELYEARTVSQLAQDYERILAAVAESP 1363
Cdd:cd19533 381 desgLRIDFDANPALYSGEDLARHQERLLRLLEEAAADP 419
|
|
| AFD_class_I |
cd04433 |
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as ... |
151-442 |
1.69e-48 |
|
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as the ANL (acyl-CoA synthetases, the NRPS adenylation domains, and the Luciferase enzymes) superfamily. It includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases.The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341228 [Multi-domain] Cd Length: 336 Bit Score: 176.32 E-value: 1.69e-48
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 151 DPIYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPESReiilD 230
Cdd:cd04433 1 DPALILYTSGTTGKPKGVVLSHRNLLAAAAALAASGGLTEGDVFLSTLPLFHIGGLFGLLGALLAGGTVVLLPKF----D 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 231 PLRLVHWLEHSRVHVVHCTPSLFRFINHLSLTAD-SYPDLRYVLLAGETIRPESLKNWYDNLGnrVRLVNLYGPTETTMI 309
Cdd:cd04433 77 PEAALELIEREKVTILLGVPTLLARLLKAPESAGyDLSSLRALVSGGAPLPPELLERFEEAPG--IKLVNGYGLTETGGT 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 310 KLFYPikPEDVHRESIPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTAFIpdpcrDQSGeim 389
Cdd:cd04433 155 VATGP--PDDDARKPGSVGRPVPGVEVRIVDPDGGELPPGEIGELVVRGPSVMKGYW--NNPEATAAV-----DEDG--- 222
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|...
gi 517718121 390 MYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd04433 223 WYRTGDLGRLDEDGYLYIVGRLKDMIKSGGENVYPAEVEAVLLGHPGVAEAAV 275
|
|
| PRK04813 |
PRK04813 |
D-alanine--poly(phosphoribitol) ligase subunit DltA; |
17-442 |
2.14e-47 |
|
D-alanine--poly(phosphoribitol) ligase subunit DltA;
Pssm-ID: 235313 [Multi-domain] Cd Length: 503 Bit Score: 178.17 E-value: 2.14e-47
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 17 PERKAIECGQQTLSYKELDAESDRICELLHAHGAAQ------YDHIGILMqdrcasIAAVIGILKLGGVFVPLDPLHPDE 90
Cdd:PRK04813 16 PDFPAYDYLGEKLTYGQLKEDSDALAAFIDSLKLPDkspiivFGHMSPEM------LATFLGAVKAGHAYIPVDVSSPAE 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 91 RLVTMLDTAEVSCLLC-DDAQFERAETLqghegkyfVLRARQ-AMSVQAGSKEAYSHSANATDPIYIYFTSGSTGKPKAV 168
Cdd:PRK04813 90 RIEMIIEVAKPSLIIAtEELPLEILGIP--------VITLDElKDIFATGNPYDFDHAVKGDDNYYIIFTSGTTGKPKGV 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 169 VGKNESLLHFMNWEASWLDL-TDPMRVSQlTSIGFDAVLRDIFVPICAGGT-ICIPesREIILDPLRLVHWLEHSRVHVV 246
Cdd:PRK04813 162 QISHDNLVSFTNWMLEDFALpEGPQFLNQ-APYSFDLSVMDLYPTLASGGTlVALP--KDMTANFKQLFETLPQLPINVW 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 247 HCTPSlFRFINHL--SLTADSYPDLRYVLLAGETIR---PESLKNWYDNlgnrVRLVNLYGPTETTM----IKlfypIKP 317
Cdd:PRK04813 239 VSTPS-FADMCLLdpSFNEEHLPNLTHFLFCGEELPhktAKKLLERFPS----ATIYNTYGPTEATVavtsIE----ITD 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 318 EDVHR-ESIPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQT--AFIpdpcrdQSGEIMMYRTG 394
Cdd:PRK04813 310 EMLDQyKRLPIGYAKPDSPLLIIDEEGTKLPDGEQGEIVISGPSVSKGYL--NNPEKTaeAFF------TFDGQPAYHTG 381
|
410 420 430 440
....*....|....*....|....*....|....*....|....*...
gi 517718121 395 DMGRwLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK04813 382 DAGY-LEDGLLFYQGRIDFQIKLNGYRIELEEIEQNLRQSSYVESAVV 428
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
1-453 |
2.24e-47 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 187.30 E-value: 2.24e-47
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1 MDNTIQYELARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVF 80
Cdd:PRK05691 2186 LDQTLHGLFAAQAARTPQAPALTFAGQTLSYAELDARANRLARALRERGVGPQVRVGLALERSLEMVVGLLAILKAGGAY 2265
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 81 VPLDPLHPDERLVTMLDTAEVSCLLCDDAQFEraeTLqgheGKYFVLRARQAMSVQAGSKEAYSHS--ANATDP---IYI 155
Cdd:PRK05691 2266 VPLDPEYPLERLHYMIEDSGIGLLLSDRALFE---AL----GELPAGVARWCLEDDAAALAAYSDAplPFLSLPqhqAYL 2338
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 156 YFTSGSTGKPKAV-VGKNESLLHFmnweASWLDLTDpMRVS----QLTSIGFDAVLRDIFVPICAGGTICIpeSREIILD 230
Cdd:PRK05691 2339 IYTSGSTGKPKGVvVSHGEIAMHC----QAVIERFG-MRADdcelHFYSINFDAASERLLVPLLCGARVVL--RAQGQWG 2411
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 231 PLRLVHWLEHSRVHVVHCTPSLFRFINHLSLTADSYPDLRYVLLAGETIRPESLKnwydnlgnRVR-------LVNLYGP 303
Cdd:PRK05691 2412 AEEICQLIREQQVSILGFTPSYGSQLAQWLAGQGEQLPVRMCITGGEALTGEHLQ--------RIRqafapqlFFNAYGP 2483
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 304 TETTMIKLFYPIkPEDVHRE--SIPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYfpSSHPDQTA--FIPD 379
Cdd:PRK05691 2484 TETVVMPLACLA-PEQLEEGaaSVPIGRVVGARVAYILDADLALVPQGATGELYVGGAGLAQGY--HDRPGLTAerFVAD 2560
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 517718121 380 PCRDQSGEimMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVVrmrAKADTPKG 453
Cdd:PRK05691 2561 PFAADGGR--LYRTGDLVRLRADGLVEYVGRIDHQVKIRGFRIELGEIESRLLEHPAVREAVV---LALDTPSG 2629
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
795-1361 |
4.31e-47 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 186.70 E-value: 4.31e-47
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 795 LIAYYLADKMIDD--EQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALPSPfEQDTTARIYKAPNSSTELKLLD 872
Cdd:PRK12316 3485 LVAYVVPEDEAGDlrEALKAHLKASLPEYMVPAHLLFLERMPLTPNGKLDRKALPRP-DAALLQQDYVAPVNELERRLAA 3563
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 873 IWTHILGIKRISADDHFLQIGVHSLNIMTLIAQVYEnFQVELPLEQVFEHDTLEEIA-------AYIDEQDSQYGVRIEP 945
Cdd:PRK12316 3564 IWADVLKLEQVGLTDNFFELGGDSIISLQVVSRARQ-AGIRFTPKDLFQHQTIQGLArvarvggGVAVDQGPVSGETLLL 3642
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 946 AAKQAYYPLTAAQMRVFMDEQLVNTGsgyhittafmiyGPIDVTRLERACGQLIERHEALRTSFDIVDGDPVQR---IHE 1022
Cdd:PRK12316 3643 PIQQQFFEEPVPERHHWNQSLLLKPR------------EALDAAALEAALQALVEHHDALRLRFVEDAGGWTAEhlpVEL 3710
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1023 HCDFHLEIVHLQGQQLHTAVNGCIRPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALY------ 1096
Cdd:PRK12316 3711 GGALLWRAELDDAEELERLGEEAQRSLDLADGPLLRALLATLADGSQRLLLVIHHLVVDGVSWRILLEDLQQAYqqllqg 3790
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1097 EGRELHDLPVQYVDFAQWQTSAPVVEDLRRQEQFWQSMFADyrpLPG-IPTDHTPEANERSFAgGHITWEPDPVLSRRLY 1175
Cdd:PRK12316 3791 EAPRLPAKTSSFKAWAERLQEHARGEALKAELAYWQEQLQG---VSSeLPCDHPQGALQNRHA-ASVQTRLDRELTRRLL 3866
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1176 AVA-AEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGRRR----AEVRQVVGMFVNALAIRSYPEGDKPFS--SFLQ 1248
Cdd:PRK12316 3867 QQApAAYRTQVNDLLLTALARVVCRWTGEASALVQLEGHGREDlfadIDLSRTVGWFTSLFPVRLSPVEDLGASikAIKE 3946
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1249 EIR-------GTMLQAYEHQDYPLERLAKQLDLHHSRDHL-MFDTVFSMlNYEDFAVRSDDLQFEYAELPTLSEIYNLRV 1320
Cdd:PRK12316 3947 QLRaipnkgiGFGLLRYLGDEESRRTLAGLPVPRITFNYLgQFDGSFDE-EMALFVPAGESAGAEQSPDAPLDNWLSLNG 4025
|
570 580 590 600
....*....|....*....|....*....|....*....|.
gi 517718121 1321 EIVESPERLRGTFKygQELYEARTVSQLAQDYERILAAVAE 1361
Cdd:PRK12316 4026 RVYGGELSLDWTFS--REMFEEATIQRLADDYAAELTALVE 4064
|
|
| C_PKS-NRPS |
cd20483 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
953-1359 |
5.20e-47 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHXXXD motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380471 [Multi-domain] Cd Length: 430 Bit Score: 175.14 E-value: 5.20e-47
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 953 PLTAAQMRVFMDEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDGDPVQRIHEHCDFHLEIVH 1032
Cdd:cd20483 3 PMSTFQRRLWFLHNFLEDKTFLNLLLVCHIKGKPDVNLLQKALSELVRRHEVLRTAYFEGDDFGEQQVLDDPSFHLIVID 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1033 LQG-----QQLHTAV-NGCIRPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYE----GRELH 1102
Cdd:cd20483 83 LSEaadpeAALDQLVrNLRRQELDIEEGEVIRGWLVKLPDEEFALVLASHHIAWDRGSSKSIFEQFTALYDalraGRDLA 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1103 DLP---VQYVDFAQWQ----TSAPVVEDLrrqeQFWQSMFADYRP----LPGIPTDHTPEA-NERSFAGGHItwepDPVL 1170
Cdd:cd20483 163 TVPpppVQYIDFTLWHnallQSPLVQPLL----DFWKEKLEGIPDasklLPFAKAERPPVKdYERSTVEATL----DKEL 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1171 SRRLYAVAAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTpVEGRR-RAEVRQVVGMFVNALAIRSYPEGDKPFSSFLQE 1249
Cdd:cd20483 235 LARMKRICAQHAVTPFMFLLAAFRAFLYRYTEDEDLTIGM-VDGDRpHPDFDDLVGFFVNMLPIRCRMDCDMSFDDLLES 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1250 IRGTMLQAYEHQDYPLERLAKQLDLHHSRDHLmfdTVFSM-LNYE-----------DFAVRSDDLQfeyaELPTLSEIYn 1317
Cdd:cd20483 314 TKTTCLEAYEHSAVPFDYIVDALDVPRSTSHF---PIGQIaVNYQvhgkfpeydtgDFKFTDYDHY----DIPTACDIA- 385
|
410 420 430 440
....*....|....*....|....*....|....*....|...
gi 517718121 1318 lrVEIVESPER-LRGTFKYGQELYEARTVSQLAQDYERILAAV 1359
Cdd:cd20483 386 --LEAEEDPDGgLDLRLEFSTTLYDSADMERFLDNFVTFLTSV 426
|
|
| X-Domain_NRPS |
cd19546 |
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to ... |
953-1363 |
5.58e-46 |
|
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to the non-ribosomal peptide synthetase (NRPS); The X-domain is a catalytically inactive member of the Condensation (C) domain family of non-ribosomal peptide synthetase (NRPS). It has been shown to recruit oxygenases to the NRPS to perform side-chain crosslinking in the production of glycopeptide antibiotics. C-domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as this X-domain, the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, and dual E/C (epimerization and condensation) domains. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity; members of this X-domain subfamily lack the second H of this motif.
Pssm-ID: 380468 [Multi-domain] Cd Length: 440 Bit Score: 172.28 E-value: 5.58e-46
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 953 PLTAAQMRVFMDEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDGDPVQRIH--EHCDFHLEI 1030
Cdd:cd19546 6 PATAGQLRTWLLARLDEETRGRHLSVALRLRGRLDRDALEAALGDVAARHEILRTTFPGDGGDVHQRILdaDAARPELPV 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1031 VHLQGQQLHTAV-NGCIRPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALY----EGR--ELHD 1103
Cdd:cd19546 86 VPATEEELPALLaDRAAHLFDLTRETPWRCTLFALSDTEHVLLLVVHRIAADDESLDVLVRDLAAAYgarrEGRapERAP 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1104 LPVQYVDFAQWQTSAPVVEDLRR-----QEQFWQSMFADY---------RPLPGIPTDHTPEANERSFAGGHItwepdpv 1169
Cdd:cd19546 166 LPLQFADYALWERELLAGEDDRDsligdQIAYWRDALAGApdelelptdRPRPVLPSRRAGAVPLRLDAEVHA------- 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1170 lsrRLYAVAAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTpVEGRRRAEV--RQVVGMFVNALAIRSYPEGDKPFSSFL 1247
Cdd:cd19546 239 ---RLMEAAESAGATMFTVVQAALAMLLTRLGAGTDVTVGT-VLPRDDEEGdlEGMVGPFARPLALRTDLSGDPTFRELL 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1248 QEIRGTMLQAYEHQDYPLERLAKQLDLHHSRD-HLMFDTVFSmlnyedfaVRSDDLQ-FEYAELPTLSEI---------- 1315
Cdd:cd19546 315 GRVREAVREARRHQDVPFERLAELLALPPSADrHPVFQVALD--------VRDDDNDpWDAPELPGLRTSpvplgteame 386
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....
gi 517718121 1316 YNLRVEIVE------SPERLRGTFKYGQELYEARTVSQLAQDYERILAAVAESP 1363
Cdd:cd19546 387 LDLSLALTErrnddgDPDGLDGSLRYAADLFDRATAAALARRLVRVLEQVAADP 440
|
|
| A_NRPS_acs4 |
cd17654 |
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal ... |
28-442 |
4.98e-45 |
|
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains acyl-CoA synthethase family member 4, also known as 2-aminoadipic 6-semialdehyde dehydrogenase or aminoadipate-semialdehyde dehydrogenase, most of which are uncharacterized. Acyl-CoA synthetase catalyzes the initial reaction in fatty acid metabolism, by forming a thioester with CoA. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341309 [Multi-domain] Cd Length: 449 Bit Score: 169.96 E-value: 4.98e-45
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 28 TLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTMLDTAEVSCLLCD 107
Cdd:cd17654 16 TVSYADLAEKISNLSNFLRKKFQTEERAIGLRCDRGTESPVAILAILFLGAAYAPIDPASPEQRSLTVMKKCHVSYLLQN 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 108 DaqferaetLQGHEGKYFVLRARQ-AMSVQAGSkeayshsanatdpIYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWL 186
Cdd:cd17654 96 K--------ELDNAPLSFTPEHRHfNIRTDECL-------------AYVIHTSGTTGTPKIVAVPHKCILPNIQHFRSLF 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 187 DLTdPMRVSQLTSIG-FDAVLRDIFVPICAGGTICIPESrEIILDPLRLVHWL-EHSRVHVVHCTPSLFR-----FINHL 259
Cdd:cd17654 155 NIT-SEDILFLTSPLtFDPSVVEIFLSLSSGATLLIVPT-SVKVLPSKLADILfKRHRITVLQATPTLFRrfgsqSIKST 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 260 SLTADSypDLRYVLLAGETIrPES--LKNWYdNLGNRVRLVNLYGPTETTMIKLFYPIKPEDvhrESIPIGRPLPDTSVY 337
Cdd:cd17654 233 VLSATS--SLRVLALGGEPF-PSLviLSSWR-GKGNRTRIFNIYGITEVSCWALAYKVPEED---SPVQLGSPLLGTVIE 305
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 338 LLDEQQQPVSGSEAGE----ICIATRYMThgyfpsshpdqtafIPDPCrdqsgeimMYRTGDMGRwLPEGELALLGRKDN 413
Cdd:cd17654 306 VRDQNGSEGTGQVFLGglnrVCILDDEVT--------------VPKGT--------MRATGDFVT-VKDGELFFLGRKDS 362
|
410 420
....*....|....*....|....*....
gi 517718121 414 QVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd17654 363 QIKRRGKRINLDLIQQVIESCLGVESCAV 391
|
|
| CT_NRPS-like |
cd19542 |
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike ... |
952-1363 |
2.53e-43 |
|
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike bacterial NRPS, which typically have specialized terminal thioesterase (TE) domains to cyclize peptide products, many fungal NRPSs employ a terminal condensation-like (CT) domain to produce macrocyclic peptidyl products (e.g. cyclosporine and echinocandin). Domains in this subfamily (which includes both terminal and non-terminal domains) typically have a non-canonical conserved [SN]HxxxDx(14)Y motif at their active site compared to the standard Condensation (C) domain active site motif (HHxxxD). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380464 [Multi-domain] Cd Length: 401 Bit Score: 163.25 E-value: 2.53e-43
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 952 YPLTAAQMRVFMdEQLVNTGSgYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDGDP--VQRIHEHCDFHLE 1029
Cdd:cd19542 2 YPCTPMQEGMLL-SQLRSPGL-YFNHFVFDLDSSVDVERLRNAWRQLVQRHDILRTVFVESSAEGtfLQVVLKSLDPPIE 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1030 IVHLQGQQLHTAVNGCIRPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYEGRELHDlPVQYV 1109
Cdd:cd19542 80 EVETDEDSLDALTRDLLDDPTLFGQPPHRLTLLETSSGEVYLVLRISHALYDGVSLPIILRDLAAAYNGQLLPP-APPFS 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1110 DFAQ--WQTSAPvvedlrRQEQFWQSMFADYRPLPgIPTDHTPEANERSfagGHITWEPdpvlSRRLYAVAAEQQTTLFM 1187
Cdd:cd19542 159 DYISylQSQSQE------ESLQYWRKYLQGASPCA-FPSLSPKRPAERS---LSSTRRS----LAKLEAFCASLGVTLAS 224
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1188 VLLAAFHVLYAKYSAREEVTVGTPVEGR--RRAEVRQVVGMFVNALAIRSYPEGDKPFSSFLQEIRGTMLQAYEHQDYPL 1265
Cdd:cd19542 225 LFQAAWALVLARYTGSRDVVFGYVVSGRdlPVPGIDDIVGPCINTLPVRVKLDPDWTVLDLLRQLQQQYLRSLPHQHLSL 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1266 ERLAKQLDLHHSRdhLMFDTVFSMLNYEDFAVRSDDLQFE----YAELPTLseiYNLRVEIVESPERLRGTFKYGQELYE 1341
Cdd:cd19542 305 REIQRALGLWPSG--TLFNTLVSYQNFEASPESELSGSSVfelsAAEDPTE---YPVAVEVEPSGDSLKVSLAYSTSVLS 379
|
410 420
....*....|....*....|..
gi 517718121 1342 ARTVSQLAQDYERILAAVAESP 1363
Cdd:cd19542 380 EEQAEELLEQFDDILEALLANP 401
|
|
| alpha_am_amid |
TIGR03443 |
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are ... |
5-449 |
2.66e-42 |
|
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), product of the LYS2 gene. It is also called alpha-aminoadipate reductase. In fungi, lysine is synthesized via aminoadipate. Currently, all members of this family are fungal.
Pssm-ID: 274582 [Multi-domain] Cd Length: 1389 Bit Score: 169.86 E-value: 2.66e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 5 IQYELARAFAAFPER------KAIECGQ---QTLSYKELDAESDRICELLHAHGAAQ------YDHIGILMqdrcasIAA 69
Cdd:TIGR03443 238 IHDIFADNAEKHPDRtcvvetPSFLDPSsktRSFTYKQINEASNILAHYLLKTGIKRgdvvmiYAYRGVDL------VVA 311
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 70 VIGILKLGGVFVPLDPLHPDERLVTMLDTAEVSCLLCddaqFERAETLQGHEGKY----FVLRAR-QAMSVQA-GSKEAY 143
Cdd:TIGR03443 312 VMGVLKAGATFSVIDPAYPPARQTIYLSVAKPRALIV----IEKAGTLDQLVRDYidkeLELRTEiPALALQDdGSLVGG 387
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 144 SHSANATDPIYIY---------------------FTSGSTGKPKAVVGKNESLLHFMNWEASWLDLTDPMRVSQLTSIGF 202
Cdd:TIGR03443 388 SLEGGETDVLAPYqalkdtptgvvvgpdsnptlsFTSGSEGIPKGVLGRHFSLAYYFPWMAKRFGLSENDKFTMLSGIAH 467
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 203 DAVLRDIFVPICAGGTICIPeSREIILDPLRLVHWLEHSRVHVVHCTPSLFRFinhLSLTADS-YPDLRYVLLAGET-IR 280
Cdd:TIGR03443 468 DPIQRDMFTPLFLGAQLLVP-TADDIGTPGRLAEWMAKYGATVTHLTPAMGQL---LSAQATTpIPSLHHAFFVGDIlTK 543
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 281 PESLKnwYDNLGNRVRLVNLYGPTETTMIKLFYPIKP--EDVH-----RESIPIGRPLPDtsVYLL----DEQQQPVSGS 349
Cdd:TIGR03443 544 RDCLR--LQTLAENVCIVNMYGTTETQRAVSYFEIPSrsSDSTflknlKDVMPAGKGMKN--VQLLvvnrNDRTQTCGVG 619
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 350 EAGEICI----------------ATRYMTHGYFPSSH-PDQTAFIPDPC-------RDQsgeimMYRTGDMGRWLPEGEL 405
Cdd:TIGR03443 620 EVGEIYVragglaegylglpelnAEKFVNNWFVDPSHwIDLDKENNKPErefwlgpRDR-----LYRTGDLGRYLPDGNV 694
|
490 500 510 520
....*....|....*....|....*....|....*....|....
gi 517718121 406 ALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVVRMRAKAD 449
Cdd:TIGR03443 695 ECCGRADDQVKIRGFRIELGEIDTHLSQHPLVRENVTLVRRDKD 738
|
|
| A_NRPS_alphaAR |
cd17647 |
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as ... |
16-455 |
4.51e-41 |
|
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as alpha-aminoadipate reductase (EC 1.2.1.95) or alpha-AR or L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), which catalyzes the activation of alpha-aminoadipate by ATP-dependent adenylation and the reduction of activated alpha-aminoadipate by NADPH. The activated alpha-aminoadipate is bound to the phosphopantheinyl group of the enzyme itself before it is reduced to (S)-2-amino-6-oxohexanoate.
Pssm-ID: 341302 [Multi-domain] Cd Length: 520 Bit Score: 159.61 E-value: 4.51e-41
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 16 FPERKAI-------ECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHP 88
Cdd:cd17647 1 FPERTCVvetpslnSSKTRSFTYRDINEASNIVAHYLIKTGIKRGDVVMIYSYRGVDLMVAVMGVLKAGATFSVIDPAYP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 89 DERLVTMLDTAEVSCLLcddaqferaetlqghegkyfVLRArqaMSVQAGSkeayshSANATdpiyIYFTSGSTGKPKAV 168
Cdd:cd17647 81 PARQNIYLGVAKPRGLI--------------------VIRA---AGVVVGP------DSNPT----LSFTSGSEGIPKGV 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 169 VGKNESLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPeSREIILDPLRLVHWLEHSRVHVVHC 248
Cdd:cd17647 128 LGRHFSLAYYFPWMAKRFNLSENDKFTMLSGIAHDPIQRDMFTPLFLGAQLLVP-TQDDIGTPGRLAEWMAKYGATVTHL 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 249 TPSLFRFinhlsLTADS---YPDLRYVLLAGET-IRPESLKnwYDNLGNRVRLVNLYGPTETTMIKLFY--PIKPEDVH- 321
Cdd:cd17647 207 TPAMGQL-----LTAQAttpFPKLHHAFFVGDIlTKRDCLR--LQTLAENVRIVNMYGTTETQRAVSYFevPSRSSDPTf 279
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 322 ----RESIPIGRPLPDTSVYLLD--EQQQPVSGSEAGEICIATRYMTHGYFPSSHPDQTAFIP----DPC----RDQSGE 387
Cdd:cd17647 280 lknlKDVMPAGRGMLNVQLLVVNrnDRTQICGIGEVGEIYVRAGGLAEGYRGLPELNKEKFVNnwfvEPDhwnyLDKDNN 359
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 517718121 388 I-----------MMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVVRMRAKADTPKGMA 455
Cdd:cd17647 360 EpwrqfwlgprdRLYRTGDLGRYLPNGDCECCGRADDQVKIRGFRIELGEIDTHISQHPLVRENITLVRRDKDEEPTLV 438
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
795-1240 |
1.50e-40 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 165.13 E-value: 1.50e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 795 LIAYYLADKMIDD--EQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALPSPfEQDTTARIYKAPNSSTELKLLD 872
Cdd:PRK12316 947 LVGYVVLESEGGDwrEALKAHLAASLPEYMVPAQWLALERLPLTPNGKLDRKALPAP-EASVAQQGYVAPRNALERTLAA 1025
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 873 IWTHILGIKRISADDHFLQIGVHSLNIMTLIAQVYENfQVELPLEQVFEHDTLEEIAAyIDEQDSQYGVRIEPAAKQAyy 952
Cdd:PRK12316 1026 IWQDVLGVERVGLDDNFFELGGDSIVSIQVVSRARQA-GIQLSPRDLFQHQTIRSLAL-VAKAGQATAADQGPASGEV-- 1101
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 953 PLTAAQMRVFmdEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDGDPVQRIHEHCDFH-LEIV 1031
Cdd:PRK12316 1102 ALAPVQRWFF--EQAIPQRQHWNQSLLLQARQPLDPDRLGRALERLVAHHDALRLRFREEDGGWQQAYAAPQAGEvLWQR 1179
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1032 HLQGQQ-LHTAVNGCIRPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYEGRELhDLPVQYVD 1110
Cdd:PRK12316 1180 QAASEEeLLALCEEAQRSLDLEQGPLLRALLVDMADGSQRLLLVIHHLVVDGVSWRILLEDLQRAYADLDA-DLPARTSS 1258
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1111 FAQW----QTSAPVvedLRRQEQFWQsmfadyRPLPGIPTD---HTPEANERSFAGGHITWEPDPVLSRRLYAVA-AEQQ 1182
Cdd:PRK12316 1259 YQAWarrlHEHAGA---RAEELDYWQ------AQLEDAPHElpcENPDGALENRHERKLELRLDAERTRQLLQEApAAYR 1329
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 517718121 1183 TTLFMVLLAAFHVLYAKYSAREEVTVgtPVEGRRRA------EVRQVVGMFVNALAIRSYPEGD 1240
Cdd:PRK12316 1330 TQVNDLLLTALARVTCRWSGQASVLV--QLEGHGREdlfediDLSRTVGWFTSLFPVRLTPAAD 1391
|
|
| DCL_NRPS-like |
cd19536 |
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal ... |
952-1363 |
4.17e-40 |
|
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal fungal CT domains and Dual Epimerization/Condensation (E/C) domains; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type [D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L))], which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380459 [Multi-domain] Cd Length: 419 Bit Score: 154.53 E-value: 4.17e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 952 YPLTAAQMRVFMDEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVD-GDPVQRIHEHCDFHLEI 1030
Cdd:cd19536 2 YPLSSLQEGMLFHSLLNPGGSVYLHNYTYTVGRRLNLDLLLEALQVLIDRHDILRTSFIEDGlGQPVQVVHRQAQVPVTE 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1031 VHL-QGQQLHTAVNGCI-----RPFQLERAPLIRSILIPLAEEQH-LLVLDMHHIVADGKSVFLLQRDLAALY----EGR 1099
Cdd:cd19536 82 LDLtPLEEQLDPLRAYKeetkiRRFDLGRAPLVRAALVRKDERERfLLVISDHHSILDGWSLYLLVKEILAVYnqllEYK 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1100 ELHDLPVQ-YVDFAQWQTSApvvEDLRRQEQFWQSMF--ADYRPLPGIPTDHTPEANERSfagghiTWEPDPVLSRRLYA 1176
Cdd:cd19536 162 PLSLPPAQpYRDFVAHERAS---IQQAASERYWREYLagATLATLPALSEAVGGGPEQDS------ELLVSVPLPVRSRS 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1177 VAAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGRRR--AEVRQVVGMFVNALAIR-SYPEGdkPFSSFLQEIRGT 1253
Cdd:cd19536 233 LAKRSGIPLSTLLLAAWALVLSRHSGSDDVVFGTVVHGRSEetTGAERLLGLFLNTLPLRvTLSEE--TVEDLLKRAQEQ 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1254 MLQAYEHQDYPLeRLAKQldlhHSRDHLMFDtvfSMLNYEDFavrsdDLQFEyAELPTLSEIY-----------NLRVEI 1322
Cdd:cd19536 311 ELESLSHEQVPL-ADIQR----CSEGEPLFD---SIVNFRHF-----DLDFG-LPEWGSDEGMrrgllfsefksNYDVNL 376
|
410 420 430 440
....*....|....*....|....*....|....*....|...
gi 517718121 1323 VESPE--RLRGTFKYGQELYEARTVSQLAQDYERILAAVAESP 1363
Cdd:cd19536 377 SVLPKqdRLELKLAYNSQVLDEEQAQRLAAYYKSAIAELATAP 419
|
|
| Acs |
COG0365 |
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism]; |
9-442 |
5.28e-40 |
|
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism];
Pssm-ID: 440134 [Multi-domain] Cd Length: 565 Bit Score: 157.58 E-value: 5.28e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAI----ECG-QQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPL 83
Cdd:COG0365 15 LDRHAEGRGDKVALiwegEDGeERTLTYAELRREVNRFANALRALGVKKGDRVAIYLPNIPEAVIAMLACARIGAVHSPV 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 84 DP-LHPDErLVTMLDTAEVSCLLCDDAQFERaetlqgheGKYFVLRAR--QAMS-------------------------- 134
Cdd:COG0365 95 FPgFGAEA-LADRIEDAEAKVLITADGGLRG--------GKVIDLKEKvdEALEelpslehvivvgrtgadvpmegdldw 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 135 ---VQAGSKEAYSHSANATDPIYIYFTSGSTGKPKAVVGKNESLLHFMNWEAS-WLDLTDPMRVSQLTSIGFDAVLRDIF 210
Cdd:COG0365 166 delLAAASAEFEPEPTDADDPLFILYTSGTTGKPKGVVHTHGGYLVHAATTAKyVLDLKPGDVFWCTADIGWATGHSYIV 245
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 211 V-PICAGGTICIPESREIILDPLRLVHWLEHSRVHVVHCTPSLFR-FINHLSLTADSY--PDLRYVLLAGETIRPESLKN 286
Cdd:COG0365 246 YgPLLNGATVVLYEGRPDFPDPGRLWELIEKYGVTVFFTAPTAIRaLMKAGDEPLKKYdlSSLRLLGSAGEPLNPEVWEW 325
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 287 WYDNLGnrVRLVNLYGPTETTMIKL-FYPIKPedVHRESipIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRY--MTH 363
Cdd:COG0365 326 WYEAVG--VPIVDGWGQTETGGIFIsNLPGLP--VKPGS--MGKPVPGYDVAVVDEDGNPVPPGEEGELVIKGPWpgMFR 399
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 364 GYFpsSHPDQTA-----FIPDpcrdqsgeimMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIR 438
Cdd:COG0365 400 GYW--NDPERYRetyfgRFPG----------WYRTGDGARRDEDGYFWILGRSDDVINVSGHRIGTAEIESALVSHPAVA 467
|
....
gi 517718121 439 EAVV 442
Cdd:COG0365 468 EAAV 471
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
952-1372 |
5.59e-38 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 156.66 E-value: 5.59e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 952 YPLTAAQMRVFMdEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVD--GDPVQRIHEHCDFHLE 1029
Cdd:PRK12316 4103 YPLSPMQQGMLF-HSLYEQEAGDYINQMRVDVQGLDVERFRAAWQAALDRHDVLRSGFVWQGelGRPLQVVHKQVSLPFA 4181
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1030 IVHLQGQQ------LHTAVNGCIRPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYEGRELHD 1103
Cdd:PRK12316 4182 ELDWRGRAdlqaalDALAAAERERGFDLQRAPLLRLVLVRTAEGRHHLIYTNHHILMDGWSNSQLLGEVLERYSGRPPAQ 4261
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1104 LPVQYVDFAQWQTSapvvEDLRRQEQFWQSMFADYRPlPGIPTDHTPEANERSFAG-GHITWEPDPVLSRRLYAVAAEQQ 1182
Cdd:PRK12316 4262 PGGRYRDYIAWLQR----QDAAASEAFWREQLAALDE-PTRLAQAIARADLRSANGyGEHVRELDATATARLREFARTQR 4336
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1183 TTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGR--RRAEVRQVVGMFVNALAIRSYPEGDKPFSSFLQEIRGTMLQAYEH 1260
Cdd:PRK12316 4337 VTLNTLVQAAWLLLLQRYTGQDTVAFGATVAGRpaELPGIEGQIGLFINTLPVIATPRAQQSVVEWLQQVQRQNLALREH 4416
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1261 QDYPLERLAKQLDLHHSRdhlMFDtvfSMLNYEDFAVrSDDLQFEYAELPTLSEIYN---------LRVEIVESperLRG 1331
Cdd:PRK12316 4417 EHTPLYEIQRWAGQGGEA---LFD---SLLVFENYPV-SEALQQGAPGGLRFGEVTNheqtnypltLAVGLGET---LSL 4486
|
410 420 430 440
....*....|....*....|....*....|....*....|.
gi 517718121 1332 TFKYGQELYEARTVSQLAQDYERILAAVAESPNIKLKDIEI 1372
Cdd:PRK12316 4487 QFSYDRGHFDAATIERLARHLTNLLEAMAEDPQRRLGELQL 4527
|
|
| MACS_like |
cd05972 |
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of ... |
29-442 |
1.95e-37 |
|
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes.
Pssm-ID: 341276 [Multi-domain] Cd Length: 428 Bit Score: 146.71 E-value: 1.95e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 29 LSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTMLDTAEVSCLLCDd 108
Cdd:cd05972 1 WSFRELKRESAKAANVLAKLGLRKGDRVAVLLPRVPELWAVILAVIKLGAVYVPLTTLLGPKDIEYRLEAAGAKAIVTD- 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 109 aqferaetlqghegkyfvlrarqamsvqagskeayshsanATDPIYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLDL 188
Cdd:cd05972 80 ----------------------------------------AEDPALIYFTSGTTGLPKGVLHTHSYPLGHIPTAAYWLGL 119
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 189 TDPMRVSQLTSIGF-DAVLRDIFVPICAGGTICIPESREiiLDPLRLVHWLEHSRVHVVHCTPSLFRFINHLSLTADSYP 267
Cdd:cd05972 120 RPDDIHWNIADPGWaKGAWSSFFGPWLLGATVFVYEGPR--FDAERILELLERYGVTSFCGPPTAYRMLIKQDLSSYKFS 197
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 268 DLRYVLLAGETIRPESLKNWYDNLGNRVRlvNLYGPTETTMI---KLFYPIKPEDvhresipIGRPLPDTSVYLLDEQQQ 344
Cdd:cd05972 198 HLRLVVSAGEPLNPEVIEWWRAATGLPIR--DGYGQTETGLTvgnFPDMPVKPGS-------MGRPTPGYDVAIIDDDGR 268
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 345 PVSGSEAGEICIatRYMTHGYFpsshpdqTAFIPDPCRDQS---GEImmYRTGDMGRWLPEGELALLGRKDNQVKIRGNR 421
Cdd:cd05972 269 ELPPGEEGDIAI--KLPPPGLF-------LGYVGDPEKTEAsirGDY--YLTGDRAYRDEDGYFWFVGRADDIIKSSGYR 337
|
410 420
....*....|....*....|.
gi 517718121 422 VELGDIEHRLTNMAGIREAVV 442
Cdd:cd05972 338 IGPFEVESALLEHPAVAEAAV 358
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
808-1237 |
5.22e-37 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 153.40 E-value: 5.22e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 808 EQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALPSP-FEQDTTAriYKAPNSSTELKLLDIWTHILGIKRISAD 886
Cdd:PRK05691 2653 EALKAHLKQQLPDYMVPAHLILLDSLPLTANGKLDRRALPAPdPELNRQA--YQAPRSELEQQLAQIWREVLNVERVGLG 2730
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 887 DHFLQIG---VHSLNIMTLIAQVYENFQvelPlEQVFEHDTLEEIAAYIDEQDSqygVRIEPAAKQAYYPLTAAQmRVFM 963
Cdd:PRK05691 2731 DNFFELGgdsILSIQVVSRARQLGIHFS---P-RDLFQHQTVQTLAAVATHSEA---AQAEQGPLQGASGLTPIQ-HWFF 2802
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 964 DEQLVNTgsgYHITTAFMI--YGPIDVTRLERACGQLIERHEALRTSFDIVDGdpvqrihehcDFHLEIVHLQGQQLHTA 1041
Cdd:PRK05691 2803 DSPVPQP---QHWNQALLLepRQALDPALLEQALQALVEHHDALRLRFSQADG----------RWQAEYRAVTAQELLWQ 2869
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1042 VN-----GCI-------RPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYegRELHD-----L 1104
Cdd:PRK05691 2870 VTvadfaECAalfadaqRSLDLQQGPLLRALLVDGPQGQQRLLLAIHHLVVDGVSWRVLLEDLQALY--RQLSAgaepaL 2947
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1105 PVQYVDFAQWQT---SAPVVEDLRRQEQFWQSMFADyrPLPGIPTDHtPEANERSFAGGHITWEPDPVLSRRLYAVA-AE 1180
Cdd:PRK05691 2948 PAKTSAFRDWAArlqAYAGSESLREELGWWQAQLGG--PRAELPCDR-PQGGNLNRHAQTVSVRLDAERTRQLLQQApAA 3024
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 517718121 1181 QQTTLFMVLLAAFHVLYAKYSAREEVTVgtPVEGRRRA------EVRQVVGMFVNALAIRSYP 1237
Cdd:PRK05691 3025 YRTQVNDLLLTALARVLCRWSGQPSVLV--QLEGHGREalfddiDLTRSVGWFTSAYPLRLTP 3085
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
808-1237 |
2.66e-35 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 148.00 E-value: 2.66e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 808 EQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALPSPfEQDTTARIYKAPNSSTELKLLDIWTHILGIKRISADD 887
Cdd:PRK12467 2041 AILKNHLKASLPEYMVPAHLVFLARMPLTPNGKLDRKALPAP-DASELQQAYVAPQSELEQRLAAIWQDVLGLEQVGLHD 2119
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 888 HFLQIGVHSLNIMTLIAQVYENfQVELPLEQVFEHDTLEEIAAYIDEQDSqyGVRIEPAAKQAYYPLTAAQmRVFMDEQL 967
Cdd:PRK12467 2120 NFFELGGDSIISIQVVSRARQA-GIRFTPKDLFQHQTVQSLAAVAQEGDG--TVSIDQGPVTGDLPLLPIQ-QMFFADDI 2195
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 968 VNTgsgYHITTAFMI--YGPIDVTRLERACGQLIERHEALRTSFDIVDGDpVQRIHEHCDFHLEIVHLQ-----GQQLHT 1040
Cdd:PRK12467 2196 PER---HHWNQSVLLepREALDAELLEAALQALLVHHDALRLGFVQEDGG-WSAMHRAPEQERRPLLWQvvvadKEELEA 2271
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1041 AVNGCIRPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAA----LYEGRELHdLPVQYVDFAQW-- 1114
Cdd:PRK12467 2272 LCEQAQRSLDLEEGPLLRAVLATLPDGSQRLLLVIHHLVVDGVSWRILLEDLQTayrqLQGGQPVK-LPAKTSAFKAWae 2350
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1115 --QTSAPVVEdLRRQEQFWQSMFADYRplPGIPTDHTPEANERSFAgGHITWEPDPVLSRRLYAVA-AEQQTTLFMVLLA 1191
Cdd:PRK12467 2351 rlQTYAASAA-LADELGYWQAQLQGAS--TELPCDHPQGGLQRRHA-ASVTTHLDSEWTRRLLQEApAAYRTQVNDLLLT 2426
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|..
gi 517718121 1192 AFHVLYAKYSAREEVTVgtPVEGRRRAE------VRQVVGMFVNALAIRSYP 1237
Cdd:PRK12467 2427 ALARVIARWTGQASTLI--QLEGHGREDlfdeidLTRTVGWFTSLYPVKLSP 2476
|
|
| FC-FACS_FadD_like |
cd05936 |
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This ... |
9-442 |
2.20e-34 |
|
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This subfamily of the AMP-forming adenylation family contains Escherichia coli FadD and similar prokaryotic fatty acid CoA synthetases. FadD was characterized as a long-chain fatty acid CoA synthetase. The gene fadD is regulated by the fatty acid regulatory protein FadR. Fatty acid CoA synthetase catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341259 [Multi-domain] Cd Length: 468 Bit Score: 138.85 E-value: 2.20e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHP 88
Cdd:cd05936 5 LEEAARRFPDKTALIFMGRKLTYRELDALAEAFAAGLQNLGVQPGDRVALMLPNCPQFPIAYFGALKAGAVVVPLNPLYT 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 89 DERLVTMLDTAEVSCLLCDDAqFERAetlqghegkyfvlrarqamsVQAGSKEAYSHSANATDPIYIYFTSGSTGKPKAV 168
Cdd:cd05936 85 PRELEHILNDSGAKALIVAVS-FTDL--------------------LAAGAPLGERVALTPEDVAVLQYTSGTTGVPKGA 143
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 169 VgknesLLH---FMNWEASWLDLTDPMRVSQLT--------SIGFDAVLrdiFVPICAGGTIcIPESReiiLDPLRLVHW 237
Cdd:cd05936 144 M-----LTHrnlVANALQIKAWLEDLLEGDDVVlaalplfhVFGLTVAL---LLPLALGATI-VLIPR---FRPIGVLKE 211
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 238 LEHSRVHVVHCTPSLF-RFINHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGnrVRLVNLYGPTETTMIKLFYPIk 316
Cdd:cd05936 212 IRKHRVTIFPGVPTMYiALLNAPEFKKRDFSSLRLCISGGAPLPVEVAERFEELTG--VPIVEGYGLTETSPVVAVNPL- 288
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 317 peDVHRESIPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFPssHPDQTAfipdpcrdqsgEIMM---YRT 393
Cdd:cd05936 289 --DGPRKPGSIGIPLPGTEVKIVDDDGEELPPGEVGELWVRGPQVMKGYWN--RPEETA-----------EAFVdgwLRT 353
|
410 420 430 440
....*....|....*....|....*....|....*....|....*....
gi 517718121 394 GDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05936 354 GDIGYMDEDGYFFIVDRKKDMIIVGGFNVYPREVEEVLYEHPAVAEAAV 402
|
|
| FACL_like_6 |
cd05922 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
44-442 |
2.00e-33 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341246 [Multi-domain] Cd Length: 457 Bit Score: 135.65 E-value: 2.00e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 44 LLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGG----VFVPLDPLHPDERLVTMLDTAEVSCLLCDdaqferaETLQG 119
Cdd:cd05922 9 ALLEAGGVRGERVVLILPNRFTYIELSFAVAYAGGrlglVFVPLNPTLKESVLRYLVADAGGRIVLAD-------AGAAD 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 120 HEGKYFVLRARQAMSVQAGSKEAYSHSANA-----TDPIYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLDLTDPMRV 194
Cdd:cd05922 82 RLRDALPASPDPGTVLDADGIRAARASAPAhevshEDLALLLYTSGSTGSPKLVRLSHQNLLANARSIAEYLGITADDRA 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 195 SQLTSIGFDAVLRDIFVPICAGGTICIPESREIildPLRLVHWLEHSRVHVVHCTPSLFRFINHLSLTADSYPDLRYVLL 274
Cdd:cd05922 162 LTVLPLSYDYGLSVLNTHLLRGATLVLTNDGVL---DDAFWEDLREHGATGLAGVPSTYAMLTRLGFDPAKLPSLRYLTQ 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 275 AGETIRPESLKNWYDnLGNRVRLVNLYGPTETTMIKLFYPikPEDVHRESIPIGRPLPDTSVYLLDEQQQPVSGSEAGEI 354
Cdd:cd05922 239 AGGRLPQETIARLRE-LLPGAQVYVMYGQTEATRRMTYLP--PERILEKPGSIGLAIPGGEFEILDDDGTPTPPGEPGEI 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 355 CIATRYMTHGYFpsshpDQTAFIPDPcrdqSGEIMMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNM 434
Cdd:cd05922 316 VHRGPNVMKGYW-----NDPPYRRKE----GRGGGVLHTGDLARRDEDGFLFIVGRRDRMIKLFGNRISPTEIEAAARSI 386
|
....*...
gi 517718121 435 AGIREAVV 442
Cdd:cd05922 387 GLIIEAAA 394
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
952-1370 |
2.55e-31 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 134.70 E-value: 2.55e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 952 YPLTAAQMRVFMdEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDG--DPVQRIHEHCDFHLE 1029
Cdd:PRK12316 1557 YPLSPMQQGMLF-HSLYEQEAGDYINQLRVDVQGLDPDRFRAAWQATVDRHEILRSGFLWQDGleQPLQVIHKQVELPFA 1635
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1030 IVHLQGQ-QLHTAVNGCI-----RPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYEGRELHD 1103
Cdd:PRK12316 1636 ELDWRGReDLGQALDALAqaerqKGFDLTRAPLLRLVLVRTGEGRHHLIYTNHHILMDGWSNAQLLGEVLQRYAGQPVAA 1715
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1104 LPVQYVDFAQWQTSapvvEDLRRQEQFWQSMFADYRpLPGIPTDHTPEANERSFAGGHITwEPDPVLSRRLYAVAAEQQT 1183
Cdd:PRK12316 1716 PGGRYRDYIAWLQR----QDAAASEAFWKEQLAALE-EPTRLAQAARTEDGQVGYGDHQQ-LLDPAQTRALAEFARAQKV 1789
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1184 TLFMVLLAAFHVLYAKYSAREEVTVGTPVEGrRRAE---VRQVVGMFVNALAIRSYPEGDKPFSSFLQEIRGTMLQAYEH 1260
Cdd:PRK12316 1790 TLNTLVQAAWLLLLQRYTGQETVAFGATVAG-RPAElpgIEQQIGLFINTLPVIAAPRPDQSVADWLQEVQALNLALREH 1868
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1261 QDYPL---ERLAKQldlhhsRDHLMFDtvfSMLNYEDFAVrSDDLQ------FEYAELPTLSEI-YNLRVEiVESPERLR 1330
Cdd:PRK12316 1869 EHTPLydiQRWAGQ------GGEALFD---SLLVFENYPV-AEALKqgapagLVFGRVSNHEQTnYPLTLA-VTLGETLS 1937
|
410 420 430 440
....*....|....*....|....*....|....*....|
gi 517718121 1331 GTFKYGQELYEARTVSQLAQDYERILAAVAESPNIKLKDI 1370
Cdd:PRK12316 1938 LQYSYDRGHFDAAAIERLDRHLLHLLEQMAEDAQAALGEL 1977
|
|
| FACL_FadD13-like |
cd17631 |
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, ... |
9-442 |
3.23e-31 |
|
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, including Mycobacterium tuberculosis acid-induced operon MymA encoding the fatty acyl-CoA synthetase FadD13 which is essential for virulence and intracellular growth of the pathogen. The fatty acyl-CoA synthetase activates lipids before entering into the metabolic pathways and is also involved in transmembrane lipid transport. However, unlike soluble fatty acyl-CoA synthetases, but like the mammalian integral-membrane very-long-chain acyl-CoA synthetases, FadD13 accepts lipid substrates up to the maximum length of C26, and this is facilitated by an extensive hydrophobic tunnel from the active site to a positively charged patch. Also included is feruloyl-CoA synthetase (Fcs) in Rhodococcus strains where it is involved in biotechnological vanillin production from eugenol and ferulic acid via a non-beta-oxidative pathway.
Pssm-ID: 341286 [Multi-domain] Cd Length: 435 Bit Score: 128.50 E-value: 3.23e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDplhp 88
Cdd:cd17631 1 LRRRARRHPDRTALVFGGRSLTYAELDERVNRLAHALRALGVAKGDRVAVLSKNSPEFLELLFAAARLGAVFVPLN---- 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 89 derlvTMLDTAEVSCLLCDdaqferaetlqghegkyfvlrarqamsvqAGSKEAYShsanatDPIYIYFTSGSTGKPKAV 168
Cdd:cd17631 77 -----FRLTPPEVAYILAD-----------------------------SGAKVLFD------DLALLMYTSGTTGRPKGA 116
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 169 VGKNESLL-HFMNWEASWLDLTDP--MRVSQLTSIGFDAVLrdIFVPICAGGTICIPESreiiLDPLRLVHWLEHSRVHV 245
Cdd:cd17631 117 MLTHRNLLwNAVNALAALDLGPDDvlLVVAPLFHIGGLGVF--TLPTLLRGGTVVILRK----FDPETVLDLIERHRVTS 190
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 246 VHCTPSLFRF-INHLSLTADSYPDLRYVLLAGEtIRPESLKNWYDNLGnrVRLVNLYGPTETTMIKLFypIKPEDVHRES 324
Cdd:cd17631 191 FFLVPTMIQAlLQHPRFATTDLSSLRAVIYGGA-PMPERLLRALQARG--VKFVQGYGMTETSPGVTF--LSPEDHRRKL 265
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 325 IPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA-FIPDpcrdqsGeimMYRTGDMGRWLPEG 403
Cdd:cd17631 266 GSAGRPVFFVEVRIVDPDGREVPPGEVGEIVVRGPHVMAGYW--NRPEATAaAFRD------G---WFHTGDLGRLDEDG 334
|
410 420 430
....*....|....*....|....*....|....*....
gi 517718121 404 ELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd17631 335 YLYIVDRKKDMIISGGENVYPAEVEDVLYEHPAVAEVAV 373
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
783-1115 |
2.29e-30 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 131.44 E-value: 2.29e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 783 VQLQVEEAQEPLLIAYYLADKMIDD--EQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALPSPFEQDttARIYK 860
Cdd:PRK12467 3523 VVLARDGAGGKQLVAYVVPADPQGDwrETLRDHLAASLPDYMVPAQLLVLAAMPLGPNGKVDRKALPDPDAKG--SREYV 3600
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 861 APNSSTELKLLDIWTHILGIKRISADDHFLQIGVHSLNIMTLIAQVYENFQVELPLEQVFEHDTLEEIAAYIDEQDsqyg 940
Cdd:PRK12467 3601 APRSEVEQQLAAIWADVLGVEQVGVTDNFFELGGDSLLALQVLSRIRQSLGLKLSLRDLMSAPTIAELAGYSPLGD---- 3676
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 941 VRIEPAakqayypltaaqmrvfmdeqlvntgsgyhittafmiygpIDVTRLERACGQLIERHEALRTSFdivDGDPVQRI 1020
Cdd:PRK12467 3677 VPVNLL---------------------------------------LDLNRLETGFPALFCRHEGLGTVF---DYEPLAVI 3714
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1021 hehcdfhleivhlqgqqlhtavngcirpfqleraplirsilipLAEEQHLLVLDMHHIVADGksvfllqrdlaalYEGRE 1100
Cdd:PRK12467 3715 -------------------------------------------LEGDRHVLGLTCRHLLDDG-------------WQDTS 3738
|
330
....*....|....*
gi 517718121 1101 LHDLPVQYVDFAQWQ 1115
Cdd:PRK12467 3739 LQAMAVQYADYILWQ 3753
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
952-1367 |
7.64e-30 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 129.90 E-value: 7.64e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 952 YPLTAAQMRVFMdEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDG--DPVQRIHEHCDfhLE 1029
Cdd:PRK12467 2647 YPLSPMQQGMLF-HTLYEGGAGDYINQMRVDVEGLDVERFRTAWQAVIDRHEILRSGFLWDGEleEPLQVVYKQAR--LP 2723
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1030 IVHLQGQQLHT--------AVNGCIRPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYEGREL 1101
Cdd:PRK12467 2724 FSRLDWRDRADleqaldalAAADRQQGFDLLSAPLLRLTLVRTGEDRHHLIYTNHHILMDGWSGSQLLGEVLQRYFGQPP 2803
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1102 HDLPVQYVDFAQWQTSapvvEDLRRQEQFWQSMFADY----RPLPGIPTDHTPEanersfAGGH----ITWepDPVLSRR 1173
Cdd:PRK12467 2804 PAREGRYRDYIAWLQA----QDAEASEAFWKEQLAALeeptRLARALYPAPAEA------VAGHgahyLHL--DATQTRQ 2871
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1174 LYAVAAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGrRRAEVR---QVVGMFVNALAIRSYPEGDKPFSSFLQEI 1250
Cdd:PRK12467 2872 LIEFARRHRVTLNTLVQGAWLLLLQRFTGQDTVCFGATVAG-RPAQLRgaeQQLGLFINTLPVIASPRAEQTVSDWLQQV 2950
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1251 RGTMLQAYEHQDYPL---ERLAKQLdlhhsrDHLMFDtvfSMLNYEDFAVrSDDLQFEYAELPTLSEIYNLRVE------ 1321
Cdd:PRK12467 2951 QAQNLALREFEHTPLadiQRWAGQG------GEALFD---SILVFENYPI-SEALKQGAPSGLRFGAVSSREQTnypltl 3020
|
410 420 430 440
....*....|....*....|....*....|....*....|....*.
gi 517718121 1322 IVESPERLRGTFKYGQELYEARTVSQLAQDYERILAAVAESPNIKL 1367
Cdd:PRK12467 3021 AVGLGDTLELEFSYDRQHFDAAAIERLAESFDRLLQAMLNNPAARL 3066
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
953-1376 |
9.66e-30 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 129.01 E-value: 9.66e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 953 PLTAAQMRVFMDEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDGDPVQRIHEHCDF-HLEIV 1031
Cdd:PRK10252 9 PLVAAQPGIWMAEKLSPLPSAWSVAHYVELTGELDAPLLARAVVAGLAEADTLRMRFTEDNGEVWQWVDPALTFpLPEII 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1032 HLQGQ-QLHTAVNGCIR-----PFQLERA-PLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYEGRELHD- 1103
Cdd:PRK10252 89 DLRTQpDPHAAAQALMQadlqqDLRVDSGkPLVFHQLIQLGDNRWYWYQRYHHLLVDGFSFPAITRRIAAIYCAWLRGEp 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1104 ------LPVQYV--DFAQWQTSapvvEDLRRQEQFWQSMFADY--------RPLPG-IPTDH----TPEANERSFagghi 1162
Cdd:PRK10252 169 tpaspfTPFADVveEYQRYRAS----EAWQRDAAFWAEQRRQLpppaslspAPLPGrSASADilrlKLEFTDGAF----- 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1163 twepdpvlsRRLYAVAAEQQTTLFMVLLAAFHVlyAKYSAREEVTVGTPVEGRRRAEVRQVVGMFVNALAIRSYPEGDKP 1242
Cdd:PRK10252 240 ---------RQLAAQASGVQRPDLALALVALWL--GRLCGRMDYAAGFIFMRRLGSAALTATGPVLNVLPLRVHIAAQET 308
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1243 FSSFLQEIRGTMLQAYEHQDYPLERLAKQLDLHHSRDHLmFDTVFSMLNYeDFAVRSDDLQfeyAELPTLS-------EI 1315
Cdd:PRK10252 309 LPELATRLAAQLKKMRRHQRYDAEQIVRDSGRAAGDEPL-FGPVLNIKVF-DYQLDFPGVQ---AQTHTLAtgpvndlEL 383
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 517718121 1316 Y-------NLRVEIVESPERlrgtfkygqelYEARTVSQLAQDYERILAAVAESPNIKLKDIEIRTPQ 1376
Cdd:PRK10252 384 AlfpdehgGLSIEILANPQR-----------YDEATLIAHAERLKALIAQFAADPALLCGDVDILLPG 440
|
|
| C_NRPS-like |
cd19537 |
Condensation family domain with an atypical active site motif; Condensation (C) domains of ... |
977-1314 |
6.92e-29 |
|
Condensation family domain with an atypical active site motif; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily typically have a non-canonical conserved SHXXXDX(14)Y motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380460 [Multi-domain] Cd Length: 395 Bit Score: 120.75 E-value: 6.92e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 977 TTAF-MIY-----GPIDVTRLERACGQLIERHEALRTSFDIVDGDPVQRIHEHCdfhlEIVHLQGQ-QLHTAVNgciRPF 1049
Cdd:cd19537 21 TSSFnVSFacrlsGDVDRDRLASAWNTVLARHRILRSRYVPRDGGLRRSYSSSP----PRVQRVDTlDVWKEIN---RPF 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1050 QLERAPLIRsILIPlaeeQHLLVLDMHHIVADGKSVFLLQRDLAALYEGRELHDLPVQYVDFAQWQTSAPvvedlRRQEQ 1129
Cdd:cd19537 94 DLEREDPIR-VFIS----PDTLLVVMSHIICDLTTLQLLLREVSAAYNGKLLPPVRREYLDSTAWSRPAS-----PEDLD 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1130 FWQSmfadYrpLPGIPTDHTPE-ANERSFAGGHITWEPDPVLSRRLYAVAAEQQTTLFMVLLAA-FHVLYAKySAREEVT 1207
Cdd:cd19537 164 FWSE----Y--LSGLPLLNLPRrTSSKSYRGTSRVFQLPGSLYRSLLQFSTSSGITLHQLALAAvALALQDL-SDRTDIV 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1208 VGTPVEGRRRAEVRQVVGMFVNALAIR-SYP-EGDKPFSSFLQEIRGTMLQAYEHQdYPLERLAKQLDLH-HSRDHLMFD 1284
Cdd:cd19537 237 LGAPYLNRTSEEDMETVGLFLEPLPIRiRFPsSSDASAADFLRAVRRSSQAALAHA-IPWHQLLEHLGLPpDSPNHPLFD 315
|
330 340 350
....*....|....*....|....*....|.
gi 517718121 1285 TvfsMLNYEDFAVRSDDLQFEYAE-LPTLSE 1314
Cdd:cd19537 316 V---MVTFHDDRGVSLALPIPGVEpLYTWAE 343
|
|
| FACL_DitJ_like |
cd05934 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
30-442 |
2.40e-28 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Members of this family include DitJ from Pseudomonas and similar proteins.
Pssm-ID: 341257 [Multi-domain] Cd Length: 422 Bit Score: 119.70 E-value: 2.40e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 30 SYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPlhpderlvtmldtaevscllcdda 109
Cdd:cd05934 5 TYAELLRESARIAAALAALGIRPGDRVALMLDNCPEFLFAWFALAKLGAVLVPINT------------------------ 60
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 110 qferaeTLQGHEGKYFVLRARQAMSVqagskeayshsanaTDPIYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLDLT 189
Cdd:cd05934 61 ------ALRGDELAYIIDHSGAQLVV--------------VDPASILYTSGTTGPPKGVVITHANLTFAGYYSARRFGLG 120
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 190 DPMRVsqLTSIGF---DAVLRDIFVPICAGGTIcipesreIILDPLRLVHWLEHSRVHVVHCTPSLFRFINHLSLTADSY 266
Cdd:cd05934 121 EDDVY--LTVLPLfhiNAQAVSVLAALSVGATL-------VLLPRFSASRFWSDVRRYGATVTNYLGAMLSYLLAQPPSP 191
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 267 PD----LRYVLLAGETirPESLKNWYDNLGnrVRLVNLYGPTETTmiklFYPIKPEDVHRESIPIGRPLPDTSVYLLDEQ 342
Cdd:cd05934 192 DDrahrLRAAYGAPNP--PELHEEFEERFG--VRLLEGYGMTETI----VGVIGPRDEPRRPGSIGRPAPGYEVRIVDDD 263
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 343 QQPVSGSEAGEICIATRY---MTHGYFpsSHPDQTAfipdpcrdQSGEIMMYRTGDMGRWLPEGELALLGRKDNQVKIRG 419
Cdd:cd05934 264 GQELPAGEPGELVIRGLRgwgFFKGYY--NMPEATA--------EAMRNGWFHTGDLGYRDADGFFYFVDRKKDMIRRRG 333
|
410 420
....*....|....*....|...
gi 517718121 420 NRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05934 334 ENISSAEVERAILRHPAVREAAV 356
|
|
| AANH_WbpG-like |
cd01996 |
Rhizobium leguminosarum WbpG protein and similar proteins; This subfamily includes Rhizobium ... |
513-626 |
1.01e-27 |
|
Rhizobium leguminosarum WbpG protein and similar proteins; This subfamily includes Rhizobium leguminosarum WbpG and Campylobacter jejuni PseA proteins. They belong to the of adenine nucleotide alpha hydrolase (AANH) superfamily that also includes N-type ATP PPases and ATP sulfurylases. It forms an alpha/beta/alpha fold which binds to adenosine group. This subfamily of proteins is predicted to bind ATP. This domain has a strongly conserved motif SGGKD at the N-terminus.
Pssm-ID: 467500 [Multi-domain] Cd Length: 158 Bit Score: 110.54 E-value: 1.01e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 513 NQPSYDCLLLYSGGKDSTYALYRLVEM-GARVLAYTFDNGYISSAAFRNIDSVVKELGVDHIVGTFDG--MLDIFKEGLK 589
Cdd:cd01996 2 KGKPYDCIIGVSGGKDSTYAAHKAKEKyGLRPLLVTVDAGWNSPEAVKNIEKLVRALGVDLITFVPNWkeMRDLQRLAFK 81
|
90 100 110
....*....|....*....|....*....|....*..
gi 517718121 590 QECSVCNGCFKAMRILSTRVAAERGIPYIVTGLSRGQ 626
Cdd:cd01996 82 SNGDQDWPQDHGIFTSLYKMAVKFGIPLIIWGENPAE 118
|
|
| PRK06188 |
PRK06188 |
acyl-CoA synthetase; Validated |
9-411 |
8.42e-27 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235731 [Multi-domain] Cd Length: 524 Bit Score: 116.62 E-value: 8.42e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHP 88
Cdd:PRK06188 18 LVSALKRYPDRPALVLGDTRLTYGQLADRISRYIQAFEALGLGTGDAVALLSLNRPEVLMAIGAAQLAGLRRTALHPLGS 97
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 89 DERLVTMLDTAEVSCLLCDDAQF-ERAETLQGHegkyfVLRARQAMSV--------------QAGSKEAYSHSAnATDPI 153
Cdd:PRK06188 98 LDDHAYVLEDAGISTLIVDPAPFvERALALLAR-----VPSLKHVLTLgpvpdgvdllaaaaKFGPAPLVAAAL-PPDIA 171
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 154 YIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLrdIFVP-ICAGGTICIPESreiiLDPL 232
Cdd:PRK06188 172 GLAYTGGTTGKPKGVMGTHRSIATMAQIQLAEWEWPADPRFLMCTPLSHAGGA--FFLPtLLRGGTVIVLAK----FDPA 245
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 233 RLVHWLEHSRVHVVHCTPS-LFRFINHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGNRvrLVNLYGPTETTMIKL 311
Cdd:PRK06188 246 EVLRAIEEQRITATFLVPTmIYALLDHPDLRTRDLSSLETVYYGASPMSPVRLAEAIERFGPI--FAQYYGQTEAPMVIT 323
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 312 FYPIK---PEDVHRESiPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTAfipDPCRDqsGEI 388
Cdd:PRK06188 324 YLRKRdhdPDDPKRLT-SCGRPTPGLRVALLDEDGREVAQGEVGEICVRGPLVMDGYW--NRPEETA---EAFRD--GWL 395
|
410 420
....*....|....*....|...
gi 517718121 389 mmyRTGDMGRWLPEGELALLGRK 411
Cdd:PRK06188 396 ---HTGDVAREDEDGFYYIVDRK 415
|
|
| Firefly_Luc_like |
cd05911 |
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family ... |
27-442 |
9.07e-26 |
|
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family contains insect firefly luciferases that share significant sequence similarity to plant 4-coumarate:coenzyme A ligases, despite their functional diversity. Luciferase catalyzes the production of light in the presence of MgATP, molecular oxygen, and luciferin. In the first step, luciferin is activated by acylation of its carboxylate group with ATP, resulting in an enzyme-bound luciferyl adenylate. In the second step, luciferyl adenylate reacts with molecular oxygen, producing an enzyme-bound excited state product (Luc=O*) and releasing AMP. This excited-state product then decays to the ground state (Luc=O), emitting a quantum of visible light.
Pssm-ID: 341237 [Multi-domain] Cd Length: 486 Bit Score: 113.08 E-value: 9.07e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 27 QTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTMLDTAEVSCLLC 106
Cdd:cd05911 9 KELTYAQLRTLSRRLAAGLRKLGLKKGDVVGIISPNSTYYPPVFLGCLFAGGIFSAANPIYTADELAHQLKISKPKVIFT 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 107 DDAQFER---AETLQGHEGKYFVLRAR------QAMSVQAGSKEAYSH-----SANATDPIYIYFTSGSTGKPKAVVGKN 172
Cdd:cd05911 89 DPDGLEKvkeAAKELGPKDKIIVLDDKpdgvlsIEDLLSPTLGEEDEDlppplKDGKDDTAAILYSSGTTGLPKGVCLSH 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 173 ESLL--HFMNWEASWLDLTDPMRVsqLTSIGFD---AVLRDIFVPICaGGTICIpESREIILDPLRLVhwlEHSRVHVVH 247
Cdd:cd05911 169 RNLIanLSQVQTFLYGNDGSNDVI--LGFLPLYhiyGLFTTLASLLN-GATVII-MPKFDSELFLDLI---EKYKITFLY 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 248 CTPSLF-RFINHLSLTADSYPDLRYVLLAGETIRPEsLKNWYDNLGNRVRLVNLYGPTETTMIKLFYPikPEDVHRESIp 326
Cdd:cd05911 242 LVPPIAaALAKSPLLDKYDLSSLRVILSGGAPLSKE-LQELLAKRFPNATIKQGYGMTETGGILTVNP--DGDDKPGSV- 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 327 iGRPLPDTSVYLLDEQQQPVSG-SEAGEICIATRYMTHGYFpsSHPDQTAfipdPCRDQSGeimMYRTGDMGRWLPEGEL 405
Cdd:cd05911 318 -GRLLPNVEAKIVDDDGKDSLGpNEPGEICVRGPQVMKGYY--NNPEATK----ETFDEDG---WLHTGDIGYFDEDGYL 387
|
410 420 430
....*....|....*....|....*....|....*..
gi 517718121 406 ALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05911 388 YIVDRKKELIKYKGFQVAPAELEAVLLEHPGVADAAV 424
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
783-937 |
1.74e-25 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 115.44 E-value: 1.74e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 783 VQLQVEEAQEPLLIAYYLAD--KMIDDE--------QLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALPSPfEQ 852
Cdd:PRK12316 4981 VVIAQEGAVGKQLVGYVVPQdpALADADeaqaelrdELKAALRERLPEYMVPAHLVFLARMPLTPNGKLDRKALPQP-DA 5059
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 853 DTTARIYKAPNSSTELKLLDIWTHILGIKRISADDHFLQIGVHSLNIMTLIAQVYENFQVELPLEQVFEHDTLEEIAAYI 932
Cdd:PRK12316 5060 SLLQQAYVAPRSELEQQVAAIWAEVLQLERVGLDDNFFELGGHSLLAIQVTSRIQLELGLELPLRELFQTPTLAAFVELA 5139
|
....*
gi 517718121 933 DEQDS 937
Cdd:PRK12316 5140 AAAGS 5144
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
795-936 |
4.27e-25 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 113.60 E-value: 4.27e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 795 LIAYYLA--DKMIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALPSPfeqDTTARIY-KAPNSSTELKLL 871
Cdd:PRK10252 908 LVGYLVSqsGLPLDTSALQAQLRERLPPHMVPVVLLQLDQLPLSANGKLDRKALPLP---ELKAQVPgRAPKTGTETIIA 984
|
90 100 110 120 130 140
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 517718121 872 DIWTHILGIKRISADDHFLQIGVHSLNIMTLIAQVYENFQVELPLEQVFEHDTLEEIAAYIDEQD 936
Cdd:PRK10252 985 AAFSSLLGCDVVDADADFFALGGHSLLAMKLAAQLSRQFARQVTPGQVMVASTVAKLATLLDAEE 1049
|
|
| PRK07656 |
PRK07656 |
long-chain-fatty-acid--CoA ligase; Validated |
4-442 |
2.18e-24 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236072 [Multi-domain] Cd Length: 513 Bit Score: 109.22 E-value: 2.18e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 4 TIQYELARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPL 83
Cdd:PRK07656 6 TLPELLARAARRFGDKEAYVFGDQRLTYAELNARVRRAAAALAALGIGKGDRVAIWAPNSPHWVIAALGALKAGAVVVPL 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 84 DPLH-PDErLVTMLDTAEVSCLLCDDA---QFERAETLQGHEGKYFVLRARQAMS-----------VQAGSKEAYSHSAN 148
Cdd:PRK07656 86 NTRYtADE-AAYILARGDAKALFVLGLflgVDYSATTRLPALEHVVICETEEDDPhtekmktftdfLAAGDPAERAPEVD 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 149 ATDPIYIYFTSGSTGKPKAVVGKNESLL-HFMNWeASWLDLTD--------PM-RVSQLTsIGFDAvlrdifvPICAGGT 218
Cdd:PRK07656 165 PDDVADILFTSGTTGRPKGAMLTHRQLLsNAADW-AEYLGLTEgdrylaanPFfHVFGYK-AGVNA-------PLMRGAT 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 219 IcIPESReiiLDPLRLVHWLEHSRVHVVHCTPSLFRFI-NHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGnrVRL 297
Cdd:PRK07656 236 I-LPLPV---FDPDEVFRLIETERITVLPGPPTMYNSLlQHPDRSAEDLSSLRLAVTGAASMPVALLERFESELG--VDI 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 298 V-NLYGPTE----TTMiklfypiKPEDVHRESIP--IGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSH 370
Cdd:PRK07656 310 VlTGYGLSEasgvTTF-------NRLDDDRKTVAgtIGTAIAGVENKIVNELGEEVPVGEVGELLVRGPNVMKGYY--DD 380
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 517718121 371 PDQTAFIPDPcrdqSGEImmyRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK07656 381 PEATAAAIDA----DGWL---HTGDLGRLDEEGYLYIVDRKKDMFIVGGFNVYPAEVEEVLYEHPAVAEAAV 445
|
|
| ACS-like |
cd17634 |
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the ... |
27-442 |
2.67e-24 |
|
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases. The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341289 [Multi-domain] Cd Length: 587 Bit Score: 109.59 E-value: 2.67e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 27 QTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTMLDTAEVSCLLC 106
Cdd:cd17634 83 RTISYRELHREVCRFAGTLLDLGVKKGDRVAIYMPMIPEAAVAMLACARIGAVHSVIFGGFAPEAVAGRIIDSSSRLLIT 162
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 107 DDAQFERAETL------------------------------QGHEGKYFVLRARqamsVQAGSKEAYSHSANATDPIYIY 156
Cdd:cd17634 163 ADGGVRAGRSVplkknvddalnpnvtsvehvivlkrtgsdiDWQEGRDLWWRDL----IAKASPEHQPEAMNAEDPLFIL 238
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 157 FTSGSTGKPKAVVGKNESLLHFMNWEAS----------WLDLTDPMRVSQLTSIgfdavlrdIFVPICAGGTICIPESRE 226
Cdd:cd17634 239 YTSGTTGKPKGVLHTTGGYLVYAATTMKyvfdygpgdiYWCTADVGWVTGHSYL--------LYGPLACGATTLLYEGVP 310
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 227 IILDPLRLVHWLEHSRVHVVHCTPSLFRFINHLSLTADSYPD---LRYVLLAGETIRPESLKnWYDNL--GNRVRLVNLY 301
Cdd:cd17634 311 NWPTPARMWQVVDKHGVNILYTAPTAIRALMAAGDDAIEGTDrssLRILGSVGEPINPEAYE-WYWKKigKEKCPVVDTW 389
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 302 GPTETT--MIklfyPIKPEDVHRESIPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIAtrymthgyfpSSHPDQT-AFIP 378
Cdd:cd17634 390 WQTETGgfMI----TPLPGAIELKAGSATRPVFGVQPAVVDNEGHPQPGGTEGNLVIT----------DPWPGQTrTLFG 455
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 517718121 379 DPCRDQSGEIM----MYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd17634 456 DHERFEQTYFStfkgMYFSGDGARRDEDGYYWITGRSDDVINVAGHRLGTAEIESVLVAHPKVAEAAV 523
|
|
| CBAL |
cd05923 |
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) ... |
9-442 |
2.69e-24 |
|
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) to 4-chlorobenzoyl-coenzyme A (4-CB-CoA) by the two-step adenylation and thioester-forming reactions. 4-Chlorobenzoate (4-CBA) is an environmental pollutant derived from microbial breakdown of aromatic pollutants, such as polychlorinated biphenyls (PCBs), DDT, and certain herbicides. The 4-CBA degrading pathway converts 4-CBA to the metabolite 4-hydroxybezoate (4-HBA), allowing some soil-dwelling microbes to utilize 4-CBA as an alternate carbon source. This pathway consists of three chemical steps catalyzed by 4-CBA-CoA ligase, 4-CBA-CoA dehalogenase, and 4HBA-CoA thioesterase in sequential reactions.
Pssm-ID: 341247 [Multi-domain] Cd Length: 493 Bit Score: 108.37 E-value: 2.69e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAI--ECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDP- 85
Cdd:cd05923 7 LRRAASRAPDACAIadPARGLRLTYSELRARIEAVAARLHARGLRPGQRVAVVLPNSVEAVIALLALHRLGAVPALINPr 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 86 LHPDErLVTMLDTAEV-SCLLCDDAQFERAETLQGHEgkyfVLRarqaMSVQAGSKEAYSHSANATDPI-------YIYF 157
Cdd:cd05923 87 LKAAE-LAELIERGEMtAAVIAVDAQVMDAIFQSGVR----VLA----LSDLVGLGEPESAGPLIEDPPrepeqpaFVFY 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 158 TSGSTGKPKAVVGKN---ESLLHFMNWEASwLDLTDPMRVSQLT----SIGFDAVLrdiFVPICAGGTICIPESreiiLD 230
Cdd:cd05923 158 TSGTTGLPKGAVIPQraaESRVLFMSTQAG-LRHGRHNVVLGLMplyhVIGFFAVL---VAALALDGTYVVVEE----FD 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 231 PLRLVHWLEHSRVHVVHCTPSLFR-FINHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGNRVrlVNLYGPTEtTMI 309
Cdd:cd05923 230 PADALKLIEQERVTSLFATPTHLDaLAAAAEFAGLKLSSLRHVTFAGATMPDAVLERVNQHLPGEK--VNIYGTTE-AMN 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 310 KLFYPikpeDVHRESipIGRPLPDTSVY---LLDEQQQPVSGSEAGEICIA-------TRYMthgyfpsSHPDQTAfipd 379
Cdd:cd05923 307 SLYMR----DARTGT--EMRPGFFSEVRivrIGGSPDEALANGEEGELIVAaaadaafTGYL-------NQPEATA---- 369
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 517718121 380 pcrdQSGEIMMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05923 370 ----KKLQDGWYRTGDVGYVDPSGDVRILGRVDDMIISGGENIHPSEIERVLSRHPGVTEVVV 428
|
|
| PRK06187 |
PRK06187 |
long-chain-fatty-acid--CoA ligase; Validated |
1-442 |
2.87e-24 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235730 [Multi-domain] Cd Length: 521 Bit Score: 108.74 E-value: 2.87e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1 MDNTIqYELARAFAA-FPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGV 79
Cdd:PRK06187 4 YPLTI-GRILRHGARkHPDKEAVYFDGRRTTYAELDERVNRLANALRALGVKKGDRVAVFDWNSHEYLEAYFAVPKIGAV 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 80 FVPLD-PLHPDERLVTMLDtAEVSCLLCDD---AQFERAETLQGHEGKYFVL--RARQAMSVQAGSKEAYSHSANATDP- 152
Cdd:PRK06187 83 LHPINiRLKPEEIAYILND-AEDRVVLVDSefvPLLAAILPQLPTVRTVIVEgdGPAAPLAPEVGEYEELLAAASDTFDf 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 153 ---------IYIYfTSGSTGKPKAVVGKNESL-LHFMNwEASWLDLTD--------PMRVSQLTSIGfdavlrdiFVPIC 214
Cdd:PRK06187 162 pdidendaaAMLY-TSGTTGHPKGVVLSHRNLfLHSLA-VCAWLKLSRddvylvivPMFHVHAWGLP--------YLALM 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 215 AGGTICIPESreiiLDPLRLVHWLEHSRVHVVHCTPSLFRFI-NHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGn 293
Cdd:PRK06187 232 AGAKQVIPRR----FDPENLLDLIETERVTFFFAVPTIWQMLlKAPRAYFVDFSSLRLVIYGGAALPPALLREFKEKFG- 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 294 rVRLVNLYGPTETTMIKLFYPIKPEDVHRESIPI--GRPLPDTSVYLLDE--QQQPVSGSEAGEICIATRYMTHGYFpsS 369
Cdd:PRK06187 307 -IDLVQGYGMTETSPVVSVLPPEDQLPGQWTKRRsaGRPLPGVEARIVDDdgDELPPDGGEVGEIIVRGPWLMQGYW--N 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 370 HPDQTA--FIPDpcrdqsgeimMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRV---ELGDI--EHRltnmaGIREAVV 442
Cdd:PRK06187 384 RPEATAetIDGG----------WLHTGDVGYIDEDGYLYITDRIKDVIISGGENIyprELEDAlyGHP-----AVAEVAV 448
|
|
| WbuX |
TIGR03573 |
N-acetyl sugar amidotransferase; This enzyme has been implicated in the formation of the ... |
456-758 |
2.99e-24 |
|
N-acetyl sugar amidotransferase; This enzyme has been implicated in the formation of the acetamido moiety (sugar-NC(=NH)CH3) which is found on some exopolysaccharides and is positively charged at neutral pH. The reaction involves ligation of ammonia with a sugar N-acetyl group, displacing water. In E. coli (O145 strain) and Pseudomonas aeruginosa (O12 strain) this gene is known as wbuX and ifnA respectively and likely acts on sialic acid. In Campylobacter jejuni, the gene is known as pseA and acts on pseudaminic acid in the process of flagellin glycosylation. In other Pseudomonas strains and various organisms it is unclear what the identity of the sugar substrate is, and in fact, the phylogenetic tree of this family sports a considerably deep branching suggestive of possible major differences in substrate structure. Nevertheless, the family is characterized by a conserved tetracysteine motif (CxxC.....[GN]xCxxC) possibly indicative of a metal binding site, as well as an invariable contextual association with homologs of the HisH and HisF proteins known as WbuY and WbuZ, respectively. These two proteins are believed to supply the enzyme with ammonium by hydrolysis of glutamine and delivery through an ammonium conduit.
Pssm-ID: 274658 Cd Length: 343 Bit Score: 105.85 E-value: 2.99e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 456 QQHCAACGLPSTYPGISFDDMGKCSVCTGQEQyrsaAEQ--YFQGMEQLQSKLQPVEKENQPSYDCLLLYSGGKDSTYAL 533
Cdd:TIGR03573 1 MKFCKRCVMPTTRPGITFDEDGVCSACRNFEE----KSKidWDEREKELEELVDKIKKKGGGRYDCIIGVSGGKDSTYQA 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 534 YRLVE-MGARVLAYTFDNGYISSAAFRNIDSVVKELGVDHIVGTFDG--MLDIFKEGLKQECSVCNGCFKAMRILSTRVA 610
Cdd:TIGR03573 77 HVLKKkLGLNPLLVTVDPGWNTELGVKNLNNLIKKLGFDLHTITINPetFRKLQRAYFKKVGDPEWPQDHAIFASVYQVA 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 611 AERGIPYIVTGLS---------------RGQIYDVRLYDilqqgyrttAEIELKIQEQRVlyhGKKDYVAEAFERDELIN 675
Cdd:TIGR03573 157 LKFNIPLIIWGENiaeeyggdseeelnpDEWKYNKRGID---------AANIKDFSDKGL---SERDLYAYTYPDKEKLQ 224
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 676 RSMLDQVELVDFYRYcdvSKQDILSFlqSKSEC-WSNPEDTG----FCSSNCLINDAGIYVQRTQLGYDNYAFPNSWEVR 750
Cdd:TIGR03573 225 SKGVKVIYLGYYVKW---DKKKNYEF--IKKRGgWREGPHPGtyenYKHIDSIFTIFHDYLKYLKFGFGRATDHASIDIR 299
|
....*...
gi 517718121 751 TGHITLEQ 758
Cdd:TIGR03573 300 SGRITREE 307
|
|
| E_NRPS |
cd19534 |
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
953-1361 |
3.04e-24 |
|
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Epimerization (E) domains of nonribosomal peptide synthetases (NRPS) flip the chirality of the end amino acid of a peptide being manufactured by the NRPS. E-domains are homologous to the Condensation (C) domains. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Specialized tailoring NRPS domains such as E-domains greatly increase the range of possible peptide products created by the NRPS machinery. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the E-domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380457 [Multi-domain] Cd Length: 428 Bit Score: 107.34 E-value: 3.04e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 953 PLTAAQmRVFMDEQLVNTgsgYHITTAFMIY--GPIDVTRLERACGQLIERHEALRTSFDIVDGDPVQRIHE--HCDFHL 1028
Cdd:cd19534 3 PLTPIQ-RWFFEQNLAGR---HHFNQSVLLRvpQGLDPDALRQALRALVEHHDALRMRFRREDGGWQQRIRGdvEELFRL 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1029 EIV----HLQGQQLHTAVNGCIRPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYEGRELHDL 1104
Cdd:cd19534 79 EVVdlssLAQAAAIEALAAEAQSSLDLEEGPLLAAALFDGTDGGDRLLLVIHHLVVDGVSWRILLEDLEAAYEQALAGEP 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1105 PVQ-----YVDFAQWQTSAPVVEDLRRQEQFWQSMFA-DYRPLPGIPTDHtpEANERSFaggHITWEPDPVlSRRLYAVA 1178
Cdd:cd19534 159 IPLpsktsFQTWAELLAEYAQSPALLEELAYWRELPAaDYWGLPKDPEQT--YGDARTV---SFTLDEEET-EALLQEAN 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1179 AEQQTTLFMVLLAAFHVLYAKYSAREEVTVGtpVEGRRR------AEVRQVVGMFVNALAIRSYPEGDKPFSSFLQEIRG 1252
Cdd:cd19534 233 AAYRTEINDLLLAALALAFQDWTGRAPPAIF--LEGHGReeidpgLDLSRTVGWFTSMYPVVLDLEASEDLGDTLKRVKE 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1253 TMLQ------AYEHQDYPLERLAKQLDLHHSRDhLMFdtvfsmlNY-EDF-AVRSDDLQFEYAELPTLSEI-------YN 1317
Cdd:cd19534 311 QLRRipnkgiGYGILRYLTPEGTKRLAFHPQPE-ISF-------NYlGQFdQGERDDALFVSAVGGGGSDIgpdtprfAL 382
|
410 420 430 440
....*....|....*....|....*....|....*....|....
gi 517718121 1318 LRVEIVESPERLRGTFKYGQELYEARTVSQLAQDYERILAAVAE 1361
Cdd:cd19534 383 LDINAVVEGGQLVITVSYSRNMYHEETIQQLADSYKEALEALIE 426
|
|
| FUM14_C_NRPS-like |
cd19545 |
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond ... |
952-1363 |
3.50e-24 |
|
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond forming Fusarium verticillioides FUM14 protein; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) typically catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. However, some C-domains have ester-bond forming activity. This subfamily includes Fusarium verticillioides FUM14 (also known as NRPS8), a bi-domain protein with an ester-bond forming NRPS C-domain, which catalyzes linkages between an aminoacyl/peptidyl-PCP donor and a hydroxyl-containing acceptor. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. FUM14 has an altered active site motif DHTHCD instead of the typical HHxxxD motif seen in other subfamily members. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380467 [Multi-domain] Cd Length: 395 Bit Score: 106.61 E-value: 3.50e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 952 YPLTAAQmRVFMDEQLVNTGSgYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVD-GDPVQRIHEHCDFHlei 1030
Cdd:cd19545 2 YPCTPLQ-EGLMALTARQPGA-YVGQRVFELPPDIDLARLQAAWEQVVQANPILRTRIVQSDsGGLLQVVVKESPIS--- 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1031 vhlqgQQLHTAVNGCIRPFQLER----APLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYEGRElhdlPV 1106
Cdd:cd19545 77 -----WTESTSLDEYLEEDRAAPmglgGPLVRLALVEDPDTERYFVWTIHHALYDGWSLPLILRQVLAAYQGEP----VP 147
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1107 QYVDFAQWqTSAPVVEDLRRQEQFWQSMFADYRPLPGIPtdhTPEANERSfagghitwEPDPVLSRRL-YAVAAEQQTTL 1185
Cdd:cd19545 148 QPPPFSRF-VKYLRQLDDEAAAEFWRSYLAGLDPAVFPP---LPSSRYQP--------RPDATLEHSIsLPSSASSGVTL 215
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1186 FMVLLAAFHVLYAKYSAREEVTVGTPVEGRRR--AEVRQVVGMFVNALAIRSYPEGDKPFSSFLQEIRGTMLQAYEHQDY 1263
Cdd:cd19545 216 ATVLRAAWALVLSRYTGSDDVVFGVTLSGRNApvPGIEQIVGPTIATVPLRVRIDPEQSVEDFLQTVQKDLLDMIPFEHT 295
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1264 PLERLAKQLDlhHSRDHLMFDTVF--------SMLNYEDFAVRSDDLQFEyaELPTlseiYNLRVEIVESPERLRGTFKY 1335
Cdd:cd19545 296 GLQNIRRLGP--DARAACNFQTLLvvqpalpsSTSESLELGIEEESEDLE--DFSS----YGLTLECQLSGSGLRVRARY 367
|
410 420
....*....|....*....|....*...
gi 517718121 1336 GQELYEARTVSQLAQDYERILAAVAESP 1363
Cdd:cd19545 368 DSSVISEEQVERLLDQFEHVLQQLASAP 395
|
|
| CHC_CoA_lg |
cd05903 |
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); ... |
28-442 |
4.44e-24 |
|
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); Cyclohexanecarboxylate-CoA ligase activates the aliphatic ring compound, cyclohexanecarboxylate, for degradation. It catalyzes the synthesis of cyclohexanecarboxylate-CoA thioesters in a two-step reaction involving the formation of cyclohexanecarboxylate-AMP anhydride, followed by the nucleophilic substitution of AMP by CoA.
Pssm-ID: 341229 [Multi-domain] Cd Length: 437 Bit Score: 107.08 E-value: 4.44e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 28 TLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTMLDTAEVSCLLCD 107
Cdd:cd05903 1 RLTYSELDTRADRLAAGLAALGVGPGDVVAFQLPNWWEFAVLYLACLRIGAVTNPILPFFREHELAFILRRAKAKVFVVP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 108 DaqferaetlqghegkyfvlRARQamsvqagskeaYSHSANATDPIYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLD 187
Cdd:cd05903 81 E-------------------RFRQ-----------FDPAAMPDAVALLLFTSGTTGEPKGVMHSHNTLSASIRQYAERLG 130
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 188 LTDPMRVSQLTSIG-FDAVLRDIFVPICAGGTICIPEsreiILDPLRLVHWLEHSRV-HVVHCTPSLFRFINHLSLTADS 265
Cdd:cd05903 131 LGPGDVFLVASPMAhQTGFVYGFTLPLLLGAPVVLQD----IWDPDKALALMREHGVtFMMGATPFLTDLLNAVEEAGEP 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 266 YPDLRYVLLAGETIRPESLKNWYDNLGNRVrlVNLYGPTETTMIklFYPIKPEDVHRESIPIGRPLPDTSVYLLDEQQQP 345
Cdd:cd05903 207 LSRLRTFVCGGATVPRSLARRAAELLGAKV--CSAYGSTECPGA--VTSITPAPEDRRLYTDGRPLPGVEIKVVDDTGAT 282
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 346 VSGSEAGEICIATRYMTHGYFpsSHPDQTA-FIPDpcrdqsgeiMMYRTGDMGRWLPEGELALLGR-KDnqVKIR-GNRV 422
Cdd:cd05903 283 LAPGVEGELLSRGPSVFLGYL--DRPDLTAdAAPE---------GWFRTGDLARLDEDGYLRITGRsKD--IIIRgGENI 349
|
410 420
....*....|....*....|
gi 517718121 423 ELGDIEHRLTNMAGIREAVV 442
Cdd:cd05903 350 PVLEVEDLLLGHPGVIEAAV 369
|
|
| Cyc_NRPS |
cd19535 |
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
986-1301 |
7.77e-24 |
|
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Cyc (heterocyclization) domains catalyze two separate reactions in the creation of heterocyclized peptide products in nonribosomal peptide synthesis: amide bond formation followed by intramolecular cyclodehydration between a Cys, Ser, or Thr side chain and a carbonyl carbon on the peptide backbone to form a thiazoline, oxazoline, or methyloxazoline ring. Cyc-domains are homologous to standard NRPS Condensation (C) domains. C-domains typically have a conserved HHxxxD motif at the active site; Cyc-domains have an alternative, conserved DxxxxD active site motif, mutation of the aspartate residues in this motif can abolish or diminish condensation activity. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and Cyc-domains. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380458 [Multi-domain] Cd Length: 423 Bit Score: 106.03 E-value: 7.77e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 986 IDVTRLERACGQLIERHEALRTsfdIVDGDPVQRIHEH-CDFHLEIVHLQGQQLHTAVNGCI--------RPFQLERAPL 1056
Cdd:cd19535 37 LDPDRLERAWNKLIARHPMLRA---VFLDDGTQQILPEvPWYGITVHDLRGLSEEEAEAALEelrerlshRVLDVERGPL 113
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1057 IRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYEGRElHDLPVQYVDFAQW--QTSAPVVEDLRRQEQFWQSM 1134
Cdd:cd19535 114 FDIRLSLLPEGRTRLHLSIDLLVADALSLQILLRELAALYEDPG-EPLPPLELSFRDYllAEQALRETAYERARAYWQER 192
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1135 FADYRPLPGIPTDHTPEA-NERSFAggHITWEPDPVLSRRLYAVAAEQQTTLFMVLLAAF-HVLyAKYSAREEVTVGTPV 1212
Cdd:cd19535 193 LPTLPPAPQLPLAKDPEEiKEPRFT--RREHRLSAEQWQRLKERARQHGVTPSMVLLTAYaEVL-ARWSGQPRFLLNLTL 269
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1213 EGRRR--AEVRQVVGMFVNA--LAIRsyPEGDKPFSSFLQEIRGTMLQAYEHQDYP----LERLAKQldlHHSRDHLMfD 1284
Cdd:cd19535 270 FNRLPlhPDVNDVVGDFTSLllLEVD--GSEGQSFLERARRLQQQLWEDLDHSSYSgvvvVRRLLRR---RGGQPVLA-P 343
|
330
....*....|....*...
gi 517718121 1285 TVF-SMLNYEDFAVRSDD 1301
Cdd:cd19535 344 VVFtSNLGLPLLDEEVRE 361
|
|
| VL_LC_FACS_like |
cd05907 |
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA ... |
25-442 |
8.01e-24 |
|
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA synthetases; This family includes long-chain fatty acid (C12-C20) CoA synthetases and Bubblegum-like very long-chain (>C20) fatty acid CoA synthetases. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Drosophila melanogaster mutant bubblegum (BGM) have elevated levels of very-long-chain fatty acids (VLCFA) caused by a defective gene later named bubblegum. The human homolog (hsBG) of bubblegum has been characterized as a very long chain fatty acid CoA synthetase that functions specifically in the brain; hsBG may play a central role in brain VLCFA metabolism and myelinogenesis. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341233 [Multi-domain] Cd Length: 452 Bit Score: 106.53 E-value: 8.01e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 25 GQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTMLDTAEVSCL 104
Cdd:cd05907 2 VWQPITWAEFAEEVRALAKGLIALGVEPGDRVAILSRNRPEWTIADLAILAIGAVPVPIYPTSSAEQIAYILNDSEAKAL 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 105 LCDDAqferaetlqghegkyfvlrarqamsvqagskeayshsanaTDPIYIYFTSGSTGKPKAVVGKNESLLhfmnWEAS 184
Cdd:cd05907 82 FVEDP----------------------------------------DDLATIIYTSGTTGRPKGVMLSHRNIL----SNAL 117
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 185 WLDLTDPMRvSQLTSIGF------DAVLRDIFVPICAGGTICIPESREIILDPLRLVhwlehsRVHVVHCTPSLFRFInH 258
Cdd:cd05907 118 ALAERLPAT-EGDRHLSFlplahvFERRAGLYVPLLAGARIYFASSAETLLDDLSEV------RPTVFLAVPRVWEKV-Y 189
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 259 LSLTADSYPDLRYVLLA---GETIR---------PESLKNWYDNLGnrVRLVNLYGPTETTMIKLFYPikPEDVHRESIp 326
Cdd:cd05907 190 AAIKVKAVPGLKRKLFDlavGGRLRfaasggaplPAELLHFFRALG--IPVYEGYGLTETSAVVTLNP--PGDNRIGTV- 264
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 327 iGRPLPDTSVYLldeqqqpvsgSEAGEICIATRYMTHGYFPSshPDQTA--FIPDPcrdqsgeimMYRTGDMGRWLPEGE 404
Cdd:cd05907 265 -GKPLPGVEVRI----------ADDGEILVRGPNVMLGYYKN--PEATAeaLDADG---------WLHTGDLGEIDEDGF 322
|
410 420 430
....*....|....*....|....*....|....*....
gi 517718121 405 LALLGR-KDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05907 323 LHITGRkKDLIITSGGKNISPEPIENALKASPLISQAVV 361
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
795-933 |
5.97e-23 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 107.18 E-value: 5.97e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 795 LIAYYLADKMIDD-----EQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALPSPFEQDTTARIYKAPNSSTELK 869
Cdd:PRK05691 4166 LVGYLVPHQTVLAqgallERIKQRLRAELPDYMVPLHWLWLDRLPLNANGKLDRKALPALDIGQLQSQAYLAPRNELEQT 4245
|
90 100 110 120 130 140
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 517718121 870 LLDIWTHILGIKRISADDHFLQIGVHSLNIMTLIAQVYENFQVELPLEQVFEHDTLEEIAAYID 933
Cdd:PRK05691 4246 LATIWADVLKVERVGVHDNFFELGGHSLLATQIASRVQKALQRNVPLRAMFECSTVEELAEYIE 4309
|
|
| BCL_4HBCL |
cd05959 |
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate ... |
17-442 |
3.37e-22 |
|
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate CoA ligase and 4-hydroxybenzoate-coenzyme A ligase catalyze the first activating step for benzoate and 4-hydroxybenzoate catabolic pathways, respectively. Although these two enzymes share very high sequence homology, they have their own substrate preference. The reaction proceeds via a two-step process; the first ATP-dependent step forms the substrate-AMP intermediate, while the second step forms the acyl-CoA ester, releasing the AMP. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Some bacteria can use benzoic acid or benzenoid compounds as the sole source of carbon and energy through degradation. Benzoate CoA ligase and 4-hydroxybenzoate-Coenzyme A ligase are key enzymes of this process.
Pssm-ID: 341269 [Multi-domain] Cd Length: 508 Bit Score: 102.06 E-value: 3.37e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 17 PERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTML 96
Cdd:cd05959 18 GDKTAFIDDAGSLTYAELEAEARRVAGALRALGVKREERVLLIMLDTVDFPTAFLGAIRAGIVPVPVNTLLTPDDYAYYL 97
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 97 D-----TAEVSCLLCDdaQFERAETLQGHEgKYFVLRARQAMS----------VQAGSKEAYSHSANATDPIYIYFTSGS 161
Cdd:cd05959 98 EdsrarVVVVSGELAP--VLAAALTKSEHT-LVVLIVSGGAGPeagalllaelVAAEAEQLKPAATHADDPAFWLYSSGS 174
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 162 TGKPKAVVGKNESLLHFMNWEA-SWLDLTDPMRVSQLTSIGFDAVLRD-IFVPICAGGT-ICIPESREiildPLRLVHWL 238
Cdd:cd05959 175 TGRPKGVVHLHADIYWTAELYArNVLGIREDDVCFSAAKLFFAYGLGNsLTFPLSVGATtVLMPERPT----PAAVFKRI 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 239 EHSRVHVVHCTPSLFR-FINHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGnrVRLVNLYGPTEttMIKLFYPIKP 317
Cdd:cd05959 251 RRYRPTVFFGVPTLYAaMLAAPNLPSRDLSSLRLCVSAGEALPAEVGERWKARFG--LDILDGIGSTE--MLHIFLSNRP 326
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 318 EDVHRESIpiGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFPSshpdqtafipdpcRDQSGEIMM---YRTG 394
Cdd:cd05959 327 GRVRYGTT--GKPVPGYEVELRDEDGGDVADGEPGELYVRGPSSATMYWNN-------------RDKTRDTFQgewTRTG 391
|
410 420 430 440
....*....|....*....|....*....|....*....|....*...
gi 517718121 395 DMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05959 392 DKYVRDDDGFYTYAGRADDMLKVSGIWVSPFEVESALVQHPAVLEAAV 439
|
|
| A_NRPS_TubE_like |
cd05906 |
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) ... |
25-429 |
3.45e-22 |
|
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) synthesizing toxins and antitumor agents; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino)-acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family includes NRPSs that synthesize toxins and antitumor agents; for example, TubE for Tubulysine, CrpA for cryptophycin, TdiA for terrequinone A, KtzG for kutzneride, and Vlm1/Vlm2 for Valinomycin. Nonribosomal peptide synthetases are large multifunctional enzymes which synthesize many therapeutically useful peptides. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341232 [Multi-domain] Cd Length: 540 Bit Score: 102.36 E-value: 3.45e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 25 GQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPD----------ERLVT 94
Cdd:cd05906 36 SEEFQSYQDLLEDARRLAAGLRQLGLRPGDSVILQFDDNEDFIPAFWACVLAGFVPAPLTVPPTYdepnarlrklRHIWQ 115
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 95 MLDTAEVsclLCDD---AQFERAETLQGHEGkyFVLRARQAMSVQAGSKEAysHSANATDPIYIYFTSGSTGKPKAVVGK 171
Cdd:cd05906 116 LLGSPVV---LTDAelvAEFAGLETLSGLPG--IRVLSIEELLDTAADHDL--PQSRPDDLALLMLTSGSTGFPKAVPLT 188
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 172 NESLLHfMNWEASWLDLTDPMRVsQLTSIGFDAVLRDIFV---PICAGG-TICIPESrEIILDPLRLVHWLEHSRVHVVH 247
Cdd:cd05906 189 HRNILA-RSAGKIQHNGLTPQDV-FLNWVPLDHVGGLVELhlrAVYLGCqQVHVPTE-EILADPLRWLDLIDRYRVTITW 265
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 248 CTPSLFRFINHLSLTADSYP----DLRYVLLAGE-----TIRP--ESLKnwydNLGNRVR-LVNLYGPTETTMIKLFYPI 315
Cdd:cd05906 266 APNFAFALLNDLLEEIEDGTwdlsSLRYLVNAGEavvakTIRRllRLLE----PYGLPPDaIRPAFGMTETCSGVIYSRS 341
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 316 KPEDVHRESIP---IGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFPSSHPDQTAFIPDpcrdqsGeimMYR 392
Cdd:cd05906 342 FPTYDHSQALEfvsLGRPIPGVSMRIVDDEGQLLPEGEVGRLQVRGPVVTKGYYNNPEANAEAFTED------G---WFR 412
|
410 420 430
....*....|....*....|....*....|....*..
gi 517718121 393 TGDMGrWLPEGELALLGRKDNQVKIRGNRVELGDIEH 429
Cdd:cd05906 413 TGDLG-FLDNGNLTITGRTKDTIIVNGVNYYSHEIEA 448
|
|
| PRK04319 |
PRK04319 |
acetyl-CoA synthetase; Provisional |
26-442 |
4.41e-22 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 235279 [Multi-domain] Cd Length: 570 Bit Score: 102.28 E-value: 4.41e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 26 QQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTMLDTAEVSCLL 105
Cdd:PRK04319 71 KEKYTYKELKELSNKFANVLKELGVEKGDRVFIFMPRIPELYFALLGALKNGAIVGPLFEAFMEEAVRDRLEDSEAKVLI 150
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 106 CDDAQFER--AETL------------QGHEGKYFVLRARqamsVQAGSKEAYSHSANATDPIYIYFTSGSTGKPKAVVG- 170
Cdd:PRK04319 151 TTPALLERkpADDLpslkhvllvgedVEEGPGTLDFNAL----MEQASDEFDIEWTDREDGAILHYTSGSTGKPKGVLHv 226
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 171 KNESLLHFMNweASW-LDL---------TDPMRVSQlTSIGfdavlrdIFVPICAGGTICIPESReiiLDPLRLVHWLEH 240
Cdd:PRK04319 227 HNAMLQHYQT--GKYvLDLheddvywctADPGWVTG-TSYG-------IFAPWLNGATNVIDGGR---FSPERWYRILED 293
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 241 SRVHVVHCTPSLFR-FINHLSLTADSY--PDLRYVLLAGETIRPESLKNWYDNLGNRVRlvNLYGPTET--TMIKLFY-- 313
Cdd:PRK04319 294 YKVTVWYTAPTAIRmLMGAGDDLVKKYdlSSLRHILSVGEPLNPEVVRWGMKVFGLPIH--DNWWMTETggIMIANYPam 371
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 314 PIKPEDvhresipIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRY--MTHGYFPSSHPDQTAFIPDpcrdqsgeimMY 391
Cdd:PRK04319 372 DIKPGS-------MGKPLPGIEAAIVDDQGNELPPNRMGNLAIKKGWpsMMRGIWNNPEKYESYFAGD----------WY 434
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|.
gi 517718121 392 RTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK04319 435 VSGDSAYMDEDGYFWFQGRVDDVIKTSGERVGPFEVESKLMEHPAVAEAGV 485
|
|
| PRK06145 |
PRK06145 |
acyl-CoA synthetase; Validated |
12-442 |
5.14e-22 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 102207 [Multi-domain] Cd Length: 497 Bit Score: 101.50 E-value: 5.14e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 12 AFAAF-----PERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLD-P 85
Cdd:PRK06145 6 ASIAFharrtPDRAALVYRDQEISYAEFHQRILQAAGMLHARGIGQGDVVALLMKNSAAFLELAFAASYLGAVFLPINyR 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 86 LHPDErLVTMLDTAEVSCLLCDdaqfERAETLQGHEGKYFVLRARQAMSV----QAGSKEAYSHSANATDPIYIYFTSGS 161
Cdd:PRK06145 86 LAADE-VAYILGDAGAKLLLVD----EEFDAIVALETPKIVIDAAAQADSrrlaQGGLEIPPQAAVAPTDLVRLMYTSGT 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 162 TGKPKAVVGKNESLlhfmNWEA----SWLDLTDPMR---VSQLTSIG-FDavLRDIFVpICAGGTICIpeSREiiLDPLR 233
Cdd:PRK06145 161 TDRPKGVMHSYGNL----HWKSidhvIALGLTASERllvVGPLYHVGaFD--LPGIAV-LWVGGTLRI--HRE--FDPEA 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 234 LVHWLEHSRVHVVHCTPSLFRFInhLSL-TADSY--PDLRYVLLAGETIrPESLKNWYDNLGNRVRLVNLYGPTETTMIK 310
Cdd:PRK06145 230 VLAAIERHRLTCAWMAPVMLSRV--LTVpDRDRFdlDSLAWCIGGGEKT-PESRIRDFTRVFTRARYIDAYGLTETCSGD 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 311 LFYpikpeDVHRESIPI---GRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFPSSHPDQTAFIPDpcrdqsge 387
Cdd:PRK06145 307 TLM-----EAGREIEKIgstGRALAHVEIRIADGAGRWLPPNMKGEICMRGPKVTKGYWKDPEKTAEAFYGD-------- 373
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*
gi 517718121 388 imMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK06145 374 --WFRSGDVGYLDEEGFLYLTDRKKDMIISGGENIASSEVERVIYELPEVAEAAV 426
|
|
| PRK06178 |
PRK06178 |
acyl-CoA synthetase; Validated |
8-453 |
3.86e-21 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235724 [Multi-domain] Cd Length: 567 Bit Score: 99.35 E-value: 3.86e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 8 ELARAFAAF-PERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDrCASI-AAVIGILKLGGVFVPLDP 85
Cdd:PRK06178 37 EYLRAWARErPQRPAIIFYGHVITYAELDELSDRFAALLRQRGVGAGDRVAVFLPN-CPQFhIVFFGILKLGAVHVPVSP 115
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 86 LHPDERLVTMLDTAEVSCLLCDDAQFE-----RAET-------------------------LQG----HEGKYFVLRARQ 131
Cdd:PRK06178 116 LFREHELSYELNDAGAEVLLALDQLAPvveqvRAETslrhvivtsladvlpaeptlplpdsLRAprlaAAGAIDLLPALR 195
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 132 AMSVQAGskeaySHSANATDPIYIYFTSGSTGKPKAVVGKNESLLHFMnweASWLDLTDPMRvSQLTSIGF--------- 202
Cdd:PRK06178 196 ACTAPVP-----LPPPALDALAALNYTGGTTGMPKGCEHTQRDMVYTA---AAAYAVAVVGG-EDSVFLSFlpefwiage 266
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 203 DAvlrDIFVPICAGGTIcipesreIIL---DPLRLVHWLEHSRVhvvhctpslfrfiNHLSLTADSYPDL-------RYV 272
Cdd:PRK06178 267 NF---GLLFPLFSGATL-------VLLarwDAVAFMAAVERYRV-------------TRTVMLVDNAVELmdhprfaEYD 323
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 273 LLAGETIR---------PESLKNWYDNLGNRVRLVNlYGPTETTMIKLF---YPIKPEDVHRESIPIGRPLPDTSVYLLD 340
Cdd:PRK06178 324 LSSLRQVRvvsfvkklnPDYRQRWRALTGSVLAEAA-WGMTETHTCDTFtagFQDDDFDLLSQPVFVGLPVPGTEFKICD 402
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 341 EQQ-QPVSGSEAGEICIATRYMTHGYFpsSHPDQTAfipDPCRDQsgeimMYRTGDMGRWLPEGELALLGRKDNQVKIRG 419
Cdd:PRK06178 403 FETgELLPLGAEGEIVVRTPSLLKGYW--NKPEATA---EALRDG-----WLHTGDIGKIDEQGFLHYLGRRKEMLKVNG 472
|
490 500 510
....*....|....*....|....*....|....*
gi 517718121 420 NRVELGDIEHRLTNMAGI-REAVVrmrAKADTPKG 453
Cdd:PRK06178 473 MSVFPSEVEALLGQHPAVlGSAVV---GRPDPDKG 504
|
|
| MACS_like_2 |
cd05973 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
29-442 |
4.39e-21 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341277 [Multi-domain] Cd Length: 437 Bit Score: 97.97 E-value: 4.39e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 29 LSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTMLDTAEVSCLLCDD 108
Cdd:cd05973 1 LTFGELRALSARFANALQELGVGPGDVVAGLLPRTPELVVTILGIWRLGAVYQPLFTAFGPKAIEHRLRTSGARLVVTDA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 109 AQFERAetlqghegkyfvlrarqamsvqagskeayshsanATDPIYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLDL 188
Cdd:cd05973 81 ANRHKL----------------------------------DSDPFVMMFTSGTTGLPKGVPVPLRALAAFGAYLRDAVDL 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 189 TDPMRVSQLTSIGFDAVL-RDIFVPICAG-------GTICIPESREIIldplrlvhwlEHSRVHVVHCTPSLFRFINHLS 260
Cdd:cd05973 127 RPEDSFWNAADPGWAYGLyYAITGPLALGhptilleGGFSVESTWRVI----------ERLGVTNLAGSPTAYRLLMAAG 196
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 261 LTADSYPD--LRYVLLAGETIRPESLKnWYD-NLGNRVRlvNLYGPTETTMIKLFYPIKPEDVHRESIpiGRPLPDTSVY 337
Cdd:cd05973 197 AEVPARPKgrLRRVSSAGEPLTPEVIR-WFDaALGVPIH--DHYGQTELGMVLANHHALEHPVHAGSA--GRAMPGWRVA 271
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 338 LLDEQQQPVSGSEAGEICIATRYMTHGYFPS-SHPDQTAFIPDpcrdqsgeimMYRTGDMGRWLPEGELALLGRKDNQVK 416
Cdd:cd05973 272 VLDDDGDELGPGEPGRLAIDIANSPLMWFRGyQLPDTPAIDGG----------YYLTGDTVEFDPDGSFSFIGRADDVIT 341
|
410 420
....*....|....*....|....*.
gi 517718121 417 IRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05973 342 MSGYRIGPFDVESALIEHPAVAEAAV 367
|
|
| BCL_like |
cd05919 |
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate ... |
19-442 |
4.73e-21 |
|
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate CoA ligase (BCL) and related ligases that catalyze the acylation of benzoate derivatives, 2-aminobenzoate and 4-hydroxybenzoate. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Xenobiotic aromatic compounds are also a major class of man-made pollutants. Some bacteria use benzoate as the sole source of carbon and energy through benzoate degradation. Benzoate degradation starts with its activation to benzoyl-CoA by benzoate CoA ligase. The reaction catalyzed by benzoate CoA ligase proceeds via a two-step process; the first ATP-dependent step forms an acyl-AMP intermediate, and the second step forms the acyl-CoA ester with release of the AMP.
Pssm-ID: 341243 [Multi-domain] Cd Length: 436 Bit Score: 97.92 E-value: 4.73e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 19 RKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDP-LHPDErLVTMLD 97
Cdd:cd05919 1 KTAFYAADRSVTYGQLHDGANRLGSALRNLGVSSGDRVLLLMLDSPELVQLFLGCLARGAIAVVINPlLHPDD-YAYIAR 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 98 TAEVSCLLCDDAqferaetlqghegkyfvlrarqamsvqagskeayshsanatDPIYIYFTSGSTGKPKAVVGKNESLLH 177
Cdd:cd05919 80 DCEARLVVTSAD-----------------------------------------DIAYLLYSSGTTGPPKGVMHAHRDPLL 118
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 178 FMN-WEASWLDLTDPMRVSQLTSIGFDAVL-RDIFVPICAGGTICIPESREiilDPLRLVHWLEHSRVHVVHCTPSLF-R 254
Cdd:cd05919 119 FADaMAREALGLTPGDRVFSSAKMFFGYGLgNSLWFPLAVGASAVLNPGWP---TAERVLATLARFRPTVLYGVPTFYaN 195
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 255 FINHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGnrVRLVNLYGPTEttMIKLFYPIKPEDVHRESIpiGRPLPDT 334
Cdd:cd05919 196 LLDSCAGSPDALRSLRLCVSAGEALPRGLGERWMEHFG--GPILDGIGATE--VGHIFLSNRPGAWRLGST--GRPVPGY 269
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 335 SVYLLDEQQQPVSGSEAGEICIATRYMTHGYFPSSHPDQTAFipdpcrdqSGEimMYRTGDMGRWLPEGELALLGRKDNQ 414
Cdd:cd05919 270 EIRLVDEEGHTIPPGEEGDLLVRGPSAAVGYWNNPEKSRATF--------NGG--WYRTGDKFCRDADGWYTHAGRADDM 339
|
410 420
....*....|....*....|....*...
gi 517718121 415 VKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05919 340 LKVGGQWVSPVEVESLIIQHPAVAEAAV 367
|
|
| MACS_AAE_MA_like |
cd05970 |
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation ... |
7-442 |
4.95e-21 |
|
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This family of MACS enzymes is found in archaea and bacteria. It is represented by the acyl-adenylating enzyme from Methanosarcina acetivorans (AAE_MA). AAE_MA is most active with propionate, butyrate, and the branched analogs: 2-methyl-propionate, butyrate, and pentanoate. The specific activity is weaker for smaller or larger acids.
Pssm-ID: 341274 [Multi-domain] Cd Length: 537 Bit Score: 98.72 E-value: 4.95e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 7 YELARAFAA-FPERKAI-ECGQQT----LSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVF 80
Cdd:cd05970 20 YDVVDAMAKeYPDKLALvWCDDAGeeriFTFAELADYSDKTANFFKAMGIGKGDTVMLTLKRRYEFWYSLLALHKLGAIA 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 81 VPLDPLHPDERLVTMLDTAEVSCLLCDDAQFERAETLQGHEGKYFVLRARQA--------MSVQAGSKEAY--------S 144
Cdd:cd05970 100 IPATHQLTAKDIVYRIESADIKMIVAIAEDNIPEEIEKAAPECPSKPKLVWVgdpvpegwIDFRKLIKNASpdferptaN 179
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 145 HSANATDPIYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLDLTDPMRVSQLTSIGF-DAVLRDIFVPICAGGTICIPE 223
Cdd:cd05970 180 SYPCGEDILLVYFSSGTTGMPKMVEHDFTYPLGHIVTAKYWQNVREGGLHLTVADTGWgKAVWGKIYGQWIAGAAVFVYD 259
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 224 SREiiLDPLRLVHWLEHSRVHVVHCTPSLFRFINHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGnrVRLVNLYGP 303
Cdd:cd05970 260 YDK--FDPKALLEKLSKYGVTTFCAPPTIYRFLIREDLSRYDLSSLRYCTTAGEALNPEVFNTFKEKTG--IKLMEGFGQ 335
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 304 TETTMIKLFYP---IKPEDvhresipIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRY-----MTHGYFpsSHPDQTA 375
Cdd:cd05970 336 TETTLTIATFPwmePKPGS-------MGKPAPGYEIDLIDREGRSCEAGEEGEIVIRTSKgkpvgLFGGYY--KDAEKTA 406
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 517718121 376 fipdpcrdqsgEIM---MYRTGDMGrWLPE-GELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05970 407 -----------EVWhdgYYHTGDAA-WMDEdGYLWFVGRTDDLIKSSGYRIGPFEVESALIQHPAVLECAV 465
|
|
| AACS_like |
cd05968 |
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This ... |
27-440 |
7.83e-21 |
|
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This uncharacterized acyl-CoA synthetase family (EC 6.2.1.16, or acetoacetate#CoA ligase or acetoacetate:CoA ligase (AMP-forming)) is highly homologous to acetoacetyl-CoA synthetase. However, the proteins in this family exist in only bacteria and archaea. AACS is a cytosolic ligase that specifically activates acetoacetate to its coenzyme A ester by a two-step reaction. Acetoacetate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is the first step of the mevalonate pathway of isoprenoid biosynthesis via isopentenyl diphosphate. Isoprenoids are a large class of compounds found in all living organisms.
Pssm-ID: 341272 [Multi-domain] Cd Length: 610 Bit Score: 98.72 E-value: 7.83e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 27 QTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTMLDTAEVSCLLC 106
Cdd:cd05968 90 RTLTYGELLYEVKRLANGLRALGVGKGDRVGIYLPMIPEIVPAFLAVARIGGIVVPIFSGFGKEAAATRLQDAEAKALIT 169
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 107 DDAQFERAETLQGHEG------------KYFVLRARQAMSVQAGSKEAYSHSANAT-----------DPIYIYFTSGSTG 163
Cdd:cd05968 170 ADGFTRRGREVNLKEEadkacaqcptveKVVVVRHLGNDFTPAKGRDLSYDEEKETagdgaerteseDPLMIIYTSGTTG 249
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 164 KPKAVVGKN--------ESLLHFMnweaswlDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPESREIILDPLRLV 235
Cdd:cd05968 250 KPKGTVHVHagfplkaaQDMYFQF-------DLKPGDLLTWFTDLGWMMGPWLIFGGLILGATMVLYDGAPDHPKADRLW 322
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 236 HWLEHSRVHVVHCTPSLFR-FINHLS--LTADSYPDLRYVLLAGETIRPESLKNWYDN-LGNRVRLVNLYGPTETT---- 307
Cdd:cd05968 323 RMVEDHEITHLGLSPTLIRaLKPRGDapVNAHDLSSLRVLGSTGEPWNPEPWNWLFETvGKGRNPIINYSGGTEISggil 402
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 308 ---MIKlfyPIKPedvhresIPIGRPLPDTSVYLLDEQQQPVSGsEAGEICIATRY--MTHGYFpsshpdqtafipdpcR 382
Cdd:cd05968 403 gnvLIK---PIKP-------SSFNGPVPGMKADVLDESGKPARP-EVGELVLLAPWpgMTRGFW---------------R 456
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 517718121 383 DQSGEIMMYRT--------GDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREA 440
Cdd:cd05968 457 DEDRYLETYWSrfdnvwvhGDFAYYDEEGYFYILGRSDDTINVAGKRVGPAEIESVLNAHPAVLES 522
|
|
| MACS_like_3 |
cd05971 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
30-442 |
1.38e-20 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341275 [Multi-domain] Cd Length: 439 Bit Score: 96.35 E-value: 1.38e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 30 SYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTMLDTAEVSCLLCDDA 109
Cdd:cd05971 8 TFKELKTASNRFANVLKEIGLEKGDRVGVFLSQGPECAIAHIAILRSGAIAVPLFALFGPEALEYRLSNSGASALVTDGS 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 110 QferaetlqghegkyfvlrarqamsvqagskeayshsanatDPIYIYFTSGSTGKPKAVVGKNESLL-HFMNWEASWLDL 188
Cdd:cd05971 88 D----------------------------------------DPALIIYTSGTTGPPKGALHAHRVLLgHLPGVQFPFNLF 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 189 TDPMRVSQLTS----IGfdaVLRDIFVPICAGGtICIPESREIILDPLRLVHWLEHSRVHVVHCTPSLFRFINHLSLTAD 264
Cdd:cd05971 128 PRDGDLYWTPAdwawIG---GLLDVLLPSLYFG-VPVLAHRMTKFDPKAALDLMSRYGVTTAFLPPTALKMMRQQGEQLK 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 265 SYP-DLRYVLLAGETIRPESLKNWYDNLGnrVRLVNLYGPTETTMI----KLFYPIKPEDvhresipIGRPLPDTSVYLL 339
Cdd:cd05971 204 HAQvKLRAIATGGESLGEELLGWAREQFG--VEVNEFYGQTECNLVigncSALFPIKPGS-------MGKPIPGHRVAIV 274
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 340 DEQQQPVSGSEAGEICIATrymthgyfpsshPDQTAFIPDPCRDQSGEIMM----YRTGDMGRWLPEGELALLGRKDNQV 415
Cdd:cd05971 275 DDNGTPLPPGEVGEIAVEL------------PDPVAFLGYWNNPSATEKKMagdwLLTGDLGRKDSDGYFWYVGRDDDVI 342
|
410 420
....*....|....*....|....*..
gi 517718121 416 KIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05971 343 TSSGYRIGPAEIEECLLKHPAVLMAAV 369
|
|
| MACS_like_4 |
cd05969 |
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most ... |
29-442 |
1.56e-20 |
|
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most similar to acetyl-CoA synthetase. Acetyl-CoA synthetase (ACS) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is only present in bacteria.
Pssm-ID: 341273 [Multi-domain] Cd Length: 442 Bit Score: 96.42 E-value: 1.56e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 29 LSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTMLDTAEVSCLLCDD 108
Cdd:cd05969 1 YTFAQLKVLSARFANVLKSLGVGKGDRVFVLSPRSPELYFSMLGIGKIGAVICPLFSAFGPEAIRDRLENSEAKVLITTE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 109 AQFERAETlqghegkyfvlrarqamsvqagskeayshsanaTDPIYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLDL 188
Cdd:cd05969 81 ELYERTDP---------------------------------EDPTLLHYTSGTTGTPKGVLHVHDAMIFYYFTGKYVLDL 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 189 ---------TDPMRVSQlTSIGfdavlrdIFVPICAGGTICIPESReiiLDPLRLVHWLEHSRVHVVHCTPSLFRFINHL 259
Cdd:cd05969 128 hpddiywctADPGWVTG-TVYG-------IWAPWLNGVTNVVYEGR---FDAESWYGIIERVKVTVWYTAPTAIRMLMKE 196
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 260 SLT-ADSY--PDLRYVLLAGETIRPESLKnWYDNLGNrVRLVNLYGPTETTMIKLF----YPIKPEDvhresipIGRPLP 332
Cdd:cd05969 197 GDElARKYdlSSLRFIHSVGEPLNPEAIR-WGMEVFG-VPIHDTWWQTETGSIMIAnypcMPIKPGS-------MGKPLP 267
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 333 DTSVYLLDEQQQPVSGSEAGEICIATRY--MTHGYFPSSHPDQTAFIpdpcrdqSGeimMYRTGDMGRWLPEGELALLGR 410
Cdd:cd05969 268 GVKAAVVDENGNELPPGTKGILALKPGWpsMFRGIWNDEERYKNSFI-------DG---WYLTGDLAYRDEDGYFWFVGR 337
|
410 420 430
....*....|....*....|....*....|..
gi 517718121 411 KDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05969 338 ADDIIKTSGHRVGPFEVESALMEHPAVAEAGV 369
|
|
| alpha_am_amid |
TIGR03443 |
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are ... |
788-950 |
5.74e-20 |
|
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), product of the LYS2 gene. It is also called alpha-aminoadipate reductase. In fungi, lysine is synthesized via aminoadipate. Currently, all members of this family are fungal.
Pssm-ID: 274582 [Multi-domain] Cd Length: 1389 Bit Score: 97.06 E-value: 5.74e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 788 EEAQEPL---LIAYYladKMIDDeqLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALPSPfeqDTTARIYKAPNS 864
Cdd:TIGR03443 766 EESSDPVvkgLIKYR---KLIKD--IREYLKKKLPSYAIPTVIVPLKKLPLNPNGKVDKPALPFP---DTAQLAAVAKNR 837
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 865 S----------TELKLLDIWTHILGIK--RISADDHFLQIGVHSLNIMTLIAQVYENFQVELPLEQVFEHDTLEEIAAYI 932
Cdd:TIGR03443 838 SasaadeefteTEREIRDLWLELLPNRpaTISPDDSFFDLGGHSILATRMIFELRKKLNVELPLGLIFKSPTIKGFAKEV 917
|
170 180
....*....|....*....|...
gi 517718121 933 D-----EQDSQYGVRIEPAAKQA 950
Cdd:TIGR03443 918 DrlkkgEELADEGDSEIEEEETV 940
|
|
| PRK03640 |
PRK03640 |
o-succinylbenzoate--CoA ligase; |
11-442 |
5.89e-20 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 235146 [Multi-domain] Cd Length: 483 Bit Score: 95.03 E-value: 5.89e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 11 RAFAAfPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDP-LHPD 89
Cdd:PRK03640 11 RAFLT-PDRTAIEFEEKKVTFMELHEAVVSVAGKLAALGVKKGDRVALLMKNGMEMILVIHALQQLGAVAVLLNTrLSRE 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 90 ERLVTMLDtAEVSCLLCDDaqferaETLQGHEGKYFVLRArQAMSVQAGS---KEAYSHSANATdpiyIYFTSGSTGKPK 166
Cdd:PRK03640 90 ELLWQLDD-AEVKCLITDD------DFEAKLIPGISVKFA-ELMNGPKEEaeiQEEFDLDEVAT----IMYTSGTTGKPK 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 167 AVVG--KNesllHFMNWEASWLDL--TD--------PM-RVSqltsiGFDAVLRDIFVpicaGGTICIPESreiiLDPLR 233
Cdd:PRK03640 158 GVIQtyGN----HWWSAVGSALNLglTEddcwlaavPIfHIS-----GLSILMRSVIY----GMRVVLVEK----FDAEK 220
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 234 LVHWLEHSRVHVVHCTPS-LFRFINHLSltADSYPD-LRYVLLAGETIRP---ESLKNWydnlgnRVRLVNLYGPTETT- 307
Cdd:PRK03640 221 INKLLQTGGVTIISVVSTmLQRLLERLG--EGTYPSsFRCMLLGGGPAPKpllEQCKEK------GIPVYQSYGMTETAs 292
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 308 -MIKLfypiKPEDVHRESIPIGRPLPDTSVYLLDeQQQPVSGSEAGEICIATRYMTHGYFPSSHPDQTAFipdpcrdQSG 386
Cdd:PRK03640 293 qIVTL----SPEDALTKLGSAGKPLFPCELKIEK-DGVVVPPFEEGEIVVKGPNVTKGYLNREDATRETF-------QDG 360
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*.
gi 517718121 387 eimMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK03640 361 ---WFKTGDIGYLDEEGFLYVLDRRSDLIISGGENIYPAEIEEVLLSHPGVAEAGV 413
|
|
| MACS_like_1 |
cd05974 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
29-442 |
7.49e-20 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341278 [Multi-domain] Cd Length: 432 Bit Score: 94.17 E-value: 7.49e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 29 LSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLdplhpderlVTMLDTAEVScllcdd 108
Cdd:cd05974 1 VSFAEMSARSSRVANFLRSIGVGRGDRILLMLGNVVELWEAMLAAMKLGAVVIPA---------TTLLTPDDLR------ 65
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 109 AQFERaetlqgheGKYFVLRARQAmsvqagskeayshsANATDPIYIYFTSGSTGKPKAVVGKNESL----LHFMNW--- 181
Cdd:cd05974 66 DRVDR--------GGAVYAAVDEN--------------THADDPMLLYFTSGTTSKPKLVEHTHRSYpvghLSTMYWigl 123
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 182 ---EASWlDLTDPMRVSQLTSigfdavlrDIFVPICAGGTI-CIPESReiiLDPLRLVHWLEHSRVHVVHCTPSLFRFIN 257
Cdd:cd05974 124 kpgDVHW-NISSPGWAKHAWS--------CFFAPWNAGATVfLFNYAR---FDAKRVLAALVRYGVTTLCAPPTVWRMLI 191
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 258 HLSLTADSYPdLRYVLLAGETIRPESLKNWYDNLGNRVRlvNLYGPTETTMIKLFYPIKPEDVHResipIGRPLPDTSVY 337
Cdd:cd05974 192 QQDLASFDVK-LREVVGAGEPLNPEVIEQVRRAWGLTIR--DGYGQTETTALVGNSPGQPVKAGS----MGRPLPGYRVA 264
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 338 LLDEQQQPVSgseAGEICI---ATR---YMThGYfpSSHPDQTAfipdpcrdQSGEIMMYRTGDMGRWLPEGELALLGRK 411
Cdd:cd05974 265 LLDPDGAPAT---EGEVALdlgDTRpvgLMK-GY--AGDPDKTA--------HAMRGGYYRTGDIAMRDEDGYLTYVGRA 330
|
410 420 430
....*....|....*....|....*....|.
gi 517718121 412 DNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05974 331 DDVFKSSDYRISPFELESVLIEHPAVAEAAV 361
|
|
| E-C_NRPS |
cd19544 |
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); ... |
990-1234 |
1.93e-19 |
|
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); Dual function Epimerization/Condensation (E/C) domains have both an epimerization and a DCL condensation activity. Dual E/C domains first epimerize the substrate amino acid to produce a D-configuration, then catalyze the condensation between the D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. They are D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. These Dual E/C domains contain an extended His-motif (HHx(N)GD) near the N-terminus of the domain in addition to the standard Condensation (C) domain active site motif (HHxxxD). C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains, these include the DCL-type, LCL-type, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C domains, and the X-domain.
Pssm-ID: 380466 [Multi-domain] Cd Length: 413 Bit Score: 92.50 E-value: 1.93e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 990 RLER---ACGQLIERHEALRTSFdIVDG--DPVQRIHEHCDFHLEIVHLQG-----QQLHTAVNGCIRPFQLERAPLIRS 1059
Cdd:cd19544 37 RLDAflaALQQVIDRHDILRTAI-LWEGlsEPVQVVWRQAELPVEELTLDPgddalAQLRARFDPRRYRLDLRQAPLLRA 115
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1060 ILIP-LAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYEGRElHDL--PVQYVDF-AQWQTSAPVVEdlrrQEQFWQSMF 1135
Cdd:cd19544 116 HVAEdPANGRWLLLLLFHHLISDHTSLELLLEEIQAILAGRA-AALppPVPYRNFvAQARLGASQAE----HEAFFREML 190
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1136 ADYRPlpgiPTdhTP------EANERSFAGGHITWEPDpvLSRRLYAVAAEQQTTlfmvlLAA-FHVLYA----KYSARE 1204
Cdd:cd19544 191 GDVDE----PT--APfglldvQGDGSDITEARLALDAE--LAQRLRAQARRLGVS-----PASlFHLAWAlvlaRCSGRD 257
|
250 260 270
....*....|....*....|....*....|....
gi 517718121 1205 EVTVGTPVEGR----RRAEvrQVVGMFVNALAIR 1234
Cdd:cd19544 258 DVVFGTVLSGRmqggAGAD--RALGMFINTLPLR 289
|
|
| PRK06839 |
PRK06839 |
o-succinylbenzoate--CoA ligase; |
17-442 |
2.64e-19 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 168698 [Multi-domain] Cd Length: 496 Bit Score: 93.00 E-value: 2.64e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 17 PERKAIECGQQTLSYKELDAESDRICE-LLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLD-PLHPDErLVT 94
Cdd:PRK06839 16 PDRIAIITEEEEMTYKQLHEYVSKVAAyLIYELNVKKGERIAILSQNSLEYIVLLFAIAKVECIAVPLNiRLTENE-LIF 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 95 MLDTAEVSCLLCDDAQFERAETLQGHEGKYFVLRArqamsvqAGSKEAYSHS------ANATDPIYIYFTSGSTGKPKAV 168
Cdd:PRK06839 95 QLKDSGTTVLFVEKTFQNMALSMQKVSYVQRVISI-------TSLKEIEDRKidnfveKNESASFIICYTSGTTGKPKGA 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 169 VGKNESllhfMNWEA----SWLDLT-DPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPESreiiLDPLRLVHWLEHSRV 243
Cdd:PRK06839 168 VLTQEN----MFWNAlnntFAIDLTmHDRSIVLLPLFHIGGIGLFAFPTLFAGGVIIVPRK----FEPTKALSMIEKHKV 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 244 HVVHCTPSLFRFINHLSLTADsyPDLRYV--LLAGETIRPESLKNWYDNLGnrVRLVNLYGPTETTmiKLFYPIKPEDVH 321
Cdd:PRK06839 240 TVVMGVPTIHQALINCSKFET--TNLQSVrwFYNGGAPCPEELMREFIDRG--FLFGQGFGMTETS--PTVFMLSEEDAR 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 322 RESIPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTAfipDPCRDQsgeimMYRTGDMGRWLP 401
Cdd:PRK06839 314 RKVGSIGKPVLFCDYELIDENKNKVEVGEVGELLIRGPNVMKEYW--NRPDATE---ETIQDG-----WLCTGDLARVDE 383
|
410 420 430 440
....*....|....*....|....*....|....*....|.
gi 517718121 402 EGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK06839 384 DGFVYIVGRKKEMIISGGENIYPLEVEQVINKLSDVYEVAV 424
|
|
| EntF |
COG1020 |
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ... |
783-1198 |
6.37e-19 |
|
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440643 [Multi-domain] Cd Length: 1329 Bit Score: 93.77 E-value: 6.37e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 783 VQLQVEEAQEPLLIAYYLADK--MIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDynALPSPFEQDTTARIYK 860
Cdd:COG1020 903 VVAREDAPGDKRLVAYVVPEAgaAAAAALLRLALALLLPPYMVPAAVVLLLPLPLTGNGKLD--RLALPAPAAAAAAAAA 980
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 861 APNSSTELKLLDIWTHILGIKRISADDHFLQIGVHSLNIMTLIAQVYENFQVELPLEQVFEHDTLEEIAAYIDEQDSQYG 940
Cdd:COG1020 981 APPAEEEEEEAALALLLLLVVVVGDDDFFFFGGGLGLLLLLALARAARLLLLLLLLLLLFLAAAAAAAAAAAAAAAAAAA 1060
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 941 VRIEPAAKQAYYPLTAAQMRVFMDEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDGDPVQRI 1020
Cdd:COG1020 1061 APLAAAAAPLPLPPLLLSLLALLLALLLLLALLALLALLLLLLLLLLLLALLLLLALLLALLAALRARRAVRQEGPRLRL 1140
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1021 HEHC------DFHLEIVHLQGQQLHTAVNGCIRPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAA 1094
Cdd:COG1020 1141 LVALaaalalAALLALLLAAAAAAAELLAAAALLLLLALLLLALLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL 1220
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1095 LY----EGRELHDLPVQYVDFAQWQTSAPVVEDLRRQEQFWQSMFADYRPLPGIPTDHTPEANERSFAGGHITWEPDPVL 1170
Cdd:COG1020 1221 LLllaaAAAALLALALLLALLALAALLALAALAALAAALLALALALLALALLLLALALLLPALARARAARTARALALLLL 1300
|
410 420
....*....|....*....|....*...
gi 517718121 1171 SRRLYAVAAEQQTTLFMVLLAAFHVLYA 1198
Cdd:COG1020 1301 LALLLLLALALALLLLLLLLLALLLLAL 1328
|
|
| PRK08316 |
PRK08316 |
acyl-CoA synthetase; Validated |
3-422 |
1.97e-18 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181381 [Multi-domain] Cd Length: 523 Bit Score: 90.38 E-value: 1.97e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 3 NTIQYELARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVP 82
Cdd:PRK08316 11 QTIGDILRRSARRYPDKTALVFGDRSWTYAELDAAVNRVAAALLDLGLKKGDRVAALGHNSDAYALLWLACARAGAVHVP 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 83 LDPLHPDERLVTMLDTAEVSCLLCDDAQFERAETLQGHEGKYFVLRARQ-------------AMSVQAGSKEAYSHSANA 149
Cdd:PRK08316 91 VNFMLTGEELAYILDHSGARAFLVDPALAPTAEAALALLPVDTLILSLVlggreapggwldfADWAEAGSVAEPDVELAD 170
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 150 TDPIYIYFTSGSTGKPKAVVGKNESLLHfmnweaswldltdpMRVSQLTSIGFDAvlRDIFV---PI--CA--------- 215
Cdd:PRK08316 171 DDLAQILYTSGTESLPKGAMLTHRALIA--------------EYVSCIVAGDMSA--DDIPLhalPLyhCAqldvflgpy 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 216 ---GGTICIPESReiilDPLRLVHWLEHSRVHVVHCTP----SLFRfinhlsltadsYPDLRYVLLA-------GETIRP 281
Cdd:PRK08316 235 lyvGATNVILDAP----DPELILRTIEAERITSFFAPPtvwiSLLR-----------HPDFDTRDLSslrkgyyGASIMP 299
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 282 -ESLKNWYDNLGNrVRLVNLYGPTEttMIKLFYPIKPEDVHRESIPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRY 360
Cdd:PRK08316 300 vEVLKELRERLPG-LRFYNCYGQTE--IAPLATVLGPEEHLRRPGSAGRPVLNVETRVVDDDGNDVAPGEVGEIVHRSPQ 376
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 517718121 361 MTHGYFpsSHPDQT--AFipdpcrdQSGeimMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRV 422
Cdd:PRK08316 377 LMLGYW--DDPEKTaeAF-------RGG---WFHSGDLGVMDEEGYITVVDRKKDMIKTGGENV 428
|
|
| PRK13383 |
PRK13383 |
acyl-CoA synthetase; Provisional |
9-442 |
4.38e-18 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139531 [Multi-domain] Cd Length: 516 Bit Score: 89.29 E-value: 4.38e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHP 88
Cdd:PRK13383 41 LAVTAARWPGRTAIIDDDGALSYRELQRATESLARRLTRDGVAPGRAVGVMCRNGRGFVTAVFAVGLLGADVVPISTEFR 120
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 89 DERLVTMLDTAEVSCLLCDDaqfERAETLQGHEGKYFVLRarqamSVQAGSKEAYSHSANATDPIYIYFTSGSTGKPKAV 168
Cdd:PRK13383 121 SDALAAALRAHHISTVVADN---EFAERIAGADDAVAVID-----PATAGAEESGGRPAVAAPGRIVLLTSGTTGKPKGV 192
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 169 ---------VGKNESLLHFMNWE-ASWLDLTDPMrvsqLTSIGFDAVLrdifVPICAGGTICIPE--SREIILDPLRLVH 236
Cdd:PRK13383 193 prapqlrsaVGVWVTILDRTRLRtGSRISVAMPM----FHGLGLGMLM----LTIALGGTVLTHRhfDAEAALAQASLHR 264
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 237 WLEHSRVHVVHCT----PSLFRFINHLsltadsyPDLRYVLLAGETIRPESLKNWYDNLGNrvRLVNLYGPTETTMIKLf 312
Cdd:PRK13383 265 ADAFTAVPVVLARilelPPRVRARNPL-------PQLRVVMSSGDRLDPTLGQRFMDTYGD--ILYNGYGSTEVGIGAL- 334
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 313 ypIKPEDVHRESIPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYfpsshpdqtafipdpcRDQSGEIM--- 389
Cdd:PRK13383 335 --ATPADLRDAPETVGKPVAGCPVRILDRNNRPVGPRVTGRIFVGGELAGTRY----------------TDGGGKAVvdg 396
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|...
gi 517718121 390 MYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK13383 397 MTSTGDMGYLDNAGRLFIVGREDDMIISGGENVYPRAVENALAAHPAVADNAV 449
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
945-1361 |
5.91e-18 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 90.61 E-value: 5.91e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 945 PAAK-QAYYPLTAAQMRVFMdEQLVNTGSG-YHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVDG-DPVQRIH 1021
Cdd:PRK05691 3250 PAAEiEDVYPLTPMQEGLLL-HTLLEPGTGlYYMQDRYRINSALDPERFAQAWQAVVARHEALRASFSWNAGeTMLQVIH 3328
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1022 EHCDFHLEIVHLQG----------QQLHTAVNGCirPFQLERAPLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRD 1091
Cdd:PRK05691 3329 KPGRTPIDYLDWRGlpedgqeqrlQALHKQEREA--GFDLLNQPPFHLRLIRVDEARYWFMMSNHHILIDAWCRSLLMND 3406
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1092 LAALY----EGRELHdLPV--QYVDFAQWQTSapvvEDLRRQEQFWQSMFADY-RPLPgIPTDHTPEANERSFAGGHITW 1164
Cdd:PRK05691 3407 FFEIYtalgEGREAQ-LPVppRYRDYIGWLQR----QDLAQARQWWQDNLRGFeRPTP-IPSDRPFLREHAGDSGGMVVG 3480
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1165 EP----DPVLSRRLYAVAAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGR--RRAEVRQVVGMFVNALAIR-SYP 1237
Cdd:PRK05691 3481 DCytrlDAADGARLRELAQAHQLTVNTFAQAAWALVLRRYSGDRDVLFGVTVAGRpvSMPQMQRTVGLFINSIALRvQLP 3560
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1238 EGDKPFS--SFLQEIRGTMLQAYEHQDYPLERLAKQLDLhhSRDHLMFDTVFSmlnYEDFAVRS---DDLQFEYAELPTL 1312
Cdd:PRK05691 3561 AAGQRCSvrQWLQGLLDSNMELREYEYLPLVAIQECSEL--PKGQPLFDSLFV---FENAPVEVsvlDRAQSLNASSDSG 3635
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|
gi 517718121 1313 SEIYNLRVEIVESP-ERLRGTFKYGQELYEARTVSQLAQDYERILAAVAE 1361
Cdd:PRK05691 3636 RTHTNFPLTAVCYPgDDLGLHLSYDQRYFDAPTVERLLGEFKRLLLALVQ 3685
|
|
| PRK09088 |
PRK09088 |
acyl-CoA synthetase; Validated |
25-442 |
1.39e-17 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181644 [Multi-domain] Cd Length: 488 Bit Score: 87.55 E-value: 1.39e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 25 GQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLD-PLHPDErLVTMLDTAEVSC 103
Cdd:PRK09088 19 LGRRWTYAELDALVGRLAAVLRRRGCVDGERLAVLARNSVWLVALHFACARVGAIYVPLNwRLSASE-LDALLQDAEPRL 97
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 104 LLCDDAQfeRAETLQGHEGKYFVLRARQAmsvqagsKEAYSHSANATDPIYIYFTSGSTGKPKAV---------VGKNES 174
Cdd:PRK09088 98 LLGDDAV--AAGRTDVEDLAAFIASADAL-------EPADTPSIPPERVSLILFTSGTSGQPKGVmlsernlqqTAHNFG 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 175 LLHFMNWEASWLdLTDPMrvsqLTSIGFDAVLRdifvPICA-GGTICIPESreiiLDPLRLVHWLEHSRVHVVH--CTPS 251
Cdd:PRK09088 169 VLGRVDAHSSFL-CDAPM----FHIIGLITSVR----PVLAvGGSILVSNG----FEPKRTLGRLGDPALGITHyfCVPQ 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 252 LFR-FINHLSLTADSYPDLRYVLLAGETIRPESLKNWydnLGNRVRLVNLYGPTETTMIkLFYPIKPEDVHRESIPIGRP 330
Cdd:PRK09088 236 MAQaFRAQPGFDAAALRHLTALFTGGAPHAAEDILGW---LDDGIPMVDGFGMSEAGTV-FGMSVDCDVIRAKAGAAGIP 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 331 LPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFPSSHPDQTAFipdpcrDQSGeimMYRTGDMGRWLPEGELALLGR 410
Cdd:PRK09088 312 TPTVQTRVVDDQGNDCPAGVPGELLLRGPNLSPGYWRRPQATARAF------TGDG---WFRTGDIARRDADGFFWVVDR 382
|
410 420 430
....*....|....*....|....*....|..
gi 517718121 411 KDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK09088 383 KKDMFISGGENVYPAEIEAVLADHPGIRECAV 414
|
|
| MCS |
cd05941 |
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step ... |
18-442 |
1.57e-17 |
|
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step reaction consisting of the adenylation of malonate with ATP, followed by malonyl transfer from malonyl-AMP to CoA. Malonic acid and its derivatives are the building blocks of polyketides and malonyl-CoA serves as the substrate of polyketide synthases. Malonyl-CoA synthetase has broad substrate tolerance and can activate a variety of malonyl acid derivatives. MCS may play an important role in biosynthesis of polyketides, the important secondary metabolites with therapeutic and agrochemical utility.
Pssm-ID: 341264 [Multi-domain] Cd Length: 442 Bit Score: 86.96 E-value: 1.57e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 18 ERKAIECGQQTLSYKELDAESDRICELLHAHGA-AQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTML 96
Cdd:cd05941 1 DRIAIVDDGDSITYADLVARAARLANRLLALGKdLRGDRVAFLAPPSAEYVVAQLAIWRAGGVAVPLNPSYPLAELEYVI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 97 DTAEVSCLLcddaqferaetlqghegkyfvlrarqamsvqagskeayshsanatDPIYIYFTSGSTGKPKAVVGKNESLL 176
Cdd:cd05941 81 TDSEPSLVL---------------------------------------------DPALILYTSGTTGRPKGVVLTHANLA 115
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 177 hfmnweASWLDLTDPMRVSQLTSI----------G-FDAVLrdifVPICAGGTiCIPESReiiLDPLRLVHWLEHSRVHV 245
Cdd:cd05941 116 ------ANVRALVDAWRWTEDDVLlhvlplhhvhGlVNALL----CPLFAGAS-VEFLPK---FDPKEVAISRLMPSITV 181
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 246 VHCTPSLF-RFINHLSLTADSYPDLRYVllAGETIR---------PESLKNWYDNLGNRvRLVNLYGPTETTMIkLFYPI 315
Cdd:cd05941 182 FMGVPTIYtRLLQYYEAHFTDPQFARAA--AAERLRlmvsgsaalPVPTLEEWEAITGH-TLLERYGMTEIGMA-LSNPL 257
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 316 kpedvHRESIP--IGRPLPDTSVYLLDEQ-QQPVSGSEAGEICIATRYMTHGYFpsSHPDQT--AFIPDPcrdqsgeimM 390
Cdd:cd05941 258 -----DGERRPgtVGMPLPGVQARIVDEEtGEPLPRGEVGEIQVRGPSVFKEYW--NKPEATkeEFTDDG---------W 321
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|...
gi 517718121 391 YRTGDMGRWLPEGELALLGR-KDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05941 322 FKTGDLGVVDEDGYYWILGRsSVDIIKSGGYKVSALEIERVLLAHPGVSECAV 374
|
|
| ttLC_FACS_AlkK_like |
cd12119 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes ... |
9-412 |
1.61e-17 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes fatty acyl-CoA synthetases that can activate medium-chain to long-chain fatty acids. They catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family catalyzes the long-chain fatty acid, myristoyl acid, while another member in this family, the AlkK protein identified from Pseudomonas oleovorans, targets medium chain fatty acids. This family also includes uncharacterized FACS proteins.
Pssm-ID: 341284 [Multi-domain] Cd Length: 518 Bit Score: 87.69 E-value: 1.61e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAI----ECGQQTLSYKELdaeSDRICELLHAhgaaqYDHIGILMQDRCASIA-----------AVIGI 73
Cdd:cd12119 2 LEHAARLHGDREIVsrthEGEVHRYTYAEV---AERARRLANA-----LRRLGVKPGDRVATLAwnthrhlelyyAVPGM 73
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 74 lklGGVFVPLDPLHPDERLVTMLDTAEVSCLLCDDAQFERAETLQGH---EGKYFVLRARQAMSVQAGSK-EAYSHSANA 149
Cdd:cd12119 74 ---GAVLHTINPRLFPEQIAYIINHAEDRVVFVDRDFLPLLEAIAPRlptVEHVVVMTDDAAMPEPAGVGvLAYEELLAA 150
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 150 TDPIY------------IYFTSGSTGKPKAVVGKNESL-LHFMNweaswLDLTDPMRVSQltsigFDAVLrdIFVPI--- 213
Cdd:cd12119 151 ESPEYdwpdfdentaaaICYTSGTTGNPKGVVYSHRSLvLHAMA-----ALLTDGLGLSE-----SDVVL--PVVPMfhv 218
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 214 ----------CAGGTICIPESReiiLDPLRLVHWLEHSRVHVVHCTPSLFR-FINHLSLTADSYPDLRYVLLAGETIrPE 282
Cdd:cd12119 219 nawglpyaaaMVGAKLVLPGPY---LDPASLAELIEREGVTFAAGVPTVWQgLLDHLEANGRDLSSLRRVVIGGSAV-PR 294
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 283 SLKNWYDNLGnrVRLVNLYGPTET----TMIKL---FYPIKPEDVHRESIPIGRPLPDTSVYLLDEQQQ--PVSGSEAGE 353
Cdd:cd12119 295 SLIEAFEERG--VRVIHAWGMTETsplgTVARPpseHSNLSEDEQLALRAKQGRPVPGVELRIVDDDGRelPWDGKAVGE 372
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 354 ICIATRYMTHGYFpssHPDQTAfipdPCRDQSGeimMYRTGDMGRWLPEGELALLGR-KD 412
Cdd:cd12119 373 LQVRGPWVTKSYY---KNDEES----EALTEDG---WLRTGDVATIDEDGYLTITDRsKD 422
|
|
| MACS_euk |
cd05928 |
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step ... |
151-442 |
2.78e-17 |
|
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes. MACS enzymes are localized to mitochondria. Two murine MACS family proteins are found in liver and kidney. In rodents, a MACS member is detected particularly in the olfactory epithelium and is called O-MACS. O-MACS demonstrates substrate preference for the fatty acid lengths of C6-C12.
Pssm-ID: 341251 [Multi-domain] Cd Length: 530 Bit Score: 87.14 E-value: 2.78e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 151 DPIYIYFTSGSTGKPKAVVGKNESLLH--FMNwEASWLDLTDPMRVSQLTSIGF-DAVLRDIFVPICAGGTICIPESREi 227
Cdd:cd05928 175 EPMAIYFTSGTTGSPKMAEHSHSSLGLglKVN-GRYWLDLTASDIMWNTSDTGWiKSAWSSLFEPWIQGACVFVHHLPR- 252
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 228 iLDPLRLVHWLEHSRVHVVHCTPSLFRFINHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGnrVRLVNLYGPTETT 307
Cdd:cd05928 253 -FDPLVILKTLSSYPITTFCGAPTVYRMLVQQDLSSYKFPSLQHCVTGGEPLNPEVLEKWKAQTG--LDIYEGYGQTETG 329
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 308 MIKLFY---PIKPEDvhresipIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFPSSH---PDQTAfiPDPC 381
Cdd:cd05928 330 LICANFkgmKIKPGS-------MGKASPPYDVQIIDDNGNVLPPGTEGDIGIRVKPIRPFGLFSGYvdnPEKTA--ATIR 400
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 517718121 382 RDqsgeimMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05928 401 GD------FYLTGDRGIMDEDGYFWFMGRADDVINSSGYRIGPFEVESALIEHPAVVESAV 455
|
|
| A_NRPS_Bac |
cd17655 |
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of ... |
788-849 |
3.83e-17 |
|
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetases 1, 2, and 3 (BA1, also known as ATP-dependent cysteine adenylase or cysteine activase, BA2, also known as ATP-dependent lysine adenylase or lysine activase, and BA3, also known as ATP-dependent isoleucine adenylase or isoleucine activase) in Bacilli. Bacitracin is a mixture of related cyclic peptides used as a polypeptide antibiotic. This family also includes gramicidin synthetase 1 involved in synthesis of the cyclic peptide antibiotic gramicidin S via activation of phenylalanine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341310 [Multi-domain] Cd Length: 490 Bit Score: 86.23 E-value: 3.83e-17
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 517718121 788 EEAQEPLLIAYYLADKMIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALPSP 849
Cdd:cd17655 428 DEQGQNYLCAYIVSEKELPVAQLREFLARELPDYMIPSYFIKLDEIPLTPNGKVDRKALPEP 489
|
|
| OSB_CoA_lg |
cd05912 |
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA ... |
28-442 |
7.06e-17 |
|
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA synthetase, or MenE); O-succinylbenzoic acid-CoA synthase catalyzes the coenzyme A (CoA)- and ATP-dependent conversion of o-succinylbenzoic acid to o-succinylbenzoyl-CoA. The reaction is the fourth step of the biosynthesis pathway of menaquinone (vitamin K2). In certain bacteria, menaquinone is used during fumarate reduction in anaerobic respiration. In cyanobacteria, the product of the menaquinone pathway is phylloquinone (2-methyl-3-phytyl-1,4-naphthoquinone), a molecule used exclusively as an electron transfer cofactor in Photosystem 1. In green sulfur bacteria and heliobacteria, menaquinones are used as loosely bound secondary electron acceptors in the photosynthetic reaction center.
Pssm-ID: 341238 [Multi-domain] Cd Length: 411 Bit Score: 84.71 E-value: 7.06e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 28 TLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDP-LHPDERLVTMLDTaevscllc 106
Cdd:cd05912 1 SYTFAELFEEVSRLAEHLAALGVRKGDRVALLSKNSIEMILLIHALWLLGAEAVLLNTrLTPNELAFQLKDS-------- 72
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 107 dDAQFERAETlqghegkyfvlrarqamsvqagskeayshsanatdpiyIYFTSGSTGKPKAVVGKNESllHFMNWEASWL 186
Cdd:cd05912 73 -DVKLDDIAT--------------------------------------IMYTSGTTGKPKGVQQTFGN--HWWSAIGSAL 111
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 187 DL--TD--------PM-RVSQLTSI------GFDAVLRDIFvpicaggticipesreiilDPLRLVHWLEHSRVHVVHCT 249
Cdd:cd05912 112 NLglTEddnwlcalPLfHISGLSILmrsviyGMTVYLVDKF-------------------DAEQVLHLINSGKVTIISVV 172
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 250 PSLFRFInhLSLTADSYP-DLRYVLLAGETIrPESLKNWYDNLGnrVRLVNLYGPTETTmiKLFYPIKPEDVHRESIPIG 328
Cdd:cd05912 173 PTMLQRL--LEILGEGYPnNLRCILLGGGPA-PKPLLEQCKEKG--IPVYQSYGMTETC--SQIVTLSPEDALNKIGSAG 245
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 329 RPLPDTSVYLLDEQQQPvsgSEAGEICIATRYMTHGYFPSSHPDQTAFipdpcrdQSGeimMYRTGDMGRWLPEGELALL 408
Cdd:cd05912 246 KPLFPVELKIEDDGQPP---YEVGEILLKGPNVTKGYLNRPDATEESF-------ENG---WFKTGDIGYLDEEGFLYVL 312
|
410 420 430
....*....|....*....|....*....|....
gi 517718121 409 GRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05912 313 DRRSDLIISGGENIYPAEIEEVLLSHPAIKEAGV 346
|
|
| FAA1 |
COG1022 |
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; |
9-442 |
8.14e-17 |
|
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism];
Pssm-ID: 440645 [Multi-domain] Cd Length: 603 Bit Score: 85.92 E-value: 8.14e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIEC----GQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLD 84
Cdd:COG1022 17 LRRRAARFPDRVALREkedgIWQSLTWAEFAERVRALAAGLLALGVKPGDRVAILSDNRPEWVIADLAILAAGAVTVPIY 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 85 PLHPDERLVTMLDTAEVSCLLC-DDAQFERAETLQGH------------EGKYFVLRAR-----QAMSVQAGSKEAYSHS 146
Cdd:COG1022 97 PTSSAEEVAYILNDSGAKVLFVeDQEQLDKLLEVRDElpslrhivvldpRGLRDDPRLLsldelLALGREVADPAELEAR 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 147 ANATDP----IYIYfTSGSTGKPKAVVgknesLLH--FMnWEASWLDLTDPMRVSqltsigfDAVLrdIFVPIC------ 214
Cdd:COG1022 177 RAAVKPddlaTIIY-TSGTTGRPKGVM-----LTHrnLL-SNARALLERLPLGPG-------DRTL--SFLPLAhvfert 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 215 -------AGGTICIPESREIILDPLR----------------------------------LVHW-----LEHSRVHVVHC 248
Cdd:COG1022 241 vsyyalaAGATVAFAESPDTLAEDLRevkptfmlavprvwekvyagiqakaeeagglkrkLFRWalavgRRYARARLAGK 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 249 TPSLFRFINHLslTADS--YP--------DLRYVLLAGETIRPEsLKNWYDNLGnrVRLVNLYGPTETTmiklfyPI--- 315
Cdd:COG1022 321 SPSLLLRLKHA--LADKlvFSklrealggRLRFAVSGGAALGPE-LARFFRALG--IPVLEGYGLTETS------PVitv 389
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 316 -KPEDVHRESIpiGRPLPDTSVYLldeqqqpvsgSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDpcrdqsGeimMYR 392
Cdd:COG1022 390 nRPGDNRIGTV--GPPLPGVEVKI----------AEDGEILVRGPNVMKGYY--KNPEATAeaFDAD------G---WLH 446
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|.
gi 517718121 393 TGDMGRWLPEGELALLGRKDNQVKIR-GNRVELGDIEHRLTNMAGIREAVV 442
Cdd:COG1022 447 TGDIGELDEDGFLRITGRKKDLIVTSgGKNVAPQPIENALKASPLIEQAVV 497
|
|
| AAS_C |
cd05909 |
C-terminal domain of the acyl-acyl carrier protein synthetase (also called ... |
54-428 |
9.97e-17 |
|
C-terminal domain of the acyl-acyl carrier protein synthetase (also called 2-acylglycerophosphoethanolamine acyltransferase, Aas); Acyl-acyl carrier protein synthase (Aas) is a membrane protein responsible for a minor pathway of incorporating exogenous fatty acids into membrane phospholipids. Its in vitro activity is characterized by the ligation of free fatty acids between 8 and 18 carbons in length to the acyl carrier protein sulfydryl group (ACP-SH) in the presence of ATP and Mg2+. However, its in vivo function is as a 2-acylglycerophosphoethanolamine (2-acyl-GPE) acyltransferase. The reaction occurs in two steps: the acyl chain is first esterified to acyl carrier protein (ACP) via a thioester bond, followed by a second step where the acyl chain is transferred to a 2-acyllysophospholipid, thus completing the transacylation reaction. This model represents the C-terminal domain of the enzyme, which belongs to the class I adenylate-forming enzyme family, including acyl-CoA synthetases.
Pssm-ID: 341235 [Multi-domain] Cd Length: 490 Bit Score: 85.08 E-value: 9.97e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 54 DHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTMLDTAEVSCLLCDDAQFERAETLQGHEGKYFV------- 126
Cdd:cd05909 32 ENVGVMLPPSAGGALANFALALSGKVPVMLNYTAGLRELRACIKLAGIKTVLTSKQFIEKLKLHHLFDVEYDArivyled 111
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 127 LRAR-----------QAMSVQAGS-KEAYSHSANATDPIYIYFTSGSTGKPKAVVGKNESLLHfmnweaswldltdpmRV 194
Cdd:cd05909 112 LRAKiskadkckaflAGKFPPKWLlRIFGVAPVQPDDPAVILFTSGSEGLPKGVVLSHKNLLA---------------NV 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 195 SQLTSIgFDAVLRDIF---VPI--CAGGTICI---------------PesreiiLDPLRLVHWLEHSRVHVVHCTPSLFR 254
Cdd:cd05909 177 EQITAI-FDPNPEDVVfgaLPFfhSFGLTGCLwlpllsgikvvfhpnP------LDYKKIPELIYDKKATILLGTPTFLR 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 255 -FINhlSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGnrVRLVNLYGPTET----TMIKLFYPIKPEDVhresipiGR 329
Cdd:cd05909 250 gYAR--AAHPEDFSSLRLVVAGAEKLKDTLRQEFQEKFG--IRILEGYGTTECspviSVNTPQSPNKEGTV-------GR 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 330 PLPDTSVYLLD-EQQQPVSGSEAGEICIATRYMTHGYFPSshPDQTAFIPdpcRDQsgeimMYRTGDMGRWLPEGELALL 408
Cdd:cd05909 319 PLPGMEVKIVSvETHEEVPIGEGGLLLVRGPNVMLGYLNE--PELTSFAF---GDG-----WYDTGDIGKIDGEGFLTIT 388
|
410 420
....*....|....*....|
gi 517718121 409 GRKDNQVKIRGNRVELGDIE 428
Cdd:cd05909 389 GRLSRFAKIAGEMVSLEAIE 408
|
|
| FACL_like_1 |
cd05910 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
27-415 |
1.02e-16 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341236 [Multi-domain] Cd Length: 457 Bit Score: 84.82 E-value: 1.02e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 27 QTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTMLDTAEvscllc 106
Cdd:cd05910 1 SRLSFRELDERSDRIAQGLTAYGIRRGMRAVLMVPPGPDFFALTFALFKAGAVPVLIDPGMGRKNLKQCLQEAE------ 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 107 ddaqferaetlqghegkyfvlrarqamsvqagsKEAYSHSANATDPIYIYFTSGSTGKPKAVVGKNESLlhfmnweASWL 186
Cdd:cd05910 75 ---------------------------------PDAFIGIPKADEPAAILFTSGSTGTPKGVVYRHGTF-------AAQI 114
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 187 DltdpmRVSQLTSIGFDAVLRDIFVPI-----CAGGTICIPE---SREIILDPLRLVHWLEHSRVHVVHCTPSLFRFINH 258
Cdd:cd05910 115 D-----ALRQLYGIRPGEVDLATFPLFalfgpALGLTSVIPDmdpTRPARADPQKLVGAIRQYGVSIVFGSPALLERVAR 189
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 259 LSLTAD-SYPDLRYVLLAGETIRPESLKNWYDNLGNRVRLVNLYGPTETTMIKLfypIKPEDVHRESIP---------IG 328
Cdd:cd05910 190 YCAQHGiTLPSLRRVLSAGAPVPIALAARLRKMLSDEAEILTPYGATEALPVSS---IGSRELLATTTAatsggagtcVG 266
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 329 RPLPDTSVYLLDEQQQPVSG---------SEAGEICIATRYMTHGYFpsSHPDQTAF--IPDPcrdqsGEIMMYRTGDMG 397
Cdd:cd05910 267 RPIPGVRVRIIEIDDEPIAEwddtlelprGEIGEITVTGPTVTPTYV--NRPVATALakIDDN-----SEGFWHRMGDLG 339
|
410
....*....|....*...
gi 517718121 398 RWLPEGELALLGRKDNQV 415
Cdd:cd05910 340 YLDDEGRLWFCGRKAHRV 357
|
|
| beta-lac_NRPS |
cd19547 |
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis ... |
952-1363 |
1.76e-16 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis NocB which exhibits an unusual cyclization to form beta-lactam rings in pro-nocardicin G synthesis; Nocardia uniformis NRPS NocB acts centrally in the biosynthesis of the nocardicin monocyclic beta-lactam antibiotics. Along with another NRPS NocA, it mediates an unusual cyclization to form beta-lactam rings in the synthesis of the beta-lactam-containing pentapeptide pro-nocardicin G. This small subfamily is related to DCL-type Condensation (C) domains, which catalyze condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; domains belonging to this subfamily have an HHHxxxD motif at the active site.
Pssm-ID: 380469 [Multi-domain] Cd Length: 422 Bit Score: 83.51 E-value: 1.76e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 952 YPLTAAQMRVFMDEQLVNTGSGYHITTAFMIYGPIDVTRLERACGQLIERHEALRTSFDIVD-GDPVQRIHEHCDFHLEI 1030
Cdd:cd19547 2 YPLAPMQEGMLFRGLFWPDSDAYFNQNVLELVGGTDEDVLREAWRRVADRYEILRTGFTWRDrAEPLQYVRDDLAPPWAL 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1031 VHLQGQQLHTAVNGCIRPFQLERA--------PLIRSILIPLAEEQHLLVLDMHHIVADGKSVFLLQRDLAALYE----G 1098
Cdd:cd19547 82 LDWSGEDPDRRAELLERLLADDRAaglsladcPLYRLTLVRLGGGRHYLLWSHHHILLDGWCLSLIWGDVFRVYEelahG 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1099 RELHDLPVQ-YVDFAQWQTSAPVVEDlrRQEQFWQSMFADYRPlpgIPTDHTPEANERSFAGghITWEPDPVLSRRLYAV 1177
Cdd:cd19547 162 REPQLSPCRpYRDYVRWIRARTAQSE--ESERFWREYLRDLTP---SPFSTAPADREGEFDT--VVHEFPEQLTRLVNEA 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1178 AAEQQTTLFMVLLAAFHVLYAKYSAREEVTVGTPVEGR--RRAEVRQVVGMFVNALAIRSYPEGDKPFSSFLQEIRGTML 1255
Cdd:cd19547 235 ARGYGVTTNAISQAAWSMLLALQTGARDVVHGLTIAGRppELEGSEHMVGIFINTIPLRIRLDPDQTVTGLLETIHRDLA 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1256 QAYEHQDYPLERLAKQLDLHHSRDHLMFDTVFSMLNYEDFAVRSDDLQFEYAELPTLSEIYNLRVEIVESPERLRGTFKY 1335
Cdd:cd19547 315 TTAAHGHVPLAQIKSWASGERLSGGRVFDNLVAFENYPEDNLPGDDLSIQIIDLHAQEKTEYPIGLIVLPLQKLAFHFNY 394
|
410 420
....*....|....*....|....*...
gi 517718121 1336 GQELYEARTVSQLAQDYERILAAVAESP 1363
Cdd:cd19547 395 DTTHFTRAQVDRFIEVFRLLTEQLCRRP 422
|
|
| AFD_YhfT-like |
cd17633 |
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, ... |
151-442 |
1.93e-16 |
|
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, as well as long-chain fatty acid-CoA ligase VraA, all of which are as yet to be characterized. These proteins belong to the adenylate-forming enzymes which catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain
Pssm-ID: 341288 [Multi-domain] Cd Length: 320 Bit Score: 82.07 E-value: 1.93e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 151 DPIYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPESreiiLD 230
Cdd:cd17633 1 NPFYIGFTSGTTGLPKAYYRSERSWIESFVCNEDLFNISGEDAILAPGPLSHSLFLYGAISALYLGGTFIGQRK----FN 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 231 PLRLVHWLEHSRVHVVHCTPSLfrfINHLSLTADSYPDLRYVLLAGETIRPESLKNwYDNLGNRVRLVNLYGPTETTMIK 310
Cdd:cd17633 77 PKSWIRKINQYNATVIYLVPTM---LQALARTLEPESKIKSIFSSGQKLFESTKKK-LKNIFPKANLIEFYGTSELSFIT 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 311 lfYPIKPEDVHRESIpiGRPLPDTSVYLLDEQqqpvsGSEAGEICIATRYMTHGYFP--SSHPDQtafipdpcrdqsgei 388
Cdd:cd17633 153 --YNFNQESRPPNSV--GRPFPNVEIEIRNAD-----GGEIGKIFVKSEMVFSGYVRggFSNPDG--------------- 208
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....
gi 517718121 389 mMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd17633 209 -WMSVGDIGYVDEEGYLYLVGRESDMIIIGGINIFPTEIESVLKAIPGIEEAIV 261
|
|
| PRK07470 |
PRK07470 |
acyl-CoA synthetase; Validated |
9-442 |
3.01e-16 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 180988 [Multi-domain] Cd Length: 528 Bit Score: 83.55 E-value: 3.01e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLD-PLH 87
Cdd:PRK07470 13 LRQAARRFPDRIALVWGDRSWTWREIDARVDALAAALAARGVRKGDRILVHSRNCNQMFESMFAAFRLGAVWVPTNfRQT 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 88 PDErLVTMLDTAEVSCLLCDDAQFERAETLQG---HEGKYFVL-RARQAMSVQAGSKEAYSHS-ANAT----DPIYIYFT 158
Cdd:PRK07470 93 PDE-VAYLAEASGARAMICHADFPEHAAAVRAaspDLTHVVAIgGARAGLDYEALVARHLGARvANAAvdhdDPCWFFFT 171
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 159 SGSTGKPKAVVgknesLLH----FM--NWEAswlDLTdPMRVSQLTSIgfdavlrdIFVPICAGG-------------TI 219
Cdd:PRK07470 172 SGTTGRPKAAV-----LTHgqmaFVitNHLA---DLM-PGTTEQDASL--------VVAPLSHGAgihqlcqvargaaTV 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 220 CIPESREIILDPLRLVhwlEHSRVHVVHCTPSLFR-FINHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGNrvRLV 298
Cdd:PRK07470 235 LLPSERFDPAEVWALV---ERHRVTNLFTVPTILKmLVEHPAVDRYDHSSLRYVIYAGAPMYRADQKRALAKLGK--VLV 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 299 NLYGPTETT-MIKLFYPI--KPEDVHRESI-PIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFPSSHPDQT 374
Cdd:PRK07470 310 QYFGLGEVTgNITVLPPAlhDAEDGPDARIgTCGFERTGMEVQIQDDEGRELPPGETGEICVIGPAVFAGYYNNPEANAK 389
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 517718121 375 AFipdpcRDQsgeimMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK07470 390 AF-----RDG-----WFRTGDLGHLDARGFLYITGRASDMYISGGSNVYPREIEEKLLTHPAVSEVAV 447
|
|
| A_NRPS |
cd05930 |
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain ... |
783-846 |
3.13e-16 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341253 [Multi-domain] Cd Length: 444 Bit Score: 82.96 E-value: 3.13e-16
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 517718121 783 VQLQVEEAQEPLLIAYYLADK--MIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNAL 846
Cdd:cd05930 379 VVAREDGDGEKRLVAYVVPDEggELDEEELRAHLAERLPDYMVPSAFVVLDALPLTPNGKVDRKAL 444
|
|
| PRK07638 |
PRK07638 |
acyl-CoA synthetase; Validated |
17-442 |
3.43e-16 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236071 [Multi-domain] Cd Length: 487 Bit Score: 83.29 E-value: 3.43e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 17 PERKAIECGQQTLSYKELDAESDRICELLHAHgAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTML 96
Cdd:PRK07638 15 PNKIAIKENDRVLTYKDWFESVCKVANWLNEK-ESKNKTIAILLENRIEFLQLFAGAAMAGWTCVPLDIKWKQDELKERL 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 97 DTAEVSCLLCDDAQFERaetLQGHEGKyfVLRARQAMSVQAGSKEAYSHSANAT-DPIYIYFTSGSTGKPKAVVGKNESL 175
Cdd:PRK07638 94 AISNADMIVTERYKLND---LPDEEGR--VIEIDEWKRMIEKYLPTYAPIENVQnAPFYMGFTSGSTGKPKAFLRAQQSW 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 176 LHFMNWEASWLDLTDPMRV----SQLTSIGFDAVLRDIFVpicaGGTICIPESreiiLDPLRLVHWLEHSRVHVVHCTPS 251
Cdd:PRK07638 169 LHSFDCNVHDFHMKREDSVliagTLVHSLFLYGAISTLYV----GQTVHLMRK----FIPNQVLDKLETENISVMYTVPT 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 252 LF-------RFINHLSLTADSYPDLryvllagETIRPESLKNWYDNLgnrvRLVNLYGPTETTMIKLfypIKPEDVHRES 324
Cdd:PRK07638 241 MLeslykenRVIENKMKIISSGAKW-------EAEAKEKIKNIFPYA----KLYEFYGASELSFVTA---LVDEESERRP 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 325 IPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFPSShpdqtafIPDPCRDQSGEIMMYrtgDMGRWLPEGE 404
Cdd:PRK07638 307 NSVGRPFHNVQVRICNEAGEEVQKGEIGTVYVKSPQFFMGYIIGG-------VLARELNADGWMTVR---DVGYEDEEGF 376
|
410 420 430
....*....|....*....|....*....|....*...
gi 517718121 405 LALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK07638 377 IYIVGREKNMILFGGINIFPEEIESVLHEHPAVDEIVV 414
|
|
| PRK13382 |
PRK13382 |
bile acid CoA ligase; |
9-443 |
4.33e-16 |
|
bile acid CoA ligase;
Pssm-ID: 172019 [Multi-domain] Cd Length: 537 Bit Score: 83.27 E-value: 4.33e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAI--ECGqqTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPL--- 83
Cdd:PRK13382 49 FAIAAQRCPDRPGLidELG--TLTWRELDERSDALAAALQALPIGEPRVVGIMCRNHRGFVEALLAANRIGADILLLnts 126
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 84 ---------------DPLHPDERLVTMLDTAEVSCllcDDAQFERAETLQGHEGKYFVLRARQA-MSVQAGSKEAYShsa 147
Cdd:PRK13382 127 fagpalaevvtregvDTVIYDEEFSATVDRALADC---PQATRIVAWTDEDHDLTVEVLIAAHAgQRPEPTGRKGRV--- 200
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 148 natdpiyIYFTSGSTGKPKavvGKNESLLHFMNWEASWLDLTdPMRVSQLTSI--------GFDAVLrdifvpiCAGGTI 219
Cdd:PRK13382 201 -------ILLTSGTTGTPK---GARRSGPGGIGTLKAILDRT-PWRAEEPTVIvapmfhawGFSQLV-------LAASLA 262
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 220 C-IPESREiiLDPLRLVHWLEHSRVHVVHCTPSLFRFINHL---SLTADSYPDLRYVLLAGETIRPESLKNWYDNLGNRv 295
Cdd:PRK13382 263 CtIVTRRR--FDPEATLDLIDRHRATGLAVVPVMFDRIMDLpaeVRNRYSGRSLRFAAASGSRMRPDVVIAFMDQFGDV- 339
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 296 rLVNLYGPTETTMIKLfypIKPEDVHRESIPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFPSSHPDqta 375
Cdd:PRK13382 340 -IYNNYNATEAGMIAT---ATPADLRAAPDTAGRPAEGTEIRILDQDFREVPTGEVGTIFVRNDTQFDGYTSGSTKD--- 412
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 517718121 376 FIpdpcrdqsgEIMMyRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVVR 443
Cdd:PRK13382 413 FH---------DGFM-ASGDVGYLDENGRLFVVGRDDEMIVSGGENVYPIEVEKTLATHPDVAEAAVI 470
|
|
| FADD10 |
cd17635 |
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain ... |
151-442 |
5.19e-16 |
|
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain fatty acid CoA ligases, including FadD10 which is involved in the synthesis of a virulence-related lipopeptide. FadD10 is a fatty acyl-AMP ligase (FAAL) that transfers fatty acids to an acyl carrier protein. Structures of FadD10 in apo- and complexed form with dodecanoyl-AMP, show a novel open conformation, facilitated by its unique inter-domain and intermolecular interactions, which is critical for the enzyme to carry out the acyl transfer onto the acyl carrier protein (Rv0100) rather than coenzyme A.
Pssm-ID: 341290 [Multi-domain] Cd Length: 340 Bit Score: 81.15 E-value: 5.19e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 151 DPIYIYFTSGSTGKPKAVVGKNESLL----HFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVpicAGGTICIPESRE 226
Cdd:cd17635 2 DPLAVIFTSGTTGEPKAVLLANKTFFavpdILQKEGLNWVVGDVTYLPLPATHIGGLWWILTCLI---HGGLCVTGGENT 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 227 IILDPLRLvhwLEHSRVHVVHCTPSLFRFINHLSLTADSY-PDLRYVLLAGETIRPESLKN--WYDNlgnrVRLVNLYGP 303
Cdd:cd17635 79 TYKSLFKI---LTTNAVTTTCLVPTLLSKLVSELKSANATvPSLRLIGYGGSRAIAADVRFieATGL----TNTAQVYGL 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 304 TETTMIKLFypikpeDVHRESIPI---GRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFPSSHPDQTAFIPDp 380
Cdd:cd17635 152 SETGTALCL------PTDDDSIEInavGRPYPGVDVYLAATDGIAGPSASFGTIWIKSPANMLGYWNNPERTAEVLIDG- 224
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 517718121 381 crdqsgeimMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd17635 225 ---------WVNTGDLGERREDGFLFITGRSSESINCGGVKIAPDEVERIAEGVSGVQECAC 277
|
|
| PrpE |
cd05967 |
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or ... |
26-442 |
5.65e-16 |
|
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or propionate#CoA ligase (PrpE) catalyzes the first step of the 2-methylcitric acid cycle for propionate catabolism. It activates propionate to propionyl-CoA in a two-step reaction, which proceeds through a propionyl-AMP intermediate and requires ATP and Mg2+. In Salmonella enterica, the PrpE protein is required for growth of Salmonella enterica on propionate and can substitute for the acetyl-CoA synthetase (Acs) enzyme during growth on acetate. PrpE can also activate acetate, 3HP, and butyrate to their corresponding CoA-thioesters, although with less efficiency.
Pssm-ID: 341271 [Multi-domain] Cd Length: 617 Bit Score: 83.13 E-value: 5.65e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 26 QQTLSYKELDAESDRICELLHAHGAAQYDHIGILM---------QDRCASIAAVIGILkLGGvFVPldplhpdERLVTML 96
Cdd:cd05967 80 ERTYTYAELLDEVSRLAGVLRKLGVVKGDRVIIYMpmipeaaiaMLACARIGAIHSVV-FGG-FAA-------KELASRI 150
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 97 DTAEVSCLLCDDAQFE------------RAETLQGHEGKYFVLRARQAMSVQAGS-----------KEAYSH---SANAT 150
Cdd:cd05967 151 DDAKPKLIVTASCGIEpgkvvpykplldKALELSGHKPHHVLVLNRPQVPADLTKpgrdldwsellAKAEPVdcvPVAAT 230
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 151 DPIYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLDLTDPMRVSQLTS-IGFdaVLRDIFV---PICAGGTICIPESRe 226
Cdd:cd05967 231 DPLYILYTSGTTGKPKGVVRDNGGHAVALNWSMRNIYGIKPGDVWWAASdVGW--VVGHSYIvygPLLHGATTVLYEGK- 307
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 227 iildPLRL----VHW--LEHSRVHVVHCTPSLFRFINHLSLTAD-----SYPDLRYVLLAGETIRPESLkNWYDNLGNrV 295
Cdd:cd05967 308 ----PVGTpdpgAFWrvIEKYQVNALFTAPTAIRAIRKEDPDGKyikkyDLSSLRTLFLAGERLDPPTL-EWAENTLG-V 381
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 296 RLVNLYGPTETTmiklfYPIKPEDVHRESIPI-----GRPLPDTSVYLLDEQQQPVSGSEAGEICIAtRYMTHGYFPSSH 370
Cdd:cd05967 382 PVIDHWWQTETG-----WPITANPVGLEPLPIkagspGKPVPGYQVQVLDEDGEPVGPNELGNIVIK-LPLPPGCLLTLW 455
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 517718121 371 PDQTAFIPDPCRDQSGeimMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05967 456 KNDERFKKLYLSKFPG---YYDTGDAGYKDEDGYLFIMGRTDDVINVAGHRLSTGEMEESVLSHPAVAECAV 524
|
|
| PRK07059 |
PRK07059 |
Long-chain-fatty-acid--CoA ligase; Validated |
9-470 |
5.79e-16 |
|
Long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235923 [Multi-domain] Cd Length: 557 Bit Score: 82.76 E-value: 5.79e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLH- 87
Cdd:PRK07059 29 LEESFRQYADRPAFICMGKAITYGELDELSRALAAWLQSRGLAKGARVAIMMPNVLQYPVAIAAVLRAGYVVVNVNPLYt 108
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 88 PDERLVTMLDT-AEVSCLLcddAQFerAETLQ--------------------GHEGKY--FVLRARQAM----------- 133
Cdd:PRK07059 109 PRELEHQLKDSgAEAIVVL---ENF--ATTVQqvlaktavkhvvvasmgdllGFKGHIvnFVVRRVKKMvpawslpghvr 183
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 134 ---SVQAGSKEAYSHSANATDPI-YIYFTSGSTGkpkavVGKNESLLH------FMNWEAsWLD--LTDPMRVSQLTSIG 201
Cdd:PRK07059 184 fndALAEGARQTFKPVKLGPDDVaFLQYTGGTTG-----VSKGATLLHrnivanVLQMEA-WLQpaFEKKPRPDQLNFVC 257
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 202 fdAV-LRDIF-------VPICAGGT-ICIPESREIildPlRLVHWLEHSRVHVVHCTPSLFR-FINHLSLTADSYPDLRY 271
Cdd:PRK07059 258 --ALpLYHIFaltvcglLGMRTGGRnILIPNPRDI---P-GFIKELKKYQVHIFPAVNTLYNaLLNNPDFDKLDFSKLIV 331
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 272 VLLAGETIRPESLKNWYDNLGNRVrlVNLYGPTETTmiklfyPI---KPEDVHRESIPIGRPLPDTSVYLLDEQQQPVSG 348
Cdd:PRK07059 332 ANGGGMAVQRPVAERWLEMTGCPI--TEGYGLSETS------PVatcNPVDATEFSGTIGLPLPSTEVSIRDDDGNDLPL 403
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 349 SEAGEICIATRYMTHGYFpsSHPDQTAfipdpcrdqsgEIMM----YRTGDMGRWLPEGELALLGRKDNQVKIRGNRVEL 424
Cdd:PRK07059 404 GEPGEICIRGPQVMAGYW--NRPDETA-----------KVMTadgfFRTGDVGVMDERGYTKIVDRKKDMILVSGFNVYP 470
|
490 500 510 520
....*....|....*....|....*....|....*....|....*.
gi 517718121 425 GDIEHRLTNMAGIREavvrmrakadtpkgmaqqhCAACGLPSTYPG 470
Cdd:PRK07059 471 NEIEEVVASHPGVLE-------------------VAAVGVPDEHSG 497
|
|
| PRK07798 |
PRK07798 |
acyl-CoA synthetase; Validated |
14-415 |
5.92e-16 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236100 [Multi-domain] Cd Length: 533 Bit Score: 82.63 E-value: 5.92e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 14 AAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLV 93
Cdd:PRK07798 14 DAVPDRVALVCGDRRLTYAELEERANRLAHYLIAQGLGPGDHVGIYARNRIEYVEAMLGAFKARAVPVNVNYRYVEDELR 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 94 TMLDTAEVSCLLCDDAQFER-AETLQGHEgkyfvlRARQAMSVQAGSKEAYSH------SANAT------------DPIY 154
Cdd:PRK07798 94 YLLDDSDAVALVYEREFAPRvAEVLPRLP------KLRTLVVVEDGSGNDLLPgavdyeDALAAgsperdfgerspDDLY 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 155 IYFTSGSTGKPKAVVGKNESLlhfmnWEASwLDLTDPMRVSQLTSIgfDAVLRD-------IFVPIC------------- 214
Cdd:PRK07798 168 LLYTGGTTGMPKGVMWRQEDI-----FRVL-LGGRDFATGEPIEDE--EELAKRaaagpgmRRFPAPplmhgagqwaafa 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 215 ---AGGTICIPESREiiLDPLRLVHWLEHSRVHVVHCTPSLF-R-FINHLsLTADSY--PDLRYVLLAGETIRPESLKNW 287
Cdd:PRK07798 240 alfSGQTVVLLPDVR--FDADEVWRTIEREKVNVITIVGDAMaRpLLDAL-EARGPYdlSSLFAIASGGALFSPSVKEAL 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 288 YDNLGNRVrLVNLYGPTET-TMIKLFYPIKPEDVHRESIPIGrplPDTSVylLDEQQQPVS-GSEAGEIcIATR-YMTHG 364
Cdd:PRK07798 317 LELLPNVV-LTDSIGSSETgFGGSGTVAKGAVHTGGPRFTIG---PRTVV--LDEDGNPVEpGSGEIGW-IARRgHIPLG 389
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 365 YFpsSHPDQTAFIpdpcrdqsgeimmYRT---------GDMGRWLPEGELALLGRkDNQV 415
Cdd:PRK07798 390 YY--KDPEKTAET-------------FPTidgvryaipGDRARVEADGTITLLGR-GSVC 433
|
|
| PRK09274 |
PRK09274 |
peptide synthase; Provisional |
9-416 |
7.25e-16 |
|
peptide synthase; Provisional
Pssm-ID: 236443 [Multi-domain] Cd Length: 552 Bit Score: 82.64 E-value: 7.25e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIECGQ----------QTLSYKELDAESDRICELLHAHGAAQYDHIgILMQDRCAS-IAAVIGILKLG 77
Cdd:PRK09274 12 LPRAAQERPDQLAVAVPGgrgadgklayDELSFAELDARSDAIAHGLNAAGIGRGMRA-VLMVTPSLEfFALTFALFKAG 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 78 GVFVPLDPLHPDERLVTMLDTAE------------VSCLL------------CDDAQFERAETL----QGHEGKYFVLRA 129
Cdd:PRK09274 91 AVPVLVDPGMGIKNLKQCLAEAQpdafigipkahlARRLFgwgkpsvrrlvtVGGRLLWGGTTLatllRDGAAAPFPMAD 170
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 130 rqamsvqagskeayshsANATDPIYIYFTSGSTGKPKAVVgknesllhfmnweaswldLTDPMRVSQLTSI--------- 200
Cdd:PRK09274 171 -----------------LAPDDMAAILFTSGSTGTPKGVV------------------YTHGMFEAQIEALredygiepg 215
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 201 GFDAVLRDIFV--PICAGGTICIPE---SREIILDPLRLVHWLEHSRVHVVHCTPSLFRFINHLSLTAD-SYPDLRYVLL 274
Cdd:PRK09274 216 EIDLPTFPLFAlfGPALGMTSVIPDmdpTRPATVDPAKLFAAIERYGVTNLFGSPALLERLGRYGEANGiKLPSLRRVIS 295
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 275 AGETIRPESLKNWYDNLGNRVRLVNLYGPTET---TMI----KLFYPIKPEDVHrESIPIGRPLPDTSVYLLD------- 340
Cdd:PRK09274 296 AGAPVPIAVIERFRAMLPPDAEILTPYGATEAlpiSSIesreILFATRAATDNG-AGICVGRPVDGVEVRIIAisdapip 374
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 517718121 341 --EQQQPVSGSEAGEICIATRYMTHGYFPSSHPDQTAFIPDPCRDqsgeiMMYRTGDMGRWLPEGELALLGRKDNQVK 416
Cdd:PRK09274 375 ewDDALRLATGEIGEIVVAGPMVTRSYYNRPEATRLAKIPDGQGD-----VWHRMGDLGYLDAQGRLWFCGRKAHRVE 447
|
|
| PRK06087 |
PRK06087 |
medium-chain fatty-acid--CoA ligase; |
2-442 |
1.58e-15 |
|
medium-chain fatty-acid--CoA ligase;
Pssm-ID: 180393 [Multi-domain] Cd Length: 547 Bit Score: 81.33 E-value: 1.58e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 2 DNTIQYELARAFAAFPERKAIECGQQT-LSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVF 80
Cdd:PRK06087 22 DASLADYWQQTARAMPDKIAVVDNHGAsYTYSALDHAASRLANWLLAKGIEPGDRVAFQLPGWCEFTIIYLACLKVGAVS 101
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 81 VPLDPLHPDERLVTMLDTAEVSCLLC---------DDAQFERAETLQGHEGKYFVLRARQAMS-------VQAGSKEAYS 144
Cdd:PRK06087 102 VPLLPSWREAELVWVLNKCQAKMFFAptlfkqtrpVDLILPLQNQLPQLQQIVGVDKLAPATSslslsqiIADYEPLTTA 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 145 HSANATDPIYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLDLT--DPMRV-SQLT-SIGFdavLRDIFVPICAGGTIC 220
Cdd:PRK06087 182 ITTHGDELAAVLFTSGTEGLPKGVMLTHNNILASERAYCARLNLTwqDVFMMpAPLGhATGF---LHGVTAPFLIGARSV 258
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 221 IPEsreiILDPLRLVHWLEHSRVHVVH-CTPSLFRFINHLSLTADSYPDLRYVLLAGETIrPESLKNwyDNLGNRVRLVN 299
Cdd:PRK06087 259 LLD----IFTPDACLALLEQQRCTCMLgATPFIYDLLNLLEKQPADLSALRFFLCGGTTI-PKKVAR--ECQQRGIKLLS 331
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 300 LYGPTET---TMIKLFYPIkPEDVHREsipiGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTAF 376
Cdd:PRK06087 332 VYGSTESsphAVVNLDDPL-SRFMHTD----GYAAAGVEIKVVDEARKTLPPGCEGEEASRGPNVFMGYL--DEPELTAR 404
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 517718121 377 IPDpcrdqsgEIMMYRTGDMGRWLPEGELALLGRKdNQVKIRGNR-VELGDIEHRLTNMAGIREAVV 442
Cdd:PRK06087 405 ALD-------EEGWYYSGDLCRMDEAGYIKITGRK-KDIIVRGGEnISSREVEDILLQHPKIHDACV 463
|
|
| A_NRPS_Srf_like |
cd12117 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis ... |
783-846 |
2.27e-15 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis termination module Surfactin (SrfA-C); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the adenylation domain of the Bacillus subtilis termination module (Surfactin domain, SrfA-C) which recognizes a specific amino acid building block, which is then activated and transferred to the terminal thiol of the 4'-phosphopantetheine (Ppan) arm of the downstream peptidyl carrier protein (PCP) domain.
Pssm-ID: 341282 [Multi-domain] Cd Length: 483 Bit Score: 80.71 E-value: 2.27e-15
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 517718121 783 VQLQVEEAQEPLLIAYYLADKMIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNAL 846
Cdd:cd12117 420 VVVREDAGGDKRLVAYVVAEGALDAAELRAFLRERLPAYMVPAAFVVLDELPLTANGKVDRRAL 483
|
|
| PRK12583 |
PRK12583 |
acyl-CoA synthetase; Provisional |
2-419 |
3.04e-15 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237145 [Multi-domain] Cd Length: 558 Bit Score: 80.59 E-value: 3.04e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 2 DNTIQYELARAFAAFPERKAIECGQQTL--SYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGV 79
Cdd:PRK12583 17 TQTIGDAFDATVARFPDREALVVRHQALryTWRQLADAVDRLARGLLALGVQPGDRVGIWAPNCAEWLLTQFATARIGAI 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 80 FVPLDPLHPDERLVTMLDTAEVSCLLCDDAqFERA---ETLQG-----HEGKYFVLR----------------------- 128
Cdd:PRK12583 97 LVNINPAYRASELEYALGQSGVRWVICADA-FKTSdyhAMLQEllpglAEGQPGALAcerlpelrgvvslapapppgfla 175
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 129 --ARQAM--SVQAGSKEAYSHSANATDPIYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLDLTDPMRVSQLTSI--GF 202
Cdd:PRK12583 176 whELQARgeTVSREALAERQASLDRDDPINIQYTSGTTGFPKGATLSHHNILNNGYFVAESLGLTEHDRLCVPVPLyhCF 255
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 203 DAVLRDIfVPICAGGTICIPesrEIILDPLRLVHWLEHSRVHVVHCTPSLF-RFINHLSLTADSYPDLRYVLLAGETIRP 281
Cdd:PRK12583 256 GMVLANL-GCMTVGACLVYP---NEAFDPLATLQAVEEERCTALYGVPTMFiAELDHPQRGNFDLSSLRTGIMAGAPCPI 331
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 282 ESLKNWYDNLgNRVRLVNLYGPTETTMIKLFYPIKpEDVHRESIPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYM 361
Cdd:PRK12583 332 EVMRRVMDEM-HMAEVQIAYGMTETSPVSLQTTAA-DDLERRVETVGRTQPHLEVKVVDPDGATVPRGEIGELCTRGYSV 409
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*...
gi 517718121 362 THGYFpsSHPDQTAFIPDpcrdqsGEIMMYrTGDMGRWLPEGELALLGRKDNQVkIRG 419
Cdd:PRK12583 410 MKGYW--NNPEATAESID------EDGWMH-TGDLATMDEQGYVRIVGRSKDMI-IRG 457
|
|
| PRK05857 |
PRK05857 |
fatty acid--CoA ligase; |
25-440 |
3.26e-15 |
|
fatty acid--CoA ligase;
Pssm-ID: 180293 [Multi-domain] Cd Length: 540 Bit Score: 80.44 E-value: 3.26e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 25 GQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDErlvtmldTAEVSCL 104
Cdd:PRK05857 38 GTSALRYRELVAEVGGLAADLRAQSVSRGSRVLVISDNGPETYLSVLACAKLGAIAVMADGNLPIA-------AIERFCQ 110
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 105 LCDDAQFERAETLQ-GHEGKYFVLRARQAMSVQAGSKEAYS-HSAN-----------ATDPIYIYFTSGSTGKPKAVVGK 171
Cdd:PRK05857 111 ITDPAAALVAPGSKmASSAVPEALHSIPVIAVDIAAVTRESeHSLDaaslagnadqgSEDPLAMIFTSGTTGEPKAVLLA 190
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 172 NESLLHF--------MNWeASWLDLTDPMRVSQLTSIGFdavLRDIFVPICAGGtICIPESREiildPLRLVHWLEHSRV 243
Cdd:PRK05857 191 NRTFFAVpdilqkegLNW-VTWVVGETTYSPLPATHIGG---LWWILTCLMHGG-LCVTGGEN----TTSLLEILTTNAV 261
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 244 HVVHCTPSLF-RFINHLSLTADSYPDLRYVLLAGETIRPESLKnWYDNLGnrVRLVNLYGPTETTMIKLFYPIKPEDVHR 322
Cdd:PRK05857 262 ATTCLVPTLLsKLVSELKSANATVPSLRLVGYGGSRAIAADVR-FIEATG--VRTAQVYGLSETGCTALCLPTDDGSIVK 338
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 323 -ESIPIGRPLPDTSVYLLDEQ----QQPVSGSEA--GEICIATRYMTHGYFpsSHPDQTafipdpcrdqsGEIMM---YR 392
Cdd:PRK05857 339 iEAGAVGRPYPGVDVYLAATDgigpTAPGAGPSAsfGTLWIKSPANMLGYW--NNPERT-----------AEVLIdgwVN 405
|
410 420 430 440
....*....|....*....|....*....|....*....|....*...
gi 517718121 393 TGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREA 440
Cdd:PRK05857 406 TGDLLERREDGFFYIKGRSSEMIICGGVNIAPDEVDRIAEGVSGVREA 453
|
|
| 23DHB-AMP_lg |
cd05920 |
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2, ... |
9-442 |
7.93e-15 |
|
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2,3-dihydroxybenzoate (DHB) by ligation of AMP from ATP with the release of pyrophosphate. However, it can also catalyze the ATP-PPi exchange for 2,3-DHB analogs, such as salicyclic acid (o-hydrobenzoate), as well as 2,4-DHB and 2,5-DHB, but with less efficiency. Proteins in this family are the stand-alone adenylation components of non-ribosomal peptide synthases (NRPSs) involved in the biosynthesis of siderophores, which are low molecular weight iron-chelating compounds synthesized by many bacteria to aid in the acquisition of this vital trace elements. In Escherichia coli, the 2,3-dihydroxybenzoate-AMP ligase is called EntE, the adenylation component of the enterobactin NRPS system.
Pssm-ID: 341244 [Multi-domain] Cd Length: 482 Bit Score: 78.91 E-value: 7.93e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHP 88
Cdd:cd05920 21 LARSAARHPDRIAVVDGDRRLTYRELDRRADRLAAGLRGLGIRPGDRVVVQLPNVAEFVVLFFALLRLGAVPVLALPSHR 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 89 DERLVTMLDTAEVSCLLCDDAqferaetlqgHEGKYFVLRARQAMSVQAgskeayshsanatDPIYIYFTSGSTGKPKAV 168
Cdd:cd05920 101 RSELSAFCAHAEAVAYIVPDR----------HAGFDHRALARELAESIP-------------EVALFLLSGGTTGTPKLI 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 169 VGKNESLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLR--DIFVPICAGGTICIPESReiilDPLRLVHWLEHSRVHVV 246
Cdd:cd05920 158 PRTHNDYAYNVRASAEVCGLDQDTVYLAVLPAAHNFPLAcpGVLGTLLAGGRVVLAPDP----SPDAAFPLIEREGVTVT 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 247 HCTPSLF-RFINHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGNRVRLVnlYGPTETtMIKLFYPIKPEDV--HRE 323
Cdd:cd05920 234 ALVPALVsLWLDAAASRRADLSSLRLLQVGGARLSPALARRVPPVLGCTLQQV--FGMAEG-LLNYTRLDDPDEViiHTQ 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 324 sipiGRPL-PDTSVYLLDEQQQPVSGSEAGEIciATR--YMTHGYFPSSHPDQTAFIPDPcrdqsgeimMYRTGDMGRWL 400
Cdd:cd05920 311 ----GRPMsPDDEIRVVDEEGNPVPPGEEGEL--LTRgpYTIRGYYRAPEHNARAFTPDG---------FYRTGDLVRRT 375
|
410 420 430 440
....*....|....*....|....*....|....*....|..
gi 517718121 401 PEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05920 376 PDGYLVVEGRIKDQINRGGEKIAAEEVENLLLRHPAVHDAAV 417
|
|
| FACL_fum10p_like |
cd05926 |
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL ... |
17-442 |
2.09e-14 |
|
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Fum10p is a fatty acid CoA ligase involved in the synthesis of fumonisin, a polyketide mycotoxin, in Gibberella moniliformis.
Pssm-ID: 341249 [Multi-domain] Cd Length: 493 Bit Score: 77.74 E-value: 2.09e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 17 PERKAIECGQQT--LSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVT 94
Cdd:cd05926 1 PDAPALVVPGSTpaLTYADLAELVDDLARQLAALGIKKGDRVAIALPNGLEFVVAFLAAARAGAVVAPLNPAYKKAEFEF 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 95 MLDTAEVSCLLCDD---------AQFERAETLQ-GHE--GKYFVLRARQAMSVQAGSKEAYSHS-ANATDPIYIYFTSGS 161
Cdd:cd05926 81 YLADLGSKLVLTPKgelgpasraASKLGLAILElALDvgVLIRAPSAESLSNLLADKKNAKSEGvPLPDDLALILHTSGT 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 162 TGKPKAVVGKNESLLHFMNWEASWLDLTDPMR---VSQLTSI-GFDAVLrdiFVPICAGGTICIPESreiiLDPLRLVHW 237
Cdd:cd05926 161 TGRPKGVPLTHRNLAASATNITNTYKLTPDDRtlvVMPLFHVhGLVASL---LSTLAAGGSVVLPPR----FSASTFWPD 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 238 LEHSRVHVVHCTPSLFRFI--NHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGnrVRLVNLYGPTETTMIKLFYPI 315
Cdd:cd05926 234 VRDYNATWYTAVPTIHQILlnRPEPNPESPPPKLRFIRSCSASLPPAVLEALEATFG--APVLEAYGMTEAAHQMTSNPL 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 316 KPEDVHRESIPIGRplpDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFPSSHPDQTAFIPDPcrdqsgeimMYRTGD 395
Cdd:cd05926 312 PPGPRKPGSVGKPV---GVEVRILDEDGEILPPGVVGEICLRGPNVTRGYLNNPEANAEAAFKDG---------WFRTGD 379
|
410 420 430 440
....*....|....*....|....*....|....*....|....*..
gi 517718121 396 MGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05926 380 LGYLDADGYLFLTGRIKELINRGGEKISPLEVDGVLLSHPAVLEAVA 426
|
|
| FAAL |
cd05931 |
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and ... |
9-429 |
2.96e-14 |
|
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and is homologous to fatty acyl-coenzyme A (CoA) ligases (FACLs). However, FAALs produce only the acyl adenylate and are unable to perform the thioester-forming reaction, while FACLs perform a two-step catalytic reaction; AMP ligation followed by CoA ligation using ATP and CoA as cofactors. FAALs have insertion motifs between the N-terminal and C-terminal subdomains that distinguish them from the FACLs. This insertion motif precludes the binding of CoA, thus preventing CoA ligation. It has been suggested that the acyl adenylates serve as substrates for multifunctional polyketide synthases to permit synthesis of complex lipids such as phthiocerol dimycocerosate, sulfolipids, mycolic acids, and mycobactin.
Pssm-ID: 341254 [Multi-domain] Cd Length: 547 Bit Score: 77.28 E-value: 2.96e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERkaiecGQQTLSYKELDAESDRICELLHAHGAAQyDHIGILMQDRCASIAAVIGILKLGGVFVPL---DP 85
Cdd:cd05931 10 PAYTFLDDEGG-----REETLTYAELDRRARAIAARLQAVGKPG-DRVLLLAPPGLDFVAAFLGCLYAGAIAVPLpppTP 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 86 LHPDERLVTMLDTAEVSCLLCDDAqFERAETLQGHEGKYFVLRARQAMSVQAGSKEAYSH--SANATDPIYIYFTSGSTG 163
Cdd:cd05931 84 GRHAERLAAILADAGPRVVLTTAA-ALAAVRAFAASRPAAGTPRLLVVDLLPDTSAADWPppSPDPDDIAYLQYTSGSTG 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 164 KPKAVVGKNESLLH---------FMNWE---ASWLDLTDPMRVsqltsIGFdavlrdIFVPICAGGTICIPESREIILDP 231
Cdd:cd05931 163 TPKGVVVTHRNLLAnvrqirrayGLDPGdvvVSWLPLYHDMGL-----IGG------LLTPLYSGGPSVLMSPAAFLRRP 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 232 LRlvhWLEH-SRVHVVHcT--PSlFRFinhlSLTADSYPD----------LRYVLLAGETIRPESLKNWYDnlgnRVRLV 298
Cdd:cd05931 232 LR---WLRLiSRYRATI-SaaPN-FAY----DLCVRRVRDedlegldlssWRVALNGAEPVRPATLRRFAE----AFAPF 298
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 299 NL--------YGPTETTMI---------------------KLFYPIKPEDVH-RESIPIGRPLPDTSVYLLDEQ-QQPVS 347
Cdd:cd05931 299 GFrpeafrpsYGLAEATLFvsggppgtgpvvlrvdrdalaGRAVAVAADDPAaRELVSCGRPLPDQEVRIVDPEtGRELP 378
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 348 GSEAGEICIATRYMTHGYFpsSHPDQTAFIPDPCRDQSGEIMMyRTGDMGRwLPEGELALLGRKDNQVKIRGNRVELGDI 427
Cdd:cd05931 379 DGEVGEIWVRGPSVASGYW--GRPEATAETFGALAATDEGGWL-RTGDLGF-LHDGELYITGRLKDLIIVRGRNHYPQDI 454
|
..
gi 517718121 428 EH 429
Cdd:cd05931 455 EA 456
|
|
| PRK05605 |
PRK05605 |
long-chain-fatty-acid--CoA ligase; Validated |
2-449 |
8.36e-14 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235531 [Multi-domain] Cd Length: 573 Bit Score: 76.19 E-value: 8.36e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 2 DNTIQYELARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFV 81
Cdd:PRK05605 31 DTTLVDLYDNAVARFGDRPALDFFGATTTYAELGKQVRRAAAGLRALGVRPGDRVAIVLPNCPQHIVAFYAVLRLGAVVV 110
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 82 PLDPL-------HPDE----RLVTMLD-TAEVSCLLCDDAQFERAETLQGHEG----KYFVLR--------ARQAMSVQA 137
Cdd:PRK05605 111 EHNPLytaheleHPFEdhgaRVAIVWDkVAPTVERLRRTTPLETIVSVNMIAAmpllQRLALRlpipalrkARAALTGPA 190
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 138 ---------------GSKEAYSH-SANATDPIYIYFTSGSTGKPKAVVgknesLLHfMNWEA------SWL-DLTD---- 190
Cdd:PRK05605 191 pgtvpwetlvdaaigGDGSDVSHpRPTPDDVALILYTSGTTGKPKGAQ-----LTH-RNLFAnaaqgkAWVpGLGDgper 264
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 191 -----PM-RVSQLTSIGFDAVLrdifvpicAGGTICIPESREI--ILDPLRlvhwleHSRVHVVHCTPSLFRFI------ 256
Cdd:PRK05605 265 vlaalPMfHAYGLTLCLTLAVS--------IGGELVLLPAPDIdlILDAMK------KHPPTWLPGVPPLYEKIaeaaee 330
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 257 NHLSLTAdsypdLRYVLLAGETIRPESLKNWYDNLGNRvrLVNLYGPTETTMIKLFYPIKPedvHRESIPIGRPLPDTSV 336
Cdd:PRK05605 331 RGVDLSG-----VRNAFSGAMALPVSTVELWEKLTGGL--LVEGYGLTETSPIIVGNPMSD---DRRPGYVGVPFPDTEV 400
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 337 YL-----LDEQQQPvsgSEAGEICIATRYMTHGYFpsSHPDQTA--FIPDpcrdqsgeimMYRTGDMGRWLPEGELALLG 409
Cdd:PRK05605 401 RIvdpedPDETMPD---GEEGELLVRGPQVFKGYW--NRPEETAksFLDG----------WFRTGDVVVMEEDGFIRIVD 465
|
490 500 510 520
....*....|....*....|....*....|....*....|
gi 517718121 410 RKDNQVKIRGNRVELGDIEHRLTNMAGIREAVVRMRAKAD 449
Cdd:PRK05605 466 RIKELIITGGFNVYPAEVEEVLREHPGVEDAAVVGLPRED 505
|
|
| OSB_MenE-like |
cd17630 |
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) ... |
157-442 |
1.47e-13 |
|
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) synthetase (also known as O-succinylbenzoic acid CoA ligase) that belongs to the ANL superfamily and catalyzes the ligation of CoA to o-succinylbenzoate (OSB). It includes MenE in the bacterial menaquinone biosynthesis pathway which is a promising target for the development of novel antibacterial agents. MenE catalyzes CoA ligation via an acyl-adenylate intermediate; tight-binding inhibitors of MenE based on stable acyl-sulfonyladenosine analogs of this intermediate provide a pathway toward the development of optimized MenE inhibitors.
Pssm-ID: 341285 [Multi-domain] Cd Length: 325 Bit Score: 73.52 E-value: 1.47e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 157 FTSGSTGKPKAVV-----------GKNeSLLHFmNWEASWLDLTDPMRVSqltsiGFDAVLRDIFvpicAGGTICIPESR 225
Cdd:cd17630 7 LTSGSTGTPKAVVhtaanllasaaGLH-SRLGF-GGGDSWLLSLPLYHVG-----GLAILVRSLL----AGAELVLLERN 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 226 eiilDPLRLVHwlEHSRVHVVHCTPSLFRFINHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNlgnRVRLVNLYGPTE 305
Cdd:cd17630 76 ----QALAEDL--APPGVTHVSLVPTQLQRLLDSGQGPAALKSLRAVLLGGAPIPPELLERAADR---GIPLYTTYGMTE 146
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 306 T-TMIKLfypiKPEDVHRESIpIGRPLPDTSVYLldeqqqpvsgSEAGEICIATRYMTHGYFpsshpdqTAFIPDPCRDQ 384
Cdd:cd17630 147 TaSQVAT----KRPDGFGRGG-VGVLLPGRELRI----------VEDGEIWVGGASLAMGYL-------RGQLVPEFNED 204
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*...
gi 517718121 385 SgeimMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd17630 205 G----WFTTKDLGELHADGRLTVLGRADNMIISGGENIQPEEIEAALAAHPAVRDAFV 258
|
|
| A_NRPS_Ta1_like |
cd12116 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A ... |
788-846 |
1.93e-13 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A polyketide synthase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the myxovirescin (TA) antibiotic biosynthetic gene in Myxococcus xanthus; TA production plays a role in predation. It also includes the salinosporamide A polyketide synthase which is involved in the biosynthesis of salinosporamide A, a marine microbial metabolite whose chlorine atom is crucial for potent proteasome inhibition and anticancer activity.
Pssm-ID: 341281 [Multi-domain] Cd Length: 470 Bit Score: 74.64 E-value: 1.93e-13
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 517718121 788 EEAQEPLLIAYYLAD--KMIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNAL 846
Cdd:cd12116 410 EDGGDRRLVAYVVLKagAAPDAAALRAHLRATLPAYMVPSAFVRLDALPLTANGKLDRKAL 470
|
|
| PRK13295 |
PRK13295 |
cyclohexanecarboxylate-CoA ligase; Reviewed |
2-419 |
4.77e-13 |
|
cyclohexanecarboxylate-CoA ligase; Reviewed
Pssm-ID: 171961 [Multi-domain] Cd Length: 547 Bit Score: 73.55 E-value: 4.77e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 2 DNTIQYELARAFAAFPERKAI-----ECGQ-QTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILK 75
Cdd:PRK13295 23 DRTINDDLDACVASCPDKTAVtavrlGTGApRRFTYRELAALVDRVAVGLARLGVGRGDVVSCQLPNWWEFTVLYLACSR 102
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 76 LGGVFVPLDPLHPDERLVTMLDTAEVSCLLC-------DDAQFerAETLQ------------GHEG-----KYFVLRAR- 130
Cdd:PRK13295 103 IGAVLNPLMPIFRERELSFMLKHAESKVLVVpktfrgfDHAAM--ARRLRpelpalrhvvvvGGDGadsfeALLITPAWe 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 131 QAMSVQAGSKeaySHSANATDPIYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLDLT--------DPMrvSQLTsiGF 202
Cdd:PRK13295 181 QEPDAPAILA---RLRPGPDDVTQLIYTSGTTGEPKGVMHTANTLMANIVPYAERLGLGaddvilmaSPM--AHQT--GF 253
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 203 DAVLRdifVPICAGGTICIPEsreiILDPLRLVHWLEHSRV-HVVHCTPSLFRFINHLSLTADSYPDLRYVLLAGETIRP 281
Cdd:PRK13295 254 MYGLM---MPVMLGATAVLQD----IWDPARAAELIRTEGVtFTMASTPFLTDLTRAVKESGRPVSSLRTFLCAGAPIPG 326
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 282 ESLKNWYDNLGNRVrlVNLYGPTETTMIKLFYPIKPEDVHRESipIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYM 361
Cdd:PRK13295 327 ALVERARAALGAKI--VSAWGMTENGAVTLTKLDDPDERASTT--DGCPLPGVEVRVVDADGAPLPAGQIGRLQVRGCSN 402
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*....
gi 517718121 362 THGYFpsSHPDQTAfipdpcRDQSGeimMYRTGDMGRWLPEGELALLGR-KDnqVKIRG 419
Cdd:PRK13295 403 FGGYL--KRPQLNG------TDADG---WFDTGDLARIDADGYIRISGRsKD--VIIRG 448
|
|
| PRK08751 |
PRK08751 |
long-chain fatty acid--CoA ligase; |
4-439 |
7.20e-13 |
|
long-chain fatty acid--CoA ligase;
Pssm-ID: 181546 [Multi-domain] Cd Length: 560 Bit Score: 72.99 E-value: 7.20e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 4 TIQYELARAFAAFPERKAIECGQQTLSYKELDAESDRICE-LLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVP 82
Cdd:PRK08751 26 TVAEVFATSVAKFADRPAYHSFGKTITYREADQLVEQFAAyLLGELQLKKGDRVALMMPNCLQYPIATFGVLRAGLTVVN 105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 83 LDPLHPDERLVTMLDTAEVSCLL-----CDDAQFERAET------------LQGHEGKYFV------------------- 126
Cdd:PRK08751 106 VNPLYTPRELKHQLIDSGASVLVvidnfGTTVQQVIADTpvkqvittglgdMLGFPKAALVnfvvkyvkklvpeyringa 185
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 127 LRARQAMSVqaGSKEAYSHSANATDPI-YIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLDLTDPMRVSQLTSIgfDAV 205
Cdd:PRK08751 186 IRFREALAL--GRKHSMPTLQIEPDDIaFLQYTGGTTGVAKGAMLTHRNLVANMQQAHQWLAGTGKLEEGCEVVI--TAL 261
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 206 -LRDIFVpICAGGTIC--IPESREIILDPLRL---VHWLEHSRVHVVHCTPSLFR-FINHLSLTADSYPDLRYVLLAGET 278
Cdd:PRK08751 262 pLYHIFA-LTANGLVFmkIGGCNHLISNPRDMpgfVKELKKTRFTAFTGVNTLFNgLLNTPGFDQIDFSSLKMTLGGGMA 340
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 279 IRPESLKNWYDNLGnrVRLVNLYGPTETTMIKLfypIKPEDVHRESIPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIAT 358
Cdd:PRK08751 341 VQRSVAERWKQVTG--LTLVEAYGLTETSPAAC---INPLTLKEYNGSIGLPIPSTDACIKDDAGTVLAIGEIGELCIKG 415
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 359 RYMTHGYFpsSHPDQTAFIpdpcRDQSGeimMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIR 438
Cdd:PRK08751 416 PQVMKGYW--KRPEETAKV----MDADG---WLHTGDIARMDEQGFVYIVDRKKDMILVSGFNVYPNEIEDVIAMMPGVL 486
|
.
gi 517718121 439 E 439
Cdd:PRK08751 487 E 487
|
|
| AcpP |
COG0236 |
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the ... |
861-935 |
7.27e-13 |
|
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the Pathway/BioSystem: Fatty acid biosynthesis
Pssm-ID: 440006 [Multi-domain] Cd Length: 80 Bit Score: 65.26 E-value: 7.27e-13
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 517718121 861 APNSSTELKLLDIWTHILGIK--RISADDHFLQ-IGVHSLNIMTLIAQVYENFQVELPLEQVFEHDTLEEIAAYIDEQ 935
Cdd:COG0236 1 MPREELEERLAEIIAEVLGVDpeEITPDDSFFEdLGLDSLDAVELIAALEEEFGIELPDTELFEYPTVADLADYLEEK 78
|
|
| A_NRPS_PvdJ-like |
cd17649 |
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal ... |
792-847 |
7.85e-13 |
|
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes pyoverdine biosynthesis protein PvdJ involved in the synthesis of pyoverdine, which consists of a chromophore group attached to a variable peptide chain and comprises around 6-12 amino acids that are specific for each Pseudomonas species, and for which the peptide might be first synthesized before the chromophore assembly. Also included is ornibactin biosynthesis protein OrbI; ornibactin is a tetrapeptide siderophore with an l-ornithine-d-hydroxyaspartate-l-serine-l-ornithine backbone. The adenylation domain at the N-terminal of OrbI possibly initiates the ornibactin with the binding of N5-hydroxyornithine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341304 [Multi-domain] Cd Length: 450 Bit Score: 72.40 E-value: 7.85e-13
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 792 EPLLIAYY-LADKMI---DDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALP 847
Cdd:cd17649 391 GKQLVAYVvLRAAAAqpeLRAQLRTALRASLPDYMVPAHLVFLARLPLTPNGKLDRKALP 450
|
|
| A_NRPS_ProA |
cd17656 |
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the ... |
788-847 |
1.10e-12 |
|
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains gramicidin S synthase 2 (also known as ATP-dependent proline adenylase or proline activase or ProA). ProA is a multifunctional enzyme involved in synthesis of the cyclic peptide antibiotic gramicidin S and able to activate and polymerize the amino acids proline, valine, ornithine and leucine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341311 [Multi-domain] Cd Length: 479 Bit Score: 72.12 E-value: 1.10e-12
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 788 EEAQEPLLIAYYLADKMIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALP 847
Cdd:cd17656 420 DDKGEKYLCAYFVMEQELNISQLREYLAKQLPEYMIPSFFVPLDQLPLTPNGKVDRKALP 479
|
|
| ABCL |
cd05958 |
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate ... |
19-442 |
1.14e-12 |
|
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate aerobic degradation pathway by activating 2-aminobenzoate to 2-aminobenzoyl-CoA. The reaction is carried out via a two-step process; the first step is ATP-dependent and forms a 2-aminobenzoyl-AMP intermediate, and the second step forms the 2-aminobenzoyl-CoA ester and releases the AMP. 2-Aminobenzoyl-CoA is further converted to 2-amino-5-oxo-cyclohex-1-ene-1-carbonyl-CoA catalyzed by 2-aminobenzoyl-CoA monooxygenase/reductase. ABCL has been purified from cells aerobically grown with 2-aminobenzoate as sole carbon, energy, and nitrogen source, and has been characterized as a monomer.
Pssm-ID: 341268 [Multi-domain] Cd Length: 439 Bit Score: 71.74 E-value: 1.14e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 19 RKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDH-IGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTMLD 97
Cdd:cd05958 1 RTCLRSPEREWTYRDLLALANRIANVLVGELGIVPGNrVLLRGSNSPELVACWFGIQKAGAIAVATMPLLRPKELAYILD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 98 TAEVSCLLCDDAQferaetlqghegkyfvlrarqamsvqagskeayshsaNATDPIYIY-FTSGSTGKPKAVVGKNESLL 176
Cdd:cd05958 81 KARITVALCAHAL-------------------------------------TASDDICILaFTSGTTGAPKATMHFHRDPL 123
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 177 H-FMNWEASWLDLTDPMRVSQLTSI----GFDAVLrdIFVPICAGGTICIPESreiilDPLRLVHWLEHSRVHVVHCTPS 251
Cdd:cd05958 124 AsADRYAVNVLRLREDDRFVGSPPLaftfGLGGVL--LFPFGVGASGVLLEEA-----TPDLLLSAIARYKPTVLFTAPT 196
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 252 LFRFInhLSLTADSYPD---LRYVLLAGETIRPESLKNWYDNLGnrVRLVNLYGPTEttMIKLFYPIKPEDVHRESipIG 328
Cdd:cd05958 197 AYRAM--LAHPDAAGPDlssLRKCVSAGEALPAALHRAWKEATG--IPIIDGIGSTE--MFHIFISARPGDARPGA--TG 268
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 329 RPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFPSSHpdQTAFipdpcrdQSGEIMmyrTGDMGRWLPEGELALL 408
Cdd:cd05958 269 KPVPGYEAKVVDDEGNPVPDGTIGRLAVRGPTGCRYLADKRQ--RTYV-------QGGWNI---TGDTYSRDPDGYFRHQ 336
|
410 420 430
....*....|....*....|....*....|....*
gi 517718121 409 GRKDNQVKIRGNRVELGDIEHRLTNMAGIRE-AVV 442
Cdd:cd05958 337 GRSDDMIVSGGYNIAPPEVEDVLLQHPAVAEcAVV 371
|
|
| LC_FACS_like |
cd05935 |
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain ... |
29-442 |
1.32e-12 |
|
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain fatty acyl-CoA synthetases, which catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters.
Pssm-ID: 341258 [Multi-domain] Cd Length: 430 Bit Score: 71.74 E-value: 1.32e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 29 LSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPlhpderlvtMLDTAEVSCLLCDd 108
Cdd:cd05935 2 LTYLELLEVVKKLASFLSNKGVRKGDRVGICLQNSPQYVIAYFAIWRANAVVVPINP---------MLKERELEYILND- 71
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 109 aqferaetlqghegkyfvlrarqamsvqAGSKEAYSHSaNATDPIYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLDL 188
Cdd:cd05935 72 ----------------------------SGAKVAVVGS-ELDDLALIPYTSGTTGLPKGCMHTHFSAAANALQSAVWTGL 122
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 189 TdPMRVSQLT-----SIGFDAVLRdifVPICAGGTICIPE--SREIILDPLRlvhwlEHSRVHVVHCTPSLFRFINHLSL 261
Cdd:cd05935 123 T-PSDVILAClplfhVTGFVGSLN---TAVYVGGTYVLMArwDRETALELIE-----KYKVTFWTNIPTMLVDLLATPEF 193
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 262 TADSYPDLRYVLLAGETIRPESLKNWYDNLGnrVRLVNLYGPTET-TMIKLFYPIKPedvhrESIPIGRPLPDTSVYLLD 340
Cdd:cd05935 194 KTRDLSSLKVLTGGGAPMPPAVAEKLLKLTG--LRFVEGYGLTETmSQTHTNPPLRP-----KLQCLGIP*FGVDARVID 266
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 341 -EQQQPVSGSEAGEICIATRYMTHGYFPSSHPDQTAFIPDPCRDqsgeimMYRTGDMGRWLPEGELALLGRKDNQVKIRG 419
Cdd:cd05935 267 iETGRELPPNEVGEIVVRGPQIFKGYWNRPEETEESFIEIKGRR------FFRTGDLGYMDEEGYFFFVDRVKRMINVSG 340
|
410 420
....*....|....*....|...
gi 517718121 420 NRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05935 341 FKVWPAEVEAKLYKHPAI*EVCV 363
|
|
| PRK06164 |
PRK06164 |
acyl-CoA synthetase; Validated |
14-442 |
2.34e-12 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235722 [Multi-domain] Cd Length: 540 Bit Score: 71.31 E-value: 2.34e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 14 AAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDplhpderlv 93
Cdd:PRK06164 21 RARPDAVALIDEDRPLSRAELRALVDRLAAWLAAQGVRRGDRVAVWLPNCIEWVVLFLACARLGATVIAVN--------- 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 94 TMLDTAEVSCLL----------------------CDDAQFERAETLQGhegkYFVL-------------RARQAMSV--Q 136
Cdd:PRK06164 92 TRYRSHEVAHILgrgrarwlvvwpgfkgidfaaiLAAVPPDALPPLRA----IAVVddaadatpapapgARVQLFALpdP 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 137 AGSKEAYSHSANATDPIYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLDLTDPMRVsqLTSIGFDAV--LRDIFVPIC 214
Cdd:PRK06164 168 APPAAAGERAADPDAGALLFTTSGTTSGPKLVLHRQATLLRHARAIARAYGYDPGAVL--LAALPFCGVfgFSTLLGALA 245
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 215 AGGTI-CIPesreiILDPLRLVHWLEHSRVHVVHCTPSLFRFINHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGn 293
Cdd:PRK06164 246 GGAPLvCEP-----VFDAARTARALRRHRVTHTFGNDEMLRRILDTAGERADFPSARLFGFASFAPALGELAALARARG- 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 294 rVRLVNLYGPTETTMIKLFYPIKPEDVHReSIPIGRPL-PDTSVYLLDEQQQPV-SGSEAGEICIATRYMTHGYFpsSHP 371
Cdd:PRK06164 320 -VPLTGLYGSSEVQALVALQPATDPVSVR-IEGGGRPAsPEARVRARDPQDGALlPDGESGEIEIRAPSLMRGYL--DNP 395
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 517718121 372 DQT--AFIPDPcrdqsgeimMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK06164 396 DATarALTDDG---------YFRTGDLGYTRGDGQFVYQTRMGDSLRLGGFLVNPAEIEHALEALPGVAAAQV 459
|
|
| A_NRPS_VisG_like |
cd17651 |
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) ... |
792-847 |
5.50e-12 |
|
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes virginiamycin S synthetase (VisG) in Streptomyces virginiae; VisG is involved in virginiamycin S (VS) biosynthesis as the provider of an L-pheGly molecule, a highly specific substrate for the last condensation step by VisF. This family also includes linear gramicidin synthetase B (LgrB) in Brevibacillus brevis. Substrate specificity analysis using residues of the substrate-binding pockets of all 16 adenylation domains has shown good agreement of the substrate amino acids predicted with the sequence of linear gramicidin. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341306 [Multi-domain] Cd Length: 491 Bit Score: 70.07 E-value: 5.50e-12
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....*...
gi 517718121 792 EPLLIAYYLADKMIDD--EQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALP 847
Cdd:cd17651 434 EKRLVAYVVGDPEAPVdaAELRAALATHLPEYMVPSAFVLLDALPLTPNGKLDRRALP 491
|
|
| PRK07788 |
PRK07788 |
acyl-CoA synthetase; Validated |
12-446 |
6.02e-12 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236097 [Multi-domain] Cd Length: 549 Bit Score: 69.96 E-value: 6.02e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 12 AFAAF--PERKAI--ECGqqTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLH 87
Cdd:PRK07788 56 AHAARraPDRAALidERG--TLTYAELDEQSNALARGLLALGVRAGDGVAVLARNHRGFVLALYAAGKVGARIILLNTGF 133
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 88 PDERLVTMLDTAEVSCLLCDDAQFERAETLQGHEGKYFVLRA-RQAMSVQAGSKEAYSHSANATDPI----------YIY 156
Cdd:PRK07788 134 SGPQLAEVAAREGVKALVYDDEFTDLLSALPPDLGRLRAWGGnPDDDEPSGSTDETLDDLIAGSSTAplpkppkpggIVI 213
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 157 FTSGSTGKPKAVVGKNESLLhfmnweASWLDLTD--PMRVSQLTSIG---FDAVLRDIFVPICA-GGTICIPEsreiILD 230
Cdd:PRK07788 214 LTSGTTGTPKGAPRPEPSPL------APLAGLLSrvPFRAGETTLLPapmFHATGWAHLTLAMAlGSTVVLRR----RFD 283
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 231 PLRLVHWLEHSRVHVVHCTPSLFRFINHLSLTADSYPD---LRYVLLAGETIRPESLKNWYDNLGNRvrLVNLYGPTETT 307
Cdd:PRK07788 284 PEATLEDIAKHKATALVVVPVMLSRILDLGPEVLAKYDtssLKIIFVSGSALSPELATRALEAFGPV--LYNLYGSTEVA 361
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 308 miklFYPI-KPEDVHRESIPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFPSSHPDqtafIPDpcrdqsG 386
Cdd:PRK07788 362 ----FATIaTPEDLAEAPGTVGRPPKGVTVKILDENGNEVPRGVVGRIFVGNGFPFEGYTDGRDKQ----IID------G 427
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 387 eimMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV----------RMRA 446
Cdd:PRK07788 428 ---LLSSGDVGYFDEDGLLFVDGRDDDMIVSGGENVFPAEVEDLLAGHPDVVEAAVigvddeefgqRLRA 494
|
|
| PRK06334 |
PRK06334 |
long chain fatty acid--[acyl-carrier-protein] ligase; Validated |
29-440 |
6.83e-12 |
|
long chain fatty acid--[acyl-carrier-protein] ligase; Validated
Pssm-ID: 180533 [Multi-domain] Cd Length: 539 Bit Score: 69.84 E-value: 6.83e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 29 LSYKELdaeSDRICELlhAHGAAQY--DHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTMLDTAEVSCLLC 106
Cdd:PRK06334 46 LSYNQV---RKAVIAL--ATKVSKYpdQHIGIMMPASAGAYIAYFATLLSGKIPVMINWSQGLREVTACANLVGVTHVLT 120
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 107 DDAQFERAETLQGHEGKY-----FVLRARQAMSVQAGSKEAY--------------SHSANATDPIYIYFTSGSTGKPKA 167
Cdd:PRK06334 121 SKQLMQHLAQTHGEDAEYpfsliYMEEVRKELSFWEKCRIGIymsipfewlmrwfgVSDKDPEDVAVILFTSGTEKLPKG 200
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 168 VVGKNESLLHfmNWEASwLDLTDPMRVSQLTSI-------GFDAVlrdIFVPICAGgtICIPESREIiLDPLRLVHWLEH 240
Cdd:PRK06334 201 VPLTHANLLA--NQRAC-LKFFSPKEDDVMMSFlppfhayGFNSC---TLFPLLSG--VPVVFAYNP-LYPKKIVEMIDE 271
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 241 SRVHVVHCTPSLFRFI-NHLSLTADSYPDLRYVLLAGETIRpESLKNWYDNLGNRVRLVNLYGPTETTMIklfYPIKPED 319
Cdd:PRK06334 272 AKVTFLGSTPVFFDYIlKTAKKQESCLPSLRFVVIGGDAFK-DSLYQEALKTFPHIQLRQGYGTTECSPV---ITINTVN 347
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 320 VHRESIPIGRPLPDTSVYLLDEQQQ-PVSGSEAGEICIATRYMTHGYFpSSHPDQtAFIpdpcrdQSGEIMMYRTGDMGR 398
Cdd:PRK06334 348 SPKHESCVGMPIRGMDVLIVSEETKvPVSSGETGLVLTRGTSLFSGYL-GEDFGQ-GFV------ELGGETWYVTGDLGY 419
|
410 420 430 440
....*....|....*....|....*....|....*....|..
gi 517718121 399 WLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREA 440
Cdd:PRK06334 420 VDRHGELFLKGRLSRFVKIGAEMVSLEALESILMEGFGQNAA 461
|
|
| LC_FACS_like |
cd17640 |
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA ... |
27-442 |
7.48e-12 |
|
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA synthetases, including an Arabidopsis gene At4g14070 that plays a role in activation and elongation of exogenous fatty acids. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341295 [Multi-domain] Cd Length: 468 Bit Score: 69.31 E-value: 7.48e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 27 QTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTMLDTAEVSCLLc 106
Cdd:cd17640 4 KRITYKDLYQEILDFAAGLRSLGVKAGEKVALFADNSPRWLIADQGIMALGAVDVVRGSDSSVEELLYILNHSESVALV- 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 107 ddaqferaetlqghegkyfvlrarqamsVQAGSKEAyshsanATdpiyIYFTSGSTGKPKAVVGKNESLLHfmnweaswl 186
Cdd:cd17640 83 ----------------------------VENDSDDL------AT----IIYTSGTTGNPKGVMLTHANLLH--------- 115
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 187 dltdpmRVSQLTSIgFDAVLRDIFVPIC---------------AGGTICIPESREIILDPLRLVhwlehsRVHVVHCTPS 251
Cdd:cd17640 116 ------QIRSLSDI-VPPQPGDRFLSILpiwhsyersaeyfifACGCSQAYTSIRTLKDDLKRV------KPHYIVSVPR 182
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 252 LF---------------RFINHLSLTADSYPDLRYVLLAGETIrPESLKNWYDNLGnrVRLVNLYGPTETTmiklfyPIK 316
Cdd:cd17640 183 LWeslysgiqkqvskssPIKQFLFLFFLSGGIFKFGISGGGAL-PPHVDTFFEAIG--IEVLNGYGLTETS------PVV 253
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 317 PEDVHRESI--PIGRPLPDTSVYLLDEQ-QQPVSGSEAGEICIATRYMTHGYFpsSHPDQTAFIpdpcRDQSGeimMYRT 393
Cdd:cd17640 254 SARRLKCNVrgSVGRPLPGTEIKIVDPEgNVVLPPGEKGIVWVRGPQVMKGYY--KNPEATSKV----LDSDG---WFNT 324
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|
gi 517718121 394 GDMGRWLPEGELALLGR-KDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd17640 325 GDLGWLTCGGELVLTGRaKDTIVLSNGENVEPQPIEEALMRSPFIEQIMV 374
|
|
| FadD3 |
cd17638 |
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ... |
155-442 |
9.58e-12 |
|
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ligases, including FadD3 which is an acyl-CoA synthetase that initiates catabolism of cholesterol rings C and D in actinobacteria. The cholesterol catabolic pathway occurs in most mycolic acid-containing actinobacteria, such as Rhodococcus jostii RHA1, and is critical for Mycobacterium tuberculosis (Mtb) during infection. FadD3 catalyzes the ATP-dependent CoA thioesterification of 3a-alpha-H-4alpha(3'-propanoate)-7a-beta-methylhexahydro-1,5-indanedione (HIP) to yield HIP-CoA. Hydroxylated analogs of HIP, 5alpha-OH HIP and 1beta-OH HIP, can also be used.
Pssm-ID: 341293 [Multi-domain] Cd Length: 330 Bit Score: 67.91 E-value: 9.58e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 155 IYFTSGSTGKPKAVVGKN-ESLLHFMNWeASWLDLTDPMRVSQLT----SIGFDAvlrDIFVPICAGGTIcIPESreiIL 229
Cdd:cd17638 5 IMFTSGTTGRSKGVMCAHrQTLRAAAAW-ADCADLTEDDRYLIINpffhTFGYKA---GIVACLLTGATV-VPVA---VF 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 230 DPLRLVHWLEHSRVHVVHCTPSLFR-FINHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGNRVRLVNlYGPTETTM 308
Cdd:cd17638 77 DVDAILEAIERERITVLPGPPTLFQsLLDHPGRKKFDLSSLRAAVTGAATVPVELVRRMRSELGFETVLTA-YGLTEAGV 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 309 IKLFYPikPEDVHRESIPIGRPLPDTSVYLLDeqqqpvsgseAGEICIATRYMTHGYFpsSHPDQTAfipdPCRDQSGEI 388
Cdd:cd17638 156 ATMCRP--GDDAETVATTCGRACPGFEVRIAD----------DGEVLVRGYNVMQGYL--DDPEATA----EAIDADGWL 217
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....
gi 517718121 389 mmyRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd17638 218 ---HTGDVGELDERGYLRITDRLKDMYIVGGFNVYPAEVEGALAEHPGVAQVAV 268
|
|
| PRK08279 |
PRK08279 |
long-chain-acyl-CoA synthetase; Validated |
9-189 |
1.06e-11 |
|
long-chain-acyl-CoA synthetase; Validated
Pssm-ID: 236217 [Multi-domain] Cd Length: 600 Bit Score: 69.52 E-value: 1.06e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHP 88
Cdd:PRK08279 43 FEEAAARHPDRPALLFEDQSISYAELNARANRYAHWAAARGVGKGDVVALLMENRPEYLAAWLGLAKLGAVVALLNTQQR 122
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 89 DERLVTMLDTAEVSCLLCDDAQFERAETLQGH---EGKYFVLRARQAMSVQA-GSKEAYSHSANATDP------------ 152
Cdd:PRK08279 123 GAVLAHSLNLVDAKHLIVGEELVEAFEEARADlarPPRLWVAGGDTLDDPEGyEDLAAAAAGAPTTNPasrsgvtakdta 202
|
170 180 190
....*....|....*....|....*....|....*..
gi 517718121 153 IYIYfTSGSTGKPKAVVGKNESLLHFMNWEASWLDLT 189
Cdd:PRK08279 203 FYIY-TSGTTGLPKAAVMSHMRWLKAMGGFGGLLRLT 238
|
|
| A_NRPS_AB3403-like |
cd17646 |
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or ... |
783-846 |
1.12e-11 |
|
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341301 [Multi-domain] Cd Length: 488 Bit Score: 68.84 E-value: 1.12e-11
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 517718121 783 VQLQVEEAQEPLLIAYYLADKM---IDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNAL 846
Cdd:cd17646 422 VVARAAPAGAARLVGYVVPAAGaagPDTAALRAHLAERLPEYMVPAAFVVLDALPLTANGKLDRAAL 488
|
|
| A_NRPS_PpsD_like |
cd17650 |
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation ... |
783-846 |
1.82e-11 |
|
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetase 1 (BacA) in Bacillus licheniformis, tyrocidine synthetase in Brevibacillus brevis, plipastatin synthase (PpsD, an important antifungal protein) in Bacillus subtilis and mannopeptimycin peptide synthetase (MppB) in Streptomyces hygroscopicus. Plipastatin has strong fungitoxic activity and is involved in inhibition of phospholipase A2 and biofilm formation. Bacitracin, a mixture of related cyclic peptides, is used as a polypeptide antibiotic while function of tyrocidine is thought to be regulation of sporulation. MppB is involved in biosynthetic pathway of mannopeptimycin, a novel class of mannosylated lipoglycopeptides. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341305 [Multi-domain] Cd Length: 447 Bit Score: 68.26 E-value: 1.82e-11
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 517718121 783 VQLQVEEAQEPLLIAYYLADKMIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNAL 846
Cdd:cd17650 384 VAVREDKGGEARLCAYVVAAATLNTAELRAFLAKELPSYMIPSYYVQLDALPLTPNGKVDRRAL 447
|
|
| PP-binding |
pfam00550 |
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached ... |
869-927 |
1.99e-11 |
|
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached through a serine. This prosthetic group acts as a a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups. This domain forms a four helix bundle. This family includes members not included in Prosite. The inclusion of these members is supported by sequence analysis and functional evidence. The related domain of Swiss:P19828 has the attachment serine replaced by an alanine.
Pssm-ID: 425746 [Multi-domain] Cd Length: 62 Bit Score: 60.65 E-value: 1.99e-11
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 517718121 869 KLLDIWTHILGI--KRISADDHFLQIGVHSLNIMTLIAQVYENFQVELPLEQVFEHDTLEE 927
Cdd:pfam00550 2 RLRELLAEVLGVpaEEIDPDTDLFDLGLDSLLAVELIARLEEEFGVEIPPSDLFEHPTLAE 62
|
|
| A_NRPS_Cytc1-like |
cd17643 |
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation ... |
795-846 |
2.00e-11 |
|
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Streptomyces sp. cytotrienin synthetase (CytC1), a relatively promiscuous adenylation enzyme that installs the aminoacyl moieties on the phosphopantetheinyl arm of the holo carrier protein CytC2. Also included are Streptomyces sp Thr1, involved in the biosynthesis of 4-chlorothreonine, Pseudomonas aeruginosa pyoverdine synthetase D (PvdD), involved in the biosynthesis of the siderophore pyoverdine and Pseudomonas syringae syringopeptin synthetase, where syringpeptin is a necrosis-inducing phytotoxin that functions as a virulence determinant in the plant-pathogen interaction. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341298 [Multi-domain] Cd Length: 450 Bit Score: 68.10 E-value: 2.00e-11
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....
gi 517718121 795 LIAYYLAD--KMIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNAL 846
Cdd:cd17643 397 LVAYVVADdgAAADIAELRALLKELLPDYMVPARYVPLDALPLTVNGKLDRAAL 450
|
|
| A_NRPS_LgrA-like |
cd17645 |
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This ... |
792-847 |
2.60e-11 |
|
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes linear gramicidin synthetase (LgrA) in Brevibacillus brevis. LgrA has a formylation domain fused to the N-terminal end that formylates its substrate for linear gramicidin synthesis to proceed. This formyl group is essential for the clinically important antibacterial activity of gramicidin by enabling head-to-head gramicidin dimers to make a beta-helical pore in gram-positive bacterial membranes, allowing free passage of monovalent cations, destroying the ion gradient and killing bacteria. This family also includes bacitracin synthetase 1 (known as ATP-dependent cysteine adenylase or BA1); it activates cysteine, incorporates two D-amino acids, releases and cyclizes the mature bacitracin, an antibiotic that is a mixture of related cyclic peptides that disrupt gram positive bacteria by interfering with cell wall and peptidoglycan synthesis. Also included is surfactin synthetase which activates and polymerizes the amino acids Leu, Glu, Asp, and Val to form the antibiotic surfactin.
Pssm-ID: 341300 [Multi-domain] Cd Length: 440 Bit Score: 67.58 E-value: 2.60e-11
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....*.
gi 517718121 792 EPLLIAYYLADKMIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALP 847
Cdd:cd17645 385 RKYLVAYVTAPEEIPHEELREWLKNDLPDYMIPTYFVHLKALPLTANGKVDRKALP 440
|
|
| EntE |
COG1021 |
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase ... |
2-419 |
3.06e-11 |
|
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440644 [Multi-domain] Cd Length: 533 Bit Score: 67.86 E-value: 3.06e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 2 DNTIQYELARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFV 81
Cdd:COG1021 24 GETLGDLLRRRAERHPDRIAVVDGERRLSYAELDRRADRLAAGLLALGLRPGDRVVVQLPNVAEFVIVFFALFRAGAIPV 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 82 PLDPLHPDERLVTMLDTAEVSCLLCDDAQ--F---ERAETLQ-GHEG-KYFVL--RARQAMSVQAGSKEAYSHSANATDP 152
Cdd:COG1021 104 FALPAHRRAEISHFAEQSEAVAYIIPDRHrgFdyrALARELQaEVPSlRHVLVvgDAGEFTSLDALLAAPADLSEPRPDP 183
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 153 IYIYF---TSGSTGKPKavvgkneslL----H---FMNWEASwldlTDPMRVSQ---------------LTSIGFDAVLr 207
Cdd:COG1021 184 DDVAFfqlSGGTTGLPK---------LiprtHddyLYSVRAS----AEICGLDAdtvylaalpaahnfpLSSPGVLGVL- 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 208 difvpiCAGGTICIPESreiiLDPLRLVHWLEHSRVHVVHCTPSLF-RFINHLSLTADSYPDLRYVLLAG--------ET 278
Cdd:COG1021 250 ------YAGGTVVLAPD----PSPDTAFPLIERERVTVTALVPPLAlLWLDAAERSRYDLSSLRVLQVGGaklspelaRR 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 279 IRPEslknwydnLGnrVRLVNLYGPTE----TTMIKlfypiKPEDVHRESIpiGRPL-PDTSVYLLDEQQQPVSGSEAGE 353
Cdd:COG1021 320 VRPA--------LG--CTLQQVFGMAEglvnYTRLD-----DPEEVILTTQ--GRPIsPDDEVRIVDEDGNPVPPGEVGE 382
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 517718121 354 ICiaTR--YMTHGYFPSSHPDQTAFIPDpcrdqsGeimMYRTGDMGRWLPEGELALLGRKDNQVkIRG 419
Cdd:COG1021 383 LL--TRgpYTIRGYYRAPEHNARAFTPD------G---FYRTGDLVRRTPDGYLVVEGRAKDQI-NRG 438
|
|
| PRK07786 |
PRK07786 |
long-chain-fatty-acid--CoA ligase; Validated |
8-446 |
6.25e-11 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 169098 [Multi-domain] Cd Length: 542 Bit Score: 66.72 E-value: 6.25e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 8 ELARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLD-PL 86
Cdd:PRK07786 22 QLARHALMQPDAPALRFLGNTTTWRELDDRVAALAGALSRRGVGFGDRVLILMLNRTEFVESVLAANMLGAIAVPVNfRL 101
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 87 HPDE-----------RLVTMLDTAEVSCLLCDDAQFERAETLQGHEGKYFVLRARQAMSvQAGSKEAYSHSANATdPIYI 155
Cdd:PRK07786 102 TPPEiaflvsdcgahVVVTEAALAPVATAVRDIVPLLSTVVVAGGSSDDSVLGYEDLLA-EAGPAHAPVDIPNDS-PALI 179
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 156 YFTSGSTGKPKAVVgknesLLHfMNWEASWLDLTDPMRVSQLTSIGFDAV-------LRDIFVPICAGGTICI-PESrei 227
Cdd:PRK07786 180 MYTSGTTGRPKGAV-----LTH-ANLTGQAMTCLRTNGADINSDVGFVGVplfhiagIGSMLPGLLLGAPTVIyPLG--- 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 228 ILDPLRLVHWLEHSRVHVVHCTPSLFRFInhlsltadsypdlryvlLAGETIRPESLK----NW-----YDNLGNRV--- 295
Cdd:PRK07786 251 AFDPGQLLDVLEAEKVTGIFLVPAQWQAV-----------------CAEQQARPRDLAlrvlSWgaapaSDTLLRQMaat 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 296 ----RLVNLYGPTETTMIKLFypIKPEDVHRESIPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHP 371
Cdd:PRK07786 314 fpeaQILAAFGQTEMSPVTCM--LLGEDAIRKLGSVGKVIPTVAARVVDENMNDVPVGEVGEIVYRAPTLMSGYW--NNP 389
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 517718121 372 DQTAfipdpcrdQSGEIMMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVVRMRA 446
Cdd:PRK07786 390 EATA--------EAFAGGWFHSGDLVRQDEEGYVWVVDRKKDMIISGGENIYCAEVENVLASHPDIVEVAVIGRA 456
|
|
| PRK09029 |
PRK09029 |
O-succinylbenzoic acid--CoA ligase; Provisional |
16-414 |
7.11e-11 |
|
O-succinylbenzoic acid--CoA ligase; Provisional
Pssm-ID: 236363 [Multi-domain] Cd Length: 458 Bit Score: 66.43 E-value: 7.11e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 16 FPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQ--------YDHIGILmqdrCASIAAvigiLKLGGVFVPLDPLH 87
Cdd:PRK09029 16 RPQAIALRLNDEVLTWQQLCARIDQLAAGFAQQGVVEgsgvalrgKNSPETL----LAYLAL----LQCGARVLPLNPQL 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 88 PDERLVTMLDTAEVSCLLCDDaqferaetlqgHEGKYFVLRARQAMSVQAGSKEAYSHSANATdpiyIYFTSGSTGKPKA 167
Cdd:PRK09029 88 PQPLLEELLPSLTLDFALVLE-----------GENTFSALTSLHLQLVEGAHAVAWQPQRLAT----MTLTSGSTGLPKA 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 168 VV-------GKNESLLHFMNWEA--SWLdLTDPM-RVSqltsiGFDAVLRDIFvpicAGGTICIPESreiildplrlvHW 237
Cdd:PRK09029 153 AVhtaqahlASAEGVLSLMPFTAqdSWL-LSLPLfHVS-----GQGIVWRWLY----AGATLVVRDK-----------QP 211
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 238 LEHSRVHVVHCT--PS-LFRFINHLSLTAdsypDLRYVLLAGETIrPESL---------KNWydnLGnrvrlvnlYGPTE 305
Cdd:PRK09029 212 LEQALAGCTHASlvPTqLWRLLDNRSEPL----SLKAVLLGGAAI-PVELteqaeqqgiRCW---CG--------YGLTE 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 306 ---TTMIKLFypikpedvhrESIP-IGRPLPDTSVYLLDeqqqpvsgseaGEICIATRYMTHGYFpsshpdqtafipdpc 381
Cdd:PRK09029 276 masTVCAKRA----------DGLAgVGSPLPGREVKLVD-----------GEIWLRGASLALGYW--------------- 319
|
410 420 430 440
....*....|....*....|....*....|....*....|
gi 517718121 382 rdQSGEIM-------MYRTGDMGRWLpEGELALLGRKDNQ 414
Cdd:PRK09029 320 --RQGQLVplvndegWFATRDRGEWQ-NGELTILGRLDNL 356
|
|
| caiC |
PRK08008 |
putative crotonobetaine/carnitine-CoA ligase; Validated |
27-442 |
7.28e-11 |
|
putative crotonobetaine/carnitine-CoA ligase; Validated
Pssm-ID: 181195 [Multi-domain] Cd Length: 517 Bit Score: 66.63 E-value: 7.28e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 27 QTLSYKELDAESDRICELLHAHGAAQYDHIGILMqDRCAS-IAAVIGILKLGGVFVPLDPLHPDERLVTMLDTAEVSCLL 105
Cdd:PRK08008 36 RRYSYLELNEEINRTANLFYSLGIRKGDKVALHL-DNCPEfIFCWFGLAKIGAIMVPINARLLREESAWILQNSQASLLV 114
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 106 CDDA--------QFERAETLQGhegkyfVLRARQAMSVQAGSKEAYSHSA------------NATDPIYIYFTSGSTGKP 165
Cdd:PRK08008 115 TSAQfypmyrqiQQEDATPLRH------ICLTRVALPADDGVSSFTQLKAqqpatlcyapplSTDDTAEILFTSGTTSRP 188
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 166 KAVVGKNESLL---HFMNWEASWLDltDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPE--SREIILDPLRLVhwleh 240
Cdd:PRK08008 189 KGVVITHYNLRfagYYSAWQCALRD--DDVYLTVMPAFHIDCQCTAAMAAFSAGATFVLLEkySARAFWGQVCKY----- 261
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 241 sRVHVVHCTPSLFRFINHLSLTA-DSYPDLRYVLlagetirpeslknWYDNLGNR----------VRLVNLYGPTETtmi 309
Cdd:PRK08008 262 -RATITECIPMMIRTLMVQPPSAnDRQHCLREVM-------------FYLNLSDQekdafeerfgVRLLTSYGMTET--- 324
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 310 kLFYPI--KPEDvHRESIPIGRPLPDTSVYLLDEQQQPVSGSEAGEICI---ATRYMTHGYFpsSHPDQTAfipdpcRDQ 384
Cdd:PRK08008 325 -IVGIIgdRPGD-KRRWPSIGRPGFCYEAEIRDDHNRPLPAGEIGEICIkgvPGKTIFKEYY--LDPKATA------KVL 394
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*...
gi 517718121 385 SGEIMMYrTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK08008 395 EADGWLH-TGDTGYVDEEGFFYFVDRRCNMIKRGGENVSCVELENIIATHPKIQDIVV 451
|
|
| A_NRPS_ACVS-like |
cd17648 |
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV ... |
795-847 |
1.06e-10 |
|
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV synthetase (ACVS, EC 6.3.2.26; also known as N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase or delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase) is involved in medically important antibiotic biosynthesis. ACV synthetase is active in an early step in the penicillin G biosynthesis pathway which involves the formation of the tripeptide 6-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine (ACV); each of the constituent amino acids of the tripeptide ACV are activated as aminoacyl-adenylates with peptide bonds formed through the participation of amino acid thioester intermediates. ACV is then cyclized by the action of isopenicillin N synthase.
Pssm-ID: 341303 [Multi-domain] Cd Length: 453 Bit Score: 65.50 E-value: 1.06e-10
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....
gi 517718121 795 LIAYYLADK-MIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALP 847
Cdd:cd17648 400 LVGYYLPEPgHVPESDLLSFLRAKLPRYMVPARLVRLEGIPVTINGKLDVRALP 453
|
|
| A_NRPS_CmdD_like |
cd17652 |
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) ... |
795-847 |
1.50e-10 |
|
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes phosphinothricin tripeptide (PTT, phosphinothricylalanylalanine) synthetase, where PTT is a natural-product antibiotic and potent herbicide that is produced by Streptomyces hygroscopicus. This adenylation domain has been confirmed to directly activate beta-tyrosine, and fluorinated chondramides are produced through precursor-directed biosynthesis. Also included in this family is chondramide synthase D (also known as ATP-dependent phenylalanine adenylase or phenylalanine activase or tyrosine activase). Chondramides A-D are depsipeptide antitumor and antifungal antibiotics produced by C. crocatus, are a class of mixed peptide/polyketide depsipeptides comprised of three amino acids (alanine, N-methyltryptophan, plus the unusual amino acid beta-tyrosine or alpha-methoxy-beta-tyrosine) and a polyketide chain ([E]-7-hydroxy-2,4,6-trimethyloct-4-enoic acid).
Pssm-ID: 341307 [Multi-domain] Cd Length: 436 Bit Score: 64.97 E-value: 1.50e-10
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....*
gi 517718121 795 LIAYYLA--DKMIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALP 847
Cdd:cd17652 382 LVAYVVPapGAAPTAAELRAHLAERLPGYMVPAAFVVLDALPLTPNGKLDRRALP 436
|
|
| A_NRPS_ApnA-like |
cd17644 |
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the ... |
795-847 |
7.06e-10 |
|
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Planktothrix agardhii anabaenopeptin synthetase (ApnA A1), which is capable of activating two chemically distinct amino acids (Arg and Tyr). Structural studies show that the architecture of the active site forces Arg to adopt a Tyr-like conformation, thus explaining the bispecificity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341299 [Multi-domain] Cd Length: 465 Bit Score: 63.22 E-value: 7.06e-10
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....*
gi 517718121 795 LIAYYLADK--MIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALP 847
Cdd:cd17644 411 LVAYIVPHYeeSPSTVELRQFLKAKLPDYMIPSAFVVLEELPLTPNGKIDRRALP 465
|
|
| A_NRPS_Sfm_like |
cd12115 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene ... |
783-846 |
7.08e-10 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene cluster from Streptomyces lavendulae; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the saframycin A gene cluster from Streptomyces lavendulae which implicates the NRPS system for assembling the unusual tetrapeptidyl skeleton in an iterative manner. It also includes saframycin Mx1 produced by Myxococcus xanthus NRPS.
Pssm-ID: 341280 [Multi-domain] Cd Length: 447 Bit Score: 63.11 E-value: 7.08e-10
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 517718121 783 VQLQVEEAQEPLLIAYYLAD--KMIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNAL 846
Cdd:cd12115 382 VVAIGDAAGERRLVAYIVAEpgAAGLVEDLRRHLGTRLPAYMVPSRFVRLDALPLTPNGKIDRSAL 447
|
|
| LC_FACL_like |
cd05914 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are ... |
25-442 |
9.55e-10 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are bacterial long-chain fatty acid CoA synthetase, most of which are as yet uncharacterized. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341240 [Multi-domain] Cd Length: 463 Bit Score: 62.84 E-value: 9.55e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 25 GQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDP-LHPDErLVTMLDTAEVSC 103
Cdd:cd05914 4 GGEPLTYKDLADNIAKFALLLKINGVGTGDRVALMGENRPEWGIAFFAIWTYGAIAVPILAeFTADE-VHHILNHSEAKA 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 104 LLCDDAQferaetlqghegkyfvlrarqamsvqagskeayshsanatDPIYIYFTSGSTGKPKAVVGKNESLLhfmnWEA 183
Cdd:cd05914 83 IFVSDED----------------------------------------DVALINYTSGTTGNSKGVMLTYRNIV----SNV 118
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 184 SWLDLTDPMR-----VSQLTSIGFDAVLRDIFVPICAGGTIC----IPESREIILDPLRLVHWLEHSRVHVVhctpsLFR 254
Cdd:cd05914 119 DGVKEVVLLGkgdkiLSILPLHHIYPLTFTLLLPLLNGAHVVfldkIPSAKIIALAFAQVTPTLGVPVPLVI-----EKI 193
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 255 FINHL--SLTADSYPDLRYVLLAGETIRPESLKNWYDNLGNRVRL-------VNL----------------YGPTETTMI 309
Cdd:cd05914 194 FKMDIipKLTLKKFKFKLAKKINNRKIRKLAFKKVHEAFGGNIKEfviggakINPdveeflrtigfpytigYGMTETAPI 273
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 310 KLFYPikPEDVHRESIpiGRPLPDTSVYLLDeqqqPVSGSEAGEICIATRYMTHGYFPSSHPDQTAFIPDPcrdqsgeim 389
Cdd:cd05914 274 ISYSP--PNRIRLGSA--GKVIDGVEVRIDS----PDPATGEGEIIVRGPNVMKGYYKNPEATAEAFDKDG--------- 336
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....
gi 517718121 390 MYRTGDMGRWLPEGELALLGRKDNQ-VKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05914 337 WFHTGDLGKIDAEGYLYIRGRKKEMiVLSSGKNIYPEEIEAKINNMPFVLESLV 390
|
|
| PTZ00237 |
PTZ00237 |
acetyl-CoA synthetase; Provisional |
152-428 |
1.16e-09 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 240325 [Multi-domain] Cd Length: 647 Bit Score: 62.84 E-value: 1.16e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 152 PIYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLDLTD-PMRVSQLTSIGFDAVLRDIFVPICAGGTICIPESReiILD 230
Cdd:PTZ00237 256 PLYILYTSGTTGNSKAVVRSNGPHLVGLKYYWRSIIEKDiPTVVFSHSSIGWVSFHGFLYGSLSLGNTFVMFEGG--IIK 333
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 231 PLRLVH--W--LEHSRVHVVHCTPSLFRFINHLSLTAD------SYPDLRYVLLAGETIRpESLKNWYDNlGNRVRLVNL 300
Cdd:PTZ00237 334 NKHIEDdlWntIEKHKVTHTLTLPKTIRYLIKTDPEATiirskyDLSNLKEIWCGGEVIE-ESIPEYIEN-KLKIKSSRG 411
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 301 YGPTETTMIKLFypikpeDVHRESIPI---GRPLPDTSVYLLDEQQQPVSGSEAGEICI---------ATRYMTHGYFP- 367
Cdd:PTZ00237 412 YGQTEIGITYLY------CYGHINIPYnatGVPSIFIKPSILSEDGKELNVNEIGEVAFklpmppsfaTTFYKNDEKFKq 485
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 517718121 368 --SSHPDqtafipdpcrdqsgeimMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIE 428
Cdd:PTZ00237 486 lfSKFPG-----------------YYNSGDLGFKDENGYYTIVSRSDDQIKISGNKVQLNTIE 531
|
|
| PRK05620 |
PRK05620 |
long-chain fatty-acid--CoA ligase; |
25-442 |
2.45e-09 |
|
long-chain fatty-acid--CoA ligase;
Pssm-ID: 180167 [Multi-domain] Cd Length: 576 Bit Score: 61.72 E-value: 2.45e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 25 GQQTLSYKELDAESDRICELLHAH-GAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTMLDTAEVSC 103
Cdd:PRK05620 35 EQEQTTFAAIGARAAALAHALHDElGITGDQRVGSMMYNCAEHLEVLFAVACMGAVFNPLNKQLMNDQIVHIINHAEDEV 114
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 104 LLCDDAQFERAETLQGH----EGKYFVLR--ARQAMSVQAGSKEAYSHSA--------------NATDPIYIYFTSGSTG 163
Cdd:PRK05620 115 IVADPRLAEQLGEILKEcpcvRAVVFIGPsdADSAAAHMPEGIKVYSYEAlldgrstvydwpelDETTAAAICYSTGTTG 194
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 164 KPKAVVGKNESL-LHFMNweaswLDLTDPMRVSQLTSIGFDAVLRDIF---VPICA---GGTICIPESReiiLDPLRLVH 236
Cdd:PRK05620 195 APKGVVYSHRSLyLQSLS-----LRTTDSLAVTHGESFLCCVPIYHVLswgVPLAAfmsGTPLVFPGPD---LSAPTLAK 266
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 237 WLEHSRVHVVHCTPSLF-RFINHLSLTADSYPDLRYVLLAGETIRPESLKNWYDNLGnrVRLVNLYGPTETTMI-KLFYP 314
Cdd:PRK05620 267 IIATAMPRVAHGVPTLWiQLMVHYLKNPPERMSLQEIYVGGSAVPPILIKAWEERYG--VDVVHVWGMTETSPVgTVARP 344
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 315 ikPEDVHRES-----IPIGRpLPDTSVYLLDEQQQPVSGSE--AGEICIATRYMTHGYF--PSSHPDQTA--FIPDPCRD 383
Cdd:PRK05620 345 --PSGVSGEArwayrVSQGR-FPASLEYRIVNDGQVMESTDrnEGEIQVRGNWVTASYYhsPTEEGGGAAstFRGEDVED 421
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 517718121 384 QSGEIMM---YRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK05620 422 ANDRFTAdgwLRTGDVGSVTRDGFLTIHDRARDVIRSGGEWIYSAQLENYIMAAPEVVECAV 483
|
|
| DltA |
cd05945 |
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes ... |
795-846 |
3.01e-09 |
|
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes D-alanyl carrier protein ligase DltA and aliphatic beta-amino acid adenylation enzymes IdnL1 and CmiS6. DltA incorporates D-ala in techoic acids in gram-positive bacteria via a two-step process, starting with adenylation of D-alanine that transfers D-alanine to the D-alanyl carrier protein. IdnL1, a short-chain aliphatic beta-amino acid adenylation enzyme, recognizes 3-aminobutanoic acid, and is involved in the synthesis of the macrolactam antibiotic incednine. CmiS6 is a medium-chain beta-amino acid adenylation enzyme that recognizes 3-aminononanoic acid, and is involved in the synthesis of cremimycin, also a macrolactam antibiotic. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341267 [Multi-domain] Cd Length: 449 Bit Score: 61.11 E-value: 3.01e-09
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....*
gi 517718121 795 LIAYYLADKMIDDEQLSV---YLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNAL 846
Cdd:cd05945 395 LIAFVVPKPGAEAGLTKAikaELAERLPPYMIPRRFVYLDELPLNANGKIDRKAL 449
|
|
| PRK06710 |
PRK06710 |
long-chain-fatty-acid--CoA ligase; Validated |
16-442 |
3.06e-09 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 180666 [Multi-domain] Cd Length: 563 Bit Score: 61.20 E-value: 3.06e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 16 FPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHPDERLVTM 95
Cdd:PRK06710 37 YPEKKALHFLGKDITFSVFHDKVKRFANYLQKLGVEKGDRVAIMLPNCPQAVIGYYGTLLAGGIVVQTNPLYTERELEYQ 116
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 96 LDTAEVSCLLCDDAQFERAETLQGHEGKY--------------------FVLRARQAMSVQAGSKEAYsHSANAT----- 150
Cdd:PRK06710 117 LHDSGAKVILCLDLVFPRVTNVQSATKIEhvivtriadflpfpknllypFVQKKQSNLVVKVSESETI-HLWNSVekevn 195
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 151 -------DP----IYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLrdifvPICAGGTI 219
Cdd:PRK06710 196 tgvevpcDPendlALLQYTGGTTGFPKGVMLTHKNLVSNTLMGVQWLYNCKEGEEVVLGVLPFFHVY-----GMTAVMNL 270
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 220 CIPESREIILDP---LRLV-HWLEHSRVHVVHCTPSLF-RFINHLSLTADSYPDLRyVLLAGETIRPESLKNWYDNLGNR 294
Cdd:PRK06710 271 SIMQGYKMVLIPkfdMKMVfEAIKKHKVTLFPGAPTIYiALLNSPLLKEYDISSIR-ACISGSAPLPVEVQEKFETVTGG 349
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 295 vRLVNLYGPTETTmiklfyPIKPEDVHRES-IP--IGRPLPDTSVYLLD-EQQQPVSGSEAGEICIATRYMTHGYFpsSH 370
Cdd:PRK06710 350 -KLVEGYGLTESS------PVTHSNFLWEKrVPgsIGVPWPDTEAMIMSlETGEALPPGEIGEIVVKGPQIMKGYW--NK 420
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 517718121 371 PDQTAFIPdpcrdQSGEImmyRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK06710 421 PEETAAVL-----QDGWL---HTGDVGYMDEDGFFYVKDRKKDMIVASGFNVYPREVEEVLYEHEKVQEVVT 484
|
|
| PLN02330 |
PLN02330 |
4-coumarate--CoA ligase-like 1 |
27-442 |
4.25e-09 |
|
4-coumarate--CoA ligase-like 1
Pssm-ID: 215189 [Multi-domain] Cd Length: 546 Bit Score: 60.76 E-value: 4.25e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 27 QTLSYKELDAESDRICELLHAHGAAQyDHIGILMQDRCASIAAV-IGILKLGGVFVPLDPLHPDERLVTMLDTAEVSCLL 105
Cdd:PLN02330 54 KAVTYGEVVRDTRRFAKALRSLGLRK-GQVVVVVLPNVAEYGIVaLGIMAAGGVFSGANPTALESEIKKQAEAAGAKLIV 132
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 106 CDDAQFERAETLQ------GHEGKYFVLRARQAMSV--QAGSKEAYsHSANATDPIYIYFTSGSTGKPKAVVGKNESLLH 177
Cdd:PLN02330 133 TNDTNYGKVKGLGlpvivlGEEKIEGAVNWKELLEAadRAGDTSDN-EEILQTDLCALPFSSGTTGISKGVMLTHRNLVA 211
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 178 FMnweASWLDLTDPMRVSQLTSIGFDAvlrdiFVPICAGGTICIPESRE----IILDPLRLVHWLEHSRVHVVHCTPSLF 253
Cdd:PLN02330 212 NL---CSSLFSVGPEMIGQVVTLGLIP-----FFHIYGITGICCATLRNkgkvVVMSRFELRTFLNALITQEVSFAPIVP 283
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 254 RFInhLSLTADSYPD--------LRYVLLAGETIRPESLKNWYDNLGNrVRLVNLYGPTETTMIKLFY--PIKPEDVHRE 323
Cdd:PLN02330 284 PII--LNLVKNPIVEefdlsklkLQAIMTAAAPLAPELLTAFEAKFPG-VQVQEAYGLTEHSCITLTHgdPEKGHGIAKK 360
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 324 SiPIGRPLPDTSVYLLD-EQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTafipDPCRDQSGEImmyRTGDMGRWLPE 402
Cdd:PLN02330 361 N-SVGFILPNLEVKFIDpDTGRSLPKNTPGELCVRSQCVMQGYY--NNKEET----DRTIDEDGWL---HTGDIGYIDDD 430
|
410 420 430 440
....*....|....*....|....*....|....*....|
gi 517718121 403 GELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PLN02330 431 GDIFIVDRIKELIKYKGFQVAPAELEAILLTHPSVEDAAV 470
|
|
| AcpA |
COG3433 |
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites ... |
726-936 |
4.75e-09 |
|
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442659 [Multi-domain] Cd Length: 295 Bit Score: 59.38 E-value: 4.75e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 726 DAGIYVQRTQLGYDNYAFPNSWEVRTGHITLEQSRNELESPVNEERVHVILKELGY----DVQLQVEEAQEP------LL 795
Cdd:COG3433 67 APFIPVPYPAQPGRQADDLRLLLRRGLGPGGGLERLVQQVVIRAERGEEEELLLVLraaaVVRVAVLAALRGagvgllLI 146
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 796 IAYYLADKMIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALPSPFEQDTTARIYKAPNSSTELK---LLD 872
Cdd:COG3433 147 VGAVAALDGLAAAAALAALDKVPPDVVAASAVVALDALLLLALKVVARAAPALAAAEALLAAASPAPALETALTeeeLRA 226
|
170 180 190 200 210 220
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 517718121 873 IWTHILGIK--RISADDHFLQIGVHSLNIMTLIAQVyENFQVELPLEQVFEHDTLEEIAAYIDEQD 936
Cdd:COG3433 227 DVAELLGVDpeEIDPDDNLFDLGLDSIRLMQLVERW-RKAGLDVSFADLAEHPTLAAWWALLAAAQ 291
|
|
| A_NRPS_MycA_like |
cd05908 |
The adenylation domain of nonribosomal peptide synthetases (NRPS) similar to mycosubtilin ... |
148-428 |
4.85e-09 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS) similar to mycosubtilin synthase subunit A (MycA); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as (amino)-acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family includes NRPS similar to mycosubtilin synthase subunit A (MycA). Mycosubtilin, which is characterized by a beta-amino fatty acid moiety linked to the circular heptapeptide Asn-Tyr-Asn-Gln-Pro-Ser-Asn, belongs to the iturin family of lipopeptide antibiotics. The mycosubtilin synthase subunit A (MycA) combines functional domains derived from peptide synthetases, amino transferases, and fatty acid synthases. Nonribosomal peptide synthetases are large multifunction enzymes that synthesize many therapeutically useful peptides. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341234 [Multi-domain] Cd Length: 499 Bit Score: 60.58 E-value: 4.85e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 148 NATDPIYIYFTSGSTGKPKAVVGKNESLLHFM-------NWEA-----SWLDLTDPMRVsqltsIGFDavlrdiFVPICA 215
Cdd:cd05908 104 LADELAFIQFSSGSTGDPKGVMLTHENLVHNMfailnstEWKTkdrilSWMPLTHDMGL-----IAFH------LAPLIA 172
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 216 GGTICIPESREIILDPlrlVHWLEHSRVHVVH--CTPSLFR--FINHLSLTADSYPDL---RYVLLAGETIRPESLKNWY 288
Cdd:cd05908 173 GMNQYLMPTRLFIRRP---ILWLKKASEHKATivSSPNFGYkyFLKTLKPEKANDWDLssiRMILNGAEPIDYELCHEFL 249
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 289 DNLG----NRVRLVNLYGPTETT----MIKLFYPIKPEDVHRESIPIGRPLPD--------------------TSVYLLD 340
Cdd:cd05908 250 DHMSkyglKRNAILPVYGLAEASvgasLPKAQSPFKTITLGRRHVTHGEPEPEvdkkdsecltfvevgkpideTDIRICD 329
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 341 EQQQPVSGSEAGEICIATRYMTHGYFPSSHPDQTAFIPDpcrdqsGEImmyRTGDMGrWLPEGELALLGRKDNQVKIRGN 420
Cdd:cd05908 330 EDNKILPDGYIGHIQIRGKNVTPGYYNNPEATAKVFTDD------GWL---KTGDLG-FIRNGRLVITGREKDIIFVNGQ 399
|
....*...
gi 517718121 421 RVELGDIE 428
Cdd:cd05908 400 NVYPHDIE 407
|
|
| ACS |
cd05966 |
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); ... |
148-442 |
5.39e-09 |
|
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); Acetyl-CoA synthetase (ACS, EC 6.2.1.1, acetate#CoA ligase or acetate:CoA ligase (AMP-forming)) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is widely present in all living organisms. The activity of this enzyme is crucial for maintaining the required levels of acetyl-CoA, a key intermediate in many important biosynthetic and catabolic processes. Acetyl-CoA is used in the biosynthesis of glucose, fatty acids, and cholesterol. It can also be used in the production of energy in the citric acid cycle. Eukaryotes typically have two isoforms of acetyl-CoA synthetase, a cytosolic form involved in biosynthetic processes and a mitochondrial form primarily involved in energy generation.
Pssm-ID: 341270 [Multi-domain] Cd Length: 608 Bit Score: 60.65 E-value: 5.39e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 148 NATDPIYIYFTSGSTGKPKAVVgknesllH----FMNWEASWLDLTdpmrvsqltsigFDAVLRDIFV------------ 211
Cdd:cd05966 229 DSEDPLFILYTSGSTGKPKGVV-------HttggYLLYAATTFKYV------------FDYHPDDIYWctadigwitghs 289
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 212 -----PICAGGTICIPESREIILDPLRLVHWLEHSRVHVVHCTPSLFRfinhlSLTA--DSYPD------LRyvLLA--G 276
Cdd:cd05966 290 yivygPLANGATTVMFEGTPTYPDPGRYWDIVEKHKVTIFYTAPTAIR-----ALMKfgDEWVKkhdlssLR--VLGsvG 362
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 277 ETIRPESLKNWYDNLGN-RVRLVNLYGPTETTMIKL-----FYPIKPEDVhresipiGRPLPDTSVYLLDEQQQPVSGSE 350
Cdd:cd05966 363 EPINPEAWMWYYEVIGKeRCPIVDTWWQTETGGIMItplpgATPLKPGSA-------TRPFFGIEPAILDEEGNEVEGEV 435
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 351 AGEICIA--------TRYMTHGYFpsshpDQTAFIPDPcrdqsGeimMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRV 422
Cdd:cd05966 436 EGYLVIKrpwpgmarTIYGDHERY-----EDTYFSKFP-----G---YYFTGDGARRDEDGYYWITGRVDDVINVSGHRL 502
|
330 340
....*....|....*....|
gi 517718121 423 ELGDIEHRLTNMAGIREAVV 442
Cdd:cd05966 503 GTAEVESALVAHPAVAEAAV 522
|
|
| PRK07514 |
PRK07514 |
malonyl-CoA synthase; Validated |
7-412 |
8.40e-09 |
|
malonyl-CoA synthase; Validated
Pssm-ID: 181011 [Multi-domain] Cd Length: 504 Bit Score: 59.89 E-value: 8.40e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 7 YELARAFAAFPERKAIECGQ-QTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDP 85
Cdd:PRK07514 6 FDALRAAFADRDAPFIETPDgLRYTYGDLDAASARLANLLVALGVKPGDRVAVQVEKSPEALALYLATLRAGAVFLPLNT 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 86 LHPDERLVTMLDTAEVSCLLCDDAQFE------------RAETLQGHEGKYFVLRARQAmsvqagSKEAYSHSANATDPI 153
Cdd:PRK07514 86 AYTLAELDYFIGDAEPALVVCDPANFAwlskiaaaagapHVETLDADGTGSLLEAAAAA------PDDFETVPRGADDLA 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 154 YIYFTSGSTGKPKAVVGKNESLLhfmnweASWLDLTDPMRVSQltsigfDAVL---------RDIFVpicAGGTICIPES 224
Cdd:PRK07514 160 AILYTSGTTGRSKGAMLSHGNLL------SNALTLVDYWRFTP------DDVLihalpifhtHGLFV---ATNVALLAGA 224
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 225 REIIL---DPLRLVHWLEhsRVHVVHCTPSLF-RFINHLSLTADSYPDLR-YV-----LLAgETIRpeslkNWYDNLGNR 294
Cdd:PRK07514 225 SMIFLpkfDPDAVLALMP--RATVMMGVPTFYtRLLQEPRLTREAAAHMRlFIsgsapLLA-ETHR-----EFQERTGHA 296
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 295 V--RlvnlYGPTETTMIKlfypIKPEDVHRESIPIGRPLPDTSVYLLD-EQQQPVSGSEAGEICIATRYMTHGYFpsSHP 371
Cdd:PRK07514 297 IleR----YGMTETNMNT----SNPYDGERRAGTVGFPLPGVSLRVTDpETGAELPPGEIGMIEVKGPNVFKGYW--RMP 366
|
410 420 430 440
....*....|....*....|....*....|....*....|....
gi 517718121 372 DQTA--FIPDpcrdqsGeimMYRTGDMGRWLPEGELALLGR-KD 412
Cdd:PRK07514 367 EKTAeeFRAD------G---FFITGDLGKIDERGYVHIVGRgKD 401
|
|
| PaaK |
COG1541 |
Phenylacetate-coenzyme A ligase PaaK, adenylate-forming domain family [Coenzyme transport and ... |
151-437 |
1.64e-08 |
|
Phenylacetate-coenzyme A ligase PaaK, adenylate-forming domain family [Coenzyme transport and metabolism];
Pssm-ID: 441150 [Multi-domain] Cd Length: 423 Bit Score: 58.62 E-value: 1.64e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 151 DPIYIYFTSGSTGKPKaVVGknesllhfmnweASWLDLTDPMRVSQ--LTSIGFDAvlRDIFVpICAG------------ 216
Cdd:COG1541 84 EIVRIHASSGTTGKPT-VVG------------YTRKDLDRWAELFArsLRAAGVRP--GDRVQ-NAFGyglftgglglhy 147
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 217 -----GTICIPESreiILDPLRLVHWLEHSRVHVVHCTPSlfrFINHLSLTAD----SYPD--LRYVLLAGETIrPESLK 285
Cdd:COG1541 148 gaerlGATVIPAG---GGNTERQLRLMQDFGPTVLVGTPS---YLLYLAEVAEeegiDPRDlsLKKGIFGGEPW-SEEMR 220
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 286 NWY-DNLGnrVRLVNLYGPTETTMI---------------KLFYP--IKPEDvhresipiGRPLPDTsvylldeqqqpvs 347
Cdd:COG1541 221 KEIeERWG--IKAYDIYGLTEVGPGvayeceaqdglhiweDHFLVeiIDPET--------GEPVPEG------------- 277
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 348 gsEAGEICIAT---------RYMTHgyfpsshpDQTAFIPDPCRDqsGEIMMyRtgdMGRWlpegelalLGRKDNQVKIR 418
Cdd:COG1541 278 --EEGELVVTTltkeampliRYRTG--------DLTRLLPEPCPC--GRTHP-R---IGRI--------LGRADDMLIIR 333
|
330
....*....|....*....
gi 517718121 419 GNRVELGDIEHRLTNMAGI 437
Cdd:COG1541 334 GVNVFPSQIEEVLLRIPEV 352
|
|
| PRK07768 |
PRK07768 |
long-chain-fatty-acid--CoA ligase; Validated |
151-455 |
4.23e-08 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236091 [Multi-domain] Cd Length: 545 Bit Score: 57.70 E-value: 4.23e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 151 DPIYIYFTSGSTGKPKAVVGKNESLlhFMNWEA---------------SWLDLTDPMRVsqltsIGFdavlrdIFVPICA 215
Cdd:PRK07768 153 DLALMQLTSGSTGSPKAVQITHGNL--YANAEAmfvaaefdvetdvmvSWLPLFHDMGM-----VGF------LTVPMYF 219
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 216 GGTICIPESREIILDPLRlvhWLE--HSRVHVVHCTPS---------LFRFINHLSLTADSypdLRYVLLAGETIRPESL 284
Cdd:PRK07768 220 GAELVKVTPMDFLRDPLL---WAEliSKYRGTMTAAPNfayallarrLRRQAKPGAFDLSS---LRFALNGAEPIDPADV 293
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 285 KNWYDNLG----NRVRLVNLYGPTETT----MIKLFYPIKPEDVH-------RESIP-----------IGRPLPDTSVYL 338
Cdd:PRK07768 294 EDLLDAGArfglRPEAILPAYGMAEATlavsFSPCGAGLVVDEVDadllaalRRAVPatkgntrrlatLGPPLPGLEVRV 373
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 339 LDEQQQPVSGSEAGEICIATRYMTHGYFpsshpdqTAFIPDPCRDQSGeimMYRTGDMGRWLPEGELALLGRKDNQVKIR 418
Cdd:PRK07768 374 VDEDGQVLPPRGVGVIELRGESVTPGYL-------TMDGFIPAQDADG---WLDTGDLGYLTEEGEVVVCGRVKDVIIMA 443
|
330 340 350
....*....|....*....|....*....|....*....
gi 517718121 419 GNRVELGDIEHRLTNMAGIREA-VVRMRAKADTPK-GMA 455
Cdd:PRK07768 444 GRNIYPTDIERAAARVEGVRPGnAVAVRLDAGHSReGFA 482
|
|
| PRK08633 |
PRK08633 |
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated |
140-431 |
4.98e-08 |
|
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated
Pssm-ID: 236315 [Multi-domain] Cd Length: 1146 Bit Score: 58.01 E-value: 4.98e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 140 KEAYSHSANATDPIYIYFTSGSTGKPKAVV--GKN-----ESLLHFMNweaswLDLTDPMrVSQLT---SIGFDAVLrdi 209
Cdd:PRK08633 772 KRLYGPTFKPDDTATIIFSSGSEGEPKGVMlsHHNilsniEQISDVFN-----LRNDDVI-LSSLPffhSFGLTVTL--- 842
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 210 FVPICAG-GTICIPesreiilDPL------RLVHwlEHsRVHVVHCTPSLFR-FINHLSLTADSYPDLRYVLLAGETIRP 281
Cdd:PRK08633 843 WLPLLEGiKVVYHP-------DPTdalgiaKLVA--KH-RATILLGTPTFLRlYLRNKKLHPLMFASLRLVVAGAEKLKP 912
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 282 EsLKNWY-DNLGnrVRLVNLYGPTETT-MIKLFYP-IKPEDVHRESI----PIGRPLPDTSVYLLD-EQQQPVSGSEAGE 353
Cdd:PRK08633 913 E-VADAFeEKFG--IRILEGYGATETSpVASVNLPdVLAADFKRQTGskegSVGMPLPGVAVRIVDpETFEELPPGEDGL 989
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 517718121 354 ICIATRYMTHGYFpsSHPDQTAfipDPCRDQSGeIMMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRL 431
Cdd:PRK08633 990 ILIGGPQVMKGYL--GDPEKTA---EVIKDIDG-IGWYVTGDKGHLDEDGFLTITDRYSRFAKIGGEMVPLGAVEEEL 1061
|
|
| PRK04813 |
PRK04813 |
D-alanine--poly(phosphoribitol) ligase subunit DltA; |
803-846 |
8.25e-08 |
|
D-alanine--poly(phosphoribitol) ligase subunit DltA;
Pssm-ID: 235313 [Multi-domain] Cd Length: 503 Bit Score: 56.44 E-value: 8.25e-08
10 20 30 40
....*....|....*....|....*....|....*....|....
gi 517718121 803 KMIDDEqlsvyLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNAL 846
Cdd:PRK04813 459 KAIKKE-----LKERLMEYMIPRKFIYRDSLPLTPNGKIDRKAL 497
|
|
| LC_FACS_bac1 |
cd17641 |
bacterial long-chain fatty acid CoA synthetase; The members of this family are bacterial ... |
27-442 |
8.33e-08 |
|
bacterial long-chain fatty acid CoA synthetase; The members of this family are bacterial long-chain fatty acid CoA synthetase, most of which are as yet uncharacterized. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341296 [Multi-domain] Cd Length: 569 Bit Score: 56.66 E-value: 8.33e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 27 QTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPL--DPLHpdERLVTMLDTAEVSCL 104
Cdd:cd17641 10 QEFTWADYADRVRAFALGLLALGVGRGDVVAILGDNRPEWVWAELAAQAIGALSLGIyqDSMA--EEVAYLLNYTGARVV 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 105 LCDDA-QFERAETLQGH------------EG--KYFVLRARQAMSVQAGSKEA-------YSHSANATDP---IYIYFTS 159
Cdd:cd17641 88 IAEDEeQVDKLLEIADRipsvryviycdpRGmrKYDDPRLISFEDVVALGRALdrrdpglYEREVAAGKGedvAVLCTTS 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 160 GSTGKPKAVVGKNESLLHFmnwEASWLDLtDPMR-----VSQLTsigFDAVLRDIFV---PICAGGTICIPES------- 224
Cdd:cd17641 168 GTTGKPKLAMLSHGNFLGH---CAAYLAA-DPLGpgdeyVSVLP---LPWIGEQMYSvgqALVCGFIVNFPEEpetmmed 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 225 -REI----ILDPLRLvhW---LEHSRVHVVHCTP---SLFRFINHLSLTA----------DSYPDLRYVL---------- 273
Cdd:cd17641 241 lREIgptfVLLPPRV--WegiAADVRARMMDATPfkrFMFELGMKLGLRAldrgkrgrpvSLWLRLASWLadallfrplr 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 274 ------------LAGETIRPESLKnWYDNLGnrVRLVNLYGPTETTMiklFYPIKPE-DVHRESIpiGRPLPDTSVYLld 340
Cdd:cd17641 319 drlgfsrlrsaaTGGAALGPDTFR-FFHAIG--VPLKQLYGQTELAG---AYTVHRDgDVDPDTV--GVPFPGTEVRI-- 388
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 341 eqqqpvsgSEAGEICIATRYMTHGYFpsSHPDQTAfipdpcRDQSGEIMMyRTGDMGRWLPEGELALLGR-KDNQVKIRG 419
Cdd:cd17641 389 --------DEVGEILVRSPGVFVGYY--KNPEATA------EDFDEDGWL-HTGDAGYFKENGHLVVIDRaKDVGTTSDG 451
|
490 500
....*....|....*....|...
gi 517718121 420 NRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd17641 452 TRFSPQFIENKLKFSPYIAEAVV 474
|
|
| FATP_FACS |
cd05940 |
Fatty acid transport proteins (FATP) play dual roles as fatty acid transporters and its ... |
27-442 |
8.51e-08 |
|
Fatty acid transport proteins (FATP) play dual roles as fatty acid transporters and its activation enzymes; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. At least five copies of FATPs are identified in mammalian cells. This family also includes prokaryotic FATPs. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341263 [Multi-domain] Cd Length: 449 Bit Score: 56.21 E-value: 8.51e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 27 QTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVfvpldplhpderlVTMLDTaevscllc 106
Cdd:cd05940 2 EALTYAELDAMANRYARWLKSLGLKPGDVVALFMENRPEYVLLWLGLVKIGAV-------------AALINY-------- 60
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 107 ddaqferaeTLQGhegkyfvlrarqamsvqagskEAYSHSANATDP--------IYIYfTSGSTGKPKAVVGKNESLLHF 178
Cdd:cd05940 61 ---------NLRG---------------------ESLAHCLNVSSAkhlvvdaaLYIY-TSGTTGLPKAAIISHRRAWRG 109
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 179 MNWEASW--------LDLTDPMRVSQLTSIGFDAVLRdifvpicAGGTICIPES-------REIIldplrlvhwlEHsrv 243
Cdd:cd05940 110 GAFFAGSggalpsdvLYTCLPLYHSTALIVGWSACLA-------SGATLVIRKKfsasnfwDDIR----------KY--- 169
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 244 hvvHCTpsLFRFINHLsltadsypdLRYVL---------------LAGETIRPESlknWyDNLGNR---VRLVNLYGPTE 305
Cdd:cd05940 170 ---QAT--IFQYIGEL---------CRYLLnqppkpterkhkvrmIFGNGLRPDI---W-EEFKERfgvPRIAEFYAATE 231
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 306 TTMIKLFYPIKPEDVHRESIPIGRPLPDTSVYLLDEQQQPVSGS----------EAGE-IC-IATRYMTHGYFpsshpDQ 373
Cdd:cd05940 232 GNSGFINFFGKPGAIGRNPSLLRKVAPLALVKYDLESGEPIRDAegrcikvprgEPGLlISrINPLEPFDGYT-----DP 306
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 517718121 374 TAFIPDPCRD--QSGEImMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd05940 307 AATEKKILRDvfKKGDA-WFNTGDLMRLDGEGFWYFVDRLGDTFRWKGENVSTTEVAAVLGAFPGVEEANV 376
|
|
| A_NRPS_GliP_like |
cd17653 |
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of ... |
795-846 |
1.23e-07 |
|
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of nonribosomal peptide synthases (NRPS) gliotoxin biosynthesis protein P (GliP), thioclapurine biosynthesis protein P (tcpP) and Sirodesmin biosynthesis protein P (SirP). In the filamentous fungus Aspergillus fumigatus, NRPS GliP is involved in the biosynthesis of gliotoxin, which is initiated by the condensation of serine and phenylalanine. Studies show that GliP is not required for invasive aspergillosis, suggesting that the principal targets of gliotoxin are neutrophils or other phagocytes. SirP is a phytotoxin produced by the fungus Leptosphaeria maculans, which causes blackleg disease of canola (Brassica napus). In the fungus Claviceps purpurea, NRPS tcpP catalyzes condensation of tyrosine and glycine, part of biosynthesis of an unusual class of epipolythiodioxopiperazines (ETPs) that lacks the reactive thiol group for toxicity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341308 [Multi-domain] Cd Length: 433 Bit Score: 55.78 E-value: 1.23e-07
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|..
gi 517718121 795 LIAYYlADKMIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNAL 846
Cdd:cd17653 381 LVAFV-TPETVDVDGLRSELAKHLPSYAVPDRIIALDSFPLTANGKVDRKAL 431
|
|
| ACLS-CaiC |
cd17637 |
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ... |
250-442 |
2.48e-07 |
|
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized, but may be similar to Carnitine-CoA ligase (CaiC) which catalyzes the transfer of CoA to carnitine. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341292 [Multi-domain] Cd Length: 333 Bit Score: 54.20 E-value: 2.48e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 250 PSLFRFINHLSLTADSYPDLRYVLlaG-ETirPESLKNWYDNlgNRVRLVNLYGPTETTMIKLFYPI--KPEDVhresip 326
Cdd:cd17637 97 PILSNLLDAAEKSGVDLSSLRHVL--GlDA--PETIQRFEET--TGATFWSLYGQTETSGLVTLSPYreRPGSA------ 164
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 327 iGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFPSSHPDQTAFipdpcRDQsgeimMYRTGDMGRWLPEGELA 406
Cdd:cd17637 165 -GRPGPLVRVRIVDDNDRPVPAGETGEIVVRGPLVFQGYWNLPELTAYTF-----RNG-----WHHTGDLGRFDEDGYLW 233
|
170 180 190
....*....|....*....|....*....|....*...
gi 517718121 407 LLGRKDNQ--VKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd17637 234 YAGRKPEKelIKPGGENVYPAEVEKVILEHPAIAEVCV 271
|
|
| A_NRPS_alphaAR |
cd17647 |
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as ... |
775-849 |
3.04e-07 |
|
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as alpha-aminoadipate reductase (EC 1.2.1.95) or alpha-AR or L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), which catalyzes the activation of alpha-aminoadipate by ATP-dependent adenylation and the reduction of activated alpha-aminoadipate by NADPH. The activated alpha-aminoadipate is bound to the phosphopantheinyl group of the enzyme itself before it is reduced to (S)-2-amino-6-oxohexanoate.
Pssm-ID: 341302 [Multi-domain] Cd Length: 520 Bit Score: 54.83 E-value: 3.04e-07
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 517718121 775 ILKELGYDVQLQVEEAQEPL---LIAYYladKMIDDeqLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALPSP 849
Cdd:cd17647 448 PDDESFAQEDVPKEVSTDPIvkgLIGYR---KLIKD--IREFLKKRLASYAIPSLIVVLDKLPLNPNGKVDKPKLQFP 520
|
|
| ttLC_FACS_AEE21_like |
cd12118 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This ... |
9-169 |
3.41e-07 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This family includes fatty acyl-CoA synthetases that can activate medium to long-chain fatty acids. These enzymes catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family has been shown to catalyze the long-chain fatty acid, myristoyl acid. Also included in this family are acyl activating enzymes from Arabidopsis, which contains a large number of proteins from this family with up to 63 different genes, many of which are uncharacterized.
Pssm-ID: 341283 [Multi-domain] Cd Length: 486 Bit Score: 54.61 E-value: 3.41e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHP 88
Cdd:cd12118 10 LERAAAVYPDRTSIVYGDRRYTWRQTYDRCRRLASALAALGISRGDTVAVLAPNTPAMYELHFGVPMAGAVLNALNTRLD 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 89 DERLVTMLDTAEVSCLLCDdAQFERAETLQGHEGKYFVLRArqamsvqagskeayshsANATDPIYIYFTSGSTGKPKAV 168
Cdd:cd12118 90 AEEIAFILRHSEAKVLFVD-REFEYEDLLAEGDPDFEWIPP-----------------ADEWDPIALNYTSGTTGRPKGV 151
|
.
gi 517718121 169 V 169
Cdd:cd12118 152 V 152
|
|
| PtmA |
cd17636 |
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, ... |
328-442 |
4.08e-07 |
|
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341291 [Multi-domain] Cd Length: 331 Bit Score: 53.84 E-value: 4.08e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 328 GRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTAfipdpCRDQSGeimMYRTGDMGRWLPEGELAL 407
Cdd:cd17636 166 GRPSPLVQVRILDEDGREVPDGEVGEIVARGPTVMAGYW--NRPEVNA-----RRTRGG---WHHTNDLGRREPDGSLSF 235
|
90 100 110
....*....|....*....|....*....|....*
gi 517718121 408 LGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:cd17636 236 VGPKTRMIKSGAENIYPAEVERCLRQHPAVADAAV 270
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
1-428 |
4.24e-07 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 55.17 E-value: 4.24e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 1 MDNTIQYELARAFAAFPERKAI------ECGQQTLSYKELDAESDRICELLHAHgAAQYDHIGILMQDRCASIAAVIGIL 74
Cdd:PRK05691 7 LPLTLVQALQRRAAQTPDRLALrfladdPGEGVVLSYRDLDLRARTIAAALQAR-ASFGDRAVLLFPSGPDYVAAFFGCL 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 75 KLGGVFVPLDP-----LHPDERLVTMLDTAEVSCLLCDDAQferAETLQGHEGkyfvLRARQAM------SVQAGSKEAY 143
Cdd:PRK05691 86 YAGVIAVPAYPpesarRHHQERLLSIIADAEPRLLLTVADL---RDSLLQMEE----LAAANAPellcvdTLDPALAEAW 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 144 SHSANATDPI-YIYFTSGSTGKPKAV------VGKNESLLH-----FMNWE---ASWLDLTDPMRVsqltsIGfdAVLRD 208
Cdd:PRK05691 159 QEPALQPDDIaFLQYTSGSTALPKGVqvshgnLVANEQLIRhgfgiDLNPDdviVSWLPLYHDMGL-----IG--GLLQP 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 209 IFvpicaGGTICIPESREIILDplRLVHWLEHsrvhvvhctpslfrfINHLSLTADSYPDLRYVL---------LAG--- 276
Cdd:PRK05691 232 IF-----SGVPCVLMSPAYFLE--RPLRWLEA---------------ISEYGGTISGGPDFAYRLcservsesaLERldl 289
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 277 ----------ETIRPESLKNWYDNLG----NRVRLVNLYGPTETTmikLFYP-------IKPEDVHRESIP--------- 326
Cdd:PRK05691 290 srwrvaysgsEPIRQDSLERFAEKFAacgfDPDSFFASYGLAEAT---LFVSggrrgqgIPALELDAEALArnraepgtg 366
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 327 -----IGRPLPDTSVYLLDEQQQPVSGSEA-GEICIATRYMTHGYFPSSHPDQTAFIpdpcrDQSGEIMMyRTGDMGrWL 400
Cdd:PRK05691 367 svlmsCGRSQPGHAVLIVDPQSLEVLGDNRvGEIWASGPSIAHGYWRNPEASAKTFV-----EHDGRTWL-RTGDLG-FL 439
|
490 500
....*....|....*....|....*...
gi 517718121 401 PEGELALLGRKDNQVKIRGNRVELGDIE 428
Cdd:PRK05691 440 RDGELFVTGRLKDMLIVRGHNLYPQDIE 467
|
|
| PRK08314 |
PRK08314 |
long-chain-fatty-acid--CoA ligase; Validated |
4-189 |
4.36e-07 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236235 [Multi-domain] Cd Length: 546 Bit Score: 54.20 E-value: 4.36e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 4 TIQYELARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAH-GAAQYDHIGILMQDRCASIAAVIGILKLGGVFVP 82
Cdd:PRK08314 11 SLFHNLEVSARRYPDKTAIVFYGRAISYRELLEEAERLAGYLQQEcGVRKGDRVLLYMQNSPQFVIAYYAILRANAVVVP 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 83 LDPLHPDERLVTMLDTAEVSCLLCDDAQFERAETLQGHEGKYFVLRA------------------RQAMSVQAGSKEAY- 143
Cdd:PRK08314 91 VNPMNREEELAHYVTDSGARVAIVGSELAPKVAPAVGNLRLRHVIVAqysdylpaepeiavpawlRAEPPLQALAPGGVv 170
|
170 180 190 200 210
....*....|....*....|....*....|....*....|....*....|....*....
gi 517718121 144 -------------SHSANATDPIYIYFTSGSTGKPKAVVGKNESLLHFMNWEASWLDLT 189
Cdd:PRK08314 171 awkealaaglappPHTAGPDDLAVLPYTSGTTGVPKGCMHTHRTVMANAVGSVLWSNST 229
|
|
| COG1606 |
COG1606 |
ATP-utilizing enzyme, PP-loop superfamily [General function prediction only]; |
500-621 |
4.83e-07 |
|
ATP-utilizing enzyme, PP-loop superfamily [General function prediction only];
Pssm-ID: 441214 [Multi-domain] Cd Length: 265 Bit Score: 52.81 E-value: 4.83e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 500 EQLQSKLQPVEKenqpsydCLLLYSGGKDSTYALYRLVE-MGARVLAYTFDNGYISSAAFRNIDSVVKELGVDHIVGTFD 578
Cdd:COG1606 6 ERLKAILKELGS-------VLVAFSGGVDSTLLAKVAHDvLGDRVLAVTADSPSLPERELEEAKELAKEIGIRHEVIETD 78
|
90 100 110 120
....*....|....*....|....*....|....*....|....*.
gi 517718121 579 gMLDI--FKEGLKQECSVCngcfKAMRILS-TRVAAERGIPYIVTG 621
Cdd:COG1606 79 -ELEDpeFVANPPDRCYHC----KKELFSKlKELAKELGYAVVADG 119
|
|
| PRK08043 |
PRK08043 |
bifunctional acyl-ACP--phospholipid O-acyltransferase/long-chain-fatty-acid--ACP ligase; |
149-455 |
5.24e-07 |
|
bifunctional acyl-ACP--phospholipid O-acyltransferase/long-chain-fatty-acid--ACP ligase;
Pssm-ID: 181207 [Multi-domain] Cd Length: 718 Bit Score: 54.33 E-value: 5.24e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 149 ATDPIYIYFTSGSTGKPKAVVGKNESLLhfmnweaswldltdpMRVSQLTSIGfDAVLRD-----------------IFV 211
Cdd:PRK08043 364 PEDAALILFTSGSEGHPKGVVHSHKSLL---------------ANVEQIKTIA-DFTPNDrfmsalplfhsfgltvgLFT 427
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 212 PICAGGTICIPESreiildPL--RLVHWLEHSRvhvvHCTpSLF---RFINHLSLTADSY--PDLRYVLLAGETIRPESL 284
Cdd:PRK08043 428 PLLTGAEVFLYPS------PLhyRIVPELVYDR----NCT-VLFgtsTFLGNYARFANPYdfARLRYVVAGAEKLQESTK 496
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 285 KNWYDNLGnrVRLVNLYGPTE---TTMIKLFYPIKPEDVhresipiGRPLPDTSVYLLdeqqqPVSG-SEAGEICIATRY 360
Cdd:PRK08043 497 QLWQDKFG--LRILEGYGVTEcapVVSINVPMAAKPGTV-------GRILPGMDARLL-----SVPGiEQGGRLQLKGPN 562
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 361 MTHGYFPSSHPDQtaFIPDPCRDQSGEIMM--YRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHrLTNMAGiR 438
Cdd:PRK08043 563 IMNGYLRVEKPGV--LEVPTAENARGEMERgwYDTGDIVRFDEQGFVQIQGRAKRFAKIAGEMVSLEMVEQ-LALGVS-P 638
|
330
....*....|....*..
gi 517718121 439 EAVVRMRAKADTPKGMA 455
Cdd:PRK08043 639 DKQHATAIKSDASKGEA 655
|
|
| D-ala-DACP-lig |
TIGR01734 |
D-alanine--poly(phosphoribitol) ligase, subunit 1; This model represents the enzyme (also ... |
814-846 |
6.49e-07 |
|
D-alanine--poly(phosphoribitol) ligase, subunit 1; This model represents the enzyme (also called D-alanine-D-alanyl carrier protein ligase) which activates D-alanine as an adenylate via the reaction D-ala + ATP -> D-ala-AMP + PPi, and further catalyzes the condensation of the amino acid adenylate with the D-alanyl carrier protein (D-ala-ACP). The D-alanine is then further transferred to teichoic acid in the biosynthesis of lipoteichoic acid (LTA) and wall teichoic acid (WTA) in gram positive bacteria, both polysacchatides. [Cell envelope, Biosynthesis and degradation of murein sacculus and peptidoglycan]
Pssm-ID: 273780 [Multi-domain] Cd Length: 502 Bit Score: 53.61 E-value: 6.49e-07
10 20 30
....*....|....*....|....*....|...
gi 517718121 814 LRRFLPDYMIPARFIRLDKMPLTPNGKLDYNAL 846
Cdd:TIGR01734 464 LKKSLPAYMIPRKFIYRDQLPLTANGKIDRKAL 496
|
|
| PRK05677 |
PRK05677 |
long-chain-fatty-acid--CoA ligase; Validated |
301-465 |
1.04e-06 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 168170 [Multi-domain] Cd Length: 562 Bit Score: 53.23 E-value: 1.04e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 301 YGPTETTMIKLFYPIKpedvHRESIPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTAFIpdp 380
Cdd:PRK05677 358 YGMTETSPVVSVNPSQ----AIQVGTIGIPVPSTLCKVIDDDGNELPLGEVGELCVKGPQVMKGYW--QRPEATDEI--- 428
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 381 cRDQSGEImmyRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREavvrmrakadtpkgmaqqhCA 460
Cdd:PRK05677 429 -LDSDGWL---KTGDIALIQEDGYMRIVDRKKDMILVSGFNVYPNELEDVLAALPGVLQ-------------------CA 485
|
....*
gi 517718121 461 ACGLP 465
Cdd:PRK05677 486 AIGVP 490
|
|
| MenE/FadK |
COG0318 |
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid ... |
805-857 |
1.45e-06 |
|
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) is part of the Pathway/BioSystem: Menaquinone biosynthesis
Pssm-ID: 440087 [Multi-domain] Cd Length: 452 Bit Score: 52.51 E-value: 1.45e-06
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|...
gi 517718121 805 IDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNALPSPFEQDTTAR 857
Cdd:COG0318 400 LDAEELRAFLRERLARYKVPRRVEFVDELPRTASGKIDRRALRERYAAGALEA 452
|
|
| PRK08308 |
PRK08308 |
acyl-CoA synthetase; Validated |
328-442 |
3.17e-06 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236231 [Multi-domain] Cd Length: 414 Bit Score: 51.19 E-value: 3.17e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 328 GRPLPDTSVYLLDEQQQPV----SGSEAGEICIATRYMTH---GYfPSSHPDQTAfipDPCRDQSGEIMMY------RTG 394
Cdd:PRK08308 221 GTPLPEAWFYKLRERTTYMmqqyGCSEAGCVSICPDMKSHldlGN-PLPHVSVSA---GSDENAPEEIVVKmgdkeiFTK 296
|
90 100 110 120
....*....|....*....|....*....|....*....|....*...
gi 517718121 395 DMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK08308 297 DLGYKSERGTLHFMGRMDDVINVSGLNVYPIEVEDVMLRLPGVQEAVV 344
|
|
| PRK08276 |
PRK08276 |
long-chain-fatty-acid--CoA ligase; Validated |
26-411 |
4.24e-06 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236215 [Multi-domain] Cd Length: 502 Bit Score: 51.06 E-value: 4.24e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 26 QQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLD-PLHPDErLVTMLDTAEVSCL 104
Cdd:PRK08276 9 GEVVTYGELEARSNRLAHGLRALGLREGDVVAILLENNPEFFEVYWAARRSGLYYTPINwHLTAAE-IAYIVDDSGAKVL 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 105 LCDDAQFERAETLQGHEGKYfvLRARQAMSVQAGSKEAYSH--SANATDPI-------YIYFTSGSTGKPKAV------V 169
Cdd:PRK08276 88 IVSAALADTAAELAAELPAG--VPLLLVVAGPVPGFRSYEEalAAQPDTPIadetagaDMLYSSGTTGRPKGIkrplpgL 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 170 GKNESLLHFMNWEASWLDLTDPMRVSQLTSIGFDAVLRDIFVPICAGGTICIPESreiiLDP---LRLVhwlEHSRVHVV 246
Cdd:PRK08276 166 DPDEAPGMMLALLGFGMYGGPDSVYLSPAPLYHTAPLRFGMSALALGGTVVVMEK----FDAeeaLALI---ERYRVTHS 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 247 HCTPSLfrFINHLSLtadsypdlryvllagetirPESLKNWYDNLGNRV--------------RLVNLYGP--------T 304
Cdd:PRK08276 239 QLVPTM--FVRMLKL-------------------PEEVRARYDVSSLRVaihaaapcpvevkrAMIDWWGPiiheyyasS 297
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 305 ETTMIKLfypIKPED--VHRESipIGRPLpDTSVYLLDEQQQPVSGSEAGEIciatrYMTHGYFPSSH---PDQTAFIPD 379
Cdd:PRK08276 298 EGGGVTV---ITSEDwlAHPGS--VGKAV-LGEVRILDEDGNELPPGEIGTV-----YFEMDGYPFEYhndPEKTAAARN 366
|
410 420 430
....*....|....*....|....*....|...
gi 517718121 380 PCRdqsgeimMYRTGDMGrWLPE-GELALLGRK 411
Cdd:PRK08276 367 PHG-------WVTVGDVG-YLDEdGYLYLTDRK 391
|
|
| FACL_like_4 |
cd05944 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
151-419 |
7.02e-06 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341266 [Multi-domain] Cd Length: 359 Bit Score: 49.79 E-value: 7.02e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 151 DPIYIYF-TSGSTGKPKaVVGKNESLLHFMNWEASWLDLTDPMRV--SQLTSIGFDAVLRDIFVPICAGGTICIP----- 222
Cdd:cd05944 2 DDVAAYFhTGGTTGTPK-LAQHTHSNEVYNAWMLALNSLFDPDDVllCGLPLFHVNGSVVTLLTPLASGAHVVLAgpagy 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 223 ESREIILDPLRLVhwlEHSRVHVVHCTPSLFRFINHLSLTADsYPDLRYVLLAGETIRPESLKNWYDNLGnrVRLVNLYG 302
Cdd:cd05944 81 RNPGLFDNFWKLV---ERYRITSLSTVPTVYAALLQVPVNAD-ISSLRFAMSGAAPLPVELRARFEDATG--LPVVEGYG 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 303 PTETT-MIKLFYPIKPedvhRESIPIGRPLPDTSVYLLDEQ-----QQPVSGSEAGEICIATRYMTHGYFPSSHpDQTAF 376
Cdd:cd05944 155 LTEATcLVAVNPPDGP----KRPGSVGLRLPYARVRIKVLDgvgrlLRDCAPDEVGEICVAGPGVFGGYLYTEG-NKNAF 229
|
250 260 270 280
....*....|....*....|....*....|....*....|...
gi 517718121 377 IPDpcrdqsgeiMMYRTGDMGRWLPEGELALLGRKDNQVkIRG 419
Cdd:cd05944 230 VAD---------GWLNTGDLGRLDADGYLFITGRAKDLI-IRG 262
|
|
| AANH_PF0828-like |
cd01994 |
putative ATP pyrophosphatase PF0828 and similar proteins; This subfamily includes Pyrococcus ... |
519-621 |
7.77e-06 |
|
putative ATP pyrophosphatase PF0828 and similar proteins; This subfamily includes Pyrococcus furiosus putative ATP pyrophosphatase PF0828 and Pyrococcus horikoshii PH1257. They belong to the adenine nucleotide alpha hydrolase (AANH) superfamily that also includes other N-type ATP PPases and ATP sulfurylases. It forms an alpha/beta/alpha fold which binds to the adenosine group. This subfamily of proteins is predicted to bind ATP. This domain has a strongly conserved motif SGGKD at the N-terminus.
Pssm-ID: 467498 Cd Length: 211 Bit Score: 48.43 E-value: 7.77e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 519 CLLLYSGGKDSTYALYRLVEMGARV--LAYTFDNGYIS----SAAFRNIDSVVKELGVDHIVGTFDGMLDIFKEGLKQEC 592
Cdd:cd01994 2 VVALISGGKDSIYALLHAIRNGHEVvaLANLRPEDKDSymfqTVGHELLELQAEALGLPLIRREIRGKSVTQELGYEGEE 81
|
90 100
....*....|....*....|....*....
gi 517718121 593 SVcngCFKAMRILSTRVAAERGIPYIVTG 621
Cdd:cd01994 82 ED---EVEDLYELLKKVKERPEVEAVVSG 107
|
|
| PRK07787 |
PRK07787 |
acyl-CoA synthetase; Validated |
296-442 |
1.01e-05 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236096 [Multi-domain] Cd Length: 471 Bit Score: 49.60 E-value: 1.01e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 296 RLVNLYGPTETtMIKLFYPIkpeDVHRESIPIGRPLPDTSVYLLDEQQQPVS--GSEAGEICIATRYMTHGYFpsSHPDQ 373
Cdd:PRK07787 268 RPVERYGMTET-LITLSTRA---DGERRPGWVGLPLAGVETRLVDEDGGPVPhdGETVGELQVRGPTLFDGYL--NRPDA 341
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 374 TAfipdPCRDQSGeimMYRTGDMGRWLPEGELALLGRKD-NQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK07787 342 TA----AAFTADG---WFRTGDVAVVDPDGMHRIVGREStDLIKSGGYRIGAGEIETALLGHPGVREAAV 404
|
|
| PRK12406 |
PRK12406 |
long-chain-fatty-acid--CoA ligase; Provisional |
25-442 |
1.07e-05 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 183506 [Multi-domain] Cd Length: 509 Bit Score: 49.70 E-value: 1.07e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 25 GQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDpLH--PDERLVTMLDTAevs 102
Cdd:PRK12406 8 GDRRRSFDELAQRAARAAGGLAALGVRPGDCVALLMRNDFAFFEAAYAAMRLGAYAVPVN-WHfkPEEIAYILEDSG--- 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 103 cllcddaqferAETLQGHEGkyfvLRARQAMSVQAGSK-----------EAYSHS-------ANATD------------- 151
Cdd:PRK12406 84 -----------ARVLIAHAD----LLHGLASALPAGVTvlsvptppeiaAAYRISpalltppAGAIDwegwlaqqepydg 148
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 152 -----PIYIYFTSGSTGKPKAVVGKNESLLHFMNWEA-----------SWLDLTDPMRVSQLTSIGFDAvlrdifvpICA 215
Cdd:PRK12406 149 ppvpqPQSMIYTSGTTGHPKGVRRAAPTPEQAAAAEQmraliyglkpgIRALLTGPLYHSAPNAYGLRA--------GRL 220
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 216 GGTIcIPESReiiLDPLRLVHWLEHSRVHVVHCTPSLFrfINHLSLTAD-----SYPDLRYVLLAGETIRPE---SLKNW 287
Cdd:PRK12406 221 GGVL-VLQPR---FDPEELLQLIERHRITHMHMVPTMF--IRLLKLPEEvrakyDVSSLRHVIHAAAPCPADvkrAMIEW 294
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 288 YDNLGNRvrlvnLYGPTETTMIKLfypIKPEDVHRESIPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMT----H 363
Cdd:PRK12406 295 WGPVIYE-----YYGSTESGAVTF---ATSEDALSHPGTVGKAAPGAELRFVDEDGRPLPQGEIGEIYSRIAGNPdftyH 366
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 517718121 364 GyfpssHPDQTAFIpdpcrDQSGEIMmyrTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIEHRLTNMAGIREAVV 442
Cdd:PRK12406 367 N-----KPEKRAEI-----DRGGFIT---SGDVGYLDADGYLFLCDRKRDMVISGGVNIYPAEIEAVLHAVPGVHDCAV 432
|
|
| PPase_ThiI |
cd01712 |
pyrophosphatase domain of thiamine biosynthesis protein ThiI; ThiI is required for thiazole ... |
519-626 |
1.22e-05 |
|
pyrophosphatase domain of thiamine biosynthesis protein ThiI; ThiI is required for thiazole synthesis in the thiamine biosynthesis pathway. ThiI is also responsible for the 4-thiouridine (S4U) modification at position 8 in some prokaryotic tRNAs. ThiI contains a PP-loop pyrophosphatase domain which binds ATP and activates tRNA by adenylation. The PP-loop pyrophosphatase catalytic domain of ThiI proteins is always accompanied by a THUMP domain towards the N terminus. THUMP domains are predicted to bind RNA and are widespread in bacteria, archaea, and eukaryotes. The acronym was derived from the names of RNA-modifying enzymes in which this domain is found, namely, thiouridine synthases (ThiI), methylases, and archaeal pseudouridine synthases. ThiI proteins from gamma-proteobacteria and from archaea of the genus Thermoplasma also contain a C-terminal extension of approximately 100 amino acid residues which accepts sulfur in the form of a persulfide on a cysteine residue. This persulfide is responsible for a nucleophilic attack of the adenylated tRNA substrate, completing the sulfur insertion forming a disulfide-bridge between the rhodanese-like domain and a second cysteine residue located in the PP-loop domain. The reaction releases AMP and modified tRNA, and leaves the enzyme in an oxidized state. The disulfide is then reductively cleaved to complete the enzymatic cycle. The pyrophosphatase domain of ThiI belongs to the adenine nucleotide hydrolase (AANH) superfamily and it binds to adenosine nucleotide.
Pssm-ID: 467485 [Multi-domain] Cd Length: 185 Bit Score: 47.55 E-value: 1.22e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 519 CLLLYSGGKDSTYALYRLVEMGARVLAYTFDNG-YISSAAFRNIDSVVKELG------VDHIVGTFDGMLDIFKEGLKQE 591
Cdd:cd01712 7 VLVLLSGGIDSPVAAWMMMKRGVEVDFLHFHSGpYTSEKAVEKVKDLARVLSeyqggvKLYLVPFTDKIQKEILEKVPES 86
|
90 100 110
....*....|....*....|....*....|....*..
gi 517718121 592 --CSVCNGCFkaMRIlSTRVAAERGIPYIVTGLSRGQ 626
Cdd:cd01712 87 yrIVLMRRMM--YRI-AEKIAERLGADALVTGESLGQ 120
|
|
| PRK07867 |
PRK07867 |
acyl-CoA synthetase; Validated |
18-168 |
1.54e-05 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236120 [Multi-domain] Cd Length: 529 Bit Score: 49.29 E-value: 1.54e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 18 ERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYD-HIGILMqDRCASIAAVIGILKLGG-VFVPLDPLHPDERLVTM 95
Cdd:PRK07867 18 DDRGLYFEDSFTSWREHIRGSAARAAALRARLDPTRPpHVGVLL-DNTPEFSLLLGAAALSGiVPVGLNPTRRGAALARD 96
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 517718121 96 LDTAEVSCLLCDDAQferAETLQGHEGKYFVLRA-----RQAMSVQAGSkEAYSHSANATDPIYIYFTSGSTGKPKAV 168
Cdd:PRK07867 97 IAHADCQLVLTESAH---AELLDGLDPGVRVINVdspawADELAAHRDA-EPPFRVADPDDLFMLIFTSGTSGDPKAV 170
|
|
| LC-FACS_euk |
cd05927 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are ... |
29-413 |
1.91e-05 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are eukaryotic fatty acid CoA synthetases that activate fatty acids with chain lengths of 12 to 20. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells.
Pssm-ID: 341250 [Multi-domain] Cd Length: 545 Bit Score: 49.14 E-value: 1.91e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 29 LSYKELDAESDRICELLHAHGA--AQYDHIGILMQDRCASIAAVIGILKLGGVFVPL-DPLHPdERLVTMLDTAEVSCLL 105
Cdd:cd05927 6 ISYKEVAERADNIGSALRSLGGkpAPASFVGIYSINRPEWIISELACYAYSLVTVPLyDTLGP-EAIEYILNHAEISIVF 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 106 CDDA----QFERAETLqghegkyfvlrarqamsvqaGSKEAYSHSANATDPIY-IYFTSGSTGKPKAVVGKNE---SLLH 177
Cdd:cd05927 85 CDAGvkvySLEEFEKL--------------------GKKNKVPPPPPKPEDLAtICYTSGTTGNPKGVMLTHGnivSNVA 144
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 178 FMNW---EASWLDLTD------PM-----RVSQLT------SIGF----DAVLRD--------IF--VPicaggticipe 223
Cdd:cd05927 145 GVFKileILNKINPTDvyisylPLahifeRVVEALflyhgaKIGFysgdIRLLLDdikalkptVFpgVP----------- 213
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 224 sreiildplRLVHWLeHSRVH-VVHCTPSLFRFI---------NHLS---LTADSYPD--------------LRYVLLAG 276
Cdd:cd05927 214 ---------RVLNRI-YDKIFnKVQAKGPLKRKLfnfalnyklAELRsgvVRASPFWDklvfnkikqalggnVRLMLTGS 283
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 277 ETIRPESLKNWYDNLGnrVRLVNLYGPTETTMIKLFypikpeDVHRESIP--IGRPLPDTSVYLLD--EQQQPVSGSE-A 351
Cdd:cd05927 284 APLSPEVLEFLRVALG--CPVLEGYGQTECTAGATL------TLPGDTSVghVGGPLPCAEVKLVDvpEMNYDAKDPNpR 355
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 517718121 352 GEICIATRYMTHGYFpsSHPDQTA--FipdpcrDQSGeimMYRTGDMGRWLPEGELALLGRKDN 413
Cdd:cd05927 356 GEVCIRGPNVFSGYY--KDPEKTAeaL------DEDG---WLHTGDIGEWLPNGTLKIIDRKKN 408
|
|
| A_NRPS_SidN3_like |
cd05918 |
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); ... |
809-846 |
1.94e-05 |
|
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family of siderophore-synthesizing NRPS includes the third adenylation domain of SidN from the endophytic fungus Neotyphodium lolii, ferrichrome siderophore synthetase, HC-toxin synthetase, and enniatin synthase. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341242 [Multi-domain] Cd Length: 481 Bit Score: 49.08 E-value: 1.94e-05
10 20 30
....*....|....*....|....*....|....*...
gi 517718121 809 QLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNAL 846
Cdd:cd05918 436 ELRSKLRQRLPSYMVPSVFLPLSHLPLTASGKIDRRAL 473
|
|
| PRK13391 |
PRK13391 |
acyl-CoA synthetase; Provisional |
28-170 |
4.31e-05 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 184022 [Multi-domain] Cd Length: 511 Bit Score: 47.76 E-value: 4.31e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 28 TLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDP-LHPDErLVTMLDTAEVSCLLC 106
Cdd:PRK13391 24 VVTYRELDERSNRLAHLFRSLGLKRGDHVAIFMENNLRYLEVCWAAERSGLYYTCVNShLTPAE-AAYIVDDSGARALIT 102
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 517718121 107 DDAQFERAETLQGHegkyfVLRARQAMSVQA-GSKEAYSHSANATD-----PI-------YIYFTSGSTGKPKAVVG 170
Cdd:PRK13391 103 SAAKLDVARALLKQ-----CPGVRHRLVLDGdGELEGFVGYAEAVAglpatPIadeslgtDMLYSSGTTGRPKGIKR 174
|
|
| PRK06155 |
PRK06155 |
crotonobetaine/carnitine-CoA ligase; Provisional |
9-169 |
5.26e-05 |
|
crotonobetaine/carnitine-CoA ligase; Provisional
Pssm-ID: 235719 [Multi-domain] Cd Length: 542 Bit Score: 47.45 E-value: 5.26e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVPLDPLHP 88
Cdd:PRK06155 27 LARQAERYPDRPLLVFGGTRWTYAEAARAAAAAAHALAAAGVKRGDRVALMCGNRIEFLDVFLGCAWLGAIAVPINTALR 106
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 89 DERLVTMLDTAEVSCLLCDDAQFERAETLQ------------GHEGKYFVLRARQAMSVQAGSKEAYSHSANATDPIYIY 156
Cdd:PRK06155 107 GPQLEHILRNSGARLLVVEAALLAALEAADpgdlplpavwllDAPASVSVPAGWSTAPLPPLDAPAPAAAVQPGDTAAIL 186
|
170
....*....|...
gi 517718121 157 FTSGSTGKPKAVV 169
Cdd:PRK06155 187 YTSGTTGPSKGVC 199
|
|
| Dph6 |
COG2102 |
Diphthamide synthase (EF-2-diphthine--ammonia ligase) [Translation, ribosomal structure and ... |
520-543 |
5.41e-05 |
|
Diphthamide synthase (EF-2-diphthine--ammonia ligase) [Translation, ribosomal structure and biogenesis];
Pssm-ID: 441705 Cd Length: 213 Bit Score: 45.88 E-value: 5.41e-05
10 20
....*....|....*....|....
gi 517718121 520 LLLYSGGKDSTYALYRLVEMGARV 543
Cdd:COG2102 2 VVSWSGGKDSALALYRALQEGYEV 25
|
|
| CTU1-like |
cd01713 |
cytoplasmic tRNA 2-thiolation protein 1 and similar proteins; This subfamily includes human ... |
524-621 |
6.56e-05 |
|
cytoplasmic tRNA 2-thiolation protein 1 and similar proteins; This subfamily includes human cytoplasmic tRNA 2-thiolation protein 1, also called cytosolic thiouridylase subunit 1 (CTU1), ATP-binding domain-containing protein 3 (ATPBD3), cancer-associated gene protein, or cytoplasmic tRNA adenylyltransferase 1. CTU1 plays a central role in 2-thiolation of mcm(5)S(2)U at tRNA wobble positions of tRNA(Lys), tRNA(Glu) and tRNA(Gln). It directly binds tRNAs and probably acts by catalyzing adenylation of tRNAs, an intermediate required for 2-thiolation. The CTU1-like subfamily belongs to the nucleotide alpha hydrolase (AANH) superfamily that includes N-type ATP PPases and ATP sulfurylases. It forms an alpha/beta/alpha fold which binds to the adenosine group.
Pssm-ID: 467486 Cd Length: 208 Bit Score: 45.66 E-value: 6.56e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 524 SGGKDST---YALYRLVE---MGARVLAYTFDNGyISsaAFRN--IDSVVK---ELGVDHIVGTFDgmlDIF-------- 584
Cdd:cd01713 26 SGGKDSTvllYVLKELNKrhdYGVELIAVTIDEG-IK--GYRDdsLEAARKlaeEYGIPLEIVSFE---DEFgftldeli 99
|
90 100 110
....*....|....*....|....*....|....*....
gi 517718121 585 --KEGLKQECSVCnGCFKaMRILStRVAAERGIPYIVTG 621
Cdd:cd01713 100 vgKGGKKNACTYC-GVFR-RRALN-RGARELGADKLATG 135
|
|
| LC_FACS_euk1 |
cd17639 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The ... |
269-428 |
7.09e-05 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The members of this family are eukaryotic fatty acid CoA synthetases (EC 6.2.1.3) that activate fatty acids with chain lengths of 12 to 20 and includes fungal proteins. They act on a wide range of long-chain saturated and unsaturated fatty acids, but the enzymes from different tissues show some variation in specificity. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. In Schizosaccharomyces pombe, lcf1 gene encodes a new fatty acyl-CoA synthetase that preferentially recognizes myristic acid as a substrate.
Pssm-ID: 341294 [Multi-domain] Cd Length: 507 Bit Score: 47.21 E-value: 7.09e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 269 LRYVLLAGETIRPESlKNWYDNLGNRVrlVNLYGPTETT--MIKLFypikPEDVhrESIPIGRPLPDTSVYLLDEQQ--- 343
Cdd:cd17639 252 LRYMLSGGAPLSADT-QEFLNIVLCPV--IQGYGLTETCagGTVQD----PGDL--ETGRVGPPLPCCEIKLVDWEEggy 322
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 344 QPVSGSEAGEICIATRYMTHGYFpsSHPDQT--AFIPDpcrdqsgeiMMYRTGDMGRWLPEGELALLGRKDNQVKIR-GN 420
Cdd:cd17639 323 STDKPPPRGEILIRGPNVFKGYY--KNPEKTkeAFDGD---------GWFHTGDIGEFHPDGTLKIIDRKKDLVKLQnGE 391
|
....*...
gi 517718121 421 RVELGDIE 428
Cdd:cd17639 392 YIALEKLE 399
|
|
| LarE-like |
cd01990 |
Lactate racemization operon protein LarE and similar proteins; This subfamily includes ... |
523-621 |
8.57e-05 |
|
Lactate racemization operon protein LarE and similar proteins; This subfamily includes Lactiplantibacillus plantarum LarE, a sacrificial sulfur insertase of the N-type ATP pyrophosphatase family. LarE is part of the lar operon, encoding five Lar proteins (LarA-E) that collaboratively synthesize and incorporate a niacin-derived Ni-containing cofactor into LarA, an Ni-dependent lactate racemase. It catalyzes successive thiolation reactions by donating the sulfur atom of their exclusive cysteine residues to the substrate. The LarE-like subfamily belongs to the nucleotide alpha hydrolase (AANH) superfamily that includes N-type ATP PPases and ATP sulfurylases. It forms an alpha/beta/alpha fold which binds to the adenosine group. Proteins from this subfamily probably binds ATP. This domain is about 200 amino acids long with a strongly conserved motif SGGxDS at the N-terminus.
Pssm-ID: 467494 [Multi-domain] Cd Length: 222 Bit Score: 45.33 E-value: 8.57e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 523 YSGGKDSTYALYRLVE-MGARVLAYTFDNGYISSAAFRNIDSVVKELGVDHIVGTFDGMLD-IFKEGLKQECSVCngcfK 600
Cdd:cd01990 6 FSGGVDSSLLAKLAKEvLGDNVVAVTADSPLVPREELEEAKRIAEEIGIRHEIIKTDELDDeEYVANDPDRCYHC----K 81
|
90 100
....*....|....*....|...
gi 517718121 601 AMrILST--RVAAERGIPYIVTG 621
Cdd:cd01990 82 KA-LYSTlkEIAKERGYDVVLDG 103
|
|
| PRK08349 |
PRK08349 |
hypothetical protein; Validated |
522-627 |
1.06e-04 |
|
hypothetical protein; Validated
Pssm-ID: 169396 Cd Length: 198 Bit Score: 44.73 E-value: 1.06e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 522 LYSGGKDSTYALYRLVEMGARVLAYTFDNGYISSAAFRNIDSVVKELGVD-----HIVGTFDGMLDIFkEGLKQECS--- 593
Cdd:PRK08349 6 LLSSGIDSPVAIYLMLRRGVEVYPVHFRQDEKKEEKVRELVERLQELHGGklkdpVVVDAFEEQGPVF-EKLRELKKekw 84
|
90 100 110
....*....|....*....|....*....|....
gi 517718121 594 VCNGCFKAMRILSTRVAAERGIPYIVTGLSRGQI 627
Cdd:PRK08349 85 TCIFCKYTMYRKAERIAHEIGASAIITGDSLGQV 118
|
|
| TilS |
COG0037 |
tRNA(Ile)-lysidine synthase TilS/MesJ [Translation, ribosomal structure and biogenesis]; tRNA ... |
514-621 |
1.13e-04 |
|
tRNA(Ile)-lysidine synthase TilS/MesJ [Translation, ribosomal structure and biogenesis]; tRNA(Ile)-lysidine synthase TilS/MesJ is part of the Pathway/BioSystem: tRNA modification
Pssm-ID: 439807 [Multi-domain] Cd Length: 235 Bit Score: 45.21 E-value: 1.13e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 514 QPSYDCLLLYSGGKDST---YALYRLV-EMGARVLAYTFDNGYISSAAF--RNIDSVVKELGVDHIVGTFDGMLDIFKEG 587
Cdd:COG0037 13 EPGDRILVAVSGGKDSLallHLLAKLRrRLGFELVAVHVDHGLREESDEdaEFVAELCEELGIPLHVVRVDVPAIAKKEG 92
|
90 100 110
....*....|....*....|....*....|....*...
gi 517718121 588 LkqecSVCNGC----FKAMRilstRVAAERGIPYIVTG 621
Cdd:COG0037 93 K----SPEAAArrarYGALY----ELARELGADKIATG 122
|
|
| PRK08162 |
PRK08162 |
acyl-CoA synthetase; Validated |
9-169 |
1.41e-04 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236169 [Multi-domain] Cd Length: 545 Bit Score: 46.09 E-value: 1.41e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 9 LARAFAAFPERKAIECGQQTLSYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVF----VPLD 84
Cdd:PRK08162 24 LERAAEVYPDRPAVIHGDRRRTWAETYARCRRLASALARRGIGRGDTVAVLLPNIPAMVEAHFGVPMAGAVLntlnTRLD 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 85 PlhpdERLVTMLDTAEVSCLLCD-------------------------DAQFERAETLQGHEGKYFVlrarqamsvQAGS 139
Cdd:PRK08162 104 A----ASIAFMLRHGEAKVLIVDtefaevarealallpgpkplvidvdDPEYPGGRFIGALDYEAFL---------ASGD 170
|
170 180 190
....*....|....*....|....*....|.
gi 517718121 140 KE-AYSHSANATDPIYIYFTSGSTGKPKAVV 169
Cdd:PRK08162 171 PDfAWTLPADEWDAIALNYTSGTTGNPKGVV 201
|
|
| entE |
PRK10946 |
(2,3-dihydroxybenzoyl)adenylate synthase; |
328-431 |
1.43e-04 |
|
(2,3-dihydroxybenzoyl)adenylate synthase;
Pssm-ID: 236803 [Multi-domain] Cd Length: 536 Bit Score: 46.14 E-value: 1.43e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 328 GRPL-PDTSVYLLDEQQQPVSGSEAGEicIATR--YMTHGYFPSSHPDQTAFipdpcrDQSGeimMYRTGDMGRWLPEGE 404
Cdd:PRK10946 356 GRPMsPDDEVWVADADGNPLPQGEVGR--LMTRgpYTFRGYYKSPQHNASAF------DANG---FYCSGDLVSIDPDGY 424
|
90 100
....*....|....*....|....*..
gi 517718121 405 LALLGRKDNQVKIRGNRVELGDIEHRL 431
Cdd:PRK10946 425 ITVVGREKDQINRGGEKIAAEEIENLL 451
|
|
| PLN02614 |
PLN02614 |
long-chain acyl-CoA synthetase |
327-509 |
1.44e-04 |
|
long-chain acyl-CoA synthetase
Pssm-ID: 166255 [Multi-domain] Cd Length: 666 Bit Score: 46.17 E-value: 1.44e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 327 IGRPLPDTSVYL--LDEQQQPVSGSEA-GEICIATRYMTHGYFPSSHPDQTAFIPDpcrdqsgeimMYRTGDMGRWLPEG 403
Cdd:PLN02614 441 VGPPVPNVDIRLesVPEMEYDALASTPrGEICIRGKTLFSGYYKREDLTKEVLIDG----------WLHTGDVGEWQPNG 510
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 404 ELALLGRKDNQVKI-RGNRVELGDIEHRLTNMAGIREAVVR-------MRAKADTPKGMAQQHCAACGLPSTYPGISFDD 475
Cdd:PLN02614 511 SMKIIDRKKNIFKLsQGEYVAVENIENIYGEVQAVDSVWVYgnsfesfLVAIANPNQQILERWAAENGVSGDYNALCQNE 590
|
170 180 190
....*....|....*....|....*....|....*
gi 517718121 476 MGKCSVCTgqEQYRSAAEQYFQGMEQLQS-KLQPV 509
Cdd:PLN02614 591 KAKEFILG--ELVKMAKEKKMKGFEIIKAiHLDPV 623
|
|
| A_NRPS_TlmIV_like |
cd12114 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including ... |
783-846 |
1.77e-04 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Streptoalloteichus tallysomycin biosynthesis genes; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the TLM biosynthetic gene cluster from Streptoalloteichus that consists of nine NRPS genes; the N-terminal module of TlmVI (NRPS-5) and the starter module of BlmVI (NRPS-5) are comprised of the acyl CoA ligase (AL) and acyl carrier protein (ACP)-like domains, which are thought to be involved in the biosynthesis of the beta-aminoalaninamide moiety.
Pssm-ID: 341279 [Multi-domain] Cd Length: 477 Bit Score: 45.72 E-value: 1.77e-04
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 517718121 783 VQLQVEEAQEPLLIAYYLADKMID-DEQLSVYLRR--FLPDYMIPARFIRLDKMPLTPNGKLDYNAL 846
Cdd:cd12114 411 VVVVLGDPGGKRLAAFVVPDNDGTpIAPDALRAFLaqTLPAYMIPSRVIALEALPLTANGKVDRAAL 477
|
|
| QueC |
pfam06508 |
Queuosine biosynthesis protein QueC; This family of proteins participate in the biosynthesis ... |
519-574 |
2.16e-04 |
|
Queuosine biosynthesis protein QueC; This family of proteins participate in the biosynthesis of 7-carboxy-7-deazaguanine. They catalyze the conversion of 7-deaza-7-carboxyguanine to preQ0.
Pssm-ID: 428982 [Multi-domain] Cd Length: 210 Bit Score: 44.15 E-value: 2.16e-04
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....*.
gi 517718121 519 CLLLYSGGKDSTYALYRLVEMGARVLAYTFDNGYISSAAFRNIDSVVKELGVDHIV 574
Cdd:pfam06508 2 AVVLLSGGLDSTTCLAWAKKEGYEVYALSFDYGQRHRKELECAKKIAKALGVEHKI 57
|
|
| PKS_PP |
smart00823 |
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the ... |
870-935 |
2.16e-04 |
|
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the prosthetic group of acyl carrier proteins (ACP) in some multienzyme complexes where it serves as a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups.
Pssm-ID: 214834 [Multi-domain] Cd Length: 86 Bit Score: 41.47 E-value: 2.16e-04
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 517718121 870 LLDIWTHILGI---KRISADDHFLQIGVHSLNIMTLIAQVYENFQVELPLEQVFEHDTLEEIAAYIDEQ 935
Cdd:smart00823 17 VREQVAAVLGHaaaEAIDPDRPFRDLGLDSLMAVELRNRLEAATGLRLPATLVFDHPTPAALAEHLAAE 85
|
|
| FACL_like_6 |
cd05922 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
795-846 |
4.15e-04 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341246 [Multi-domain] Cd Length: 457 Bit Score: 44.74 E-value: 4.15e-04
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|..
gi 517718121 795 LIAYYLADKMIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNAL 846
Cdd:cd05922 405 LALFVTAPDKIDPKDVLRSLAERLPPYKVPATVRVVDELPLTASGKVDYAAL 456
|
|
| PRK12492 |
PRK12492 |
long-chain-fatty-acid--CoA ligase; Provisional |
296-428 |
5.11e-04 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 171539 [Multi-domain] Cd Length: 562 Bit Score: 44.43 E-value: 5.11e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 296 RLVNLYGPTETTMIKlfyPIKPEDVHRESIPIGRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsSHPDQTA 375
Cdd:PRK12492 360 TIVEGYGLTETSPVA---STNPYGELARLGTVGIPVPGTALKVIDDDGNELPLGERGELCIKGPQVMKGYW--QQPEATA 434
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|...
gi 517718121 376 fipdPCRDQSGeimMYRTGDMGRWLPEGELALLGRKDNQVKIRGNRVELGDIE 428
Cdd:PRK12492 435 ----EALDAEG---WFKTGDIAVIDPDGFVRIVDRKKDLIIVSGFNVYPNEIE 480
|
|
| OSB_CoA_lg |
cd05912 |
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA ... |
796-846 |
5.64e-04 |
|
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA synthetase, or MenE); O-succinylbenzoic acid-CoA synthase catalyzes the coenzyme A (CoA)- and ATP-dependent conversion of o-succinylbenzoic acid to o-succinylbenzoyl-CoA. The reaction is the fourth step of the biosynthesis pathway of menaquinone (vitamin K2). In certain bacteria, menaquinone is used during fumarate reduction in anaerobic respiration. In cyanobacteria, the product of the menaquinone pathway is phylloquinone (2-methyl-3-phytyl-1,4-naphthoquinone), a molecule used exclusively as an electron transfer cofactor in Photosystem 1. In green sulfur bacteria and heliobacteria, menaquinones are used as loosely bound secondary electron acceptors in the photosynthetic reaction center.
Pssm-ID: 341238 [Multi-domain] Cd Length: 411 Bit Score: 43.87 E-value: 5.64e-04
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|.
gi 517718121 796 IAYYLADKMIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNAL 846
Cdd:cd05912 359 VAFVVSERPISEEELIAYCSEKLAKYKVPKKIYFVDELPRTASGKLLRHEL 409
|
|
| AANH-like |
cd01986 |
adenine nucleotide alpha hydrolase (AANH)-like proteins; This group of adenine nucleotide ... |
519-577 |
6.22e-04 |
|
adenine nucleotide alpha hydrolase (AANH)-like proteins; This group of adenine nucleotide alpha hydrolase (AANH)-like proteins includes N-type ATP PPases and ATP sulfurylases. The domain forms an alpha/beta/alpha fold which binds to adenosine nucleotide.
Pssm-ID: 467490 [Multi-domain] Cd Length: 74 Bit Score: 39.74 E-value: 6.22e-04
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 517718121 519 CLLLYSGGKDSTYALYRLVE--MGARVLAYTFDNGY--------ISSAAFRNIDSVVKELGVDHIVGTF 577
Cdd:cd01986 1 VVVGYSGGKDSSVALHLASRlgRKAEVAVVHIDHGIgfkeeaesVASIARRSILKKLAEKGARAIATGV 69
|
|
| ThiI |
pfam02568 |
Thiamine biosynthesis protein (ThiI); ThiI is required for thiazole synthesis, required for ... |
518-627 |
1.09e-03 |
|
Thiamine biosynthesis protein (ThiI); ThiI is required for thiazole synthesis, required for thiamine biosynthesis.
Pssm-ID: 280691 [Multi-domain] Cd Length: 197 Bit Score: 41.65 E-value: 1.09e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 518 DCLLLYSGGKDSTYALYRLVEMGARVLAYTFDNGYISSAAFRN----IDSVVKELGVDH----IVGTFDGMLDIFKEGL- 588
Cdd:pfam02568 5 KVLALISGGIDSPVAAYMMMRRGCRVVALHFINNPGTSAEAIGkvqkLAELLARYGTSHevrlVVFDFTDVQKEILEKAp 84
|
90 100 110 120
....*....|....*....|....*....|....*....|
gi 517718121 589 -KQECSVCNGCFkaMRILStRVAAERGIPYIVTGLSRGQI 627
Cdd:pfam02568 85 eGYRCVLLKRCM--YRIAE-KVAEEEGADALVTGESLGQV 121
|
|
| PRK07868 |
PRK07868 |
acyl-CoA synthetase; Validated |
30-120 |
1.22e-03 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236121 [Multi-domain] Cd Length: 994 Bit Score: 43.55 E-value: 1.22e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 30 SYKELDAESDRICELLHAHGAAQYDHIGILMQDRCASIAAVIGILKLGGVFVpldPLHPDERLVTMLDTAEVSCLLCDDA 109
Cdd:PRK07868 474 TYEAVNRRINNVVRGLIAVGVRQGDRVGVLMETRPSALVAIAALSRLGAVAV---LMPPDTDLAAAVRLGGVTEIITDPT 550
|
90
....*....|.
gi 517718121 110 QFERAETLQGH 120
Cdd:PRK07868 551 NLEAARQLPGR 561
|
|
| LC_FACS_bac |
cd05932 |
Bacterial long-chain fatty acid CoA synthetase (LC-FACS), including Marinobacter ... |
272-458 |
1.28e-03 |
|
Bacterial long-chain fatty acid CoA synthetase (LC-FACS), including Marinobacter hydrocarbonoclasticus isoprenoid Coenzyme A synthetase; The members of this family are bacterial long-chain fatty acid CoA synthetase. Marinobacter hydrocarbonoclasticus isoprenoid Coenzyme A synthetase in this family is involved in the synthesis of isoprenoid wax ester storage compounds when grown on phytol as the sole carbon source. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341255 [Multi-domain] Cd Length: 508 Bit Score: 43.23 E-value: 1.28e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 272 VLLAGETIRPESLKNWYDNLGnrVRLVNLYGPTETTMIK-LFYPIKpedvhRESIPIGRPLPDTSVYLldeqqqpvsgSE 350
Cdd:cd05932 279 LAGCGSAPVPPALLEWYRSLG--LNILEAYGMTENFAYShLNYPGR-----DKIGTVGNAGPGVEVRI----------SE 341
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 351 AGEICIATRYMTHGYFpsSHPDQTA--FIPDPcrdqsgeimMYRTGDMGRWLPEGELALLGR-KDNQVKIRGNRVELGDI 427
Cdd:cd05932 342 DGEILVRSPALMMGYY--KDPEATAeaFTADG---------FLRTGDKGELDADGNLTITGRvKDIFKTSKGKYVAPAPI 410
|
170 180 190
....*....|....*....|....*....|.
gi 517718121 428 EHRLTNMAGIrEAVVRMRAKADTPKGMAQQH 458
Cdd:cd05932 411 ENKLAEHDRV-EMVCVIGSGLPAPLALVVLS 440
|
|
| COG1365 |
COG1365 |
Predicted ATPase, PP-loop superfamily [General function prediction only]; |
523-625 |
1.41e-03 |
|
Predicted ATPase, PP-loop superfamily [General function prediction only];
Pssm-ID: 440976 Cd Length: 256 Bit Score: 41.96 E-value: 1.41e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 523 YSGGKDSTYALYRLVEMGARVLAYTFDNGYISSAAFR-NIDSVVKELGVDHIVGTFDgMLDIFKEGLKQECSVCNGCFKA 601
Cdd:COG1365 67 FSGGVDSSASLIIAKWIGFDVEAVTVKSTIILPQMFKkNIKELCKKLNVKHEFIEID-LGEIIEDALKGKFHPCGRCHSL 145
|
90 100
....*....|....*....|....*.
gi 517718121 602 MRILSTRVAAERGIPYIVTG--LSRG 625
Cdd:COG1365 146 IEEAVEDYAKKNGIKIVIFGdlLSVG 171
|
|
| PRK08315 |
PRK08315 |
AMP-binding domain protein; Validated |
4-168 |
1.55e-03 |
|
AMP-binding domain protein; Validated
Pssm-ID: 236236 [Multi-domain] Cd Length: 559 Bit Score: 42.88 E-value: 1.55e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 4 TIQYELARAFAAFPERKAI-ECGQQT-LSYKELDAESDRICELLHAHGAAQYDHIGI---------LMQDRCAsiaavig 72
Cdd:PRK08315 17 TIGQLLDRTAARYPDREALvYRDQGLrWTYREFNEEVDALAKGLLALGIEKGDRVGIwapnvpewvLTQFATA------- 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 73 ilKLGGVFVPLDPLHPDERLVTMLDTAEVSCLLCDDA-------------------------QFERAETL--------QG 119
Cdd:PRK08315 90 --KIGAILVTINPAYRLSELEYALNQSGCKALIAADGfkdsdyvamlyelapelatcepgqlQSARLPELrrviflgdEK 167
|
170 180 190 200 210
....*....|....*....|....*....|....*....|....*....|.
gi 517718121 120 HEGKYFV--LRARqAMSVQAGSKEAYSHSANATDPIYIYFTSGSTGKPKAV 168
Cdd:PRK08315 168 HPGMLNFdeLLAL-GRAVDDAELAARQATLDPDDPINIQYTSGTTGFPKGA 217
|
|
| PLN02387 |
PLN02387 |
long-chain-fatty-acid-CoA ligase family protein |
301-432 |
1.55e-03 |
|
long-chain-fatty-acid-CoA ligase family protein
Pssm-ID: 215217 [Multi-domain] Cd Length: 696 Bit Score: 42.80 E-value: 1.55e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 301 YGPTETTMIKLFYPIKPEDVHResipIGRPLPDTSVYLLDEQQQPVSGSEA----GEICIATRYMTHGYFPSSHPDQTAF 376
Cdd:PLN02387 452 YGLTETCAGATFSEWDDTSVGR----VGPPLPCCYVKLVSWEEGGYLISDKpmprGEIVIGGPSVTLGYFKNQEKTDEVY 527
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*..
gi 517718121 377 IPDpcrdQSGEIMMYrTGDMGRWLPEGELALLGRKDNQVKIR-GNRVELGDIEHRLT 432
Cdd:PLN02387 528 KVD----ERGMRWFY-TGDIGQFHPDGCLEIIDRKKDIVKLQhGEYVSLGKVEAALS 579
|
|
| PRK00174 |
PRK00174 |
acetyl-CoA synthetase; Provisional |
148-169 |
1.62e-03 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 234677 [Multi-domain] Cd Length: 637 Bit Score: 42.82 E-value: 1.62e-03
|
| PRK08576 |
PRK08576 |
hypothetical protein; Provisional |
491-588 |
2.96e-03 |
|
hypothetical protein; Provisional
Pssm-ID: 236300 [Multi-domain] Cd Length: 438 Bit Score: 41.60 E-value: 2.96e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 491 AAEQYFQGMEQLQSKLQPVEKEnqpsYDCLLLYSGGKDSTYALYRLVEMGARVLAYTFDNGYISSAAFRNIDSVVKELGV 570
Cdd:PRK08576 213 ANREVLEAFEKASIKFLRKFEE----WTVIVPWSGGKDSTAALLLAKKAFGDVTAVYVDTGYEMPLTDEYVEKVAEKLGV 288
|
90
....*....|....*...
gi 517718121 571 DHIVGTFDGMLDIFKEGL 588
Cdd:PRK08576 289 DLIRAGVDVPMPIEKYGM 306
|
|
| QueC-like |
cd01995 |
7-cyano-7-deazaguanine synthase QueC and similar proteins; 7-cyano-7-deazaguanine synthase (EC ... |
519-588 |
3.13e-03 |
|
7-cyano-7-deazaguanine synthase QueC and similar proteins; 7-cyano-7-deazaguanine synthase (EC 6.3.4.20) is also called 7-cyano-7-carbaguanine synthase, preQ(0) synthase, or queuosine biosynthesis protein QueC. It catalyzes the ATP-dependent conversion of 7-carboxy-7-deazaguanine (CDG) to 7-cyano-7-deazaguanine (preQ(0)), as part of the biosynthesis pathway of queuosine (Q). Q is one of the most complex modifications occurring at the wobble position of tRNAs with GUN anticodons, and is implicated in a number of biological activities, including accuracy of decoding, virulence, and cellular differentiation. This subfamily belongs to the adenine nucleotide alpha hydrolase (AANH) superfamily that also includes other N-type ATP PPases and ATP sulfurylases. It forms an alpha/beta/alpha fold which binds to the adenosine group.
Pssm-ID: 467499 [Multi-domain] Cd Length: 208 Bit Score: 40.67 E-value: 3.13e-03
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 517718121 519 CLLLYSGGKDSTYALYRLVEMGARVLAYTFDNGYISSA----AFRNIDsvvKELGVDHIVGTFDGMLDIFKEGL 588
Cdd:cd01995 3 AVVLLSGGLDSTTLLYWALKEGYEVHALTFDYGQRHAKeeleAAKLIA---KLLGIEHKVIDLSFLGELGGSSL 73
|
|
| mnmA |
PRK14665 |
tRNA-specific 2-thiouridylase MnmA; Provisional |
520-621 |
3.17e-03 |
|
tRNA-specific 2-thiouridylase MnmA; Provisional
Pssm-ID: 173128 [Multi-domain] Cd Length: 360 Bit Score: 41.46 E-value: 3.17e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 520 LLLYSGGKDSTYALYRLVEMGARVLAYTF-------DNGYISSAAfrnidSVVKELGVDHIvgTFDGMlDIFKEGLKQ-- 590
Cdd:PRK14665 9 LLGMSGGTDSSVAAMLLLEAGYEVTGVTFrfyefngSTEYLEDAR-----ALAERLGIGHI--TYDAR-KVFRKQIIDyf 80
|
90 100 110 120
....*....|....*....|....*....|....*....|..
gi 517718121 591 -----------ECSVCNGCFKAMriLSTRVAAERGIPYIVTG 621
Cdd:PRK14665 81 ideymsghtpvPCTLCNNYLKWP--LLAKIADEMGIFYLATG 120
|
|
| TIGR00364 |
TIGR00364 |
queuosine biosynthesis protein QueC; Members of this protein family are QueC, involved in ... |
519-574 |
3.80e-03 |
|
queuosine biosynthesis protein QueC; Members of this protein family are QueC, involved in synthesizing pre-Q0 from GTP en route to tRNA modification with queuosine. This protein family is represented by a single member in nearly every completed large (> 1000 genes) prokaryotic genome. In Rhizobium meliloti, the gene was designated exsB, possibly because of polar effects on exsA expression in a shared polycistronic mRNA. In Arthrobacter viscosus, the homologous gene was designated ALU1 and was associated with an aluminum tolerance phenotype. [Unknown function, General]
Pssm-ID: 129461 [Multi-domain] Cd Length: 201 Bit Score: 40.07 E-value: 3.80e-03
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....*.
gi 517718121 519 CLLLYSGGKDSTYALYRLVEMGARVLAYTFDNGYISSAAFRNIDSVVKELGVDHIV 574
Cdd:TIGR00364 1 AIVVLSGGQDSTTCLLWAKDEGYEVHAVTFDYGQRHSRELESARKIAEALGIEHHL 56
|
|
| FACL_fum10p_like |
cd05926 |
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL ... |
801-846 |
4.82e-03 |
|
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Fum10p is a fatty acid CoA ligase involved in the synthesis of fumonisin, a polyketide mycotoxin, in Gibberella moniliformis.
Pssm-ID: 341249 [Multi-domain] Cd Length: 493 Bit Score: 41.14 E-value: 4.82e-03
10 20 30 40
....*....|....*....|....*....|....*....|....*.
gi 517718121 801 ADKMIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNAL 846
Cdd:cd05926 446 EGASVTEEELRAFCRKHLAAFKVPKKVYFVDELPKTATGKIQRRKV 491
|
|
| PRK09192 |
PRK09192 |
fatty acyl-AMP ligase; |
328-428 |
5.15e-03 |
|
fatty acyl-AMP ligase;
Pssm-ID: 236403 [Multi-domain] Cd Length: 579 Bit Score: 41.14 E-value: 5.15e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 328 GRPLPDTSVYLLDEQQQPVSGSEAGEICIATRYMTHGYFpsshpdqtafipdpcRDQ-SGEIMM----YRTGDMGrWLPE 402
Cdd:PRK09192 388 GKALPGHEIEIRNEAGMPLPERVVGHICVRGPSLMSGYF---------------RDEeSQDVLAadgwLDTGDLG-YLLD 451
|
90 100
....*....|....*....|....*.
gi 517718121 403 GELALLGRKDNQVKIRGNRVELGDIE 428
Cdd:PRK09192 452 GYLYITGRAKDLIIINGRNIWPQDIE 477
|
|
| PRK07529 |
PRK07529 |
AMP-binding domain protein; Validated |
295-470 |
5.88e-03 |
|
AMP-binding domain protein; Validated
Pssm-ID: 236043 [Multi-domain] Cd Length: 632 Bit Score: 41.09 E-value: 5.88e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 295 VRLVNLYGPTETTMIKlfyPIKPEDVHRESIPIGRPLP--DTSVYLLDEQ---QQPVSGSEAGEICIATRYMTHGYFPSS 369
Cdd:PRK07529 359 VRIVEGYGLTEATCVS---SVNPPDGERRIGSVGLRLPyqRVRVVILDDAgryLRDCAVDEVGVLCIAGPNVFSGYLEAA 435
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 517718121 370 HpDQTAFIPDpcrdqsgeiMMYRTGDMGRWLPEGELALLGR-KDnqVKIRGNrvelgdieHrltNM--AGIREAVVRMra 446
Cdd:PRK07529 436 H-NKGLWLED---------GWLNTGDLGRIDADGYFWLTGRaKD--LIIRGG--------H---NIdpAAIEEALLRH-- 490
|
170 180
....*....|....*....|....
gi 517718121 447 kadtPkgmAQQHCAACGLPSTYPG 470
Cdd:PRK07529 491 ----P---AVALAAAVGRPDAHAG 507
|
|
| AMP-binding_C |
pfam13193 |
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to ... |
808-840 |
6.00e-03 |
|
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to pfam00501. It has a central beta sheet core that is flanked by alpha helices.
Pssm-ID: 463804 [Multi-domain] Cd Length: 76 Bit Score: 37.14 E-value: 6.00e-03
10 20 30
....*....|....*....|....*....|...
gi 517718121 808 EQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGK 840
Cdd:pfam13193 44 EELVAHVREELGPYAVPKEVVFVDELPKTRSGK 76
|
|
| OSB_MenE-like |
cd17630 |
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) ... |
795-846 |
6.87e-03 |
|
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) synthetase (also known as O-succinylbenzoic acid CoA ligase) that belongs to the ANL superfamily and catalyzes the ligation of CoA to o-succinylbenzoate (OSB). It includes MenE in the bacterial menaquinone biosynthesis pathway which is a promising target for the development of novel antibacterial agents. MenE catalyzes CoA ligation via an acyl-adenylate intermediate; tight-binding inhibitors of MenE based on stable acyl-sulfonyladenosine analogs of this intermediate provide a pathway toward the development of optimized MenE inhibitors.
Pssm-ID: 341285 [Multi-domain] Cd Length: 325 Bit Score: 40.39 E-value: 6.87e-03
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|..
gi 517718121 795 LIAYYLADKMIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLDYNAL 846
Cdd:cd17630 270 PVAVIVGRGPADPAELRAWLKDKLARFKLPKRIYPVPELPRTGGGKVDRRAL 321
|
|
| QueC |
COG0603 |
7-cyano-7-deazaguanine synthase (queuosine biosynthesis) [Translation, ribosomal structure and ... |
520-583 |
9.44e-03 |
|
7-cyano-7-deazaguanine synthase (queuosine biosynthesis) [Translation, ribosomal structure and biogenesis]; 7-cyano-7-deazaguanine synthase (queuosine biosynthesis) is part of the Pathway/BioSystem: tRNA modification
Pssm-ID: 440368 [Multi-domain] Cd Length: 223 Bit Score: 39.37 E-value: 9.44e-03
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 517718121 520 LLLYSGGKDSTYALYRLVEMGARVLAYTFDngY-------ISSAAfrnidSVVKELGV-DHIVGTFDGMLDI 583
Cdd:COG0603 6 VVLLSGGLDSTTCLAWALARGYEVYALSFD--YgqrhrkeLEAAR-----RIAKALGVgEHKVIDLDFLGEI 70
|
|
| AFD_YhfT-like |
cd17633 |
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, ... |
794-842 |
9.53e-03 |
|
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, as well as long-chain fatty acid-CoA ligase VraA, all of which are as yet to be characterized. These proteins belong to the adenylate-forming enzymes which catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain
Pssm-ID: 341288 [Multi-domain] Cd Length: 320 Bit Score: 39.70 E-value: 9.53e-03
10 20 30 40
....*....|....*....|....*....|....*....|....*....
gi 517718121 794 LLIAYYLADKmIDDEQLSVYLRRFLPDYMIPARFIRLDKMPLTPNGKLD 842
Cdd:cd17633 272 IAVALYSGDK-LTYKQLKRFLKQKLSRYEIPKKIIFVDSLPYTSSGKIA 319
|
|
|